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Marı́a Costanza Jara-Sep úlveda, Leopoldo Parada-Pozas and Ricardo Cartes-Velásquez
Coupling between Osseointegration and Mechanotransduction to Maintain Foreign 
Body Equilibrium in the Long-Term: A Comprehensive Overview




Tomas Albrektsson started working together with p-I Brånemark in the development of
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Preface to “Osseointegrated Oral implants” 
Osseointegrated Oral Implants: Mechanisms of Implant Anchorage, Threats and Long 
Term Survival Rate 
Osseointegrated oral implants were first used clinically in 1965 at the Gothenburg 
University of Sweden, and then only in small numbers. There, the original osseointegration 
team, of which I was a participant, worked clinically and experimentally under the leadership 
of P-I Branemark to test osseointegration principles not only in the oral cavity but also as 
craniofacial and orthopedic implants [1–7]. Other pioneers of the early days were Willi Schulte 
of Tübingen University, Germany, and André Schroeder of Bern University, Switzerland, who 
published their first papers on bone-anchored oral implants in 1976, in all probability without 
knowing about Brånemark´s earlier work [8,9]. These three University-employed innovators 
became the fathers of the most used oral implant systems of our day—the Nobel, the Dentsply 
and the Straumann implants. 
The present volume represents the state-of-the-art in oral implants today. Some 
interpretations may be too old and others too untested to survive the scrutiny of time. However, 
this is how scientific ideas usually develop. The pioneering team behind osseointegration was 
convinced that titanium was inert and that its incorporation in bone simulated a simple wound 
healing phenomenon [2,10], hypotheses that today are recognized as being incorrect. 
Nevertheless, the very good clinical results achieved with moderately rough osseointegrated 
oral implants with a 10 year survival rate in the range of 96–99% [11] meant that other 
hypotheses could be verified, despite some errors in interpretations. We learned countless 
lessons from the early work behind modern oral implants. In a similar manner, I personally 
consider those who believe marginal bone loss around oral implants to be solely dependent on 
bacteria to be on the wrong track, which does not preclude the future value of some of the 
findings of this research.  
New valuable findings on osseointegration include a most interesting paper by Chen et 
al. [12], who present evidence that a novel type of osteotomy may preserve implant site viability 
by using a very low drill speed with the potential advantage of minimal tissue violence. Han et 
al. [13] present an in vitro study using 3D printed carbon fiber reinforced PEEK material that, in 
the future, may provide possibilities for applications in oral implantology, on the condition that 
the in vitro findings of the biocompatibility of this material can be supported by in vivo 
analyses. An animal study by Choi et al. [14] evaluates osteogenic cell behavior in a new 
manner by using ultrastructural techniques and immune flourescence analyses during the first 
10 days after implant placement. The notion that oral implants must be rounded bodies 
belonged to our old convictions. In this volume, we learn about the potential advantages of 
changing the implant design to a tri-oval one. Implants with this design displayed significantly 
enhanced implant stability in the bone when tested in animal studies [15]. 
 Zipprich et al. [16] point out that the insertion of ceramic implants may cause more 
interfacial heat than the placement of titanium implants, indicative of the need to use a very 
slow drill speed with the ceramic devices. Stocchero et al. [17) analyze intraosseous 
temperatures when performing undersized drilling and report a negative impact on the bone 
some distance away from the implant. Duddeck et al. [18] demonstrate that our commercially 
available oral implants may be contaminated, perhaps having an effect on clinical outcomes. 
xii 
The effects of a novel type of electrolytical cleaning technique for implant surfaces 
decontaminated by biofilms is presented in two papers [19,20]. It proved possible not only to 
clean away the biofilm in vitro but also to re-establish osseointegration of a previously infected 
implant in a dog model. To the knowledge of the editor this is the first time we have seen 
evidence of re-osseointegration under such circumstances. 
Three papers test potential improvements of osseointegrated implants in clinical settings. 
Lombardi et al. [21] evaluate factors that influence marginal bone loss during the first year after 
implantation, a time when most clinical scientists do not talk about peri-implantitis but, instead, 
of bone remodeling. Greater initial marginal bone loss was seen with deep insertion protocols, 
thin peri-implant mucosa and short abutments. Marconcini et al. [22] describe the tapered 
abutments that were found to result in minimal marginal bone loss in a one year retrospective 
study. Doornewaard et al. [23] present a three year prospective study of implant-supported 
mandibular overdentures in a split mouth model. The equicrestal implant placement was 
reported to yield significantly higher implant surface exposure.  
Threats to osseointegration include marginal bone loss that, if continuous, may result in 
clinical failure. Currently, the most quoted reason for such unwanted marginal bone loss is 
what some investigators call peri-implantitis, allegedly behind all marginal bone loss after the 
first year of implantation. Schlee et al. [24] analyze their previously described electrolytical 
cleaning method and suggest that 100 million oral implants around the world may be infected 
and threatened by failure. I judge this great number of implants suffering from risk of failure to 
be unrealistic and rather based on unsuitable criteria for disease. However, the potential for re-
osseointegration in case of marginal bone loss may, nevertheless, be of substantial aesthetical 
importance. The electrolytical cleaning technique was not improved by simultaneous 
mechanical cleaning based on a 6 month randomized study [24]. Monje and co-workers [25] 
describe the peri-implantitis site-specific entity and present a traditional overview of 
predisposing factors for ailment. As previously indicated, I do not personally believe that 
implants and teeth are the same [26], nor do I agree with all bacterial interpretations of these 
papers. An overly strong immune reaction may likewise lead to marginal bone resorption. 
Having said so, bacterial attacks may follow secondary to strong immune reactions. Certainly, 
time will tell more about the right and wrong than our present reasoning. 
The last part of this book is centered on immunological findings of osseointegrated 
implants, discussed in 8 different papers. Menini et al. [27] present a follow up of a previously 
published paper [28] that claimed plaque causes inflammation but not marginal bone loss. In 
the new paper, they demonstrate that some specific mRNA signatures appear to protect from 
bone resorption despite plaque accumulation. Coli and Sennerby [29] question the use of tests 
like probing depth and bleeding on probing that have been taken over from periodontology, 
but never independently assessed with respect to oral implants. Reinedahl et al. [30,31] 
demonstrate significant immune reactions to ligatures around titanium implants. Marginal 
bone resorption was demonstrated despite lack of implant plaque and all implants having been 
placed in a bacteria free environment in the tibia of research animals. These strong and adverse 
immune reactions to the implant/ligature compound caused marginal bone loss due to the 
immune system control of the osteoblast/osteoclast balance, thereby contradicting hundreds of 
previously published papers suggesting a direct bacterial attack due to the ligatures. Bacterial 
attacks in such cases may largely represent a secondary phenomenon only. 
xiii 
Trindade et al. [32], in a previous experimental publication, demonstrated that titanium 
gives rise to immune reactions. In two separate papers, Trindade et al. [33,34] confirm these 
observations, but the authors notice an even stronger immune reaction to materials such as 
copper and PEEK at 28 days of follow up in an in vivo study. It seems that the body accepts 
mild immune reactions, like those emanating from titanium implants, and reacts either by 
preventing osseointegration, like in the case of copper and PEEK, or resulting in marginal bone 
loss around already integrated implants if provoked by very strong/imbalanced immune 
reactions [35]. Christiansen et al. [36] examine marginal bone loss in total hip replacement cases 
and report a significantly different cytokine profile compared to the situation without bone loss, 
suggesting an association with innate and adaptive immunity. Naveau et al. [37] point out that 
osseointegration is a foreign body reaction, indicative of an immune response to oral implants 
in the normal clinical situation. Amengual-Peñafiel et al. [38] agree with these observations and 
refer to the functioning oral implant as being in a state of foreign body equilibrium. This is a 
new way to look at an oral implant that is in opposition both with the notion that titanium is 
inert and, further, with those who see titanium implants as similar to teeth 
All in all, this book contains a collection of research that clearly increases our knowledge 
of osseointegration. The papers in this book will be repeatedly quoted and serve as inspiration 
for further research efforts in our discipline of oral implantology. 
Gothenburg, Sweden June 10th, 2020 
Tomas Albrektsson Professor emeritus of Dept of Biomaterials, University of Gothenburg, 
Sweden 
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Abstract: The preservation of bone viability at an osteotomy site is a critical variable for subsequent
implant osseointegration. Recent biomechanical studies evaluating the consequences of site
preparation led us to rethink the design of bone-cutting drills, especially those intended for implant
site preparation. We present here a novel drill design that is designed to efficiently cut bone at a
very low rotational velocity, obviating the need for irrigation as a coolant. The low-speed cutting
produces little heat and, consequently, osteocyte viability is maintained. The lack of irrigation,
coupled with the unique design of the cutting flutes, channels into the osteotomy autologous bone
chips and osseous coagulum that have inherent osteogenic potential. Collectively, these features result
in robust, new bone formation at rates significantly faster than those observed with conventional
drilling protocols. These preclinical data have practical implications for the clinical preparation of
osteotomies and alveolar bone reconstructive surgeries.
Keywords: osteogenesis; osteotomy; bone healing; bone chips; drilling tool design
1. Introduction
The medical and dental professions, with few exceptions, adapted commercially available tools
for use that were developed for drilling other materials [1]. For example, bone-cutting tools, which are
largely predicated on the design of metal-cutting instruments. Metal drills are end-cutting tools, e.g.,
only the tip of the drill is engaged in producing a hole, and the same is true for the vast majority of
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bone-cutting drills [2]. Metal drills and most bone drills are also designed to cut at a high rotational
velocity, which means that the drill can be advanced with minimal axial thrust force [3]. Metal and
bone drills generally have a relatively small rake angle, which means that particles generated by
cutting are typically scattered from the site to avoid obstructing the drill. Metal drilling typically
requires a lubricant that serves as a coolant [4]; in bone cutting, these functions are replaced by saline
irrigation [5].
We studied the biological responses to osteotomy site preparation in multiple animal species [6–9]
including humans [10], and these analyses, coupled with computational and finite element
modeling [5], prompted us to reconsider the design of a bone-cutting tool, optimized for osteotomy site
preparation. The resulting tool, called the OsseoShaper, is designed to limit osteocyte death caused by
mechanical and thermal damage, and simultaneously retain osseous coagulum/bone chips generated
by bone cutting. For this study, cutting tools were downscaled to accommodate the smaller size of
the rat maxillae; however, the ratio of cutting-tool diameter and bone surface area was representative
of what is used clinically. The purpose of this study was then to compare osteotomies produced by a
downscaled OsseoShaper versus a conventional drill in terms of heat generation, osteocyte viability,
bone remodeling, and onset of new bone formation.
2. Materials and Methods
2.1. Animals and Experimental Plan
Stanford APLAC approved all procedures (#13146), which conform to ARRIVE guidelines. In total,
18 female Wistar rats (Charles River Laboratories) were used in this study. All animals underwent
ovariectomy (OVX) and bilateral maxillary first molar (M1) extraction when they were seven weeks
old. Animals were then maintained for eight weeks, during which time the osteoporotic phenotype
developed [11,12] and the extraction socket completed its healing [9]. All animals were then subjected
to bilateral osteotomy site preparation in the healed M1 location. Animals were sacrificed at intervals of
0.5 days, three days, and seven days. Before surgery, general anesthesia was reached via intraperitoneal
injection of ketamine (100 mg/kg) (Vedco, Inc., St. Joseph, MO, USA) and xylazine (10 mg/kg) (Akorn,
Inc., Lake Forest, IL, USA), while analgesia was reached via subcutaneous injection of Buprenorphine
SR (0.5 mg/kg). After surgery, rats recovered in a controlled, 37 ◦C environment, fed a soft food diet for
the duration of the experiment and housed in groups of two. Weight changes were <10%. No adverse
events (e.g., uncontrolled pain, infection, prolonged inflammation) were encountered.
2.2. Ovariectomy and Tooth Extraction
To align our experimental model with the average patient receiving a dental implant, e.g.,
>50 years old [13], seven-week-old female rats underwent OVX [14]. This produced in our animal
model an osteopenic/osteoporotic phenotype, which is representative of patients over 50 years
of age [15]. In brief, a dorsal midline incision was made between the mid-back and tail base.
The peritoneal cavity was accessed through bilateral muscle layer incisions, the ovary was identified,
and the connection between the fallopian tube and the uterine horn was suture-ligated. After bilateral
removal of the ovaries, the wounds were closed layer by layer.
In parallel with the OVX, bilateral maxillary first molars (M1) were extracted. This further aligned
our experimental model with patients, in which the majority of dental implants are placed in healed
extraction sites [16]. In brief, micro-forceps were used to loosen and remove the tooth in toto. Bleeding
was controlled by local compression. Healing of the extraction site was confirmed using histology and
micro-computed tomographic (μCT) imaging. By post-extraction day 21 (PED21), the extraction site
was fully healed, as shown by the fact that the bone volume/total volume (BV/TV) of the extraction
site was equivalent to adjacent, pristine bone [10].
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2.3. Osteotomy Site Preparation
To directly compare two surgical drilling tools for their ability to maintain osteotomy site viability,
rats were anesthetized before a full thickness periosteal flap was elevated at the M1 tooth extraction site.
A handpiece (KaVo Dental, Uxbridge, UK) with saline irrigation was used to produce a pilot 1.0-mm
drill hole, followed by step-wise enlargement using progressively larger drill diameters (Table 1).
In the OsseoShaper protocol, the same type of pilot drill was used to produce a pilot osteotomy;
thereafter, a downscaled prototype of the OsseoShaper was used to enlarge the osteotomy to the same
final maximum diameter as was achieved with the conventional surgical drill protocol. The mini
OsseoShaper was used without irrigation. Drill speeds were adjusted to result in the same radial
velocity for all drills and to compensate for slightly different diameters. Each osteotomy was made
with a new drill. After osteotomy, tension-free primary closure of the periosteal flap was achieved
using tissue glue (VetClose, Henry Schein, Dublin, OH, USA).
Table 1. Surgical drill parameters.
Company External Diameter Product Identifier
OsteoMed 1.0 mm 220-0065
OsteoMed 1.3 mm 220-0064
OsteoMed 1.6 mm 220-0116
Downscaled prototype of the
OsseoShaper
1.0 mm (apex)
1.6 mm (crest) Non-commercial prototype
2.4. Tissue Collection and Processing
Tissues were collected at post-osteotomy day (POD) 0.5 to evaluate micro-damage and
programmed cell death caused by surgical drilling, as well as at POD3 and POD7, when new bone
formation is initiated [7]. In brief, animals were euthanized; then, the entire maxillae were dissected free
from other tissues and transferred to 4% paraformaldehyde (PFA) and stored at 4 ◦C overnight. After
fixation, samples were decalcified in ethylenediaminetetraacetic acid (EDTA), embedded in paraffin,
and sectioned at an 8-μm thickness for analyses. Tissue sections were deparaffinized in Citrisolv
(Decon Labs, Inc., King of Prussia, PA, USA) and hydrated via a series of decreasing concentrations of
ethanol before staining or other histological/cellular activity analyses.
2.5. Histology
For aniline blue staining, sections were treated with a saturated solution of picric acid followed
by a 5% phosphotungstic acid solution and staining in 1% aniline blue. Slides were then dehydrated
and mounted using Permount (Fisher Scientific, Hampton, NH, USA). For pentachrome staining,
sections were pre-treated with 6% nitric acid and stained with toluidine blue solution for 5 min (0.5 g
toluidine blue in 100 mL of distilled water at pH 1 to 1.5, adjusted with 0.5% HCl). Picrosirius red
staining [17] was used to detect collagenous osteoid matrix. Tissues were stained with picrosirius red
then viewed under polarized light. Tightly aligned fibrillary collagen molecules appear red compared
to less organized collagen fibrils that show a color of shorter (green–yellow) wavelengths.
2.6. Quantification of Programmed Cell Death
Terminal deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick end labeling
(TUNEL) staining (Roche Diagnostics GmbH, Mannheim, Germany) was performed according to
the manufacturers’ guidelines. Following deparaffinization and rehydration, paraffin sections were
stained by incubating slides in permeabilization solution for 8 min, adding TUNEL reaction mixture,
then incubating at 37 ◦C in the dark. Between these steps, paraffin sections were washed with
phosphate-buffered saline (PBS). To quantify the extent of apoptotic osteocytes, TUNEL-stained tissue
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sections from 4–6 different samples were analyzed. Each section was photographed using a Leica
digital image system at 20× magnification. The number of TUNEL-labeled osteocytes corresponding
to apoptotic cells was determined, and the cells grouped according to their distance from the cut edge.
The corresponding area for each group was then calculated. The number of apoptotic cells per unit
area was calculated by dividing the number of apoptotic cells to the corresponding area (cell/mm2).
2.7. Tartrate-Resistant Acid Phosphatase (TRAP) Activity
Identification of osteoclasts was done using TRAP staining. TRAP activity was observed using
a leukocyte acid phosphatase staining kit (catalog #386A-1KT, Sigma-Aldrich, St. Louis, MO, USA).
Tissue sections were processed according to the manufacturer’s instructions. To quantify the TRAP
activity, TRAP-stained tissue sections were photographed using a Leica digital image system at 10×
magnification. The TRAP+ve area corresponding to osteoclasts was determined within the radial zone
extending 300 μm from the cutting edge. The TRAP+ve ratio was calculated by dividing the TRAP+ve
pixels by the total pixels of the region of interest.
2.8. Immunostaining
To localize, within the osteotomies, cells that had initiated differentiation down an osteogenic
lineage, immunostaining was performed using standard procedures [18]. In brief, following
deparaffinization, endogenous peroxidase activity was quenched by 3% hydrogen peroxide for
5 min, and then washed in PBS. Slides were blocked with 5% goat serum (Vector S-1000) for 1 h
at room temperature. The appropriate primary antibody was added and incubated overnight at 4 ◦C,
then washed in PBS. The primary antibodies used in this study were Osterix (1:1200; ab22552, Abcam,
Cambridge, MA, USA) and Cathepsin K (1:200; ab19027, Abcam, Cambridge, MA, USA). Samples were
incubated with appropriate biotinylated secondary antibodies (Vector BA-x) for 30 min, then washed
in PBS. An avidin/biotinylated enzyme complex (Kit ABC Peroxidase Standard Vectastain PK-4000,
Vectorlabs, Burlingame, CA, USA) was added and incubated for 30 min, and a 3,3′-diaminobenzidine
(DAB) substrate kit (Kit Vector Peroxidase substrate DAB SK-4100, Vectorlabs, Burlingame, CA, USA)
was used to develop the color reaction. Phalloidin immunostaining was performed using Palloidin
Control, DyLight 488 conjugate (1:300; PI21833, Invitrogen, Grand Island, NY, USA).
2.9. Histomorphometric Analyses
Histomorphometric measurements were performed using ImageJ software v.1.51 (NIH, Bethesda,
MD, USA). To quantify the amount of new bone formation in the osteotomy site as a function of time,
a minimum of four osteotomy sites were analyzed. For each osteotomy site, a minimum of six aniline
blue-stained histologic sections that spanned the distance from the furcation to the apex were used to
quantify new bone formation. Each section was photographed using a Leica digital image system at
20× magnification. To calculate the percentage of new bone formation, the number of aniline blue+ve
pixels within an osteotomy was measured and divided by the number of the total pixels in the same
osteotomy area.
2.10. Micro-Computed Tomography (μCT)
Scanning and analyses followed published guidelines [19]. Three-dimensional μCT imaging was
performed at various times after surgery. In brief, samples were fixed in 4% PFA at 4 ◦C overnight.
Then, they were transferred to 70% ethanol solution for μCT scanning before the decalcification process.
A μCT tomography data-acquisition system (VivaCT 40, Scanco, Brüttisellen, Switzerland) at 10.5-μm
voxel size (70 kV, 115 μA, 300 ms of integration time) was used for scanning and reconstruction. Bone
morphometry was performed using the acquisition system’s analysis software (Scanco). Multiplanar
reconstruction and volume rendering were carried out using Avizo (FEI, Hillsboro, OR, USA) and
ImageJ v1.51 (NIH, Bethesda, MD, USA) software, before being imported into Adobe Photoshop and
Illustrator (CC2017, Adobe, San Jose, CA, USA).
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2.11. Calculation of Osteotomy Surface Roughness
To calculate the irregularity of the osteotomy walls, the Shape Filter plugin for ImageJ was
employed [20]. Ten transverse sections were used to outline the contours of osteotomies using ImageJ.
The contours were then converted to black-and-white images, and the plugin was used to obtain
the convexity and solidity values. Convexity measured the surface roughness of a two-dimensional
(2D) shape and was defined as H/P, where H was the perimeter of convex hull of the shape, and P
was the perimeter of the contour. Solidity was defined as C/A, where C was the area occupied
by the contour, and A was the area occupied by the convex hull of the contour. The perimeter of
the contour was defined as the total length of the shape’s perimeter. Shapes such as a square have
equal lengths of convex hulls and perimeter of the contours, which results in a convexity = 1. A star,
however, has a pentagon convex hull (consider the shape when surrounded by a rubber band) while
the perimeter of the contour is the star shape itself. Since the perimeter of the star contour (P) is larger
than the convex hull (H), its convexity (H/P) is <1 and, therefore, its surface is rougher compared to a
same-sized pentagon.
2.12. Heat Transfer During Drilling
The temperature produced when cutting with a conventional protocol involving multiple drills
was compared to site preparation with the mini OsseoShaper. Sawbones 35 (Pacific Research
Laboratory, Vashon Island, DC, USA) was used. Drills and drilling protocols used are as listed
in Table 1. Thermal radiation was measured immediately after drilling via an infrared camera (SEEK
CompactPRO, Seek Thermal Application, Santa Barbara, CA, USA). The drilling protocol was repeated
six times in new Sawbones. Means and standard deviations were reported.
The temperature distribution during drilling was also calculated in MATLAB using a finite
difference method. Details of the heat transfer model are described in Reference [5]. The differences
between the conventional drill and mini OsseoShaper models can be summarized as follows: in the
conventional high-speed drilling, the heat flux was applied to the drill hole’s boundary where the tip
of the drill was located, and the tip was moved vertically. Below the drill tip, the value of the heat flux
was set to zero, and irrigation was applied above the drill tip. In the OsseoShaper low-speed drilling,
the heat flux was applied to the drill hole’s boundary at and above the tip due to the tapered shape of
the drill, such that the points of engagement between the drill and the bone increased over time as the
drill was moved vertically.
2.13. Statistical Analyses
Results were presented in the form of means ± standard deviations, with N equal to the number of
samples analyzed. Student’s t-tests were performed. Significance was set at p < 0.05, and all statistical
analyses were performed with SPSS software (IBM, Armonk, NY, USA).
3. Results
3.1. A New Surgical Drilling Tool That Cuts Efficiently at Very Low Speeds
Most osteotomies are produced through the stepwise enlargement of an initial pilot drill hole
with sequentially larger diameter drills [21], all coupled with the use of copious irrigation [22].
We recapitulated that clinical scenario in a rat model, by producing osteotomies using surgical drills
with progressively larger diameters. The final drill was 1.6 mm in diameter and was run at 1000 rpm
with irrigation (Figure 1A). In osteotomies produced with the downscaled prototype of OsseoShaper,
the same pilot drill hole was produced and then followed by a single drill, the OsseoShaper (Figure 1A).
The OsseoShaper was run at 50 rpm without irrigation.
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Figure 1. Osteotomy site preparation with OsseoShaper requires fewer steps and, unlike conventional
drills, produces a rough surface. (A) All osteotomy site preparations began with the use of a 1.0-mm
pilot drill run at 1600 rpm plus irrigation; afterward, the conventional osteotomy procedure used
a 1.3-mm drill (1250 rpm plus irrigation) followed by a 1.6-mm drill (1000 rpm plus irrigation).
The OsseoShaper protocol used the same 1.0-mm pilot drill at 1600 rpm plus irrigation, and was
then followed by the OsseoShaper run at 50 rpm without irrigation. Using a conventional drill (B)
in plexiglass demonstrates the shape and texture of a cut surfaces, and (C) in bone, μCT sections
illustrate the parallel walls of the osteotomy. (D) Picrosirius red staining of a representative transverse
tissue section demonstrates the resulting smooth cut surface. (E) Quantification of surface texture,
as expressed by convexity and solidity, resulting from a conventional drilling protocol. Using an
OsseoShaper (F) in plexiglass demonstrates a tapered shape with a threaded surface, (G) which is
validated by μCT imaging. (H) Picrosirius red staining of a representative transverse tissue section
demonstrates the textured cut surface and the retention of collagen containing osseous coagulum.
Solid and dotted lines show the edge of the osteotomy. Two asterisks indicate p < 0.01. Three asterisks
indicate p < 0.001. Scale bars (B,C,F,G) = 1 mm, and (D,H) = 200 μm. Abbreviations: ab, alveolar bone;
os, osteotomy.
A conventional surgical drill is designed to cut only at its tip, which produces a smooth-walled
osteotomy, visible both in plexiglass (Figure 1B) and μCT section of bone (Figure 1C). Analyses using
picrosirius red staining revealed, under polarized light, the collagen organization at the cut edge when
a conventional drill was employed (Figure 1D). Quantification of surface texture, as expressed by
convexity and solidity, resulting from a conventional drilling protocol demonstrated the smoother cut
edge (Figure 1E). By contrast, the OsseoShaper was designed with a cutting flute running its length;
this resulted in a heteromorphic, textured osteotomy surface, visible both in plexiglass (Figure 1F) and
in μCT (Figure 1G). Picrosirius red staining demonstrates the textured cut surface and the retention of
collagen containing osseous coagulum (Figure 1H).
3.2. The OsseoShaper Allows the Retention of Viable, Autologous Bone Chips in the Osteotomy
Conventional drills have a rake angle that ranges from 0 to approximately 5◦, the consequence of
which is the production of small (<30 μm) bone particles. In addition, conventional drills are typically
run at rotational velocities of 800 rpm or higher [23]. Finally, conventional drills are designed to rotate
in the same direction, regardless of whether they are being advanced or withdrawn from the osteotomy.
Collectively, these attributes result in minimal retention of particulate matter, as can be visualized
when cutting Sawbone in vitro (Figure 2A). Coupled with irrigation, the majority of bone debris is
typically removed from the osteotomy (Figure 2B).
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Figure 2. OsseoShaper-produced osteotomies retain more viable bone chips and osseous coagulum.
Gross view of a hole produced in 0.32 g/cc Sawbone prepared with (A) a conventional drilling
protocol versus (C) OsseoShaper. Representative transverse sections stained with aniline blue in the
osteotomy sites using (B) a conventional drilling protocol and (D) OsseoShaper protocol. Micro-CT
imaging of an osteotomy prepared with (E) a conventional drilling protocol versus (G) an OsseoShaper.
(F) Quantification of bone chips in the osteotomy by μCT imaging (N = 5). Representative tissue
sections of bone chips produced by the OsseoShaper using (H) 4′,6-diamidino-2-phenylindole (DAPI)
and (I) phalloidin staining. Intra-operative view of an osteotomy prepared with conventional drills
versus the OsseoShaper in rats (J,M), in mini-pigs (K,N), and in patients (L,O). Arrows indicate
the osteotomy. Small arrows in (D) indicate the osteoid matrix. Dotted lines show the edge of the
osteotomy. Asterisk indicates p < 0.05. Scale bars = 1 mm (A,C,J–O) and 200 μm (B,E). Abbreviations:
as indicated previously.
By comparison, the rake angle on a mini OsseoShaper produces osseous coagulum and relatively
large (~100 μm) bone chips; additionally, the OsseoShaper is designed to be reversed upon removal.
These features result in the collection of bone chips in the cutting flutes, which are then transferred
into the osteotomy while the tool is being withdrawn. These events can be visualized when cutting
Sawbone (Figure 2C), and upon histologic examination of the osteotomy using aniline blue staining to
detect osteoid matrix (Figure 2D).
Micro-CT imaging was used to quantify the volume of osseous coagulum and bone chips retained
in the osteotomy. These analyses verified that OsseoShaper osteotomies retained significantly more
osseous material than did conventionally prepared osteotomies (Figure 2E,F,G). A closer examination
of the bone chips produced by the OsseoShaper using 4′,6-diamidino-2-phenylindole (DAPI; to detect
viable cells) and phalloidin staining (to detect actin filaments) revealed that a subset of chips retained
viable osteocytes within the osseous matrix (Figure 2H) and that the majority of chips were surrounded
by viable cells (Figure 2I). Clinically, bone chips were only visible in the OsseoShaper-prepared
osteotomy sites; this aspect was consistent among species, including rats, mini-pigs, and humans
(Figure 2J–O).
3.3. The Mini OsseoShaper Preserves Peri-Implant Bone by Limiting Heat Transfer and Minimizing
Thermal Apoptosis
A zone of osteocyte death is produced by conventional drilling [6,7,10]. For example, cutting
at 1000 rpm with irrigation produced a ~250-μm-wide, circumferential distribution of TUNEL+ve,
apoptotic osteocytes (Figure 3A, quantified in C). By comparison, minimal osteocyte apoptosis was
detected after OsseoShaper site preparation (Figure 3B, quantified in C).
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Figure 3. The OsseoShaper generates less heat, which results in a smaller zone of cell death and
less tartrate-resistant acid phosphatase (TRAP)-mediated bone remodeling than conventional drills.
(A) Representative tissue section from an osteotomy prepared using standard drills, where terminal
deoxynucleotidyl transferase deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL)+ve cells are
apoptotic osteocytes. (B) Equivalent tissue section from an osteotomy prepared using the OsseoShaper,
where the majority of apoptotic cells are detected in the osseous coagulum. (C) Distribution of
TUNEL+ve cells as a function of distance from cut edge of osteotomy. Computational models were
used to map the distribution of heat in bone as a function of distance from the cut edge, in osteotomies
produced using (D) conventional drills and (E) using the OsseoShaper. (F) Calculated temperatures
in bone, expressed as a function of radial distance from conventional drills (dotted red line) and
from the OsseoShaper (blue line) (N = 6). (G) Representative transverse tissue section from an
osteotomy produced with conventional drills, analyzed on for TRAP activity on post-osteotomy day 7
(POD7). (H) TRAP activity on a representative transverse tissue section from an OsseoShaper-produced
osteotomy. (I) Quantification of TRAP+ve pixels/total pixels in the region of interest (ROI). A dotted
line is used to indicate the cut edge of the osteotomy. Asterisk indicates p < 0.05. Scale bars = 200 μm.
Abbreviations: as indicated previously.
A computational model was used to calculate peak temperatures produced by both types of
cutting tools, taking into account the speed at which the drills were run, the density of the bone being
cut, and, in the case of conventional drill protocols, the use of irrigation [5]. In the case of conventional
protocols, a peak temperature of ~80 ◦C was generated at the cut edge, despite the use of copious
irrigation (Figure 3D; quantified in F). Temperatures decreased as a function of distance from the cut
edge but nevertheless, temperatures were >40 ◦C within a ~150-μm circumferential zone (Figure 3A
and [6]).
By comparison, the mini OsseoShaper generated significantly lower (~40 ◦C) peak temperatures
(Figure 3E; quantified in F). Even without the use of irrigation, calculated temperatures immediately
adjacent to the cut edge remained in the physiologic range (Figure 3F), well below temperatures known
to cause osteocytes necrosis, i.e., 45 ◦C [24].
An in vitro method supported our conclusion that drilling with the mini OsseoShaper produced
less heat. Using Sawbones, site preparation was carried out following the same protocol as used for
the site preparation in the rat maxilla (Figure 1A) and, immediately thereafter, the temperature of
each drill was measured using an infrared camera (Figure S1, Supplementary Materials). The same
method was used to measure heat radiating from the mini OsseoShaper. In the conventional protocol,
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the heat radiating from conventional drills was significantly higher for each step compared to the heat
radiating from the mini OsseoShaper (Figure S1).
Osteocyte death is typically accompanied by peri-implant bone resorption [6,7]. In the case of
osteotomies produced with conventional drills, the osteoclast marker TRAP was detected throughout
the bone adjacent to the osteotomy edge, as well as in the osteotomy itself (Figure 3G). By contrast,
mini OsseoShaper osteotomies exhibited minimal TRAP-mediated bone resorption (Figure 3H).
The TRAP activity that was detected reflected new bone remodeling in the osteotomy (Figure 3H;
quantified in I).
3.4. In Mini OsseoShaper Osteotomies, New Bone Formation Is Accelerated
The OsseoShaper was designed to retain osseous coagulum, e.g., mineralized particles including
cortical and trabecular bone chips, blood, and stroma that have inherent osteogenic potential [25,26].
On POD3, evidence of this retained osseous coagulum was abundant; compared to conventionally
prepared osteotomies, those prepared with the mini OsseoShaper were filled with aniline blue+ve
osteoid matrix (compare Figure 4A,B). This matrix served as a nidus for new bone formation and
remodeling, as demonstrated by significantly higher Cathepsin K (Figure 4C,D; quantified in E) and
Osterix (Figure 4F,G) expression in the mini OsseoShaper osteotomies. By POD7, mini OsseoShaper
osteotomies were filled with new bone at a time point when conventionally prepared osteotomies had
not yet started to repair (Figure 4H,I; quantified in J).
Figure 4. OsseoShaper drilling protocol promotes alveolar bone healing. Representative transverse
tissue sections stained with aniline blue on post-osteotomy day 3 (POD3) following osteotomy site
preparation with (A) conventional drills versus (B) the Nobel OsseoShaper. Note the presence of
osseous coagulum in the osteotomy site prepared with the OsseoShaper. Adjacent tissue sections
immunostained with Cathepsin K in the osteotomy sites of (C) conventional drills versus (D) the Nobel
OsseoShaper. (E) Quantification of Cathepsin K+ve pixels/total pixels in the osteotomy site. Adjacent
tissue sections immunostained with Osterix in the osteotomy sites of (F) conventional drills versus
(G) the OsseoShaper. (H) Tissue sections stained with aniline blue show minimal new bone formation
in conventional drill group, while (I) osteotomies in the OsseoShaper group show more new bone
formation on POD7. (J) Quantification of aniline blue+ve pixels/total pixels in the osteotomy site.
Dotted lines show the edge of the osteotomy. One asterisk indicates p < 0.05. Two asterisks indicate
p < 0.01. Scale bars = 100 μm. Abbreviations: as indicated previously.
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4. Discussion
Most reconstructive surgeries involve the cutting and removal of bone tissue [27] and, ideally,
the goal is to resect a well-defined volume of bone and leave behind a cut edge that is favorable to early
cell attachment and matrix deposition [28,29]. Clinicians universally agree that the preservation of cell
viability is of utmost importance [30–32], and that high-speed rotating instruments can compromise
this viability because they create thermal and mechanical trauma [33–37]. Irrigation can reduce some
of the heat generated by high-speed rotatory surgical drills [22,38], but irrigation also removes bone
chips, connective tissue stroma, blood, and stem-cell populations, collectively referred to as osseous
coagulum, which have osteogenic potential [39–42].
The importance of preserving bone viability led to the development of a wide variety of new
cutting tools for bone [43]. For example, gas and solid-state lasers use linear thermal absorption to
ablate osteoid tissues and, while they are effective at removing the bone, they also generate heat and
consequently show many of the same detrimental effects as drilling [44,45]. Plasma ablation lasers
avoid some of these problems by creating energy pulses in very small (i.e., μm) zones that result in
very high (several thousand Kelvin) temperatures over a very short (picosecond) duration. The result
is limited thermal damage to the bone [46]; technical constraints, however, limit the use of these lasers
in most clinical practices [47].
The OsseoShaper was designed to efficiently cut bone at a low (<50 rpm) velocity. This low-speed
drilling results in less bone being cut per unit time and, therefore, less heat evolution per unit time
(Figure 3). Less heat generation by the OsseoShaper translates into less of a temperature rise in the
bone, which obviates the need for a coolant (Figure 3). The biological sequelae of lower heat generation
by the mini OsseoShaper was shown by analyses for osteocyte apoptosis and osteoclast activity;
because of the minimal temperature rise, few osteocytes underwent programmed cell death, which
translated into less peri-implant bone resorption (Figure 3). Clinicians are fully aware that a viable
osteotomy site is critical for new bone formation, and this point is perhaps best illustrated by the
extent to which surgeons will go to reduce heat produced by rotary cutting tools. Here, we show
that improved osteotomy site viability is indeed directly related to enhanced osteogenesis, which we
believe will logically translate into a faster osseointegration of an implant placed into such osteotomies.
4.1. A Unique Design That Enables Retention of Bone Chips and Osseous Coagulum in an Osteotomy Site
Most drills produce bone chips and osseous coagulum, which has inherent osteogenic material
that can stimulate new bone formation [25,26]. Most of this osteogenic material is flushed out of the
site by irrigation [25], which is required to cool conventional drills. The rake angle of the OsseoShaper
produces larger bone chips than conventional drilling protocols.
Most conventional drills rotate clockwise, whether advancing or withdrawing the tool and,
coupled with the high rotational velocity, effectively disperse the bone chips and osseous coagulum.
The OsseoShaper slowly rotates clockwise when advanced and is then reversed upon withdrawal;
this design feature effectively retains bone chips and osseous coagulum in the osteotomy site (Figure 2).
This feature was also visible in osteotomy site preparation performed in mini-pig and human
individuals (Figure 2). Historic studies demonstrated that such bone chips that remain in situ are
highly osteogenic [48].
Cutting flute placement affects the roughness of the osteotomy. Compared to the smooth-walled
osteotomies produced by conventional drills, osteotomies produced by the OsseoShaper are textured
(Figure 1). Some investigators speculated that a textured surface represents an optimal site for new bone
deposition because it mimics the bone surface left behind after osteoclast-mediated remodeling [49].
Clinicians recognize that a bone graft from a patient has osteogenic potential and, therefore,
a variety of methods were developed in an attempt to collect this autologous material [50]. Most, if not
all, of these collection methods necessitate removal of the autologous bone chips from the body and
storage ex vivo. In doing so, the bone graft material is potentially subjected to desiccation, temperature
changes, e.g., deviations from 37 ◦C, and bacterial contamination. Use of the OsseoShaper negates
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these concerns; bone chips remain in situ and, in doing so, their viability is likely to be enhanced
and/or preserved.
4.2. A Streamlined Protocol for Osteotomy Site Preparation
In conventional drilling protocols, a pilot hole is first produced; then, the osteotomy is gradually
enlarged through the use of progressively larger diameter drills. A pilot hole is also created before
use of the OsseoShaper, after which the final sized osteotomy is produced in a single step (Figure 1).
In conventional drilling protocols, the use of multiple drills increases the chance of deviating from
the intended axis of the osteotomy, which in turn impacts the axis of the implant placed into the
osteotomy [51]. By reducing the number of surgical drills required to produce the final osteotomy,
the alignment error is also effectively reduced [52], and subsequent implant placement will follow the
axis of the last drill.
5. Conclusions
In our study, we present a new drill design that is meant to efficiently cut bone at a very low
rotational speed, obviating the need for irrigation as a coolant and a lubricant. Osteocyte viability is
maintained by the low-speed cutting that produces little heat. Autologous bone chips are generated
and maintained on site thanks to the lack of irrigation, coupled with the unique design of the cutting
flutes. This osseous coagulum has inherent osteogenic capacities. Collectively, a robust formation
of new bone is observed with the new drill design, at rates significantly faster than those observed
with conventional drilling protocols. These data have practical applications for clinical implant site
preparation and alveolar bone reconstruction.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/8/2/170/s1,
Figure S1: Thermal radiation measurements of conventional and Osseoshaper protocols in Sawbones.
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Abstract: Fused deposition modeling (FDM) is a rapidly growing three-dimensional (3D) printing
technology and has great potential in medicine. Polyether-ether-ketone (PEEK) is a biocompatible
high-performance polymer, which is suitable to be used as an orthopedic/dental implant material.
However, the mechanical properties and biocompatibility of FDM-printed PEEK and its composites
are still not clear. In this study, FDM-printed pure PEEK and carbon fiber reinforced PEEK (CFR-PEEK)
composite were successfully fabricated by FDM and characterized by mechanical tests. Moreover,
the sample surfaces were modified with polishing and sandblasting methods to analyze the influence
of surface roughness and topography on general biocompatibility (cytotoxicity) and cell adhesion.
The results indicated that the printed CFR-PEEK samples had significantly higher general mechanical
strengths than the printed pure PEEK (even though there was no statistical difference in compressive
strength). Both PEEK and CFR-PEEK materials showed good biocompatibility with and without
surface modification. Cell densities on the “as-printed” PEEK and the CFR-PEEK sample surfaces
were significantly higher than on the corresponding polished and sandblasted samples. Therefore, the
FDM-printed CFR-PEEK composite with proper mechanical strengths has potential as a biomaterial
for bone grafting and tissue engineering applications.
Keywords: fused deposition modeling; polyether ether ketone; biocomposite; orthopedic implant;
oral implant; mechanical properties; wettability; topography; biocompatibility; cell adhesion
1. Introduction
Cranio-maxillofacial defects related to tumors, traumas, infections, or congenital deformities are
highly challenging tasks for oral and maxillofacial surgeons to reconstruct [1,2]. When bone losses
are too severe for human body routine mechanisms to regenerate, autologous grafts are the first
considerations due to the simultaneous osteogenic, osteoinductive, and osteoconductive properties [3].
However, the shape of the donor sites, bone graft resorption, and infection restrict the application
of autografts [4]. Currently, the most popular orthopedic/dental artificial materials are metals like
titanium (Ti) and its alloys. These materials have many advantages, such as excellent biocompatibility,
corrosion resistance, and mechanical strength [5]. However, there are some critical drawbacks of Ti,
one of which is stress-shielding, which may occur at the interface between Ti and bone during load
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transfer and result in surrounding bone loss [6]. In addition, the radiopacity of Ti alloys in the CT and
MR scan images and the release of harmful metal ions hinder the application of metals [7]. Due to the
limitations observed in metallic biomaterials, polymers have been explored in recent years as potential
alternative materials for bone replacement.
In the last few years, polyether ether ketone (PEEK) has been investigated widely in oral and
cranio-maxillofacial surgery. Possible applications are dental implants, skull implants, osteosynthesis
plates, and bone replacement material for nasal, maxillary, or mandibular reconstructions (Figure 1) [8–11].
PEEK is considered an alternative material for Ti due to its excellent biocompatibility, radiolucency,
chemical resistance, low density (1.32 g/cm3), and mechanical properties resembling human bone.
PEEK is a polyaromatic semi-crystalline thermoplastic polymer with an elastic modulus of 3–4 GPa
(Table 1), which is much lower than that of Ti (102–110 GPa) and very close to the human trabecular
bone (1 GPa) [8,12]. Moreover, the mechanical strengths of PEEK can be enhanced by the incorporation
of other materials (e.g., carbon fibers) [8]. Normally, carbon fiber reinforced polyether ether ketone
(CFR-PEEK) has an elastic modulus close to the human cortical bone (14 GPa), depending on the amount
of reinforced carbon fiber and manufacturing methods. CFR-PEEK is considered as a promising candidate
to replace metallic materials because of the inherited advantages of PEEK and improved mechanical
properties [13,14].
Figure 1. (a) Clinical applications of PEEK; Fused deposition modeling (FDM)-printed PEEK
(b) breastbone and (c) nasal reconstructions.
Table 1. The elastic modulus of different materials and human tissues.




Cortical bone 14 [8]
Trabecular bone 1 [15]
Additive manufacturing (AM) is a layer-by-layer manufacturing method, fabricating specimens
by fusing or depositing materials, such as metals, ceramics, plastics, or even living cells [16]. This
technique is becoming popular in orthopedic surgery for fabricating patient-specific implants due to
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the low cost, the feasibility of complex architectures, and the short production time [17]. Selective
laser sintering (SLS) has been the most popular AM technology for fabricating PEEK in the past
decades [18,19]. Compared with SLS, fused deposition modeling (FDM) is one of the fastest growing
three-dimensional (3D) printing methods due to the lower costs, easier use (filament vs. powder),
and reduced risk of material contamination or degradation. Furthermore, it has increasingly been
applied to the manufacturing of PEEK and its composites in recent years [20]. However, due to
the semicrystalline structure and high melting temperature of PEEK (compared with other FDM
filament materials like polylactic acid (PLA) and acrylonitrile butadiene styrene (ABS)), it is difficult to
process PEEK objects by FDM printing and the process is liable to cause excessive thermal stress and
thermal cracks [8,18]. Yang et al. and Wu et al. have already measured the mechanical properties of
FDM-printed pure PEEK and found that compared with some traditional manufacturing methods (i.e.,
injection molding), FDM-printed PEEK had lower mechanical strengths, which were influenced by
layer thickness, printing speed, ambient temperature, nozzle temperature, and heat treatment [21,22]
FDM-printed PEEK composites, to the best of our knowledge, have not yet been studied.
Compared with Ti, the unmodified PEEK is bioinert and has limited osteoconductive properties,
which may influence the osseointegration after implantation [23,24]. Surface topographical modification
is one of the mechanical surface modification methods to increase the biological performance of
cranio-maxillofacial implants [25]. Surface roughness may influence cell adhesion, and a roughened
surface usually has a more extensive surface area which offers more binding sites for cell attachment [26].
Some studies have already analyzed the influence of surface roughness on the bioactivity of PEEK and
its composites [26–28]. However, in these reports, PEEK and its composites were all manufactured
by traditional techniques like milling, injection modeling, and compression molding. For the FDM-
manufactured PEEK, most studies only analyzed the manufacturing process and mechanical properties
of pure PEEK, without PEEK composites [17,18,22]. According to our knowledge, tests of the mechanical
properties of FDM-printed CFR-PEEK are still lacking. Therefore, the aim of this study was to evaluate
the mechanical properties and microstructures of PEEK and CFR-PEEK samples manufactured by
FDM. Specific attention was paid to the question of whether the FDM printing process has introduced
or produced toxic substances and to the influence of surface treatments on the cell adhesion on
sample surfaces.
2. Materials and Methods
2.1. Sample Preparation and Surface Modification
2.1.1. Sample Preparation
A 3D printing system for PEEK material and its composite from Jugao-AM Tech. Corp. (Xi’an,
China) was used to prepare all test specimens. In the printing process, the PEEK material was heated
and transformed into a semi-liquid state inside the nozzle. Then, the feedstock filament was forced
to pass through the nozzle where it was melted and deposited in the form of a thin layer onto the
platform. After one layer was finished, the platform went down along the z-axis equal to the pre-setting
layer thickness. The desired geometry of the final complex objects was built layer-by-layer under
the control of a computer. The extrusion temperature was set at 420 ◦C, and the printing speed was
40 mm/s. The bead width of each printing line was 0.4 mm, and the layer thickness was 0.2 mm
(Table 2). Moreover, the PEEK filaments, as the material for 3D printing in this paper, were reprocessed
from pellets (450G, VICTREX Corp., Thornton Cleveleys, UK), and 5% milled carbon fibers with
a length of 80–150 μm and a diameter of 7 μm (Nanjing WeiDa Composite Material Co. Ltd., Nanjing,
China) were chosen as the reinforcements. Before printing, a special fixative paper (Mingtai 3D
Technology Co., Ltd., Shenzhen, China) was applied to the print bed for the objects’ adhesion and
warping improvement. After printing the samples and cooling them down to room temperature,
the samples were placed into a furnace (101-0 s, Shaoxing SuPo Instrument Corp., Shaoxing, China) for
the heat treatment (tempering) process. After heating for 2 h at 300 ◦C, the samples were cooled down
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to room temperature to decrease shrinkage distortion and residual stress to obtain good mechanical
performance of the parts.
Table 2. Technical specifications of the FDM printer.
Parameters Technical Specifications
Nozzle diameter 0.4 mm
Bead width 0.4 mm
Layer thickness 0.2 mm
Printing speed 40 mm/s
Raster angle Consistent with the longest edge
Ambient temperature 20 ◦C
Nozzle temperature 420 ◦C
The dimension of the PEEK and CFR-PEEK samples for testing the mechanical properties (tensile,
bending, and compressive tests) was according to ISO standards. The dog-bone shape tensile testing
specimens (90 mm × 5 mm × 4 mm) were printed according to ISO 527-1 standard [29], and the
cuboid bending specimens (80 mm × 10 mm × 4 mm) were printed according to ISO 178 standard
(Figure 2) [30]. According to ISO 604 standard, two sample groups were manufactured for testing
compressive strength and compressive modulus, respectively [31]. The round-shaped PEEK and
CFR-PEEK disc samples for the wettability, roughness, microstructure, and biological tests were
produced with a diameter of 14 mm and a thickness of 1 mm.
Figure 2. Pure PEEK and CFR-PEEK samples for testing mechanical properties: (a,e) tensile samples
of PEEK and CFR-PEEK; (b,f) bending samples of PEEK and CFR-PEEK; (c,g) compressive samples
(compressive strength) of PEEK and CFR-PEEK; (d,h) compressive samples (compressive modulus) of
PEEK and CFR-PEEK; (i) tensile test; (j) bending test; (k,l) compressive tests of strength and modulus.
Ti disc samples (Grade: 4, Straumann AG, Basel, Switzerland) with 15 mm diameter and 1 mm
thickness were prepared from Ti sheet metal (Straumann AG, Basel, Switzerland) with a punching tool.
The Ti samples were used as an additional control group for the wettability, roughness, and biological
tests. All titanium discs underwent a surface treatment, which was consistent with the polished PEEK
and CFR-PEEK.
18
J. Clin. Med. 2019, 8, 240
2.1.2. Sample Surface Modification
After printing, the PEEK and CFR-PEEK disc samples for wettability, roughness, microstructure,
and biological tests were divided into three groups: as-printed (untreated) group, polished group, and
sandblasted group (n = 12 per group). The untreated group included the directly printed samples,
without any surface treatment. For the polished and sandblasted groups, all the discs were manually
polished with a series of SiC abrasive papers up to P4000 (Buehler, Lake Bluff, IL, USA) by a polisher
(Buehler, Coventry, UK). Then, the samples of the sandblasted group were further modified using
a sandblasting machine (P-G 400, Harnisch + Rieth, Winterbach, Germany) with 120 μm alumina
(Al2O3) particles (Cobra, Renfert, Hilzingen, Germany) under the pressure of 0.1 MPa at a distance of
50 mm for 15 s.
All Ti disc surfaces were modified using the same processes as for PEEK and CFR-PEEK samples
by a series of SiC abrasive papers (1200, 2500, 4000 grit, Buehler, Lake Bluff, IL, USA) by a polisher
(Buehler, Coventry, UK). After polishing, all the samples were cleaned with deionized (DI) water by
an ultrasonic cleaner (Sonorex Super RK102H, Bandelin, Berlin, Germany) to remove residual Al2O3
particles on the sample surfaces.
2.2. Mechanical Properties Test
Mechanical tests were carried out using an electro-hydraulic servo mechanical testing machine
(CMT4304, MTS Corp., Eden Prairie, MN, USA) according to ISO standards. ISO 527-1: 2012
(Plastics—Determination of tensile properties), ISO 178: 2010 (Plastics—Determination of flexural
properties), and ISO 604: 2002 (Plastics—Determination of compressive properties) were applied for
the tensile, bending, and compressive tests, respectively [29–31]. Six samples were tested for each
batch with a 1 mm/min testing speed, and the test was performed at an ambient temperature of 20 ◦C.
2.3. Surface Characterization
To determine the surface morphology, samples of PEEK and CFR-PEEK from the untreated,
polished, and sandblasted groups (n = 2 per group) were sputtered with a 20 nm thick Au–Pd coating
(SCD 050, Baltec, Lübeck, Germany) and characterized by a scanning electron microscope (SEM) (LEO
1430, Zeiss, Oberkochen, Germany) at 200× and 2000× magnification.
The surface topography of the discs (n = 6 per group) was analyzed by a profilometer (Perthometer
Concept S6P, Mahr, Göttingen, Germany). For each sample, 121 profiles were measured over a 3 mm
× 3 mm area. The arithmetic mean height (Sa) and root mean square height (Sq) were calculated based
on these topographies by software (MountainsMap Universal 7.3, Digital Surf, Besançon, France).
The water contact angle (WCA) was measured at room temperature on six samples per group
using a drop shape analyzer (DSA 10-MK 2, Kruess, Hamburg, Germany). Drops of 2 μL of distilled
water were deposited on the respective disc surfaces using an automatic pipette. After 20 s wetting
time, the contact angle at the air–water–substrate interface was quantified from the drop geometry
using DSA software (version 1.90.0.11, Kruess, Hamburg, Germany).
2.4. Biological Tests
Biological tests consisted of an extract test and a direct contact test to analyze the cytotoxicity and
of the investigation of cell attachment to the different samples (n = 9 per group). Two materials (PEEK
and CFR-PEEK) with three different surfaces each (untreated, polished, and sandblasted) were tested.
In each test, n = 3 samples were used for each surface modification. All tests were performed three
times in independent experiments. Directly before the biological tests, samples were ultrasonically
cleaned with DI water for 15 min and sterilized with 70% ethanol and 100% ethanol (15 min each).
Subsequently, the samples were dried on filter paper in a sterile workbench (Lamin Air HB2472,
Burgdorf, Switzerland).
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2.4.1. Cell Culture
L929 fibroblasts (DSMZ GmbH, Braunschweig, Germany) were cultured in DMEM medium
(21063-029, Gibco, Paisley, UK) containing 10% fetal bovine serum (FBS, Life Technologies, Carlsbad,
CA, USA), 1% penicillin/streptomycin (15140-122, Life Technologies Co., Carlsbad, CA, USA), and 1%
GlutaMAX (Life Technologies Co., Paisley, UK) in 75 cm2 sterile cell culture flasks (Costar, Corning,
Tewksbury, MA, USA). The cells were maintained in an incubator under a humidified atmosphere
with 5% CO2 at 37 ◦C. The DMEM culture medium was renewed twice a week. When cells reached
confluence, Trypsin (GIBCO, Paisley, UK) was used to detach cells from the bottom of flasks, and 1/10
of the total cells were transferred into a new flask.
2.4.2. Test for In Vitro Cytotoxicity
The in vitro cytotoxicity test of PEEK and CFR-PEEK was performed by an extract method based
on ISO 10993-5 [32]. Extracts were derived from soaking the samples with DMEM cell culture medium
for 24 h at 37 ◦C. The ratio between the sample surface area and extraction vehicle volume was
3 cm2/mL. In the meantime, the cells were precultured for 24 h. The seeding concentration of L929
cells was 30,000 cells/cm2 in 200 μL DMEM medium per well in a 96-well plate (Cellstar 655180,
Greiner Bio-One, Frickenhausen, Germany). After 24 h, the culture medium was removed from the
cells and replaced by 150 μL extracts obtained from the respective sample groups. Three concentrations
of each extract were tested: (a) undiluted (150 μL extracts), (b) 1:3 diluted with medium (50 μL extracts
+ 100 μL medium), and (c) 1:10 diluted (15 μL extracts + 135 μL medium). Ti samples were used
as the negative control, and copper (Cu) samples were used as the positive control. After culturing
for an additional 24 h, the extracts in all groups were replaced by 100 μL fresh DMEM medium to
avoid artifacts in the following assay caused by blue color in the Cu extracts. The cytotoxicity was
quantitatively analyzed by CCK-8 assay (Dojindo Molecular Technologies, Inc., Rockville, MD, USA).
The volume of CCK-8 solution added to each test well was 10 μL. After incubating for 2 h, the optical
density (OD) value was measured by a microplate ELISA reader (Tecan F50, Tecan Austria, Groedig,
Austria) at 450 nm wavelength. The metabolic activity of L929 cells in the different test groups in
comparison to the negative control was calculated according to the following formula:
Cell metabolic activity (%) = (ODt − ODb)/(ODnc − ODb) 100%, (1)
where the OD value is the absorbance value of the respective test group (ODt), blank control group
(ODb), and negative control group (ODnc).
2.4.3. Cell Adhesion and Spreading
L929 cells were seeded on PEEK, CFR-PEEK, and Ti samples in 12-well plates (REF 3512, Costar,
Kennebunk, ME, USA) with a density of 30,000 cells/cm2 and incubated in 2.4 mL DMEM medium at
37 ◦C and 5% CO2. After incubation for 24 h, cell adhesion was terminated by rinsing with Hank’s
balanced salt solution (HBSS, Biochrom AG, Berlin, Germany). Adhering cells were vital stained for
10 min in a solution of 25 μg/mL fluorescein diacetate (FDA) and 1.25 μg/mL ethidium bromide
(EB) (Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany) in HBSS. For each sample, a minimum
of six typical surface areas of every magnification (25×, 100×, 200×, and 400×) was documented by
an Optishot-2 fluorescence microscope (Nikon, Tokyo, Japan) equipped with a digital camera (550D,
Canon, Tokyo, Japan). Cell adhesion and spreading were assessed by measuring the density of the
vital-stained cells (cells/cm2) and the mean area of sample surface covered by cells (% of Ti) using
a photo editing software (ImageJ, v1.8.0, National Institutes of Health, Bethesda, MD, USA).
2.5. Statistical Analysis
SPSS Version 21 (SPSS INC, Chicago, IL, USA) was used for analyzing the data. Shapiro–Wilk and
Levene tests were applied to assess the assumptions of data normal distribution and homogeneity of
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variances. The results of the mechanical properties of each parameter were tested using the Student’s
t-test of unpaired data with equal variance. One-way analysis of variance (ANOVA) was used for the
cell density, and cell adhesion and spreading followed by Tukey post-hoc test (α = 0.05). The contact
angle and roughness data were analyzed by Kruskal–Wallis analysis (α = 0.05) for the disobedience of
the data normality or homogeneity of variances.
3. Results
3.1. Mechanical Properties
Table 3 shows the results of mechanical tests for the FDM-printed PEEK and CFR-PEEK samples.
From Table 3, it is observed that the PEEK samples with reinforced carbon fiber had significantly better
strengths than the bare PEEK in the tensile and bending tests (p < 0.05). As for the compressive test,
there was no statistical difference between the two materials in compressive strength.














PEEK 95.21 ± 1.86 a 3.79 ± 0.27 a 140.83 ± 1.97 a 3.56 ± 0.13 a 138.63 ± 2.69 a 2.79 ± 0.11 a
CFR-PEEK 101.41 ± 4.23 b 7.37 ± 1.22 b 159.25 ± 13.54 b 5.41 ± 0.51 b 137.11 ± 3.43 a 3.51 ± 2.12 b
Different lowercase letters in the same column indicate significantly different groups (p < 0.05).
3.2. Surface Characterization
To understand how topological factors affect cell adhesion and spreading, the surface morphology
of PEEK and CFR-PEEK composite was determined using SEM. Figure 3 presents the SEM images of
untreated, polished, and sandblasted PEEK and CFR-PEEK samples. Printing borders, as shown
in Figure 3a,d were formed on the surface due to the deposition between two printing lines.
The clear peaks and valleys, which completely disappeared after polishing and sandblasting, could be
identified on both untreated PEEK and CFR-PEEK sample surfaces. The polished surfaces displayed
the smoothest morphology, although a few defects remained on the polished CFR-PEEK surfaces
(Figure 3b,e). The surfaces of specimens, however, after sandblasting treatment possessed surface
topography features in the micrometer scale with a homogeneous distribution of protuberances and
cavities (Figure 3c,f).
Figure 3. SEM images of PEEK and CFR-PEEK composite: (a) untreated PEEK; (b) polished PEEK;
(c) sandblasted PEEK; (d) untreated CFR-PEEK; (e) polished CFR-PEEK; (f) sandblasted CFR-PEEK.
Bars represent 200 μm and 20 μm (inserts), respectively.
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Figure 4 illustrates the roughness of specimens of different groups. It is obvious that the untreated
specimens displayed the roughest surfaces, both for PEEK and CFR-PEEK materials with the Sa value
of 17.67 ± 5.7 μm and 32.36 ± 17.02 μm, which were significantly higher than the values of the polished
and sandblasted groups (p < 0.05). The Sa values of sandblasted PEEK (0.85 ± 0.14 μm) and CFR-PEEK
(0.97 ± 0.26 μm) samples were slightly higher than those of the polished surfaces (0.42 ± 0.26 μm and
0.67 ± 0.42 μm). In contrast, the polished Ti samples showed a very smooth surface (0.2 ± 0.04 μm),
which was more homogenous compared with that of the polished PEEK and CFR-PEEK samples.
The same trend could also be seen in the Sq data.
Figure 4. Reconstructed three-dimensional (3D) surface topographies of analyzed samples, and Sa and
Sq values: (a) untreated PEEK; (b) polished PEEK; (c) sandblasted PEEK; (d) untreated CFR-PEEK;
(e) polished CFR-PEEK; (f) sandblasted CFR-PEEK; (g) polished Ti; (h,i) Sa and Sq values of as-printed,
polished, and sandblasted PEEK and CFR-PEEK samples, the polished Ti was used as an additional
reference. The data are presented as means ± standard deviation, * p < 0.05.
The result of contact angle analysis is shown in Figure 5. Data revealed that the untreated surfaces
of pure PEEK reflected an obvious hydrophobic response to water with a mean contact angle of 105 ±
26◦. The polished PEEK specimens exhibited a hydrophilic behavior (78 ± 3◦). After sandblasting,
the contact angle rose slightly (88 ± 7◦), but the difference was not significant (p > 0.05). As for
the CFR-PEEK samples, the untreated group also indicated the most hydrophobic sample surface
(92 ± 12◦) compared with polished (82 ± 5◦) and sandblasted (75 ± 3◦) specimens. Both PEEK and
CFR-PEEK samples, whether with or without surface modifications, revealed a more hydrophobic
response to water compared to Ti (51 ± 5◦).
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Figure 5. Water contact angle measured on untreated, polished, and sandblasted PEEK and CFR-PEEK
samples: (a) untreated PEEK; (b) polished PEEK; (c) sandblasted PEEK; (d) untreated CFR-PEEK;
(e) polished CFR-PEEK; (f) sandblasted CFR-PEEK. (g) Ti (additional reference); (h) quantitative
contact angle values (means ± standard deviation). The dotted line indicates the contact angle of 90◦,
which is the division of hydrophilicity and hydrophobicity, * p < 0.05.
3.3. Cytotoxicity
Cell metabolic activity is expressed as a percentage of the mean OD value of cells cultured with
extracts of the negative control (Ti), as displayed in Figure 6i,j. The data showed high cell viability in
the cultures treated with 1:1, 1:3, and 1:10 extract concentrations of both tested materials, PEEK and
CFR-PEEK, independent of the respective surface treatment (PEEK: untreated: 98 ± 23%, 106 ± 17%,
97 ± 22%; polished: 105 ± 25%, 106 ± 16%, 102 ± 15%; sandblasted: 106 ± 33%, 114 ± 27%, 98 ±
37%; CFR-PEEK: untreated: 98 ± 20%, 100 ± 28%, 97 ± 23%; polished: 102 ± 27%, 97 ± 31%, 105 ±
25%; sandblasted: 99 ± 38%, 100 ± 33%, 96 ± 23%). All extracts of PEEK and CFR-PEEK samples
showed no toxicity after 24 h incubation. Cell viability in all cultures was significantly above the 70%
level regarded as toxicity threshold according to ISO 10993-5 [32]. The results were confirmed by
morphology analysis as seen in Figure 6a–h. Cells in the 100% extracts of the PEEK and CFR-PEEK
groups exhibited a similar appearance as the negative control (Ti) group with distinct fibroblastic
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profiles. On the contrary, a large number of dead cells appeared in the positive group with a cell
survival rate of 1 ± 2%.
Figure 6. Cytotoxicity tests of L929 cells of PEEK and CFR-PEEK 100% extracts: (a) untreated
PEEK; (b) polished PEEK; (c) sandblasted PEEK; (d) untreated CFR-PEEK; (e) polished CFR-PEEK;
(f) sandblasted CFR-PEEK; (g) negative control (Ti); (h) positive control (Cu). (i,j) shows the quantitative
result of the CCK-8 test in the culture media with different extract concentrations of PEEK and
CFR-PEEK. The data are presented as means ± standard deviation. UP: untreated PEEK; PP: polished
PEEK; SP: sandblasted PEEK; NC: negative control; PC: positive control; UCP: untreated CFR-PEEK;
PCP: polished CFR-PEEK; SCP: sandblasted CFR-PEEK. The dotted line indicates the toxicity threshold
of 70% cell viability according to ISO 10993-5.
3.4. Cell Adhesion and Spreading
Cell viability, attachment, and spreading were examined through a LIVE/DEAD staining assay,
as shown in Figure 7. Compared with polished and sandblasted samples, untreated samples indicated
more attached cells on the surfaces, both for PEEK and CFR-PEEK materials (Figure 7a–f). In addition,
many cells attached in lines in the valleys resulting from the FDM manufacturing process (Figure 7a,d).
Figure 7h,i reveals the quantitative cell density and quantification of the mean surface area covered
by cells. Cell density on the sample surfaces of untreated PEEK and CFR-PEEK was significantly
higher than on the corresponding polished and sandblasted groups (p < 0.05), where density was
close to the Ti group. Moreover, the untreated groups showed higher cell coverage compared to
the modified surfaces. The polished groups showed the lowest cell attachment for PEEK as well as
CFR-PEEK samples.
Figure 8 shows the attached L929 cells around PEEK (Figure 8a–c), CFR-PEEK (Figure 8d–f), and Ti
(Figure 8g) samples of the direct contact test after culturing for 24 h. The cells on PEEK and CFR-PEEK
samples showed fibroblastic features and distinct profiles unaffected by the different materials and
surface modifications. Moreover, the cell number was also similar to the negative control (Ti), which
confirmed that the PEEK and CFR-PEEK materials were not toxic.
24
J. Clin. Med. 2019, 8, 240
Figure 7. LIVE/DEAD staining of L929 cells on PEEK and CFR-PEEK samples after culturing for
24 h, with Ti as an additional control. (a) untreated PEEK; (b) polished PEEK; (c) sandblasted PEEK;
(d) untreated CFR-PEEK; (e) polished CFR-PEEK; (f) sandblasted CFR-PEEK; (g) Ti. (h,i) shows the
quantitative cell density and quantification of the mean surface area covered by cells. The data are
presented as means ± standard deviation, * p < 0.05. P: PEEK; CP: CFR-PEEK; black bar: untreated
group; orange bar: polished group; blue bar: sandblasted group. Cytotoxic effects, indicated by dead
(red stained) cells, are not detectable.
Figure 8. Microscopic images of L929 cells observed around samples of direct contact test after culturing
for 24 h. (a) untreated PEEK; (b) polished PEEK; (c) sandblasted PEEK; (d) untreated CFR-PEEK;
(e) polished CFR-PEEK; (f) sandblasted CFR-PEEK; (g) Ti; (h) PEEK samples (untreated, polished, and
sandblasted); (i) CFR-PEEK samples (untreated, polished, and sandblasted).
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4. Discussion
This study aimed to investigate the mechanical properties of FDM-printed PEEK composite, the
influence of manufacturing on the materials’ cytotoxicity, and the impact of surface topography and
wettability on cell adhesion. To the best of our knowledge, there is currently no literature on these
topics, whereas the manufacturing parameters and mechanical properties of FDM-processed bare
PEEK and the SLS-printed PEEK composite have already been published elsewhere [18,21,33–35].
According to the manufacturing principles of FDM, only thermoplastic filaments can be used, like
PLA, ABS, and PEEK [33]. However, it is a great challenge to fabricate ideal-performance PEEK objects
through FDM equipment due to its high melting temperature (above 300 ◦C), high melting expansion,
and especially the semicrystalline property, in particular for PEEK composites [22,34]. In this study,
FDM-printed CFR-PEEK composite was successfully fabricated, and the mechanical properties were
first measured. Moreover, the influence of the surface topography and roughness on biocompatibility
and cell adhesion of FDM-printed PEEK and CFR-PEEK was also estimated for the first time.
The mechanical results indicated that the pure PEEK showed low strength in tensile, bending,
and compressive tests. However, the addition of 5% carbon fiber into the PEEK matrix improved
the mechanical strengths (Table 3), showing values similar to those of human cortical bone (elastic
modulus: 14 GPa) [8] Normally, the mechanical properties of additively manufactured PEEK were
obviously lower than the traditionally produced parts (i.e., injection molding) [21]. Although some
studies have been done on PEEK composites by adding reinforcement fillers using SLS technology,
the mechanical properties of FDM-printed PEEK composites were still insufficient, compared with
their cast counterparts as a bone replacement material for severe cranio-maxillofacial defects [34,35].
The manufacturing conditions of the FDM process, such as layer thickness, printing speed, ambient
temperature, nozzle temperature, and heat treatment, can produce a significant impact on the
mechanical properties of PEEK samples [21,22]. In this study, the tensile strength of bare PEEK
was 95.21 ± 1.86 MPa with an elastic modulus of 3.79 ± 0.27 GPa, which was comparable to the
injection-molded pure PEEK (100 MPa and 4 GPa) [21]. While the tensile strength and elastic
modulus of CFR-PEEK composites reached 101.41 ± 4.23 MPa and 7.37 ± 1.22 GPa, which were
much higher than the injection-molded pure PEEK, the similar trend could also be seen in the bending
and compressive tests. This result indicates that the printing conditions used in this study were suitable
for PEEK and CFR-PEEK manufacturing. Deng et al. and Wu et al. have measured the mechanical
properties of FDM-printed pure PEEK and found that the mechanical strength of printed PEEK samples
was significantly lower than the traditionally produced objects, whereas in this study the values were
quite similar [18,21]. One proper explanation for the excellent mechanical properties in this research
is the application of post heat treatment (tempering). Theoretically, heat treatment methods can
increase the degree of crystallinity and relieve the residual stress and shrinkage distortion, which
will increase the mechanical performance of PEEK parts [22]. Therefore, the mechanical strengths of
PEEK composite could be tailored by carbon fibers to mimic human cortical bone, thus avoiding stress
shielding [8].
Polishing and sandblasting are common surface processing methods in dentistry to get a smooth
or rough surface. However, the FDM-printed sample surfaces were much rougher compared with
sandblasted ones, as shown in Figures 3 and 4. This finding can be related to the working principle of
FDM. Thermoplastic materials are extruded by the printing nozzle, which can move across the building
platform in x- and y-axes, to generate a 2D layer line by line. Then, a 3D object is built up by melting
the successive 2D layers together. The crosswise oriented, threadlike inner structure of the specimen
results in some unfilled areas between lines and layers, and also in the original printing structures on
sample surfaces [36]. In this study, the sandblasted samples showed slightly rougher surfaces than the
polished ones. Compared with some previous studies, the sandblasting parameters (i.e., distance and
pressure) in this research had to be set lower in order not to perforate the layer-by-layer manufacturing
pattern [26,27,37]. In other studies, using traditional methods to fabricate PEEK and its composite
samples like injection molding or milling, the interior of the blocks was homogenous without layers or
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unfilled areas. The samples in this study were produced using FDM technology, laying down objects
in layers with a thickness of 0.2 mm. If a higher sandblasting pressure or closer distance were applied
to modify the sample, the upper surface layer would be exfoliated (Figure 9). Therefore, based on the
parameters used for sandblasting in this study, the sandblasted sample surfaces were slightly rougher
than the polished ones, but not obviously different.
Figure 9. Optical micrographs of sandblasted PEEK samples (a) under 0.1 MPa pressure; (b) under
0.5 MPa pressure.
It is recognized that the surface wettability of biomaterials is important for their bioactivities,
such as cell adhesion and spreading [38]. Therefore, the hydrophilicity of the samples was evaluated
by the static sessile drop method, and the results are shown in Figure 5. Both PEEK and CFR-PEEK
materials, before surface modification, represented a hydrophobic response to water (contact angle
between 90–110◦), which is typical for PEEK materials [8,39]. After polishing and sandblasting,
both samples exhibited slightly hydrophilic behavior with contact angles below 90◦. Commonly,
wettability is closely related to the surface topography and chemical composition of a material [39].
The higher water contact angle in the untreated group in this study could be explained by the printing
structures produced by FDM (Figures 3 and 4). On highly roughened surfaces, the peaks and valleys
prevent the water droplet from spreading on the surface, which can result in increased contact angles
since the peaks and valleys on the sample surfaces constitute “geometrical barriers” for the droplet
spreading [37,40]. According to the study undertaken by Ourahmoune et al., the surface morphology
strongly influences the hydrophilic behavior of PEEK and its composites [37]. For the polished and
sandblasted samples, since the differences of roughness values between these two groups were not
obvious, the water contact angles were similar.
Due to its chemical inertness, PEEK provides inherent good biocompatibility, and this is also one
of its advantages that favors its clinical use [8]. However, for the FDM-printed PEEK using a relatively
new technology to fabricate PEEK using AM, studies focusing on the possible introduction of toxic
substances during the printing process are still lacking, especially for its composites. According to
ISO 10993-5, a reduction of cell viability by more than 30% indicates a cytotoxic effect [32]. In this study
(Figure 6), the cell metabolic test of PEEK and CFR-PEEK samples showed that more than 96% of cells
survived in all sample groups tested, independent of the respective surface modification. This result
was comparable to the negative control group (Ti). The cytotoxicity results indicated that there were no
toxic effects generated by the printing process. Moreover, after surface treatment, some carbon fibers
were exposed on the surface of CFR-PEEK samples. However, this exposure has not led to increased
cytotoxicity. Zhao et al. investigated FDM-printed pure PEEK and obtained a similar result that no
toxic substances were introduced during the printing process [17].
Cell adhesion and spreading are closely related to surface properties, that is, composition,
roughness, morphology, and wettability [41]. In addition to chemical composition, surface roughness
and morphology play a critical role in the biological responses of biomaterial surfaces. In this study,
the untreated PEEK and CFR-PEEK sample surfaces exhibited significantly more cell attachment
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than the polished and sandblasted samples, where the attachment level was close to the Ti surfaces.
The as-printed PEEK and CFR-PEEK showed a higher cell density which might be due to the special
3D-printed structures. As shown in Figure 3a,d and Figure 4a,d, the clear ridges and valleys on the
surfaces could be identified on both PEEK and CFR-PEEK sample surfaces. These special printing
structures could enlarge the surface area significantly compared with polished and sandblasted
surfaces. Significantly more spaces are available for cells to attach and spread on this geometrical
morphology. For many engineering applications, a post-printing process is always needed to eliminate
the manufactured structures [39]. However, to improve the cell attachment and spreading, a rough
surface as generated by FDM seems beneficial, which could not be achieved by sandblasting. It was
obvious that the cells accumulated in the surface grooves resulting from the manufacturing process
(Figure 7a,d). Figure 4a,d showed the reconstructed 3D surface topographies of the as-printed PEEK
and CFR-PEEK samples. The cells could slide into the valleys on the sample surfaces and attach
there. As for both the polished and sandblasted surfaces, the originally printed surface structures were
removed and the surfaces showed a lower cell density, but the cells appeared more homogeneously
attached. After polishing and sandblasting, the exposure of carbon fibers on the surface of CFR-PEEK
samples did not improve the cell attachment significantly. This finding confirmed that reinforced
carbon fibers could improve the mechanical properties of FDM-printed PEEK, but would not influence
the cytotoxicity and cell adhesion. In this study, the biological response of FDM-printed PEEK was
investigated at a basic level, including cytotoxicity and cell adhesion. In future studies, more biological
tests (e.g., in vitro cell metabolic activity, proliferation, and in vivo osseointegration) should be applied
to evaluate bioactivities.
To sum up, the results indicate that the FDM-printed CFR-PEEK has excellent mechanical
properties compared with the printed bare PEEK. In addition, no toxic substances were introduced
during the FDM printing process. FDM technology can yield a highly roughened surface suitable for
cells to attach.
5. Conclusions
In this study, the mechanical properties of FDM-printed, carbon fiber reinforced PEEK
composite were systematically studied for the first time, including tensile, bending, and compressive
tests. The experimental results confirmed that samples printed from pure PEEK material showed
mechanical properties comparable to traditionally manufactured PEEK objects, obtained by extrusion
techniques for example. On the contrary, the printed CFR-PEEK specimen represented significantly
improved mechanical properties compared to printed pure PEEK. FDM technology could be used
to provide more satisfactory mechanical strength of PEEK and its composites. Therefore, it is
an appropriate method for matching the mechanical properties of PEEK composites with carbon
fibers to mimic human cortical bone and avoid stress shielding in clinical applications, like dental
implants, skull implants, osteosynthesis plates, and bone replacement material for nasal, maxillary,
or mandibular reconstructions.
Additionally, the impact of the surface topography and roughness of FDM-printed PEEK
and its composites on biocompatibility and cell adhesion was also estimated for the first time.
Laboratory experiments here clearly showed that no toxic substances were introduced during the FDM
manufacturing process of pure PEEK and CFR-PEEK. Surface treatments leading to partial exposure
of the fiber compound in the bulk material did not lead to increased cytotoxicity. FDM-manufactured
surfaces had highly rough topographies, which could not be achieved by typical dental sandblasting
processes. This structure was more suitable for cells to attach and spread compared with polished and
sandblasted surfaces, resulting in a cell density comparable to that on Ti sample surfaces. Although
tests carried out in this study are limited, it is expected that the CFR-PEEK composite with its enhanced
mechanical properties has great potential to be used as an orthopedic or dental implant material in
bone repair, regeneration, and tissue engineering applications.
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Abstract: It is challenging to remove dental implants once they have been inserted into the bone
because it is hard to visualize the actual process of bone formation after implant installation, not to
mention the cellular events that occur therein. During bone formation, contact osteogenesis occurs
on roughened implant surfaces, while distance osteogenesis occurs on smooth implant surfaces. In
the literature, there have been many in vitro model studies of bone formation on simulated dental
implants using flattened titanium (Ti) discs; however, the purpose of this study was to identify the
in vivo cell responses to the implant surfaces on actual, three-dimensional (3D) dental Ti implants
and the surrounding bone in contact with such implants at the electron microscopic level using
two different types of implant surfaces. In particular, the different parts of the implant structures
were scrutinized. In this study, dental implants were installed in rabbit tibiae. The implants and
bone were removed on day 10 and, subsequently, assessed using scanning electron microscopy
(SEM), immunofluorescence microscopy (IF), transmission electron microscopy (TEM), focused
ion-beam (FIB) system with Cs-corrected TEM (Cs-STEM), and confocal laser scanning microscopy
(CLSM)—which were used to determine the implant surface characteristics and to identify the cells
according to the different structural parts of the turned and roughened implants. The cell attachment
pattern was revealed according to the different structural components of each implant surface and
bone. Different cell responses to the implant surfaces and the surrounding bone were attained at an
electron microscopic level in an in vivo model. These results shed light on cell behavioral patterns
that occur during bone regeneration and could be a guide in the use of electron microscopy for 3D
dental implants in an in vivo model.
Keywords: osteogenesis; cell plasticity; dental implants; electron microscopy; scanning transmission
electron microscopy; bone-implant interface
1. Introduction
Dental implants are cylindrical prosthetics with screw threads, usually made of titanium (Ti),
which are used to replace missing teeth and to support the mastication function of artificial teeth.
However, the biological contact with the surface of dental implants is different from that with natural
teeth. Osseointegration, the direct contact between bone and implant, is viewed as a hard tissue
encapsulation, a foreign body immune reaction that isolates the implant; this bone response is generally
accepted as a bio-affinitive reaction to a biocompatible material [1]. To enhance the activity of osteogenic
cells in bone integration, the physical and chemical characteristics of the implant surface—including
J. Clin. Med. 2019, 8, 604; doi:10.3390/jcm8050604 www.mdpi.com/journal/jcm33
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the surface energy, wettability, and topography—are modified, because direct enhancement of the
bone surface is much more difficult [2–11]. Such surface treatments can be, in reality, an enhancement
to encase the foreign body in hard connective tissue [1,12,13]. Therefore, it is necessary to investigate
the in vivo biological response to implant surfaces at the cellular level.
To control the variables, and thereby produce a sound scientific result, in vitro studies using
purified cell lines and flat Ti discs with modified surfaces can be performed. However, promising
in vitro results in cell responses to such Ti discs do not guarantee obtainment of the desired reactions
for Ti implants with the same modified surfaces in in vivo environments. The Ti implants used
today to treat patients are screw-shaped, rather than flat disc-shaped. Screw threads have macro-
and microstructures—such as roots, flanks, and crests—which the homogeneous Ti disc surfaces
for the in vitro experiments are unable to simulate [14]. The cell lines for in vitro tests are usually
osteoblast-like cells, rather than human osteogenic cells, and the in vivo environment is very different
from an in vitro cell culture medium [5,8,15]. Nonetheless, osteoblastic cell lines in in vitro tests form a
simplified system which does not take into account aspects such as immune responses [16]. Therefore,
translational evidence is required to create a bridge between the in vitro cell results and the in vivo
tissue results—that is, the cellular response to a Ti implant surface in the in vivo environment.
This study aimed to observe Ti implants and the surrounding bone in contact with such implants
at the electron microscopic level to identify the in vivo cell responses to the implant surfaces
2. Materials and Methods
2.1. In Vivo Study
This study was approved by the Ethics Committee of the Animal Experimentation of the
Institutional Animal Care and Use Committee (CRONEX-IACUC 201702003; Cronex, Hwasung, Korea).
All experiments were conducted in accordance with the ARRIVE guidelines for reporting in vivo
animal experiments [17]. A total of 8 male New Zealand white rabbits (age: 1–2 years; body weight:
2.6–3.0 kg) with no signs of disease were used. The rabbits were anaesthetized via intramuscular
injection of tiletamine/zolazepam (15 mg/kg; Zoletil 50, Virbac Korea Co., Ltd., Seoul, Korea) and
xylazine (5 mg/kg; Rompun, Bayer Korea Ltd., Seoul, Korea). Before surgery, the skin over the area of
the proximal tibia was shaved and washed with betadine, and an antibiotic (Cefazolin, Yuhan Co.,
Seoul, Korea) was intramuscularly administered. Lidocaine was locally injected into each surgical site.
The skin was incised, and the tibiae were exposed after muscle dissection and periosteal elevation.
Drills and profuse sterile saline irrigation were used to prepare the implant sites on the flat tibial surface.
The drilling was performed with a final diameter of 4.0 mm at the upper cortical bone, in which the
implants were installed in cortical bone and medullary space. Only the V-shaped parts of the threads
were engaged (Figure 1A). A total of 5 rabbits received acid-etched (SLA) implants only. Each rabbit
received 4 SLA implants, 2 on each side of the rabbit tibia. Three rabbits received turned implants
only, each receiving 4 turned implants, 2 on each side of the tibia. The cover screw was covered. The
muscle and fascia were sutured with absorbable 4–0 Vicryl sutures, and the outer dermis was closed
with a nylon suture. The rabbits were separately housed after surgery. All rabbits were sacrificed via
an intravenous overdose of potassium chloride after 10 days of bone healing. After 10 days [1,18,19],
the tibiae were exposed, all of the inserted implants were removed through unscrewing, and the
surrounding bone was surgically removed en bloc with an adjacent bone collar and immediately
placed in Karnovsky’s solution for cell fixation in falcon tubes, while the specimens for fluorescence
immunocytochemistry were preserved in Roswell Park Memorial Institute (RPMI) media and fetal
bovine serum (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) in cell culture dish.
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Figure 1. (A) Simplified diagram of, and terminology regarding, the screw-shaped implants used in
this study. The inner half, close to the minor diameter of the implant, was defined as the root area. The
outer half, close to the major diameter of the implant, was called the crest area. The upper half of the
thread was defined as the upper flank (UF), and the lower half was the lower flank (LF). (B) Cs-corrected
transmission electron microscopy (Cs-STEM) analysis retrieved from focused ion beam specimens of
the turned and (C) acid-etched (SLA) implants on day 10. There were no cells detected on the turned
surface (yellow arrow) beneath the Pt-coated layer (black arrow), whereas, cells were detected on
SLA surface (red arrow). (D) Confocal laser scanning microscopy (CLSM) of the turned and (E) SLA
surfaces measured in root, UF, and LF. The turned implant revealed a smooth texture, and no cells were
seen after in vivo experiment. The SLA implants displayed cell attachment in the root area, depicted as
irregular structure of grey color on top of roughened topography in the 3D mapping of the CLSM.
2.2. Sample Preparation and Implant Surface Modification
Herein, 26 Ti sandblasted, large-grit, and SLA implants and 18 turned implants were used (Deep
Implant System, Inc., Seongnam, Korea). The implants were made of grade 4 commercially pure Ti
by computer numerical control (CNC) machining. The implant surface was called ‘turned’ when the
surface had no further modification after CNC machining. The SLA surface was made by sandblasting
the implant surface with 250–500 μm alumina particles and by etching the surface with HCl/H2SO4
35
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acid mixture. All of the implants were 4.0 mm in diameter and 5.0 mm in length. A total of 20 SLA
implants were used in an in vivo study, and 6 were used in the surface analysis, while 12 turned
implants were used in the in vivo analysis, and 6 were used in the surface analysis.
2.3. Surface Characteristics
Among the 6 SLA implants and 6 turned implants used in the surface analysis, 2 of each type
of implant were used for scanning electron microscopy (SEM; Hitachi S-4700, Hitachi, Tokyo, Japan),
2 were used for confocal laser scanning microscopy (CLSM; LSM 800, Carl Zeiss AG, Oberkochen,
Germany), and the remaining 2 implants were used for focused ion beam (FIB; Helios 650, FEI,
Hillsboro, OR, USA) and Cs-corrected transmission electron microscopy (Cs-STEM; JEM-ARM200F,
Cold FEG, FEOL Ltd., Tokyo, Japan), which are capable of producing transmission electron microscopy
(TEM) images directly from an undecalcified specimen. SEM was used to observe the topographical
features, while CLSM was used to analyze the surface roughness levels. The measured area roughness
parameters included the average height deviation value (Sa) and the developed surface area ratio
(Sdr). FIB and Cs-STEM were used to observe the undecalcified implant surface directly without any
resin embedding.
2.4. Scanning Electron Microscopy (SEM) Analysis
The retrieved implant specimens and surrounding bony specimens were fixed with Karnovsky’s
solution and washed in 0.1 M phosphate buffer saline (PBS) 3 times every 15 min. The specimens were
dehydrated through a graded 70–100% ethanol series and then treated with hexamethyldisilazane for
15 min. The surrounding bone specimens were cut in half around the round hole in which the implant
had been inserted, after degradation with 80% ethanol using rotary discs within an appropriate amount
of time. Prior to the SEM analysis, the implant and bone specimens were sputter coated with a thin
film of platinum to protect the implant and bony surfaces. All specimens were handled with Ti forceps
and surgical gloves in a clean laboratory environment. Each implant and bone sample was attached
using adhesive carbon tape, as well as aluminum tape, on the SEM sample stub. The samples were
inserted into a Hitachi S-4700 (Hitachi, Tokyo, Japan), which was operated at 20 kV.
2.5. Immunofluorescence Microscopy (IF) Analysis
Prior to the sacrifice of the rabbit tibiae, the implants were removed from each tibia and, along
with the surrounding bone, the specimens were preserved for 3 h in the refrigerator in the RPMI
media, which contained penicillin (50 U/mL) and streptomycin (50 μg/mL). The cells underwent
immunostaining and were incubated for 15 min with a protein block (DAKO, Agilent, Santa Clara, CA,
USA, X0909) to remove non-specific binding protein. The cells were then incubated for 30 min with a
diluted osteocalcin primary antibody (1:100 dilution in 3% bovine serum albumin (BSA), #MA120788,
Thermo Fisher Scientific, USA). After being rinsed in PBS, these cells were incubated for 1 h with a
diluted secondary antibody (1:200 diluted goat anti-mouse IgG-FITC in 3% BSA, #A10530, Thermo
Fisher Scientific, Waltham, MA, USA) in a dark room and washed with PBS. Subsequently, nuclear
counterstaining was performed using Hoechst 33342 (Thermo Fisher Scientific, Waltham, MA, USA)
(1:10,000 dilution) for 5 min. After the counterstaining, the images were obtained by fluorescence
microscopy using Axio Observer.A1 (Carl Zeiss, Jena, Germany).
2.6. Transmission Electron Microscopy (TEM) Analysis
Prior to sacrifice, the implants were removed, and the cells were isolated with a cell scraper and
fixed in Karnovsky’s solution. After sacrifice, the cells from the bony structures around the area where
implants had been placed were collected and fixed in Karnovsky’s solution. They were washed in 0.1 M
PBS 3 times every 15 min. The specimens were dehydrated through a graded 70–100% ethanol series,
exchanged with propylene oxide, and embedded in a mixture of Epon 812 and Araldite. Ultrathin
sections (70 nm) were cut using a Leica EM UC6 Ultramicrotome (Leica, Vienna, Austria). A ribbon of
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serial ultrathin sections from each bony specimen and implant were collected on copper grids and
stained with uranyl acetate and lead citrate. The serial fields were photographed at ×500 magnification
using a JEOL 1400-Flash electron microscope (JEOL, Tokyo, Japan) operated at 120 kV.
2.7. TEM Sample Preparation by Focused Ion Beam (FIB)
The implant specimens were fixed with Karnovsky’s solution and washed in 0.1 M PBS 3 times
every 15 min. The specimens were dehydrated through a graded 70–100% ethanol series and finally
treated with hexamethyldisilazane for 15 min. A Helios 650 (FEI, Hillsboro, OR, USA) dual-beam FIB
system was used for the TEM sample preparation. The specimens were deposited with a platinum
layer to protect the implant and bony surfaces prior to milling. A Ga+ ion beam accelerated voltage of
30 kV was used for milling. The TEM sample (under 100 nm) was attached to a Cu TEM grid. The
TEM analysis at Cs-STEM was observed using a JEM-AFM200F (Cold FEG, JEOL, Tokyo, Japan).
3. Results
3.1. Parts of the Implant
The distribution of the main locations of cells was classified into three major structures within the
implant: The root, the lower flank (LF), and the upper flank (UF). The implants used in this study were
specially designed: The sharp V-shape parts for the firm engagement of bone, and the square area
between the threads for the biologic response with no physical intervention such as stress (Figure 1A).
3.2. TEM Sample Preparation by Focused Ion Beam (FIB)
Surface characteristics along with cell attachment were probed using Cs-TEM from the FIB system.
The cells were detected directly from an undecalcified specimen without the need to undergo cell
isolation. The cells on the turned surface were unseen (Figure 1B), while on the SLA surface, organic
matter was detected under the Pt-coated layer (Figure 1C).
3.3. Confocal Laser Scanning Microscopy (CLSM) Analysis of the Implant
The different topographical features [10,20,21] of the implants may affect cell attachment. Therefore,
CLSM was used to measure the height parameters (Sa), as well as the hybrid parameters (Sdr), for the
root, UF, and LF areas. The Sa values for the turned surface were 0.163 μm, 0.086 μm, and 0.098 μm,
and the Sdr values were 10.3%, 8.2%, and 12.1% in the root, UF, and LF, respectively (Figure 1D). On
the SLA surfaces, the Sa values were 1.14 μm, 1.17 μm, and 1.09 μm, and the Sdr values were 237%,
235%, and 239% for the root, UF, and LF, respectively. The Sa and Sdr values differed in terms of surface
characteristics, with the SLA being higher; however, based on the different structural components, no
differences were found in either the Sa or Sdr. After the cells were fixed, the 3D topographical mapping
of the cells also showed higher cell quantities in the root area of the SLA implants (Figure 1E). To see
the correlation of the surrounding bone and the retrieved implant, the topographical parameters of the
bone were also tested, but unfortunately, due to the sputtering of the Pt, the parameters could not be
calculated in the bone area.
3.4. Scanning Electron Microscopy (SEM) Analysis of the Implant
In our research, the cell attachment and spreading varied depending on the structural differences
in the implant thread. Cells were not attached in turned surfaces in all parts of the implants (Figure 2A).
In the root area of SLA implants, an active cellular event took place. The cells were aggregated and
spread out effectively, with their cellular processes extended. The fibrin of the cell could be detected. In
the crest area, osteocytes and their processes were observed on both the UF and LF. However, they were
not as active as the cells in the root area, in which the cells maintained a round shape, insufficiently
spreading, and were in a static form (Figure 2B).
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Figure 2. (A) Scanning Electron Microscopy (SEM) analysis of the turned implants. The smooth surface
is displayed with many turned grooves. No cells were attached after 10 days. (B) SEM analysis of
sandblasted, large-grit, and SLA implants. The surface characteristics of the SLA implants, which
are typically porous, with honeycomb shapes (white arrow); the rather sharp peaks (left top white
arrow) are definite, and the texture of the surface is rough. On the right-hand-side, the cells (green
arrow) are shown to be mainly attached and actively spread out in the root area, with their filopodia
extended (blue arrow). The fibrin can be seen on the cells (red arrow). In the UF, osteocytes and their
processes are seen (yellow arrow). In the LF, the cell process is being extended, getting ready to migrate.
The round cells are in static status (orange arrow). (C) SEM analysis of the surrounding bone of the
removed turned and SLA implants at day 10. In the upper row, the overall image reveals traces of the
smooth implant surface; thus, the bone texture is rather regular. The formation of the fibrin network is
shown beneath some active cells (blue arrow). The lower row demonstrates the surrounding bone of
the removed SLA implant. The texture of the bone is rather rough compared with that of the turned
implant. The red blood cells can be seen underneath the cells. The mineralization grains (green arrow)
are shown, and collagen (red arrow) is depicted well with striped bands. Scale bars = 10 μm.
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3.5. Scanning Electron Microscopy (SEM) Analysis of the Surrounding Bone of the Retrieved Implant
The SEM analysis of the surrounding bone of the retrieved turned implants revealed a fibrin
network among the cells, whereas a striped pattern of supposed collagen bands was elucidated in
the SLA implants. In the area where the bone was in contact with the UF and LF, a bone matrix was
formed, while the crest area of the thread showed a fibrin network and an active cellular response.
In the surrounding bone of the SLA-retrieved implants, the texture of the bone surface was rougher
compared to that of the turned implants. Red blood cells were embedded, and a mineralization process
had occurred in the crest area where the collagen bands were visible; cell folding could be observed
with granules (Figure 2C).
3.6. Immunofluorescence Microscopy (IF) Analysis
Among the cells attached on the SLA surfaces, osteogenic cells needed to be identified because
they are the key cells in bone formation. Accordingly, the attachment of osteogenic cells to the
implant surface was confirmed through the use of osteocalcin—antibody targeted for rabbits in vivo.
Immunofluorescence microscopy enabled the development of images of osteogenic cells on the SLA
implants and the surrounding bone after 10 days, and consequently, confirmed the existence of
osteogenic cells on the implant surface. While osteogenic cells were detected on the implant surface,
the surrounding bone showed few osteogenic cells (Figure 3A).
Figure 3. (A) Immunofluorescence microscopy (IF) of the SLA implants and surrounding bone on day
10, including nucleus, marker, and colocalization. Osteogenic cells (red arrow) are attached to the
SLA implant surface rather than to the surrounding bone, which showed few osteogenic cells. The
magnification of the photographs is ×200. (B) Transmission electron microscopy (TEM) analysis of
retrieved SLA implant at day 10. (C) Macrophages (blue arrow) and osteogenic cell (red arrow) can be
seen in the SLA implants. (D) TEM analysis of surrounding bone on day 10. (E) In the surrounding
bone, osteocytes (white arrow) were detected.
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3.7. Transmission Electron Microscopy (TEM) Analysis
The samples were also scrutinized by TEM. The TEM images of the SLA implants revealed
macrophages and osteogenic cells (Figure 3B,C), while in the surrounding bone, osteocytes were
detected (Figure 3D,E).
4. Discussion
In the present study, we aimed to determine the cell activity that occurs during the bone-forming
process. We targeted the challenges concerning the lack of actual visualization of bone formation,
and put much effort into presenting data on the active process in a bony environment with an actual
3D implant structure rather than the flat Ti discs used in in vitro studies. Our experimental data
showed that a positive cell reaction occurred on the SLA surfaces, whereas the turned surfaces lacked
cell adhesion. Meanwhile, the surrounding bone of the turned surface implants exhibited active
cellular events. This may be confirmation of contact osteogenesis on the SLA surfaces. Whilst distance
osteogenesis appears to occur around the smooth turned surfaces, it is well known that rougher turned
surfaces (that were not investigated in this paper) also display contact osteogenesis [19,22–24].
According to the IF results seen, confirmation of osteogenic cells on the roughened implant
surfaces might be further evidence of contact osteogenesis. However, further investigation is required
to determine why only few osteogenic cells were detected on the bone surface—which is considered to
be the place for distance osteogenesis. In addition, although limitations exist, in that cell classification
is difficult in FIB specimens, the results reveal further evidence of contact osteogenesis on the SLA
surface. Investigations are needed to better understand the link between such a phenomenon and the
higher clinical long-term survival rate of implants with the SLA surfaces (over 95%), compared to that
of turned implants (81–91%) [25,26].
The cells on the Ti implant surfaces seemed to be able to read the configuration of the structural
parts of the implant. Considering the fact that implant geometry is a major factor in the initial stability
of an implant inserted into bone and that osseointegration contributes to the subsequent stability, such
SEM results imply that the initial, or primary, stability is associated with the shape of the crest area
and that the secondary, or biological, stability is mainly connected to the cellular behavior at the root
area [27,28].
Under the circumstances of immobility, exogenous foreign material such as Ti implants, exhibit
bone demarcation instead of implant rejection; hence, the stability-enhancing structures of an implant
may be of particular importance [29]. Cylindrical implants without threads have uniform but weak
attachment to the bone, which is especially weak to shear stress. This weakness may have been one
reason why the cylindrical implants displayed a lot of bone resorption in situ [30]. With regards to
the electron microscopic images captured in the in vivo environment of this study, all the implant
components shown, including the thread structure and microtopography, are important in the cellular
response during the osseointegration process. Altering the surface roughness of a material may
affect the biological processes regulating the behavioral mechanisms (e.g., cell activity, adhesion) of
osteoblastic/immune cells, such extracellular protein deposition at the moment of implantation has an
influence on the cellular behavior which later leads to differences in in vivo outcomes [31,32]. This study
was qualitative. Quantitative investigations are necessary for various modified surfaces. Recently,
implants made of other materials—including ceramic and polyetheretherketone (PEEK)—have been
developed, the surfaces of which need to be further investigated with respect to this in vivo cellular
response [33,34].
This study successfully presented direct evidence of the behavior of osteogenic cells on the implant
surface in an in vivo environment at the electron microscopic level. According to the interpreted data
herein, in the bone surrounding dental implants, cell behavior is determined by the treated surface of
the implant, whereas cells attached to the SLA implants seem to be able to read the configuration of
different implant structures and develop an attachment pattern that conforms to those structures.
40
J. Clin. Med. 2019, 8, 604
Author Contributions: Conceptualization, J.-Y.C. and Y.-J.J.; Methodology, J.-Y.C., Y.-J.J., and T.A.; Software, J.-Y.C.;
Validation, J.-Y.C., T.A., and I.-S.L.Y.; Formal Analysis, J.-Y.C. and Y.-J.J.; Investigation, J.-Y.C.; Resources, J.-Y.C.,
T.A., Y.-J.J., and I.-S.L.Y.; Data Curation, J.-Y.C., T.A., Y.-J.J., and I.-S.L.Y.; Writing—Original Draft Preparation,
J.-Y.C.; Writing—Review & Editing, J.-Y.C., T.A., and I.-S.L.Y.; Visualization, J.-Y.C., T.A., Y.-J.J., and I.-S.L.Y.;
Supervision, I.-S.L.Y.; Project Administration, J.-Y.C. and I.-S.L.Y.; Funding Acquisition, I.-S.L.Y.
Funding: This work was supported by a National Research Foundation of Korea (NRF) grant funded by the
Ministry of Science, ICT and Future Planning, the Korean Government [No. NRF-2016R1A2B4014330].
Conflicts of Interest: The authors declare that there are no conflicts of interest regarding the publication of
this paper.
References
1. Trindade, R.; Albrektsson, T.; Galli, S.; Prgomet, Z.; Tengvall, P.; Wennerberg, A. Osseointegration and foreign
body reaction: Titanium implants activate the immune system and suppress bone resorption during the first
4 weeks after implantation. Clin. Implant Dent. Relat. Res. 2018, 20, 82–91. [CrossRef] [PubMed]
2. Kohles, S.S.; Clark, M.B.; Brown, C.A.; Kenealy, J.N. Direct assessment of profilometric roughness variability
from typical implant surface types. Int. J. Oral Maxillofac. Implants 2004, 19, 510–516.
3. Yeo, I.S.; Han, J.S.; Yang, J.H. Biomechanical and histomorphometric study of dental implants with different
surface characteristics. J. Biomed. Mater. Res. B Appl. Biomater. 2008, 87, 303–311. [CrossRef] [PubMed]
4. Choi, J.Y.; Lee, H.J.; Jang, J.U.; Yeo, I.S. Comparison between bioactive fluoride modified and bioinert
anodically oxidized implant surfaces in early bone response using rabbit tibia model. Implant Dent. 2012, 21,
124–128. [CrossRef]
5. Kang, H.K.; Kim, O.B.; Min, S.K.; Jung, S.Y.; Jang, D.H.; Kwon, T.K.; Min, B.M.; Yeo, I.S. The effect of the
dltiddsywyri motif of the human laminin alpha2 chain on implant osseointegration. Biomaterials 2013, 34,
4027–4037. [CrossRef]
6. Koh, J.W.; Kim, Y.S.; Yang, J.H.; Yeo, I.S. Effects of a calcium phosphate-coated and anodized titanium surface
on early bone response. Int. J. Oral Maxillofac. Implants 2013, 28, 790–797. [CrossRef] [PubMed]
7. Kwon, T.K.; Lee, H.J.; Min, S.K.; Yeo, I.S. Evaluation of early bone response to fluoride-modified and
anodically oxidized titanium implants through continuous removal torque analysis. Implant Dent. 2012, 21,
427–432. [CrossRef]
8. Yeo, I.S.; Min, S.K.; Kang, H.K.; Kwon, T.K.; Jung, S.Y.; Min, B.M. Identification of a bioactive core sequence
from human laminin and its applicability to tissue engineering. Biomaterials 2015, 73, 96–109. [CrossRef]
[PubMed]
9. Wennerberg, A.; Albrektsson, T.; Chrcanovic, B. Long-term clinical outcome of implants with different surface
modifications. Eur. J. Oral Implantol. 2018, 11 (Suppl. 1), S123–S136. [PubMed]
10. Wennerberg, A.; Albrektsson, T. On implant surfaces: A review of current knowledge and opinions. Int. J.
Oral Maxillofac. Implants 2010, 25, 63–74. [PubMed]
11. Choi, J.Y.; Jung, U.W.; Kim, C.S.; Jung, S.M.; Lee, I.S.; Choi, S.H. Influence of nanocoated calcium phosphate
on two different types of implant surfaces in different bone environment: An animal study. Clin. Oral
Implants Res. 2013, 24, 1018–1022. [CrossRef] [PubMed]
12. Albrektsson, T.; Chrcanovic, B.; Molne, J.; Wennerberg, A. Foreign body reactions, marginal bone loss and
allergies in relation to titanium implants. Eur. J. Oral Implantol. 2018, 11 (Suppl. 1), S37–S46.
13. Albrektsson, T. On implant prosthodontics: One narrative, twelve voices-1. Int. J. Prosthodont. 2018, 31,
s11–s14.
14. Choi, J.Y.; Kang, S.H.; Kim, H.Y.; Yeo, I.L. Control variable implants improve interpretation of surface
modification and implant design effects on early bone responses: An in vivo study. Int. J. Oral
Maxillofac. Implants 2018, 33, 1033–1040. [CrossRef] [PubMed]
15. Min, S.K.; Kang, H.K.; Jang, D.H.; Jung, S.Y.; Kim, O.B.; Min, B.M.; Yeo, I.S. Titanium surface coating with
a laminin-derived functional peptide promotes bone cell adhesion. Biomed. Res. Int. 2013, 2013, 638348.
[CrossRef]
16. Araújo-Gomes, N.; Romero-Gavilán, F.; Sánchez-Pérez, A.M.; Gurruchaga, M.; Azkargorta, M.; Elortza, F.;
Martinez-Ibañez, M.; Iloro, I.; Suay, J.; Goñi, I. Characterization of serum proteins attached to distinct sol-gel
hybrid surfaces. J. Biomed. Mater. Res. B Appl. Biomater. 2018, 106, 1477–1485. [CrossRef]
41
J. Clin. Med. 2019, 8, 604
17. Kilkenny, C.; Browne, W.J.; Cuthi, I.; Emerson, M.; Altman, D.G. Improving bioscience research reporting:
The arrive guidelines for reporting animal research. Vet. Clin. Pathol. 2012, 41, 27–31. [CrossRef]
18. Trindade, R.; Albrektsson, T.; Galli, S.; Prgomet, Z.; Tengvall, P.; Wennerberg, A. Bone immune response to
materials, part i: Titanium, peek and copper in comparison to sham at 10 days in rabbit tibia. J. Clin. Med.
2018, 7, 526. [CrossRef]
19. Choi, J.Y.; Sim, J.H.; Yeo, I.L. Characteristics of contact and distance osteogenesis around modified implant
surfaces in rabbit tibiae. J. Periodontal Implant Sci. 2017, 47, 182–192. [CrossRef] [PubMed]
20. Wennerberg, A.; Albrektsson, T. Effects of titanium surface topography on bone integration: A systematic
review. Clin. Oral Implants Res. 2009, 20 (Suppl. 4), 172–184. [CrossRef]
21. Yeo, I.S. Reality of dental implant surface modification: A short literature review. Open Biomed. Eng. J. 2014,
8, 114–119. [CrossRef] [PubMed]
22. Albrektsson, T.; Brånemark, P.I.; Hansson, H.A.; Lindström, J. Osseointegrated titanium implants.
Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop. Scand.
1981, 52, 155–170. [CrossRef]
23. Davies, J.; Turner, S.; Sandy, J.R. Distraction osteogenesis—A review. Br. Dent. J. 1998, 185, 462–467.
[CrossRef] [PubMed]
24. Davies, J.E. Mechanisms of endosseous integration. Int. J. Prosthodont. 1998, 11, 391–401.
25. Buser, D.; Janner, S.F.; Wittneben, J.G.; Brägger, U.; Ramseier, C.A.; Salvi, G.E. 10-year survival and success
rates of 511 titanium implants with a sandblasted and acid-etched surface: A retrospective study in 303
partially edentulous patients. Clin. Implant Dent. Relat. Res. 2012, 14, 839–851. [CrossRef]
26. Adell, R.; Lekholm, U.; Rockler, B.; Brånemark, P.I. A 15-year study of osseointegrated implants in the
treatment of the edentulous jaw. Int. J. Oral Surg. 1981, 10, 387–416. [CrossRef]
27. Kwon, T.K.; Kim, H.Y.; Yang, J.H.; Wikesjö, U.M.; Lee, J.; Koo, K.T.; Yeo, I.S. First-order mathematical
correlation between damping and resonance frequency evaluating the bone-implant interface. Int. J. Oral
Maxillofac. Implants 2016, 31, 1008–1015. [CrossRef]
28. Meredith, N. Assessment of implant stability as a prognostic determinant. Int. J. Prosthodont. 1998, 11,
491–501.
29. Donath, K.; Laass, M.; Günzl, H.J. The histopathology of different foreign-body reactions in oral soft tissue
and bone tissue. Virchows Arch. A Pathol. Anat. Histopathol. 1992, 420, 131–137. [CrossRef]
30. Chrcanovic, B.R.; Albrektsson, T.; Wennerberg, A. Reasons for failures of oral implants. J. Oral Rehabil. 2014,
41, 443–476. [CrossRef]
31. Romero-Gavilán, F.; Gomes, N.C.; Ródenas, J.; Sánchez, A.; Azkargorta, M.; Iloro, I.; Elortza, F.; García
Arnáez, I.; Gurruchaga, M.; Goñi, I.; et al. Proteome analysis of human serum proteins adsorbed onto
different titanium surfaces used in dental implants. Biofouling 2017, 33, 98–111. [CrossRef] [PubMed]
32. Dodo, C.G.; Senna, P.M.; Custodio, W.; Paes Leme, A.F.; Del Bel Cury, A.A. Proteome analysis of the plasma
protein layer adsorbed to a rough titanium surface. Biofouling 2013, 29, 549–557. [CrossRef]
33. Bormann, K.H.; Gellrich, N.C.; Kniha, H.; Schild, S.; Weingart, D.; Gahlert, M. A prospective clinical study
to evaluate the performance of zirconium dioxide dental implants in single-tooth edentulous area: 3-year
follow-up. BMC Oral Health 2018, 18, 181. [CrossRef] [PubMed]
34. Najeeb, S.; Zafar, M.S.; Khurshid, Z.; Siddiqui, F. Applications of polyetheretherketone (peek) in oral
implantology and prosthodontics. J. Prosthodont. Res. 2016, 60, 12–19. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution





Mechanical and Biological Advantages of a Tri-Oval
Implant Design
Xing Yin 1,2, Jingtao Li 1,2, Waldemar Hoffmann 3, Angelines Gasser 3, John B. Brunski 2
and Jill A. Helms 2,*
1 State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases,
West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China; yinxing@scu.edu.cn (X.Y.);
lijingtao86@163.com (J.L.)
2 Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford School of Medicine,
Stanford, CA 94305, USA; brunsj6@stanford.edu
3 Nobel Biocare Services AG, P.O. Box, Zurich-Airport, 8058 Zurich, Switzerland;
waldemar.hoffmann@nobelbiocare.com (W.H.); angelines.gasser@nobelbiocare.com (A.G.)
* Correspondence: jhelms@stanford.edu
Received: 2 February 2019; Accepted: 25 March 2019; Published: 28 March 2019
Abstract: Of all geometric shapes, a tri-oval one may be the strongest because of its capacity to
bear large loads with neither rotation nor deformation. Here, we modified the external shape
of a dental implant from circular to tri-oval, aiming to create a combination of high strain and
low strain peri-implant environment that would ensure both primary implant stability and rapid
osseointegration, respectively. Using in vivo mouse models, we tested the effects of this geometric
alteration on implant survival and osseointegration over time. The maxima regions of tri-oval
implants provided superior primary stability without increasing insertion torque. The minima regions
of tri-oval implants presented low compressive strain and significantly less osteocyte apoptosis,
which led to minimal bone resorption compared to the round implants. The rate of new bone accrual
was also faster around the tri-oval implants. We further subjected both round and tri-oval implants
to occlusal loading immediately after placement. In contrast to the round implants that exhibited
a significant dip in stability that eventually led to their failure, the tri-oval implants maintained
their stability throughout the osseointegration period. Collectively, these multiscale biomechanical
analyses demonstrated the superior in vivo performance of the tri-oval implant design.
Keywords: dental implant; osseointegration; alveolar bone remodeling/regeneration; bone biology;
finite element analysis (FEA); biomechanics
1. Introduction
Implants have undergone a nearly continual transformation since their inception. Variations in
fabrication materials, surface texture, coating, and taper have yielded implants that osseointegrated
and are clinically successful [1–5]. Most dental implants, however, still have a circular cross-section,
which reflects their origins as titanium screws [6,7].
A non-circular cross-section may have advantages. When placed into a cylindrical osteotomy,
conventional implants typically have a uniform bone-implant contact (BIC), and the resulting
peri-implant strains are uniformly distributed around its circumference [8]. Although the relationship
is not straightforward [9], it is generally presumed that the greater the amount of bone-implant contact
(BIC) the better is implant stability [10].
A non-circular, e.g., a tri-oval shaped implant, on the other hand, would be predicted to engage
bone on its vertices, or tri-oval maxima, which would provide mechanical stability and result in
peri-implant strains concentrated at these regions.
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Depending on the extent of tri-ovality, there would also be sites of minimal BIC. An extensive
literature has shown that new woven bone first forms in areas where BIC is absent [8,11–14].
In previous studies, we demonstrated that when an implant is placed with high insertion torque
(IT), then peri-implant bone is compressed and osteocytes within this bone begin to die [8,15,16].
Some proposed embodiments of dental implants have had non-circular cross-sectional shapes
to reduce “friction between the bone and implant during insertion” [17,18]. Once the implant is in
place, however, it is not friction but rather peri-implant stresses and strains that appear to be most
important: Inserting an implant creates strains in peri-implant tissues [11,19,20], and the magnitude of
these strains has a direct, quantifiable impact on the behavior of cells and tissues in the peri-implant
environment [20,21].
In areas where an implant contacts bone, the stiff interface stabilizes the implant [15]. There is
a biological downside to this relationship, though: if the implant is placed with high IT, then the stiff
interfacial bone is compressed to a greater extent, and the result is higher strain. Cells within the bone
matrix, i.e., osteocytes, respond to this high strain by dying [8,15,16].
The converse is also true: in areas of low strain, fewer peri-implant osteocytes die and bone
resorption is minimal [22]. If the peri-implant bone is “soft”, e.g., has a trabecular microstructure,
then cells in the low strain environment tend to proliferate. Ultimately, these cells can differentiate into
osteoblasts and osseointegration ensues [22].
Once osteocytes have died, necrotic bone is resorbed via an osteoclast-mediated process [8,15].
Thereafter, new bone formation ensues [8,23]. The resorption of dead peri-implant bone, however,
jeopardizes implant stability. We speculated that there could be a way to avoid this by purposefully
creating a combination of high strain and low strain peri-implant environments that would ensure both
mechanical engagement in the surrounding bone, i.e., primary stability, and rapid osseointegration,
respectively. In a tri-oval implant design, the maxima regions would theoretically correspond to areas
of higher strain and provide initial mechanical stability. The minima regions of the tri-oval design
would theoretically correspond to areas of low strain and constitute pro-osteogenic zones where new
bone formation would contribute to secondary implant stability. Here, we tested the veracity of this
theory by comparing outcomes of tri-oval and round implants placed into healed maxillary sites
according to a well-established in vivo mouse model of oral implant osseointegration.
2. Materials and methods
2.1. Implant Design
Implants were manufactured from CP Titanium Grade 4 with a TiUnite surface (Nobel Biocare
AB, Goteborg, Sweden). Geometries for round (control) and tri-oval implants are described in
Supplemental Table S1.
2.2. Animals and Tooth Extraction Surgeries
Procedures were approved by Stanford Committee on Animal Research (protocol #13146) and
conformed to the ARRIVE guidelines. Wild-type C57BL/6 mice (Jackson Laboratory, Bar Harbor,
ME, USA, #003291) were housed in a temperature-controlled environment with 12h light/dark cycles.
In total, 96 eight-week-old male mice were used.
2.3. Implant Placement, Osteotomy Site Preparation, and Experimental Groups
Extraction of bilateral maxillary 1st molars (mxM1) was performed using forceps. Bleeding was
controlled by local pressure. Extraction sockets were allowed to fully heal for four weeks [22].
Pain control was ensured by daily delivery of analgesics. Immediately following surgery mice received
sub-cutaneous injections of buprenorphine (0.05–0.1 mg/kg) for analgesia once a day for a total of
three days. Animals were fed with regular hard chow diet. Daily monitoring revealed no evidence
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of prolonged inflammation during healing at the surgical sites. No antibiotics were given to the
operated animals.
Following anesthesia, osteotomy sites were produced using a dental engine (NSK, Tokyo, Japan)
and a 0.45mm diameter drill bit at 800 rpm (Drill Bit City, Prospect Heights, IL, USA). Aseptic saline
was used for irrigation during the drilling process.
A split-mouth design was employed for this study, wherein each mouse received one round
implant and one tri-oval implant. See Supplemental Table S2 for the distribution of groups and
analyses performed in each group. Implants were placed either below the occlusal plane or at the level
of occlusion.
2.4. Implant Insertion Torque Measurement
To compare the insertion torque (IT) of the round and tri-oval implants, two independent
experimental setting were performed. In one experimental design, holes (0.45mm diameter) were
produced in a uniform block of poplar wood and then round and tri-oval implants were inserted all
the way into the wood block. The IT was then recorded by attaching the implants to a miniature torque
cell (MRT Miniature Flange Style Reaction Torque Transducer, Interface Inc., Scottsdale, AZ, USA).
Poplar wood had an elastic modulus of 10.9 GPa [24], which is on the same order of magnitude as
dense bone (e.g., 10–20 GPa) [25].
In another experimental design, the IT was measured directly on mice [26]. Osteotomies (0.45 mm
in diameter) were prepared in the healed maxillary tooth extraction sites and the implants were
inserted. The animals were sacrificed immediately after implant placement. The mandible was
removed to fully expose the inserted implant, and the IT was then measured by connecting the implant
to a pre-calibrated hand-held gauge (Tonichi, Tokyo, Japan).
The rationale for comparing insertion torques (IT) of round and trioval implants in wood was
not to imply that wood is an excellent substitute test material for bone; rather it was because (a)
wood offered a uniform material allowing side-by-side IT tests of round and trioval implants under
identical conditions, and (b) the IT tests in wood could be conducted using a sensitive miniature torque
transducer that could not be used in vivo.
2.5. Lateral Stability Testing, Finite Element Modeling, and Calculation of Elastic Modulus
A lateral stiffness test (LST) of implants in alveolar bone was carried out using maxillae samples
retrieved on PID 0, 3, 7, 14, and 20. The LST was based on an assumed linear relationship between
a lateral force exerted on the top of an implant and the resulting lateral displacement of the implant in
bone. Our experience with this method, including modeling with finite element analysis indicates that
this assumption is valid for displacements in the range of about 0 to 50 μm [15,27].
To carry out LST, the animals were sacrificed and the skulls, with the maxillae removed and
sectioned in half sagittally, were submerged in 100% ethanol. The half-maxilla containing the implants
was then rigidly clamped to a solid support so that the implant was positioned between a linear
actuator (Ultra Motion Digit D-A.083-AB-HT17075-2-K-B/3, Mattituck, NY, USA) equipped with an
in-line 10 N force transducer (Honeywell Model 31), and a displacement transducer (MG-DVRT-3,
Lord MicroStrain, Williston, VT, USA). A tare load of 0.05 N was applied to one side of the implant
while the stylus of the displacement transducer was positioned against the diametrically-opposite
side of the implant. Under software command, the actuator was triggered to deliver three cycles of
a displacement vs. time waveform with a peak displacement of about 30 μm (Figure 1M). The force
was applied, and the resulting lateral displacement of the implant was measured at a consistent height
of ~0.5 mm above the crest of the maxillary bone. Previous tests and calculations show that under
the force conditions in this test, there is negligible deformation of the titanium implant, meaning that
virtually all lateral displacement arises from displacements in the peri-implant tissue. Lateral force
and lateral displacement of the implant were recorded and stored to disc for later data analysis and
calculation of the ratio between force and displacement, i.e., lateral stiffness (in Newtons/micron).
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Figure 1. Tri-oval implants placed in type III bone with the same insertion torque exhibit higher
primary stability as compared to conventional round implants. (A) Maxillary first molars (M1) were
extracted from skeletally mature (8-week-old) male mice. (B) Intraoral photos of extraction socket
(white arrow) and (C) Healed extraction site (black arrow). (D) Representative micro-CT imaging and
(E) Representative aniline blue staining of the healed extraction socket on PED28. (F) Quantification
of mean bone mineral density (BMD) on PED28, where the BMD of the healed extraction site was
equivalent to surrounding pristine alveolar bone. (G) Osteotomies (0.45 mm dia.; pink arrow) were
produced in the healed extraction sites using dental drill. (H) Representative micro-CT image of
the prepared osteotomy site. (I) Geometries of the round and (J) tri-oval implants in cross-section.
(K) Implant placement surgery. (L) Implants were positioned at the height of the gingiva. (M) In vitro
IT testing and (N) In vivo IT testing where the white arrow indicates a round implant; blue arrow
indicates a tri-oval implant. (O) Quantification of in vivo IT for round (white) and tri-oval (blue)
implants. (P) Lateral stability testing of round and tri-oval implants (arrows) in the mouse maxillae;
a stepper motor laterally displaces the implant a known amount while the force to do so is measured
by a transducer. (Q) Tri-oval implants are significantly more stable than round implants at the time
of insertion. Abbreviations: M1, maxillary first molar; M2, maxillary second molar; M3, maxillary
third molar; hES, healed extraction site; PED, post-extraction day; imp, implant; IT, insertion torque.
Scale bars = 500 μm.
Finite element (FE) modeling provided insight into the relationship between the
experimentally-measured lateral stiffness and the elastic properties of the surrounding peri-implant
bone [28]. Based on stiffness values from lateral stability testing at post-implant day 3 (PID3), a FE
model was used to estimate the elastic modulus of peri-implant tissue. A computer-aided design
(CAD) file of each implant was obtained from the manufacturer (Nobel Biocare AB, Göteborg, Sweden)
and imported into COMSOL Multiphysics 5.3 when formulating models of the lateral stiffness testing
(LST). Each implant was installed to full depth (i.e., eight threads) into a 0.45 mm drill hole made
completely through a cylinder (2 mm diameter, 1.45 mm height) of uniform bone having a Young’s
elastic modulus and Poisson’s ratio selected so that the lateral stiffness computed from the FE model
matched the experimentally-measured lateral stiffness. A no-slip boundary condition was applied
between implant and bone, and the side and bottom surfaces of the bone cylinder were fixed in space.
In the FE model simulating LST, a 0.2N lateral load was applied on the side of the implant’s top
portion, at a height of 0.58 mm above the surface of the bone. The direction of the applied force was
perpendicular to the long axis of the implant. The resulting displacement of the implant in the same
direction of the lateral force was measured from the displacement output. The ratio of the applied
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lateral force to the measured lateral displacement at 0.58 mm above the surface of the bone was defined
as the lateral stiffness. A typical FE model formulated as described above involved about 238,000
degrees of freedom. To match the results from a given experimental stiffness test of a round or tri-oval
implant, the Young’s elastic modulus of the bone in the model was parametrically changed until
there was a match in lateral stiffness between the FE model and the actual experiment. These FE
models demonstrated that the lateral stiffness strongly depended on the Young’s elastic modulus of
the peri-implant bone.
2.6. Calculating Elastic Modulus of Peri-Implant Bone as a Function of Lateral Stability
Implant insertion caused dynamic tissue remodeling, which could potentially change the tissue
elastic modulus in the peri-implant region. Although the changes in peri-implant elastic modulus
could not be measured directly on mice, we used FE modeling to generate estimates basing on stiffness
values from lateral stability testing at PID3. In the round implant cases, the mean lateral stiffness
was 0.00198 N/μm, which corresponded to a modulus of ~2.6 MPa for the peri-implant bone. In the
tri-oval implant cases, the mean lateral stiffness was 0.00689 N/μm, which corresponded to a modulus
of ~9.2 MPa, a 3.5 times stiffer peri-implant bone than in the case of the round implants.
2.7. Sample Preparation, Tissue Processing, and Histology
Mice were euthanized on PID 3, 7, 10, 14, and 20. For those animals whose implants were to be
subjected to mechanical testing, maxillae were harvested with skin and superficial muscles removed,
fixed in 100% ethanol, and then subjected to lateral stiffness testing. In cases where implants were
evaluated by histology/histomorphometry, tissues were fixed in 4% paraformaldehyde overnight at
4 ◦C then decalcified in 19% EDTA.
After complete demineralization, specimens were dehydrated through an ascending ethanol
series and underwent clearing in xylene prior to paraffin embedding. Before immersion in xylene,
implants were gently removed from the samples. Eight-micron-thick longitudinal sections were cut and
collected on Superfrost-plus slides [27]. Tissue sections prepared for histology, immunohistochemistry,
and immunofluorescence were prepared by one individual then quantified by a blinded individual.
Aniline blue staining was performed to detect osteoid matrix. Tissues sections were also stained
with the acidic dye, picrosirius red, to discriminate tightly packed and aligned collagen molecules.
Viewed under polarized light, well-aligned fibrillary collagen molecules present polarization colors of
longer wavelengths (red) as compared to less organized collagen fibrils that show colors of shorter
(green-yellow) wavelengths [27].
2.8. Histomorphometry
Maxillae were embedded in paraffin and sectioned in the transverse planes. The space occupied by
the 0.5mm implant was represented across ~60 tissue sections, each of which were 8 μm thick. Of those
60 sections, a minimum of four Aniline blue-stained tissue sections were used for the quantification
of new peri-implant bone formation. Each section was photographed using a Leica digital imaging
system at 5× and 10× magnification. The digital images were analyzed using ImageJ software 1.4
(National Institute of Mental Health, Bethesda, MD, USA). The percentage of aniline blue-positive new
bone (%NB) was calculated using the area occupied by aniline-blue-positive pixels divided by the
total number of pixels in the defined region of interest (ROI). Pixel counts from these individual tissue
sections were performed in triplicate then averaged for each sample.
2.9. TUNEL Staining, Alkaline Phosphatase Activity, and Tartrate Resistant Acid Phosphatase Activity
TUNEL staining was performed as described by the manufacturer. Briefly, sections were incubated
in proteinase K buffer (20 μg/mL in 10 mM Tris pH 7.5), applied to a TUNEL reaction mixture (In Situ
Cell Death Detection Kit, Roche, Mannheim, Germany), and mounted with DAPI mounting medium
(Vector Laboratories, Burlingame, CA, USA). Slides were viewed under an epifluorescence microscope.
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Alkaline phosphatase (ALP) activity was detected by incubation in nitro blue tetrazolium
chloride (NBT; Roche, Mannheim, Germany), 5-bromo-4-chloro-3-indolyl phosphate (BCIP; Roche,
Mannheim, Germany), and NTM buffer (100 mM NaCl, 100 mM Tris pH 9.5, 5 mM MgCl). After its
development, the slides were dehydrated in a series of ethanol and xylene and subsequently
cover-slipped with Permount mounting media (Thermo Fisher Scientific, Waltham, MA, USA).
Tartrate-resistant acid phosphatase (TRAP) activity was observed using a leukocyte acid
phosphatase staining kit (Sigma, St. Louis, MO, USA). After its development, the slides were
dehydrated in a series of ethanol and xylene and subsequently cover-slipped with Permount mounting
media (Thermo Fisher Scientific, Waltham, MA, USA).
2.10. Micro-CT Imaging
Scanning and analyses followed published guidelines [29]. Ex vivo high-resolution acquisitions
(VivaCT 40, Scanco, Brüttisellen, Switzerland) at 10.5 μm voxel size (55 kV, 145 μA, 347 ms
integration time), were performed on post-extraction days 28 and immediately after drill preparation.
Multiplanar reconstruction and volume rendering were carried out using OsiriX software (version 5.8,
Pixmeo, Bernex, Switzerland).
2.11. Statistical Analyses
For lateral stiffness tests, results are presented as the mean ± 95% confidence interval. In testing
for differences among five means in the stiffness tests for the round or the tri-oval implants at PID 0
through 20, we used one-way ANOVA with PID time as the factor. In comparing the stiffness of round
vs. tri-oval implants at any given time point (PID), Student’s t-test was used to quantify differences.
p ≤ 0.05 was significant.
3. Results
3.1. Tri-oval Implants Exhibit Higher Primary Stability Compared to Round Implants
Most dental implants are placed into healed sites [30]; to recapitulate this clinical condition,
maxillary first molars (mxM1) were extracted from skeletally mature mice (Figure 1A,B). Within seven
days, soft tissue healing was complete (Figure 1C). After four weeks, sites were evaluated clinically,
by μCT imaging (Figure 1D), and by histology (Figure 1E), which together confirmed complete
healing (Figure 1F).
A split-mouth design was then used: osteotomies were produced in healed sites (Figure 1G,H)
and two implants were placed, one round (Figure 1I) and the other tri-oval (Figure 1J). All implants
were placed ~0.5 mm above the alveolar bone crest and below the plane of occlusion (Figure 1K,L).
Insertion torque (IT) was measured using in vitro and in vivo methods. Both analyses indicated that
IT values were equivalent between the round and tri-oval implants (Figure 1M,N,O). Primary stability
was measured (Figure 1P) and these lateral stability tests demonstrated that tri-oval implants had
significantly higher primary stability than round implants (Figure 1Q). How was this greater primary
stability achieved?
3.2. The Maxima of a Tri-Oval Implant Provide Higher Stability
Computational models were generated to determine whether a difference in contributed to the
higher primary stability of tri-oval implants. These analyses showed that the threads of a round
implant penetrated ~25 μm into bone whereas for a tri-oval implant, the maxima penetrated ~45 μm
into bone (Figure 2A). Despite the fact that minima regions were not in contact with bone, a tri-oval
implant still had a larger calculated BIC (Figure 2B).
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Figure 2. Compared to a round implant, the minima of a tri-oval implant are associated with
significantly lower strains and a significantly smaller zone of osteocyte death. (A) FE modeling
of round (left) and tri-oval (right) implants in bone, using CAD files of the actual implants used
in vivo. In a transverse plane, the threads of each type of implant (blue) penetrate the bone,
which is modeled as a solid material. (B) The calculated bone-implant contact area due to thread
penetration. (C) Formulation of a FE model of laterally-loaded implant in bone. (D) Peri-implant
strains surrounding laterally-loaded round and tri-oval implants in the sagittal plane. (E) Peri-implant
strains arising from initial misfit of the round and tri-oval implants as seen in the transverse plane;
only the maxima of the tri-oval implant penetrate the bone. (F) DAPI staining of interfacial bone
surrounding a representative round implant and (G) a representative tri-oval implant; white arrow
denotes a circumferential osteocyte-free zone and dotted white line demarcates the osteotomy edge.
(F’, G’) TUNEL staining on adjacent tissue sections. Quantification of the distribution of (H) viable
and (I) apoptotic osteocytes as a function of distance from implant. Abbreviations: imp, implant; PID,
post-implant day. Scale bars = 50 μm.
We used FE modeling to understand how the difference in BIC affected peri-implant strains
and, in turn, lateral stiffness of the implants. Lateral loading was simulated in the FE model
(arrow, Figure 2C) and in both cases the resulting strains concentrated at sites of BIC (Asterix, Figure 2D).
The magnitude of these strains, however, was higher in the round implant case (Figure 2D). This meant
that when exposed to the same lateral force, the stability of the tri-oval implant was greater than that
for the round implant.
The distribution of the peri-implant strains was different, depending on the implant geometry.
For example, the round implants had a circumferential zone of high strain whereas the tri-oval implants
had strains concentrated only at the maxima; the minima (gaps) had no strain (Figure 2E).
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We correlated these strain distributions with biological sequelae. Surrounding round implants
was a ~150 μm circumferential zone in which no viable DAPI+ve osteocytes were detectable (white
arrow, Figure 2F). Most dying TUNEL+ve osteocytes were found within this same zone (Figure 2F’.
Around tri-oval implants, the tri-oval maxima had a similar distribution of dead and dying cells, but in
the minima, viable osteocytes were abundant (Figure 2G; quantified in 2H). Dying osteocytes were
significantly lower (Figure 2G’; quantified in I). The distribution of DAPI+ve versus dead and TUNEL+ve
osteocytes was calculated (Figure 2H, I and Supplemental Figure S1); these data demonstrated that
bone viability in the tri-oval minima—which comprised approximately 50% of the circumference of
the implant—was significantly higher around the round implants.
3.3. Tri-oval Implants Exhibit Less Bone Resorption, which Allows them to Maintain their Stability Over Time
Peri-implant TRAP activity was more abundant around the round implants (Figure 3A) compared
to the tri-oval implants (Figure 3B; quantified in Figure 3C). Resorption removes mineralized
matrix, which reduces the elastic modulus of bone and leads to implant instability (white bars,
Figure 3D). The tri-oval implants showed no significant loss in stability (blue bars, Figure 3D).
Therefore, minimal TRAP activity observed around the tri-oval implants correlated with their greater
stability after 3 days.
Figure 3. Tri-oval implants exhibits less bone resorption but more robust mineralization. (A) TRAP
staining of interfacial tissues surrounding a representative round implant on PID3. (B) TRAP staining
of the minima region around a tri-oval implant on PID3. (C) TRAP staining was quantified around
the entire circumference of round and tri-oval implants. (D) Lateral stiffness test of round and tri-oval
implants on PID0 and 3. (E) ALP staining of interfacial tissues surrounding a representative round and
(F) a tri-oval implant on PID10, quantified in (G). (H) TRAP staining of interfacial tissues surrounding
a representative round and (I) a tri-oval implant on PID10, quantified in (J). (K) Aniline blue staining of
interfacial tissues surrounding a representative round and (L) a tri-oval implant on PID20; quantified
in (M). Abbreviations as previously stated. Scale bars = 50 μm.
Eventually, both round and tri-oval implants showed evidence of new peri-implant bone
mineralization (Figure 3E,F), although the amount of ALP activity was significantly greater around the
tri-oval implants (quantified in Figure 3G). This new bone underwent normal remodeling (Figure 3H,I;
quantified in Figure 3J). By PID20, both the round and tri-oval implants were fully surrounded by
bone (Figure 3K,L; quantified in Figure 3M).
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3.4. Tri-Oval Implants Exhibit Superior Osseointegration Compared to Conventional Round Implants
In the experiments conducted thus far, tri-oval implants exhibited better primary stability than
round implants, yet both eventually were surrounded by bone. This result was not unexpected because
in both cases, implants were placed sub-occlusally, and in previous studies we have shown that
sub-occlusal round implants osseointegrate efficiently and effectively [31,32]. Moreover, no differences
in quantity of bone or in lateral stability were detected at PID14 (Figure 4B).
Figure 4. Stability over time as the function of implant geometry. (A) Schematic of an occlusal,
or functional implant. (B) Quantification of lateral stability of sub-occlusal round and tri-oval implants
at different timepoints. Aniline blue-stained tissue sections from PID20 through an (C,C’) occlusal
round implant and (D,D’) an occlusal tri-oval implant. (E) Quantification of lateral stability of
occlusal round and tri-oval implants on PID20. (F) In round occlusal implants, FE modeling of
peri-implant strain on PID3 and (G) picrosirius-red stained tissues from PID20. (H) In tri-oval occlusal
implants, FE modeling of peri-implant strain on PID3 and (I) picrosirius red-stained tissues from PID20.
Abbreviations: op, occlusal plane; imp, implant; fe, fibrous encapsulation. Scale bars = 50 μm.
We wondered if the fact that significantly better primary stability exhibited by the tri-oval implant
would have a long-term benefit if the implants were immediately loaded. Both the round and tri-oval
implants were subjected to functional loading, immediately after placement, which was achieved
by positioning the very top of the implant at the same height as the adjacent molar (Figure 4A).
The difference in outcome was dramatic: whereas the round implants underwent fibrous encapsulation
(Figure 4C,C’), these tri-oval implants osseointegrated (Figure 4D,D’).
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Lateral stability results were consistent with histologic/histomorphometric analyses: the soft
interfacial tissues surrounding the round implant cases offered little support and consequently,
the round implants exhibited poor secondary stability (i.e., small values of lateral stiffness).
In comparison, the stiffer interfacial tissues around the tri-oval implants translated into larger lateral
stiffness and thus higher secondary stability (Figure 4E).
3.5. The Magnitude of Interfacial Strain is a Key Influence on Whether an Implant will Undergo Fibrous
Encapsulation or Osseointegration
Why did these round occlusal implants fail? The key to answering this question lies in the
observation that the same round implants can osseointegrate, provided they are placed sub-occlusally
to reduce loading (Figure 3). Thus, the round implants failed because they lacked sufficient primary
stability (Figure 1Q). We sought to link this observation about stiffness at PID0 with the fates of the
implants on PID20, and to do so, we turned again to FE modeling.
Implant stability is a function of the elastic modulus of peri-implant tissue; in other words,
the stiffer the tissue, the less the implant will move under loading. FE modeling was used to
back-calculate the peri-implant bone modulus that corresponded to the experimentally-measured
lateral stability (see Materials and methods). At PID0 and PID3, the peri-implant tissues surrounding
trioval implants were 3.5 times stiffer than those surrounding round implants. Using these modulus
values, FE models demonstrated that peri-implant strains at PID0 and PID3 were significantly
higher around the round occlusal implant (Figure 4F). For example, at the crestal thread tips of an
occlusally-loaded round implant, principal compressive strain magnitudes reached >50% (Figure 4F).
On the other hand, identically-loaded tri-oval implants were surrounded by stiffer peri-implant tissue
and the resulting strains at PID0 and PID3 were less than 10% (Figure 4H). Collectively, these data
provide critical insights as to why a round implant with significantly less primary stability underwent
fibrous encapsulation when subjected to immediate loading (Figure 4G), whereas a tri-oval implant,
with statistically higher primary stability, underwent osseointegration when subjected to the same
immediate loading conditions (Figure 4I).
4. Discussion
We coupled mechanical testing with computational studies and histologic/immunohistologic
analyses to assess how altering an implant’s geometry affected its ability to osseointegrate. We tested
implants that were placed below the level of the occlusal plane, and those placed in function. In both
scenarios, the tri-oval implants out-performed the round implants. Evidence supporting this conclusion
came from mechanical, computational, and biological analyses.
4.1. The Maxima of a Tri-Oval Implant aid in Mechanical Stability
Compared to round implants, the tri-oval implants exhibited better primary stability, which was
achieved without using a higher IT (Figure 1). The larger stability was achieved because the maxima
of the tri-oval implant penetrated a greater distance into bone than did the threads of the round
implant (Figure 2). Based on our data, one might legitimately ask if the novel tri-oval implant design
would be negated simply by undersizing the osteotomy for the round implant. In this thought
experiment, the threads of the round implant would penetrate deeper into bone and as a result
the implant would presumably demonstrate better initial stability. But just as reliably, this scenario
would also increase IT [8], peri-implant strain [11], and its associated micro-damage [8,15,33]. In turn,
this micro-damage would increase the spatial extent of peri-implant bone resorption (Figure 3) during
the early post-operative stages of bone remodeling, which would lower the net modulus of the
peri-implant bone and result in a transient decrease of initial stability–as seen for example at PID 3
(Figure 4B).
Clinical observations are consistent with this line of reasoning: in multiple studies, sub-occlusal
implants showed a decline in mean ISQ values between weeks 1-4 [34–36]. Friberg also reported
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a decrease in stability for a majority of sub-occlusal implants [37,38]. Our preclinical study appears to
be the first to provide direct molecular, cellular, histologic, and mechanical data to explain how this
transient “dip” in implant stability actually occurs.
4.2. The Minima of a Tri-Oval Implant Create a Pro-Osteogenic Environment
Fifty percent of the peri-tri-oval implant environment had very low/no strain (Figure 2E),
where damage to the mineralized matrix is minimized, osteocyte death is minimal, and bone resorption
is reduced [8,15,33]. Together these events culminated in significantly more new bone around the
tri-oval implants (Figures 2 and 3). A similar finding has been reported using a canine implant model,
where investigators demonstrated that new woven bone forms first in regions where there is a gap
in the bone-implant contact [12]. We find that areas of low/no strain strongly support osteoblast
differentiation and new mineralized matrix deposition, provided the osteogenic potential of the bone
is good [22].
4.3. Clinical Implications of this Study
Round-shaped implants can osseointegrate, even when subjected to loading immediately after
placement. Why, then, did we observe that round implants failed to undergo osseointegration?
The answer is straightforward: in those cases where round implants became encapsulated in
fibrous tissue it was because loading was allowed on an implant that lacked sufficient primary
stability (Figure 1). If the same implant—with the same degree of instability—was buried, then
by PID20 it was surrounded by new bone (Figure 3). These data indicate the importance of an
“unloaded” healing period proposed by Branemark [39]. What if the healing period is eliminated?
Our data predict that healing periods between implant placement and loading could be shortened-
or eliminated—without jeopardizing long-term implant success if osteocyte death was minimized
during site preparation, and the implant had a geometry that provided both mechanical stability and
a pro-osteogenic environment.
5. Conclusions
These multiscale biomechanical analyses demonstrated that the novel tri-oval implant design
provided mechanically and biologically favorable environment for peri-implant bone formation and
promoted osseointegration.
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osteocytes in four zones circumscribing the implant. (D–F) The same procedure was used to analyze the minima
regions of tri-oval implants. Abbreviations: imp, implant. Scale bars = 50 μm.; Table S1. Osteotomy and implant
parameters; Table S2. Osteotomy and implant parameters.
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Abstract: Purpose: The aim of this study is to record material- and surface-dependent heat
dissipation during the process of inserting implants into native animal bone. Materials and
Methods: Implants made of titanium and zirconium that were identical in macrodesign were
inserted under controlled conditions into a bovine rib tempered to 37 ◦C. The resulting surface
temperature was measured on two bone windows by an infrared camera. The results of the six
experimental groups, ceramic machined (1), sandblasted (2), and sandblasted and acid-etched surfaces
(3) versus titanium implants with the corresponding surfaces (4, 5, and 6) were statistically tested.
Results: The average temperature increase, 3 mm subcrestally at ceramic implants, differed with high
statistical significance (p = 7.163 × 10−9, resulting from group-adjusted linear mixed-effects model)
from titanium. The surface texture of ceramic implants shows a statistical difference between group
3 (15.44 ± 3.63 ◦C) and group 1 (19.94 ± 3.28 ◦C) or group 2 (19.39 ± 5.73 ◦C) surfaces. Within the
titanium implants, the temperature changes were similar for all surfaces. Conclusion: Within the
limits of an in vitro study, the high temperature rises at ceramic versus titanium implants should be
limited by a very slow insertion velocity.
Keywords: zirconia; dental implant; insertion; bone–implant interface; heat; bone damage; early loss
1. Introduction
Although titanium and its alloys have been used successfully in dental implantology for more
than five decades, there is increasing demand for a nonmetallic alternative.
The alternative material should, of course, retain the good properties of titanium and, if possible,
even improve it and eliminate the disadvantages. These primarily include the color, which can cause
a greyish discoloration of the peri-implant soft tissue in the esthetic area, leading to the patient’s
perception that the replaced tooth root is made of metal. Patients particularly prioritize high simulation
quality for materials used to replace lost tissue. This has led to a similar development in restorative
dentistry, although inlays and onlays made of gold alloy or crowns and bridges with a metal framework
have had excellent long-term clinical results. Nevertheless, their importance is increasingly diminishing
because they are being replaced by all-ceramic restorations, as patients perceive ceramic to simulate
tooth hardness much better than metal. Even metal crowns and bridge frameworks that are nonvisible,
because they are fully veneered, have increasingly been replaced by high-strength ceramic versions.
This trend, which exists in restorative dentistry, now seems to be repeated in oral implantology:
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an artificial tooth root made of ceramic simulates the replaced tissue better than titanium. In other
words, in terms of the choice of materials, patients always opt for, or clinicians always tend to use,
ceramics for replacing tooth tissue.
A major disadvantage of ceramic implants is their early loss that occurs in clinical trials and is
observable in daily practice, which is usually associated with no clinically apparent inflammation.
This phenomenon, described as aseptic loosening, is caused by a lack of osseointegration [1] or linked
to reactivation of the inflammatory immune system [2]. Different forms of bone injury caused by
osteotomy can be eliminated because identical osteotomy protocols are used clinically to create the
bone cavity for titanium and ceramic implants. Only during implant insertion can it be assumed
that there is a higher risk of overheating with ceramics than with titanium because of their different
thermal conductivities. Overheating leads to increased damage or destruction of the bone directly on
the implant surface.
The aim of this study is to record the material-dependent heat dissipation during the process of
inserting implants into native animal bone in an in vitro setup. In addition, the influence of different
implant surface treatments is evaluated. Implants made of titanium and zirconium that were identical
in macrodesign were used for this purpose.
2. Materials and Methods
2.1. Implant Specimen and Surface Treatments
Y-TZP (Yttria–Tetragonal Zirconia Polycrystal) two-piece zirconia implants (5 × 14 mm) from the
BPI system (BPI Biological and Physical GmbH & Co. KG, Sindelfingen, Germany) served in their
packed original state as the specimen for machined ceramic implants. These cylindrical screw implants
were designed with four apical cutting grooves and had a self-cutting property (Figure 1).
Figure 1. Implants made of zirconia and titanium with identical macrodesigns of the endosteal part
coupled with the metallic insertion device.
However, the implants made of titanium from the same manufacturer differed in macrodesign
from the above-mentioned ceramic implants. Therefore, the endosteal parts of the BPI ceramic implants
were re-engineered to match endosteal titanium grade 4 machined parts. To simplify the re-engineering,
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the titanium implants were not manufactured as a two-piece (implant and abutment separable) but as
a one-piece implant system (Figure 1).
In addition to the influence of the implant materials on heat generation at the implant–bone
interface during the insertion process, the effect of an implant surface modification was also investigated.
The topography of each surface type was scanned under a scanning electron microscope (SEM S-4500,
Hitachi, Tokyo, Japan) (Figure 2). The roughness (Sa) of the implant surface in each group was
measured according to ISO-25178 by a laser-scanning microscope (KEYENCE, VK-X100, Osaka, Japan).
Figure 2. SEM images showing results of the different implant surface treatments. Groups 1 and 4:
nontreated machined surfaces; Groups 2 and 5: sandblasted surfaces (corundum mesh size = 110 μm,
working pressure = 6 bar); Groups 3 and 6: sandblasted and acid-etched surfaces (result: hydrophilic).
Based on two different methods of surface treatment, 6 groups of implant specimens were produced:
Groups 1 and 4: nontreated, machined, Y-TZP, two-piece zirconia (group 1) and one-piece titanium
implants (group 4). The machined surface is shown in Figure 2 (Groups 1 and 4). The diameter of both
implants was 5.00 mm.
Groups 2 and 5: once testing with group 1 and 4 implant specimens was finished, each implant
was cleaned by water steam jet and 70% ethanol. The implant was additionally given a microstructure
by sandblasting with corundum (mesh size = 110 μm, working pressure = 6 bar) at an automatic
turning speed of 100 rpm until the diameter of the implants was reduced to 4.95 mm. The SEM images
in Figure 2 (Groups 2 and 5) show the result of the surface treatment.
Groups 3 and 6: Once testing with group 2 and 5 implant specimens was finished, each implant
was cleaned again by water steam jet and ethanol (70%). The sandblasted surface was then acid-etched
to produce a nanostructure showing hydrophilic properties. The result of the acid-etching process is
shown in Figure 2 (Groups 3 and 6). The diameter of the implants was further reduced to 4.90 mm.
2.2. Measurement of Heat Generation and Dissipation
The temperature at the bone–implant interface during insertion was dynamically measured by an
infrared camera PI160 (PI16048T900, Optris, Berlin, Germany). The infrared camera took real-time
images at a frequency of 120 Hz with an uncooled microbolometer focal plane array (FPA) detector with
160× 120 pixels. The sensor had a spectral range from 7.5 to 13 μm and was equipped with a wide-angle
lens with a field of view (FOV) of 48◦ × 37◦. The thermal sensitivity with respect to the relative accuracy
of the camera was 0.1 ◦C, and the minimum measuring distance was 20 mm. The absolute accuracy of
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the measurement was 2 ◦C. The temperature data from the camera were transmitted to the computer
as thermal images, evaluated using Optris PI Connect software, and transferred to a spreadsheet for
statistical analysis.
2.3. Bone Segments
It has been reported that the macroscopic structure of cortex and cancellous bone in the bovine rib
is similar to that in the human jaw, and the bone density dependent on its position could be comparable
to classes I–IV according to Lekholm & Zarb or D2–D4 according to the Mish classification in the
human jaw [3–6]. The distal part of the bovine rib was used and classified as D2/D3 bone. Therefore,
14 ribs were used in this study to simulate the condition in the human jaw. Bone density measurements
have not been made because the friction when inserting cylindrical implants arises mainly on the hard
cortex bone [7,8] if a sufficiently high torque has been generated there (40 to 60 Ncm in this study).
Therefore, when selecting the bone segments, particular care was taken to ensure that the cortical layer
thickness was somewhat the same for all bovine bony ribs [7].
2.4. Experimental Settings
In each experiment, the implant was connected to the screwing unit, ensuring a stable rotational
speed during insertion of the implant. In the screwing unit, the driving force was produced by
a pneumatic cylinder (C85N10-75, ISO air cylinder series C85, SMC Pneumatik GmbH, Egelsbach,
Germany). Then, the motor (DC-servo drive series 3564K024B CS, Faulhaber GmbH & Co KG,
Schöneich, Germany) connected to a gearbox (series 30/1, 134:1, Faulhaber GmbH & Co KG, Schöneich,
Germany) transmitted the force to the torque sensor (DR-20-2Nm; Lorenz Messtechnik GmbH, Alfdorf,
Germany) and the collet holder. The implant was connected to the collet holder by a round-headed
Allen key (3 mm) to allow rotation. The Allen key was loosely fitted to the mounting post of the
implant so that insertion of the implant could remain centered in the prepared bone cavity guided by
implant threads and a cone-shaped apex.
The screwing unit could be driven forward or backward axially, and its movement was recorded by
a linear inductive distance sensor (LVP 100, Micro-Epsilon Messtechnik GmbH & Co. KG, Ortenburg,
Germany). To simulate the environment of surrounding tissues, the bone segment and the implant
were covered in a preheated polycarbonate thermo box (37 ◦C) to prevent heat dissipation. The infrared
camera was fixed to the cover of the thermo box. The complete experimental settings are shown in
Figure 3.
Figure 3. Diagram of the experimental setting. (1) Thermo box; (2) lens of infrared camera; (3) fully
inserted ceramic implant; (4) transection of the rib segment; (5) collet holder (CH); (6) bearing unit (BU);
(7) torque sensor (TS); (8) gearbox (GB); (9) motor (M); (10) linear bearing; (11) pneumatic cylinder;
(12) distance sensor.
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2.5. Experimental Protocol
Fourteen of the zirconia implants (groups 1–3) were included in the whole experiment, and each
implant underwent 3 loops as a result of the surface treatments applied. After each implant had
been assigned to one bovine rib, each bovine rib (BR(1)–BR(14)) was cut into 3 sequential rib segments
(RS1BR(1)–RS3BR(1) to RS1BR(14)–RS3BR(14)). Each implant (I1–I14) would undergo one type of surface
modification (machined (m), sandblasted (sb), sandblasted and acid-etched (ae)) before each test
program (TP1–TP3). The test sequence of the samples and the corresponding rib segments were
organized as follows:
Each implant was inserted into one new rib segment after each surface modification. First,
all machined implants (I1(m)–I14(m)) were inserted into 14 rib segments (RS1BR(1)–BR(14)). Then,
after sandblasting, implants (I1(sb)–I14(sb)) were inserted into rib segments (RS2BR(1)–BR(14)). Finally,
after acid-etched treatment, implants (I1(ae)–I14(ae)) were inserted into rib segments (RS3BR(1)–BR(14)).
Surface modification usually took several days. In order to maintain the bone in the same fresh
condition in all the tests, bone segments were frozen beforehand in Ringer’s solution at −10 ◦C and
were defrosted immediately prior to the experiment.
The titanium implants underwent identical protocols. Since they were made especially for this
study, a higher number of pieces was available at the beginning of the trial. Therefore, with torques
outside the interval of 40 to 60 Ncm, new Ti implants were used to repeat the insertion test so that
15 measurements per group could be realized (Table 1). The selected torque window was clinically
sufficient for immediate restoration of ceramic implants (>35 Ncm), which are often still used as
one-piece implants. Furthermore, smaller torques do not produce sufficiently high temperatures by
friction between the implant surface and the hard cortical bone [8] to be able to detect the effect of
different thermal conductivities between titanium and ceramic at the bone–implant interface.
Contrary to Ti implants, for this study only 14 ceramic implants were available from the
manufacturer. Therefore, when the torque was too low or too high, bone penetration tests with the
respective surface structure were no longer repeated in order to mechanically protect the connection of
the implant driver with the ceramic implant. In addition, cleaning the surfaces of bone remnants would
have been a process in which, above all, the roughened ceramic surfaces could have been structurally
changed; thus, the equality of specimens could no longer be ensured. Because of this limitation of
available ceramic implants, only 8 measurements in group 1, 11 measurements in group 2, and 11
measurements in group 3 could be realized (Table 1).
When one test started, the selected bone segment would be defrosted in Ringer’s solution at 37 ◦C
and stored at the same temperature in the oven to simulate the human condition.
The implant bed was prepared using a twist drill (Type N, 118◦ DIN 338 R-N, Gühring KG,
Albstadt, Germany) at the speed of 800 rpm. Since the bone was already wetted, additional water
cooling was not necessary. To ensure a comparable insertion resistance in the three loops, the diameter
of each implant site matched the implant diameter, that is, twist drills with diameters of 4.3, 4.25,
and 4.20 mm were used in loops 1, 2, and 3, respectively.
To dynamically record temperature directly at the bone–implant interface, two bone windows
perpendicular to the insertion path were made at 3 and 9 mm subcrestally by a twist drill (Figure 4).
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Figure 4. Dynamic temperature record at the bone–implant interface. (a) Transection of a rib segment;
(b) overview of a rib segment; (c) infrared image at T3 in Figure 5; (d) infrared image at T7 in Figure 5.
I-C = Implant Cavity 1; B-W 1 = Bone Window 1; B-W 2 = Bone Window 2.
Figure 5. Cont.
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Figure 5. Box plots comparing (A) insertion torque, (B) cortical bone thickness, and (C) roughness.
Before each test, the bone was brought to a temperature of 37 ◦C inside an oven with saturated
humidity. After the bone segment was immobilized, the implant was prewetted in Ringer’s solution
used to simulate human blood, and then it was driven with a starting pressure of 5 N and a constant
rotational speed of 25 rpm to a depth of 12 mm inside the bone. Meanwhile, the infrared camera
continuously recorded the temperature through each bone window (2b & T7 in Figure 5), and the
difference between the maximum and the starting temperature (37 ◦C) during insertion would be
calculated (ΔT). The change of torque was recorded by torque sensors (DR-20, Lorenz Messtechnik
GmbH, Alfdorf, Germany) with the frequency of 100 Hz. Data from groups in which the insertion
torque was above 60 Ncm or below 40 Ncm were excluded from the analysis.
After each experiment, the thickness of cortical bone at the insertion point was measured with
a caliper gauge. When the temperature, measured at the position 3 mm subcrestally, exceeded
47 ◦C (ΔT >10 ◦C) [9], 50 ◦C (>13 ◦C) [10], or 55 ◦C (>18 ◦C) [11], the corresponding exposure time
was calculated.
2.6. Statistical Analysis
Continuous variables are represented as mean ± standard deviation for each group. Comparisons
were performed using the Mann–Whitney U test, t-test, or paired t-test. Comparisons with more than
2 groups were analyzed by ANOVA or the Kruskal–Wallis test, depending on Gaussian distribution.
Additionally, comparisons using adjusted linear mixed-effects models (LMEs) were performed.
Gaussian distributions of data were assessed with the Shapiro–Wilk test. The level of significance
in post hoc tests was corrected for multiple testing. The level of significance was set at α = 0.05,
and all tests were two-sided. Statistical analysis was performed using R 3.6.1 with the packages
multicomp 1.4-10, nlme 3.1-140, and plotrix 3.6-3. R, and the packages used are available from CRAN
at http://CRAN.R-project.org/.
3. Results
3.1. Group-Related Parameters of Specimens and in Vitro Setup
To ensure that temperature change assessments were comparable with each other, only the
implants with insertion torque between 40 and 60 Ncm were included in the analysis. Six machined
and three sandblasted implants (groups 1 and 2, respectively) that exceeded an insertion torque of
60 Ncm, and three sandblasted etched implants (group 3) that had an insertion torque under 40 Ncm,
were excluded from the analysis. From groups 4 to 6, all 15 specimens were analyzed. The resulting
insertion torque was comparable for all 6 groups (group 1: 52.61 ± 5.10 Ncm; group 2: 48.97 ± 6.43
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Ncm; group 3: 48.79 ± 5.19 Ncm; group 4: 50.10 ± 8.69 Ncm; group 5: 50.99 ± 7.97 Ncm; group 6:
50.72 ± 7.22 Ncm; p > 0.05; Figure 5a.).
The thickness of the cortical plate of the bovine bone rib was similar between the 6 groups (group
1: 2.51 ± 0.25 mm; group 2: 2.75 ± 0.47 mm; group 3: 2.61 ± 0.39 mm; group 4: 2.46 ± 0.12 mm; group 5:
2.46 ± 0.12 mm; group 6: 2.42 ± 0.09 mm; p > 0.05; Figure 5b).
The average roughness (Sa) of the machined implants (group 1: 0.93± 0.16μm; group 4: 0.37 ± 0.04)
was, as expected, significantly lower than that of sandblasted implants (group 2: 1.86 ± 0.38 μm; group
5: 2.15 ± 0.24 μm; all comparisons have p-values < 0.001) and sandblasted and acid-etched implants
(group 3: 2.14 ± 0.62 μm; group 6: 1.89 ± 0.18 μm; all comparisons have p-values < 0.001; Figure 5c).
The difference in surface roughness between ceramic and titanium implants after sandblasting
(group 2 vs. group 5) and after sandblasting and acid-etching (groups 3 vs. 6) was not statistically
significant (p > 0.05). The roughness between the machined surfaces (groups 1 and 4) was not
statistically significant (p > 0.05). In paired comparisons of the surface treatments, the machined and
the sandblasted groups showed significant differences (groups 1 and 4 p = 1.213 × 10−4; groups 2
and 5 p = 0.025756). The sandblasted and acid-etched groups (groups 3 and 6) showed no significant
differences (p > 0.05).
3.2. Maximum Temperature Increase
3.2.1. Bone Window 1
In bone window 1 (located 3 mm subcrestally), the average temperature increase at the zirconia
implants had a high statistically significant difference to that of titanium implants (p = 7.163 × 10–9,
resulting from group-adjusted linear mixed-effects models).
Within the zirconia implants (groups 1: 19.94 ◦C ± 3.28 ◦C; 2: 19.39 ◦C ± 5.73 ◦C; 3:
15.44 ◦C ± 3.63 ◦C) there were significant differences between groups 2 and 3 (p = 0.04426) and
groups 1 and 3 (p = 0.007525; Figure 6). By contrast, there was no significant difference between the
comparison of groups 1 and 2 (p > 0.05).
Figure 6. Box plots showing rise of temperature at bone window 1—results of all 6 groups.
Within the titanium implants (group 4: 9.33 ◦C ± 4.18 ◦C; group 5: 9.20 ◦C ± 3.31 ◦C; group 6:
7.68 ◦C ± 2.68 ◦C), the temperature changes were similar for all groups (p > 0.05).
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In paired comparisons of the different materials with the identical surface treatments, all groups
showed highly significant differences (groups 1 and 4 p = 3.728 × 10–11; groups 2 and 5 p = 7.721 × 10–6;
groups 3 and 6 p = 1.725 × 10–6 Figure 6).
3.2.2. Bone Window 2
In bone window 2 (located 9 mm subcrestally), the average temperature increase at the zirconia
implants had a high statistically significant difference than that of titanium implants (p = 7.182 × 10–12,
resulting from group-adjusted linear mixed-effects models).
Within the zirconia implants (group 1: 7.50 ◦C ± 2.64 ◦C; group 2: 6.14 ◦C ± 2.40 ◦C; group 3:
6.07 ◦C ± 3.11 ◦C), the temperature changes were similar for all groups (p > 0.05).
Within the titanium implants (group 4: 6.03 ◦C ± 3.69 ◦C; group 5: 4.33 ◦C ± 3.26 ◦C; group 6:
4.41 ◦C ± 2.47 ◦C), the temperature changes were similar for all groups (p > 0.05).
3.3. Overheating Exposure Time
3.3.1. Bone Window 1
ΔT > 10 ◦C
In bone window 1, the average exposure times under ΔT > 10 ◦C at the zirconia implants were
39.06 s for machined (all 8 of 8 in group 1), 28.10 s for sandblasted (11 of 11 in group 2), and then
decreased to 20.37 s for sandblasted etched implants (10 of 11 in group 3). The average exposure times
under ΔT >10 ◦C at the titanium implants were 22.49 s for machined (7 of 15 in group 4), 23.05 s for
sandblasted (6 of 15 in group 5), and then decreased to 17.45 s for sandblasted etched implants (2 of 15
in group 6). None of the tested implants experienced a temperature increase of more than 10 ◦C over a
period of more than 60 s.
ΔT > 13 ◦C
The average exposure time under ΔT >13 ◦C for ceramic implants was 25.10 s in group 1, 16.93 s
in group 2, and 10.19 s in group 3. Three machined implants (group 1: 42.2, 36.1, and 32.1 s) and two
sandblasted implants (group 2: 34.6 and 33.2 s) experienced more than 30 s temperature increase of
over 13 ◦C. No sandblasted and acid-etched implants (group 3) experienced such a temperature change
for longer than 30 s.
The average exposure time under ΔT >13 ◦C for titanium implants was 19.03 s at 3 of 15 implants
in group 4 (group 4: 19.8, 21.8, and 15.6 s). Two machined implants experienced more than 13 ◦C
temperature increase (group 5: 13.9 and 17.4 s) No sandblasted and acid-etched implants (group 6)
experienced a temperature increase of 13 ◦C or more.
ΔT > 18 ◦C
The average exposure time under ΔT > 18 ◦C for ceramic implants was 11.36 s at 5 of 8 implants in
group 1, 7.98 s at 6 of 11 implants in group 2, and 0.43 s at 3 of 11 implants in group 3. Two machined
ceramic implants (group 1: 25.4 and 14.2 s) and two sandblasted ceramic implants (group 2: 19.0 and
16.7 s) experienced a temperature increase of more than 18 ◦C for more than 14 s. No sandblasted and
acid-etched implants (group 3) experienced a temperature change greater than 18 ◦C for more than 14 s.
Only one titanium implant (group 4) exceeded 18.70 ◦C and had an exposure time of 20.40 s for
ΔT > 18 ◦C.
3.3.2. Bone Window 2
In bone window 2, the temperature increase never exceeded values > 10 ◦C.
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3.4. Material-Dependent Thermal Energy Propagation
Figure 7 shows the image captured by the infrared camera during the process of inserting
titanium and ceramic implants, both with sandblasted and acid-etched surfaces. Prior to the insertion
process—meaning the implants were completely outside of the bone cavity—there was very little
temperature difference between the titanium implant (33.2 ◦C) and the ceramic implant (31.2 ◦C).
Bone window 1 shows the nearly regulated temperature of the thermo box (Figure 3) encapsulating
the in vitro setup (37.5 ◦C; 37.2 ◦C).
Figure 7. Material-dependent heat dissipation. (a) ceramic implant before insertion; (b) ceramic
implant during insertion; (c) titanium implant before insertion; (d) titanium implant during insertion.
At the moment of maximum temperature development during implant insertion, the ceramic
implant was heated to 48.7 ◦C below the cortical bone (bone window 1) and to 33.6 ◦C outside the
bone. In contrast, the titanium implant showed 42.9 ◦C within bone window 1 and 38.0 ◦C outside the
bone. Thus, at the same distance, the titanium implant had a 3 times lower temperature gradient than
the ceramic implant during the insertion process (ΔTceramic = 15.1 ◦C vs. ΔTtitanium = 4.9 ◦C).
The summary of all results is shown in Table 1.
4. Discussion
The aim of the in vitro study was to dynamically detect heat development at the bone–implant
interface during the entire process of inserting a cylindrical screw implant into bone. For this purpose,
an in vitro setup was developed, which achieves the highest possible quality of simulation of the
clinical conditions and uses of test specimens, which differ in only one parameter, as far as possible.
4.1. Identical Specimen
It was important for good reproducibility of the temperature values at the implant surface that
the implant specimens had an identical endosteal macrodesign and were identically manufactured
(Figures 1 and 2). The measured surface roughness (Figure 5b) did not differ significantly between the
ceramic (ZrO2) and titanium implant materials in the sandblasted and sandblasted-etched surfaces.
Only on the machined implants was the titanium surface statistically significantly smoother.
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Repetition of the test series with the same implants after each additional surface treatment
allowed for a nearly identical macrodesign with a different microdesign. Only removal of material by
subtractive surface treatment caused a reduction in implant diameter. However, this was recorded by
measurement and taken into account in the osteotomy protocol. In other words, the last cutter for
bone preparation was also correspondingly smaller in diameter.
4.2. In Vitro Setup
Several published articles reporting on heat development when screwing an implant into the
bone cavity have used bovine bone [12], in particular the bovine rib [9,10,13–16]. Bone segments with a
cortical thickness of around 2.5 mm were chosen in order to mimic the known thickness of the human
mandible (1.0–2.5 mm) [17–19] and to ensure the almost same amount of friction between bone and
implant surfaces [7,8]. The temperature rise was generated in the ceramic implant mainly in the cortex
bone (see bone window No. 1). In cancellous bone, however, there were no statistically significant
differences in the temperature increase. This reinforces the assumed mechanism of temperature
generation: in the case of a sufficiently high torque (40–60 Nm) and a conventional screw thread,
most of the friction is generated between hard bone and the implant surface. Only special aggressive
threads—for example, in Nobel Active in spongy bone, a mechanism other than friction—can generate
high torque or primary stability—compression of trabeculae. Therefore, in the selection of the bone
ribs, particular attention was paid to a comparable layer thickness of the cortex [7]. Since the spongy
part of the rib in the present macrodesign of the examined implants (cylindrical, conventional screw
thread) hardly generates any friction or heating, determination of the bone mineral density was omitted.
Therefore, a high variation in the bone density in the spongy region of the rib probably has no influence
on the measurement results in bone window 2.
Although blood circulation was absent in this case, the remaining conditions such as the chemical
composition, density, humidity, structure, as well as mechanical and thermal properties were similar to
those of the human bone. By contrast, artificial bone models cannot properly simulate the human bone
because there are huge differences in thermal conductivity and heat capacity [20].
The anatomical structure—cortical bone and the underlying cancellous bone—are suitable for
simulation of a toothless, healed alveolar bone. In order to keep the high anatomical variance of bovine
ribs reasonably small in this investigation, the ribs were frozen after a test run so that measurements
could at least be done on the identical bovine rib after the respective surface treatment of the implants
for the second and third test runs.
An infrared camera (Figure 3) measured the temperature during the insertion process. In contrast
to this investigation, Markovic et al. [21] captured the temperature at the surface of a bone segment.
The two bone windows in this study allowed temperature to be measured directly on the implant
surface. As a result, system-related measurement distortions due to differently positioned temperature
probes in peri-implant bone could be avoided [9,10,13–16].
The above factors resulted in a relatively small variation of the temperature values per experimental
group (Figures 6 and 7). Thus, the goal of good reproducibility of the measurement conditions
was achieved in the experimental setup used. In addition, the direct measurement of the surface
temperature of the implants makes the nonsimulated, cooling effect of a well-perfused bone marrow
smaller than with probes placed in the peri-implant bone [9,10,13–16]. Furthermore, the low
thermal conductivity of bone (approximately 1/100 of titanium) can lead to thermal isolation of
the sensors. The temperature-controlled thermo box (Figure 3(1)) additionally contributed to the good
reproducibility of the measured temperature values (Figure 7).
In the selection of bovine ribs, care was taken to ensure that the layer thickness of the cortical bone
did not differ a great deal (Figure 5b). It is apparent that, in a cylindrical implant, the heat generated by
friction is primarily generated by the hard cortical bone and only slightly by the soft cancellous bone
located below. The torques achieved during the insertion process were another indicator of identical
experimental conditions: trial implants were hardly distinguishable in macro- and microdesigns
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and comparable layer thicknesses of the cortical bone (Figure 5a). In this study, the experimental
parameters were chosen to simulate a high insertion torque (40–60 Ncm). It was above the average
level suggested by most manufacturers (35 or 45 Ncm); nevertheless, this range was still below the
maximum endurance for the ceramic implants.
In the case of rare outliers in insertion torques, the temperature readings were not included in the
evaluation, but the complete measurement was repeated with the respective implant.
The remaining parameters (ambient temperature, rpm and feed at insertion, and dimension of the
bone cavity) were kept reproducible and constant with conventional control circuits in the experimental
setup (Figure 3).
4.3. Temperature Increase at Bone Window 1
The implant surface temperatures just below the cortical bone were highly significantly
different between the ceramic and titanium implants. Statistical evaluation was performed using a
group-adjusted linear mixed-effects model.
The increased temperature of the ceramic implant was due to its poor thermal conductivity. It was
2.5 W/mK and, thus, nearly ten times lower than titanium (22 W/mK). The thermal energy generated at
the bone–implant interface during insertion dissipated poorly over the ceramic implant at locations
further away. The thermal energy remained at the place of its formation and led to a higher temperature.
This phenomenon is visible in Figure 7 from the infrared camera image. During the insertion process,
the ceramic implant outside the bone (33.6 ◦C) heated up significantly less than the titanium implant
(38.0 ◦C) under nearly identical experimental conditions. This means that much more heat (48.7 ◦C)
was created in the bone at window 1 on the ceramic implant surface than in the titanium implant
(42.9 ◦C). The increase in temperature, due to the greatly reduced thermal conductivity of ceramics,
can hardly be reduced by intensive water cooling because the water has no access to the implant–bone
interface during screwing-in of the implant [8], and the poor heat conduction of ceramics only cools
the implant, which is not yet in the bone. It is obvious that only an extremely slow insertion of the
implant can reduce the heating of the cortex bone [7,8,12,22].
Analysis of the temperature in bone window 1 (Figure 6) for all six experimental groups again
showed a statistically significant increase in temperature at the ceramic implant compared to the
titanium implant, regardless of the surface structure. However, the increase in temperature of ceramic
implants with sandblasted and acid-etched surfaces (15.44 ◦C) was statistically significantly smaller
than that with the machined (19.94 ◦C) or purely sandblasted (19.39 ◦C) ceramic surface. This effect
of surface modification could possibly occur as a result of the high porosity of the sandblasted and
acid-etched surface of ZrO2 implants (Figure 2). In particular, it shows nanoscopic pores smaller
than 500 nm. This type of pore is too small to be reflected in the roughness average (Sa) but can be
filled with blood and other tissue fluids, which in turn can function as heat storage and a cooling
fluid. In other words, the blood and tissue fluid on the surface are heated. The heat capacity of
water is 4.182 kJ/kg/K, which is more than 10 times higher than that of zirconia at 0.4 kJ/kg/K, and the
density of zirconia is 6.08 g/cm3, which is 6 times higher than that of water. Thus, in order to increase
the temperature of blood or tissue fluid on the blasted and acid-etched surface by 1 ◦C, a 1.72 times
higher heat energy would be required than in the ZrO2 surfaces without fluids captured in nanoscopic
pores—like machined (group 1) or sandblasted surfaces (group 2), where the latter results in a higher
temperature increase at the implant–bone interfaces (Figure 6).
Another explanation of the result is based on a tribological effect [23]. Improved lubrication by
the fluid trapped in the nanoscopic pores produces reduced heat development as it rotates through the
cortical bone.
However, the temperature increase in the titanium implants is independent of their surface
condition (Figure 6). This result might be related to good thermal conductivity, which allows rapid
cooling of the titanium surface in bone window 1. In the bone window itself, there is no friction caused
by close-fitting peri-implant bone.
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4.4. Temperature Increase at Bone Window 2
The temperatures at the implant surface occurring in cancellous bone were different between the
ceramic and titanium implants. Statistical evaluation was performed using a group-adjusted linear
mixed-effects model.
The inter-group comparison (Figure 8) shows no statistically significant differences in temperature
increase with respect to the test parameters of implant material and surface texture. Owing to low
rigidity and the tissue structure interspersed with fat, the cancellous bone causes considerably less
friction at the implant–bone interface than at the stiff and hard cortical bone. Therefore, the different
thermal conductivities of the ceramic and titanium implants probably play a minor role in the
temperature increase in bone window 2.
Figure 8. Box plots showing rise of temperature at bone window 2—results of all 6 groups.
4.5. Differences in Bone Window 1 versus Bone Window 2
In this study, the bone windows for heat measurement were prepared 3 and 9 mm subcrestally in
order to measure the change of the bone–implant interfacial temperature during implant insertion at
the positions near the cortex and inside the implant cavity, respectively. As expected, the interfacial
increase of temperature near the cortex was higher than that deep in the cancellous bone, regardless
of the surface modification. In the study by Sener et al., the highest temperature in the process of
preparing the implant bed was also observed in the superficial part of the implant cavity, and the heat
decreased in the direction of the implant apex [17].
The different structure of cortical and cancellous bone as well as the higher frictional coefficient
of hard cortical bone can lead to different frictional effects on the bone–implant surface; furthermore,
the bone region at window 1 is exposed to friction for a longer time than the region of window 2 near
the apex of the implant cavity. These factors, combined with the different thermal conductivities of the
cortical and cancellous bone, result in more heat energy produced and accumulated in the cortical part
during implant insertion.
Previously published studies showed different temperature increases during insertion of a titanium
implant (0.55–9.81 ◦C) [12,21,24,25]. This might be due to temperatures being measured at the outer
surface of the bone segment [24] or at a distance of 0.5–1 mm from the implant [12,21,25]. In addition,
Sumer et al. [9] found more heat was generated with ceramic drills than with stainless steel drills at the
superficial part of the drilling cavity.
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4.6. Heat Caused Damage to Peri-implant Bone
The damage to the bone caused by overheating is related to the time it is exposed to the
heating [26–28]. The higher the bone–implant interfacial temperature, the shorter the time it takes
for bone damage to appear [26]. Eriksson and Albrektsson claim that bone damage occurs when the
bone–implant interfacial temperature reaches at least 47 ◦C for 1 min [27]. As a result, the primary
stability of the implants would decrease, and implants might loosen shortly after loading [28].
Furthermore, it was shown by Lundskog [26] that osteocytes underwent necrosis as soon as the bone
was exposed to 50 ◦C for more than 30 s. Schmelzeisen et al. [28] showed that a temperature between
50 and 60 ◦C caused irreversible damage to osteocytes for an exposure time of 8 to 20 s. Based on that
study, the median values of 55 ◦C and 14 s were applied as critical parameters in the current study.
The interfacial temperature of ceramic implants measured near the cortical plate (bone window 1)
were 56.94 ◦C on machined, 56.39 ◦C on sandblasted, and 52.43 ◦C on sandblasted-etched implants,
with the starting temperature of 37 ◦C. Thus, the potential for bone damage induced by overheating
was present on each surface. However, the heat and the relative exposure time decreased with the
sandblasted and acid-etched surfaces, suggesting that the risk of bone damage could be reduced with
proper surface modification.
Nevertheless, the results of this in vitro study might not fully represent the reality under clinical
conditions [11,29]. The difference resulting from blood circulation and the thermal conductivity
between nonlive and live tissues can influence the change in interfacial temperature [26]. Since the
blood flow is six times higher in cancellous bone than in cortical bone, and blood can absorb part of the
heat produced during implant insertion, the interfacial temperature increase in the cancellous bone is
supposed to be smaller than that in the cortical bone. In view of this fact, the authors did not expect a
significant cooling effect inside a patient’s cortical bone.
Based on this study, the heat produced during the implant insertion process mainly depends on
the implant material and less on surface modification.
5. Conclusions
The results of this in vitro study show a temperature rise that is dangerous for the peri-implant
cortical bone when a ceramic implant is inserted. Despite limited transferability to the clinical situation,
the authors recommend a very slow insertion velocity for ceramic implants to avoid early implant losses.
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Abstract: Background: The intraosseous temperature during implant installation has never been
evaluated in an in vivo controlled setup. The aims were to investigate the influence of a drilling
protocol and implant surface on the intraosseous temperature during implant installation, to evaluate
the influence of temperature increase on osseointegration and to calculate the heat distribution in
cortical bone. Methods: Forty Brånemark implants were installed into the metatarsal bone of Finnish
Dorset crossbred sheep according to two different drilling protocols (undersized/non-undersized)
and two surfaces (moderately rough/turned). The intraosseous temperature was recorded, and
Finite Element Model (FEM) was generated to understand the thermal behavior. Non-decalcified
histology was carried out after five weeks of healing. The following osseointegration parameters
were calculated: Bone-to-implant contact (BIC), Bone Area Fraction Occupancy (BAFO), and Bone
Area Fraction Occupancy up to 1.5 mm (BA1.5). A multiple regression model was used to identify the
influencing variables on the histomorphometric parameters. Results: The temperature was affected by
the drilling protocol, while no influence was demonstrated by the implant surface. BIC was positively
influenced by the undersized drilling protocol and rough surface, BAFO was negatively influenced
by the temperature rise, and BA1.5 was negatively influenced by the undersized drilling protocol.
FEM showed that the temperature at the implant interface might exceed the limit for bone necrosis.
Conclusion: The intraosseous temperature is greatly increased by an undersized drilling protocol but
not from the implant surface. The temperature increase negatively affects the bone healing in the
proximity of the implant. The undersized drilling protocol for Brånemark implant systems increases
the amount of bone at the interface, but it negatively impacts the bone far from the implant.
Keywords: oral implants; osseointegration; implant installation; anchorage technique; histology;
osteotomy; intraosseous temperature; in vivo study; finite element model
1. Introduction
Despite the high success rate of dental implants [1,2], early and late implant failures are still
encountered [3,4]. It is known that the surgical approach is one key-factor for successful implant
treatment [5]. It was advocated that an optimal surgical technique should provide initial mechanical
implant stability necessary for the initiation of the osseointegration process [6,7]. Simultaneously,
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implants should be installed with a gentle and atraumatic surgical technique, avoiding excessive
biomechanical and thermal stresses to the bone [8].
Undersized drilling is one of the most common surgical techniques for increasing primary implant
stability. With this technique, an implant is installed in a substantially smaller osteotomy than its
diameter [9]. The rationale of such a procedure is to maximize the initial implant contact with the
bone locally and, thus, secure the implant stability [10]. This approach increases the implant rotational
resistance, measured as the insertion torque value (ITV) [11]. This condition is often considered
desirable [12], especially when immediate or early loading protocols are applied [13].
However, there are some concerns among researchers and clinicians regarding the host bone
reaction to increased lateral compression, especially when the cortical bone layer is involved [14].
Excessive stresses and strains beyond bone physiological limits can have disadvantageous effects
on the local microcirculation and bone cellular responses, leading to so-called bone compression
necrosis [15]. In vivo studies and clinical research reported an extensive area of apoptotic osteocytes,
tissue damage, and ultimately peri-implant bone loss [16–18]. Moreover, previous consensus reports
indicated compression necrosis as a possible risk factor for peri-implant tissues disease [19,20].
Besides the over-compression of the pristine bone, a thermal injury may be an additional factor
inducing bone necrosis. When the bone is heated above 53 ◦C, irreversible tissue damage was
observed [21], while 47 ◦C for 1 min is considered as the border condition for the occurrence of an
injury [22]. Although the risk of bone overheating during the drilling procedure was extensively
investigated [23], the increase of temperature during implant installation, was seldom reported [24].
During the seating into an osteotomy site, energy is supplied to the bone and part of it is transferred as
frictional heat [25]. According to thermodynamics, thermal energy is partially absorbed and conducted
by the implant itself, and by the bone, in the form of temperature increase [26].
It is unknown whether the frictional heat generated during implant installation can cause
an increase in bone temperature exceeding the threshold of initiating irreversible tissue damage.
The temperature may be influenced by several factors, including implant-osteotomy size discrepancy
and implant micro-design. One could postulate that the installation of an implant in an undersized
osteotomy and the use of a moderately rough surface would generate a greater temperature increase in
the bone than a larger osteotomy and a turned surface.
However, the in vivo intraosseous temperature during implant installation was never previously
evaluated in a controlled experimental setting. Besides that, the effect of such temperature on
histomorphometric parameters is unknown.
The primary aim of this in vivo study was to investigate the influence of the drilling protocol
and implant surface on the intraosseous temperature change during dental implant installation.
The secondary aims were to evaluate the influence of the temperature on osseointegration and
peri-implant bone healing and to calculate the heat distribution in cortical bone.
2. Materials and Methods
2.1. Study Design and Samples
This study was approved by the ethical committee of the Ecole Nationale Vétérinaire d’Alfort,
Paris, France, (reference number: 02343.03) and it is reported according to the ARRIVE (Animal
Research Reporting of in Vivo Experiments) guidelines [27]. Ten female Finnish Dorset crossbred sheep
(average; years old and 54 kg) were used and housed together for one week before surgery. A total of
forty 3.75 mm × 7 mm dental implants (Brånemark system® MKIII RP implant, Nobel Biocare AB,
Göteborg, Sweden) were installed, including 20 implants with moderately rough oxidized titanium
surface (TiUnite® surface) and 20 implants with a turned surface. The present implant surfaces,
investigated by a broad variety of preclinical and clinical research [28–30], presents the following
surface characteristics according to Wennerberg and Albrektsson with the parameters Sa (the arithmetic
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average height deviation from mean plane) and Sdr (the developed surface ratio): 1.1 μm and 0.9 μm
(Sa); 37% and 34% (Sdr) for TiUnite® and turned surface, respectively [31].
2.2. Surgical Procedures
All surgeries were done under general anesthesia with ketamine (Imalgene 1000®, Merial,
Villeurbanne, France), and diazepam (Valium, Roche, Boulogne-Billancourt, France) for injection,
and with 2.5% isoflurane (Forane®/Forene®, Drägerverk AG, Lubeck, Germany) for inhalation.
The surgical room had a controlled temperature set at 19 ◦C.
In each sheep, the metatarsal bone of one leg was shaved and disinfected with 40% ethanol and
0.5% chlorhexidine. After skin incision, the bone was exposed with periosteal elevator, and 4 implants
were installed in the ventral metatarsal bone plate, consisting of approximately 4 mm of cortical bone,
along the longitudinal direction.
Based on the drilling protocol and implant surface topography, four experimental groups were
designed as showed in Table 1.
Table 1. Description of the experimental groups.
Drilling Protocol Implant Surface
Group A (n = 10) Undersized Moderately rough
Group B (n = 10) Non-undersized Moderately rough
Group C (n = 10) Undersized Turned
Group D (n = 10) Non-undersized Turned
Each metatarsal bone received one implant per group. The sequence of the implantation for
each metatarsal bone, according to the experimental group (A, B, C, D) was randomized by a
computer-generated method, Microsoft® excel (Version 15.30). The sequential implant osteotomies
were free-hand prepared at approximately 20 mm inter-implant distance.
The surgical instrumentation sequence was performed following two different drilling protocols.
In all groups, a 2.0 mm drill, 2.8 mm step drill, and 3.0 mm drill were used. Hereafter, the osteotomy
was finalized based on the group (Figure 1a):
• Group A and C (undersized drilling protocol): 3.2 drill and tap drill were subsequently used for
the preparation of the coronal 1.5 mm, in order to favor the engagement of the first threads during
the implant installment.
• Group B and D (non-undersized drilling protocol): 3.2 drill and tap drill were subsequently used
for the entire thickness of the cortical bone.
All drilling procedures were performed at 1200 rpm under abundant saline irrigation using a total
of two new drill sets. Implant installation was carried out at 25 rpm without saline irrigation. Both the
drilling procedure and implant installation were performed using a SA-310 W&H Elcomed implant
unit (W&H, Burmoos, Austria). The insertion torque value (ITV) was recorded using the specific
function and saved to a USB memory. Implants where ITV exceeded 80 Ncm during installation were
manually installed by a manual torque wrench. Based on the ITV, three classes were distinguished: ITV
≤ 45 Ncm; 45 < ITV < 80 Ncm; ITV ≥ 80 Ncm. The flap was closed using a resorbable suture (Vicryl™,
Ethicon®, Sommerville, NJ, USA) for the inner layer and non-absorbable suture for the external layer
(Ethicon™, Ethicon®, Sommerville, NJ, USA). Morphine (0.1 mg/kg) was given intravenously every
second hour during the operation and subcutaneously for the three first postoperative days.
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Figure 1. (a) Representation of the osteotomy preparation: the undersized drilling protocol on the
left and non-undersized drilling protocol on the right. The osteotomy dimensions are depicted in
the figures. The thermocouple site was prepared 2 mm deep into the cortical bone and 1 mm from
the implant surface. (b) Overview of the surgical field with the thermocouple in position before
implant installation (left) and during implant installation (right). (c) Representation of the regions of
interest for histomorphometrical parameters. Bone-to-implant Contact (BIC) was calculated only for
the cortical portion. Bone Area Fraction Occupancy (BAFO) was calculated in the blue part. Bone Area
1.5 (BA1.5) was calculated in the yellow part. (d) The Finite Element Model (FEM) was composed of
three cylindrical elements: Cortical bone, bone marrow, and implant.
2.3. Temperature Measurement
Intraosseous temperature was measured using the type-K thermocouple (Omega Engineering
Limited, Manchester, UK) with a 0.5 mm tip, coupled to a HH12C handheld thermometer (Omega
Engineering Limited, Manchester, UK). This dual-channel meter device is able to record the lower and
maximum temperature with 2.5 measurements per second and a resolution of 0.1 ◦C. The tip of the
thermocouple was inserted in a prepared drilled hole in the proximity of the implant osteotomy. More
in details, the thermocouple site was prepared in a predetermined position in a proximal or distal site
at 1 mm from the implant surface (Figure 1a) with the aid of a metal surgical template. To prepare
the site, which had a diameter of 0.5 mm and a depth of 2 mm, a lance drill (Precision Drill, Nobel
Biocare AB, Göteborg, Sweden) was used. To ensure the reproducibility of the hole depth, the drill was
inserted until the marked line met the upper border of the template. Once the osteotomy was prepared,
the thermocouple was inserted and kept the position until the thermometer showed a stable value
(basal temperature). The installation of the implants was carried out approximately 1 min after the
finalization of the drilling procedure. During the implant installation, the temperature was measured,
and the maximum value was recorded as the maximum value (Figure 1b). The difference between the
maximum and basal temperature for each site was calculated as the temperature change.
2.4. Preparation of Samples
After a healing period of five weeks, all animals were euthanized with an intravenous injection of
a combination of 4000 mg embutramide, 538.4 mg mebezonium, and 87.8 mg tetracaine (T61, Intervet
International, Unterschleißheim, Germany) and metatarsal bone blocks containing the implants
were retrieved. Blocks were fixed in 4% formalin for seven days before dehydration by ascending
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concentration of ethanol, and embedded in light-curing methylmethacrylate (Technovit 7200 VLC,
Heraeus Kulzer, Wehrheim, Germany) for undecalcified ground section procedures. The embedded
bone samples with implant were sectioned parallel to the long axis at the center position of the
implant using a diamond saw cutting machine (EXAKT 300, EXAKT Advanced Technologies GmbH,
Norderstedt, Germany), and grinded and polished until a final section thickness of 30 μm (EXAKT
400CS, EXAKT Advanced Technologies GmbH, Norderstedt, Germany). The non-decalcified sections
were stained in toluidine blue and pyronin G, and photographed using light microscopy with a digital
imaging system (NanoZoomer S210, HAMAMATSU, Shizuoka, Japan).
2.5. Histomorphometric Analysis
Quantitative histomorphometry was performed considering the cortical layer only. All measurements
were carried out with an image analysis software (Image J v.1.43u, National Institute of Health).
The following variables were calculated:
• Bone-to-implant contact (BIC): On each side of the implant, the percentage of the bone in direct
contact with the implant surface in the entire length of the implant placed in the bone was
calculated. The mean value of the two sides was used for each implant.
• Bone Area Fraction Occupancy (BAFO): On each side of the implant, the percentage of the area
within the implant threads occupied by visibly distinguishable bone was calculated. The mean
value of the two sides was used for each implant.
• Bone Area Fraction Occupancy up to 1.5 mm (BA1.5): On each side of the implant a region of
interest up to 1.5 mm from the implant outer diameter line was considered (Figure 1c). The
percentage of the area occupied by visibly distinguishable bone was calculated. The mean value
of the two sides was used for each implant.
2.6. Finite Element Model
In order to have a deeper understanding of the thermal behavior at the peri-implant bone, a
Finite Element Model (FEM) was generated (Figure 1d). The model was composed of three cylindrical
elements: Cortical bone (dimensions: 5 mm × 4 mm), bone marrow (dimensions: 5 mm × 6 mm), and
implant (dimensions: 3.75 mm × 7 mm) designed by the CAD software (Solidworks Simulation 2011,
Dassault Systèmes Solidworks, Waltham, MA, USA). Two different calorific values were set to the
upper and bottom surface of the fixture related to the drilling hole with different diameters.
Steady conduction analysis was conducted by voxel-based Finite Element Analysis (FEA) software
(VOXELCON2015, Quint, Fuchu, Japan). The thermal conductivity of cortical bone, bone marrow, and
implant were set to 0.6 W/mK, 0.3 W/mK, and 20 W/mK, respectively [32,33]. The air temperature
around those models was set to 19 ◦C.
The temperature change in the location of the thermocouple (2 mm depth from cortical bone
surface and 1 mm away from the fixture surface) was approximated to 8 ◦C and 4 ◦C for the undersized
drilling protocol groups and non-undersized drilling protocol groups, respectively. Until converging
the calorific value, the steady conduction analysis was repeatedly conducted.
2.7. Statistical Methods
Categorical variables were reported as relative frequency, while continuous variables were reported
as mean ± standard deviation after checking the normality of the distribution. Wilcoxon rank-sum test
was used to test the influence of the drilling protocol and implant surface on temperature change.
Multiple regression models were used to evaluate the effect of the drilling protocol, implant
surface, temperature change on the histomorphometric parameters (BIC, BAFO, BA1.5). p-values
< 0.05 were considered statistically significant. The R statistical software package was used for the
statistical evaluation and modelling (available at www.r-project.org/).
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3. Results
3.1. ITV, General Healing and Temperature
All animals survived during surgical procedures and the experimental period. No implant was
lost during the healing period. Signs of minor periosteal reaction were noted in three metatarsal bone
samples. Such a response did not undermine the peri-implant bone healing and was limited to the
periosteal area, which was not considered in this study. All implants were included in the statistical
analysis. The relative distribution of the ITV class among the groups is displayed in Figure 2a.
Figure 2. (a) Cumulative percentage of insertion torque value (ITV) classes divided per group. Note
that all implants installed for group A had a ITV ≥ 80 Ncm. (b) Temperature change represented
in box-plots.
The values for basal and maximum temperature are indicated in Table 2. Temperature change
values are shown in Figure 2b. The temperature change was affected by the drilling protocol (p < 0.001),
while it was not influenced by the surface topography (p = 0.879).
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Table 2. Basal temperature and maximum temperature for the different groups are shown in ◦C. SD:
Standard deviation; Max: maximum value; Min: minimum value.
Basal Temperature Maximum Temperature
Mean SD Max Min Mean SD Max Min
Group A 31.3 2.3 34.5 28.4 39.6 3.3 45.3 34.7
Group B 31.0 3.4 34.7 23.7 36.0 3.4 41.5 28.6
Group C 31.0 3.3 34.0 23.6 39.1 3.7 44.0 33.4
Group D 31.3 2.3 34.2 27.5 36.4 1.8 39.9 33.6
3.2. Histomorphometric Parameters
Representation of the histologic sections are displayed in Figure 3.
Figure 3. Histologic sections of the implant and peri-implant bone (original magnification 20×).
Representations of group A, B, C, and D are depicted in (a), (b), (c), and (d), respectively.
Mean values and standard deviation for BIC, BAFO, and BA1.5 are presented in Figure 4.
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Figure 4. Bone to Implant Contact (BIC), Bone Area Fraction Occupancy (BAFO), and Bone Area
Fraction Occupancy up to 1.5 mm (BA1.5) results represented as mean values. Error bars represent the
standard deviation.
According to robust multiple regression analysis (Adjusted R2: 0.37, p = 0.0001), BIC was
statistically significantly influenced by the implant surface (p = 0.01) and the drilling protocol
(p = 0.0001). More specifically, BIC was increased with a moderately rough surface and undersized
drilling protocol. BAFO was negatively affected by temperature increase (p = 0.01). Moreover BAFO
was positively affected by the undersized drilling protocol (p = 0.0006) (Adjusted R2: 0.24, p = 0.005).
BA1.5 was moderately affected by the undersized drilling protocol (p < 0.001) (Adjusted R2: 0.11,
p = 0.06 for the model). No significant influence on BA1.5 was noted for the temperature change.
3.3. Finite Element Model
Temperature distribution at the center section is shown in Figure 5. The calorific value of the
normal model was 30.8 W/m3. The calorific values of the upper fixture and bottom fixture were
30.8 W/m3 and 60.4 W/m3, respectively. The calorific value of fixture for the undersized drilling model
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showed 1.96 times greater than that for the non-undersized drilling model. The bone temperature at
the interface with the implant surface was calculated for both models.
Figure 5. (a) The temperature distribution calculated on the Finite Element Model (FEM). The
undersized drilling model and non-undersized model are displayed on the left and on the right,
respectively. The temperature is displayed in ◦C. Note how the heat is poorly distributed around the
implant surface. This means that the overheating risk is limited to the bone in the proximity to the
implant. (b) Calculation of the bone temperature at the implant interface according to the FEM. This
value was calculated by entering the value recorded with the thermocouple in the experimental part.
4. Discussion
In the present in vivo study, the intraosseous temperature was measured during dental implant
installation into cortical bone, following two different drilling protocols and with two different implant
surfaces. In addition, histomorphometric parameters of osseointegration were evaluated in relation
to the bone temperature recorded during the implant installation and a computational model was
created to examine the thermal distribution. To the knowledge of the authors, the current investigation
represents the first in vivo experiment with this setup.
4.1. Bone Temperature
In the present study, it was discovered that the intraosseous temperature during implant installation
was influenced by the drilling protocol. During implant installation, a certain amount of energy is
also dissipated into heat [25]. As previous in vitro studies have observed, the rotational torque is
positively related to bone heating during implant installation [24,34]. Accordingly, in this study, the
installation of implants into undersized sites developed a great friction resistance, resulting in both
in a higher ITV (Figure 3) and temperature increase, compared with non-undersized osteotomies.
Specifically, the undersized drilling protocol groups resulted in a median increase of temperature of
approximately 8 ◦C, while in the non-undersized drilling protocol groups, it was approximately 4 ◦C.
The maximum recorded temperature of 45.3 ◦C exceeded the limit of cell damage, which is 45 ◦C
according to Ludewig [35], but it was lower than the critical value for bone necrosis, which is 50 ◦C
according to Lundskog [36]. In the early 1980s, Eriksson, whose doctoral thesis greatly contributed to
the knowledge on bone tissue regeneration, stated that the threshold level for bone survival was 47 ◦C
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for 1 min [37]. However, the temperature recorded in the present study was detected at 1 mm from the
implant surface. To have a better understanding of the temperature behavior in the proximity of the
implant, a FEM was designed. It was estimated that the temperature at the bone-implant interface for
the undersized groups and non-undersized groups reached 58.7 ◦C and 52.0 ◦C respectively (Figure 5).
Thus, according to the FEM calculation, the installation of the implant caused a frictional heat over
the critical temperature for bone injury at the bone-implant interface. One may expect that implants
installed with an undersized drilling protocol would create a major extent of tissue damage. Still, such
an overheating condition is restricted to the proximity of the implant, as shown by the model. Since
the temperature change was affected by the drilling protocol (p < 0.001), but was not influenced by the
surface topography (p = 0.879), the surface characteristics (parameters Sa and Sdr) were not included
in the design of the FEM.
Such results are confirmed by histomorphometry. In effect, it was demonstrated that the
temperature generated during implant installation has a tangible biologic impact, since the amount
of bone between the threads, namely BAFO, is negatively affected by the temperature increase. This
finding is in accordance with Eriksson’s study, in which they observed a loss of 10% of bone tissue after
30 days when a rabbit tibia was heated to 47 ◦C for 1 min [22]. This study supports the conclusion that
the portion of the bone in proximity with the implant surface might be the most sensitive to heating at
the implant installation. Moreover, based on the FEM analysis and histomorphometric results, this
heating might induce bone damage if the undersized drilling protocol is applied. The influence of the
heat generated by the drilling procedures was likely to be excluded since one minute elapsed before
the implant installation. Previous research indicated that the bone returned to baseline temperature
after approximately 30 s [38].
Nevertheless, due to the low thermal conductivity properties of cortical bone, we could expect a
low grade of heat distribution through the bone [39]. Thus, the risk of bone overheating is limited to
the bone in the proximity to the bone-to-implant interface.
It has to be said that Eriksson observed how bone cells are susceptible to the exposure time, other
than peak temperature [40]. In the present experiment, the maximum temperature endured for a few
seconds, then it gradually descended. However, the actual temperature/time curve was not recorded,
representing a limitation of the study.
4.2. Drilling Protocol
The present findings showed that an undersized drilling protocol per se might not be detrimental
to osseointegration for the Brånemark implant. In a previous study by the authors, implants were
inserted in sheep mandible according to two different drilling techniques [41]. The results showed
that implants inserted into an undersized osteotomy caused tissue damage to the peri-implant bone.
In particular, large remodeling cavities with resorption activity were noted, and a lower amount of bone
was identified up to 1.5 mm distance from the implant, both from histomorphometric μ-CT analysis.
In addition, the drilling protocol seemed not to influence the amount of total BIC. Such findings are
partially confirmed by the present results, since the amount of bone up to 1.5 mm from implant surface
(BA1.5), was negatively influenced by the undersized drilling protocol. An explanation could be that
the bone compression during the implant installation in a tight osteotomy would trigger a remodeling
process at a distance from the implant interface. On the other hand, the temperature change does not
influence this parameter, since the thermal conductivity of the bone would prevent the heat from being
transferred at such a distance from the implant.
Compared with the previous sheep study [41], a number of differences were noted. In the former
study, an implant with a micro-threaded neck was used, while the Brånemark type implant was
utilized in the present investigation. A previous FEA study on the press-fit phenomena at the implant
insertion, [42] affirmed that the micro-thread portion, induced more relevant strains compared to the
situation without microthreads. Thus, one could expect greater bone damage after undersized drilling
in such a scenario. On the contrary, the undersized drilling protocol positively influenced the amount
84
J. Clin. Med. 2019, 8, 1198
of bone in close proximity to the implant, i.e., BIC and BAFO, in the present study. It could be assumed
that a large portion of the bone in contact with the implant might be the original bone that was forced
to the implant surface during the implant installation and still not removed. This finding was observed
in several previous studies, which used a similar implant design [5,43,44]. In normal conditions, such
tissue will be gradually resorbed with time and eventually substituted with vital bone, according to
the remodeling process [45].
4.3. Surface
An interesting finding of the present study was that the type of implant surface did not influence
the bone temperature. It could be expected that a moderately rough surface could increase the friction
and thereby the heat [46,47]. However, no differences were noticed in the temperature increase between
moderately rough and turned surfaced implants. According to the results, a moderately rough surface
had a positive effect on the amount of bone in contact with the implant. This finding confirms that
such surface topography is able to promote the osteoconductive properties of the implant, compared
to turned surfaced implants, as reported by animal and human histologic reports by Ivanoff et al. and
Zechner et al. [28,48].
4.4. Clinical Applications and Limitations
The study represents one of the first attempts to study the implant insertion temperature in
an in vivo setting. Results demonstrated that an undersized drilling protocol causes an increase of
intraosseous temperature during implant seating. A temperature increase negatively affected the
amount of peri-implant bone. Thus, it may be suggested to reduce the friction overheating during
implant installation. This would include decreasing the rotational speed [49], the use of the self-tapping
implant design [24], the use of irrigation during implant installation, and the selection of the proper
drilling protocol based on the implant design and the bone quality.
Considering the limitations in the present study, the record of the temperature was limited to the
peak value during each insertion. Further studies are needed to evaluate the exact duration of the heat.
In addition, from the present study, we cannot confirm whether the increase of the temperature caused
tissue necrosis, since no specific stain for cell metabolism and tissue turnover was used. Moreover, the
relationship between the compression and the heat, following undersized drilling was not explored.
Future studies should be designed in order to indicate whether there is a predominant factor in the
generation of tissue damage in the proximity of the implant. Finally, it must be stated that the sheep
model, which has been broadly used in dental implant research, presents similarities and differences
compared to human bone [50]. The thickness and density of cortical bone may approximate clinical
scenarios, such as encountered in the mandible. In addition, sheep bone turnover resembles bone
processes in humans, even though it is slightly more rapid. The healing period of five weeks was
selected according to our previous research [41], since the influence of the surgical protocol is more
evident at this stage in the peri-implant bone. However, the metatarsal bone, while it represents an
accessible and convenient substrate for orthopedic and dental implant research, presents quite large
anatomical and physiological differences compared with the human jaw, and it may display slightly
divergent thermal properties. Therefore the present findings must be taken with reasonable caution.
5. Conclusions
Within the limitations of the present study, it was shown that different drilling protocol for the
Brånemark implant system affects both the intraosseous temperature during implant installation and
the peri-implant bone healing. The undersized drilling protocol provokes a greater increase of bone
temperature in the proximity of the implant compared with non-undersized drilling. The temperature
at the bone-implant interface may exceed the critical value for thermal necrosis, and it may have
negative effects on peri-implant bone healing. The present results indicate that undersized drilling
increases the amount of bone in the proximity of the implant, but it has a negative impact on the
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bone area far from the implant surface. The moderately rough surface does not influence the bone
temperature, while it increased the bone attached to the implant. Further studies are needed to confirm
the present results and to deeply investigate the thermal behavior and the biologic effect of peri-implant
bone overheating during implant installation and to provide guidelines on the clinical decisions for the
proper drilling protocol, based on the bone quality and implant design.
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Abstract: (1) Background: This paper aimed to compare the cleanliness of clinically well-documented
implant systems with implants providing very similar designs. The hypothesis was that three
well-established implant systems from Dentsply Implants, Straumann, and Nobel Biocare were
not only produced with a higher level of surface cleanliness but also provided significantly more
comprehensive published clinical documentation than their correspondent look-alike implants from
Cumdente, Bioconcept, and Biodenta, which show similar geometry and surface structure. (2) Methods:
Implants were analyzed using SEM imaging and energy-dispersive X-ray spectroscopy to determine
the elemental composition of potential impurities. A search for clinical trials was carried out in the
PubMed database and by reaching out to the corresponding manufacturer. (3) Results: In comparison
to their corresponding look-alikes, all implants of the original manufacturers showed—within the
scope of this analysis—a surface free of foreign materials and reliable clinical documentation, while
the SEM analysis revealed significant impurities on all look-alike implants such as organic residues
and unintended metal particles of iron or aluminum. Other than case reports, the look-alike implant
manufacturers provided no reports of clinical documentation. (4) Conclusions: In contrast to
the original implants of market-leading manufacturers, the analyzed look-alike implants showed
significant impurities, underlining the need for periodic reviews of sterile packaged medical devices
and their clinical documentation.
Keywords: dental implants; surface properties; titanium; materials testing; implant contamination;
implant surface; scanning electron microscopy; energy-dispersive X-ray spectrometry
1. Introduction
The advent of osseointegration has led to a clinical breakthrough in oral implants. Minimally
rough, turned implants were the first osseointegrated oral implants used, with the first patient treated
in 1965 [1]. These turned screws remain the most clinically documented implants of all with 75%
of all studies in long-term reports [2]. Over time, other clinically documented oral implant systems
have increasingly begun to be used. Those systems may have preferred slightly different surfaces;
moderately rough implants have been the treatment of choice since the turn of the millennium, since
they have demonstrated improved clinical results [3]. The surface of moderately rough implant systems
may be manufactured in different ways, by subtractive methods such as the combination of blasting
J. Clin. Med. 2019, 8, 1280; doi:10.3390/jcm8091280 www.mdpi.com/journal/jcm89
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and acid etching or anodization and by additive techniques, such as hydroxyapatite coating. Products
from what are regarded as the three largest oral implant companies in the world including Osseo
Speed implants from Dentsply–Sirona, SLA-implants from Straumann and TiUnite implants from
Nobel Biocare, have been clinically documented in numerous papers spanning a period of over 5 to
over 10 years of follow up with very high levels of survival and success [4–6].
Since some osseointegrated oral implant systems have been duly documented with a very
good clinical outcome, numerous new implant manufacturers have tried to mimic the surfaces and
geometries presented by the leading companies. These are so called copy-cat or at least “look-alike”
implant systems which usually lack clinical documentation of their own but claim to be as good as the
original implants they are trying to mimic. However, in clinical reality these implants lack the scientific
evidence of similar performance.
One surface characteristic of sterile packaged oral implants is their cleanliness. Oral implants
may display different surface of an inorganic or organic nature. These impurities may derive from
the manufacturing handling and packaging processes and may remain on the commercially available
implant. We are presently lacking in knowledge of the precise clinical risks of implant impurities.
However, contaminations are technically avoidable and, generally speaking, the authors assume all of
us would prefer clean implants to avoid potential problems from surface impurities.
The aim of the present paper was to compare the cleanliness of proper clinically documented
implant systems with implants that are very similar in design and surface; OsseoSpeed from Dentsply
Implants was compared to a German look-alike implant called Cumdente; Standard Plus Implant
SLA from Straumann was compared to a Chinese look-alike implant called Bioconcept (claiming
to be 100% compatible with Straumann); and a TiUnite-surfaced implant NobelActive from Nobel
Biocare was compared to a Swiss/Taiwanese implant system called Biodenta. Our hypothesis was
that the three major and well-established implant systems have significantly comprehensive clinical
documentation and have their implants produced in a significantly cleaner manner than would the
respective look-alike systems.
Every single dental implant has to be clean, as this is a medical device that could harm
patients—even if we found one single implant with impurities, this implant was intentionally
sold for the therapy of one real patient. This paper was not intended to show a statistically relevant
number of average contaminations for specific implant types. All implants in this study were randomly
purchased and labeled for clinical use. Each sample of these medical devices was produced using a
certain regime of quality management. If the quality management of a manufacturer cannot ensure a
certain level of cleanliness, a single implant with significant impurities, which are technically avoidable,
is proof of a lack of quality.
2. Experimental Section
Implant types used for this analysis were the following: Astra Tech–Dentsply Implants
(OsseoSpeed EV, Mölndal, Sweden), Straumann (Standard Plus SLA Implant, Zürich, Switzerland),
Nobel Biocare (NobelActive Internal RP, Zürich, Switzerland), Cumdente (AS Implant, Tübingen,
Germany), Bioconcept (Tissue Level Implant, Jiangsu, China), Biodenta (Dental Implant, Bernek,
Switzerland). The three implants from market-leading manufacturers and the correspondent three
look-alike implants were purchased in the period between March 2018 and May 2019, either by
ghost-shopping, where the ordering practice was reimbursed from the research fund or by direct
order. In all six cases, the manufacturers or the respective distributors were not informed about the
purpose of the implant order. None of the samples were provided free of charge. Prices varied from
191 euro to 322 euro for the samples of market-leading brands and from 78 euro to 276 euro for the
look-alike products.
All of the six samples collected were carefully unpacked, mounted on the sample holder on carbon
tabs without touching the implant surface, and analyzed with a scanning electron microscope (SEM) in
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a particle-free clean room environment (according Class 100 US Federal Standard 209E, Class 5 DIN
EN ISO 14644-1) to avoid artifacts from the ambient air (Figure 1).
 
Figure 1. Implant sample with a length of 10 mm mounted on the SEM sample holder.
The scientific workstation used was a Phenom proX Scanning Electron Microscope (Eindhoven,
Netherlands), equipped with a high-sensitivity backscattered electron (BSE) detector. The detector
for the energy-dispersive X-ray spectroscopy (EDS) and elemental analysis was a thermoelectrically
cooled silicon drift detector (SDD) type, with an active detector area of 25 mm2.
The high-sensitivity BSE detector allows a magnification of up to 100,000× with a resolution
down to 15 nm. This study used material-contrast images from 500× to a magnification of 5000×.
Material-contrast imaging gave additional information about the chemical nature and allocation of
different remnants or contaminations on the sample material.
In order to achieve a complete overview of the horizontally mounted implant sample and
comprehensive surface quality information in high resolution, implants were scanned at a magnification
of 500× in the “Image-Mapping” mode prior to the detailed analysis of potential impurities.
This technique produces up to 600 single high-resolution SEM images of the implant surface that
were digitally composed into one large image, with an extremely high resolution. The composed
SEM image, showing the full size of the implant from shoulder to apex, made it possible to count
particles in the visible field (viewing angle of approximately 120◦) and to identify areas of interest
for a subsequent EDS spot analysis. After the mapping process, SEM images of impurities and other
regions of interest were produced with 500×, 1000× 2500×, and 5000×magnification. In the next step,
the elemental composition of particles was determined and, where possible, the differential spectra of
particles were achieved to subtract signals from the core material and such focus on signals from the
superficial contamination (Figure 2).
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Figure 2. Workflow of the SEM/EDS analysis.
All of the analyses, as well as the complete setup, as described above were performed at the
Medical Materials Research Institute, Berlin, Germany, which is an officially accredited (Deutsche
Akkreditierungsstelle–DAkkS) and externally audited testing laboratory according to the international
standards DIN EN ISO 9001:2015, ISO 22309:2015 and DIN EN ISO/IEC 17025. These standards were
chosen as a precondition in order to assure testing procedures at the highest level of accuracy.
In addition to the SEM/EDS analysis, all of the implants in this study were provisionally evaluated
from a surface topographical point of view by interferometry. All implants seemed to be in the
moderately rough surface range, i.e., with Sa (Sa = arithmetical mean height of the surface) values of
between 1 and 2 micrometers.
2.1. Clinical Documentation of Analyzed “Look-Alike” Implant Systems
A search for available clinical trial regarding the dental implant systems was carried out. Initially
the website of each dental implant manufacturer was searched (www.biodenta.com, www.bioconcept.cn,
www.cumdente.com). In addition, the manufacturers were contacted via their respective contact e-mail
address on their websites, requesting any scientific documentation regarding clinical performance such
as published papers or summaries of ongoing projects. If no response was received within one week, a
reminder was sent.
Furthermore, a search for clinical trials was performed in the PubMed database (PubMed.gov,
US National Library of Medicine, National Institutes of Health). The search terms “dental implants”
(MeSH) and “dental implants” (free text) were used in combination with the product name “Biodenta”,
“Bioconcept”, and “Cumdente”. No limits were set. ((“dental implants” [MeSH Terms] OR (“dental”
[All Fields] AND “implants” [All Fields]) OR “dental implants” [All Fields]) AND biodenta [All
Fields]), ((“dental implants” [MeSH Terms] OR (“dental” [All Fields] AND “implants” [All Fields]) OR
“dental implants” [All Fields]) AND bioconcept [All Fields], ((“dental implants” [MeSH Terms] OR
(“dental” [All Fields] AND “implants” [All Fields]) OR “dental implants” [All Fields]) AND cumdente
[All Fields])).
2.2. Clinical Documentation of OsseoSpeed, SLA, and TiUnite Implant Systems
With respect to the implant systems OsseoSpeed from Dentsply-Sirona, SLA from Straumann,
and TiUnite from Nobel Biocare, these belong to the most clinically documented oral implant systems
in the world [2]. To remain brief, we decided to only quote five papers for each system as the total
number of clinical reports on these devices amounts to several hundred scientific papers.
3. Results
3.1. SEM Imaging and Elemental Analysis
Implants were analyzed in three groups. In the first group, the implant from Astra Tech–Dentsply
Implants (OsseoSpeed) and the implant from Cumdente (AS Implant) were compared. The full-size
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SEM image of the Astra Tech implant—digitally composed of 455 single SEM images (tiles)—showed a
homogenous surface with no foreign material (Figure 3).
 
Figure 3. SEM mapping of OsseoSpeed implant (Astra Tech–Dentsply Implants). Magnification of the
red marked area is shown in Figure 4.
 
(a) (b) 
Figure 4. OsseoSpeed surface: (a) the red marked area in Figure 3 magnified 500×; (b) higher
magnification (2500×) of the white marked area in the left image with EDS spot analysis of an embedded
TiO2-particle (spot is marked with “+” in the red circle) showing only signals of the blasting material.
Higher magnification could identify the TiO2 particles from the blasting process seen as
sharp-edged particles of 5–10 mm embedded in the titanium surface. Elemental analysis of these
particles only displayed signals of titanium and oxygen (Figure 4).
The Cumdente implant showed several anomalies in the correspondent full-size image, composed
of 422 tiles (Figure 5).
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Figure 5. SEM mapping of the AS Implant (Cumdente); Red marked area—see magnification in




Figure 6. AS Implant (Cumdente) with organic particles (10–50 μm) at the implant shoulder: (a)
systematic contamination of exposed threads, red marked area of Figure 5 in 500×; (b) magnification
(5000×) of white marked area in the left image. The EDS differential measurement of the marked spots
was identical to the particles in Figure 7.
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(a)  (b) 
Figure 7. AS Implant (Cumdente) with organic particles (5–70 μm) at the implant’s apex: (a) blue
marked area of Figure 5 in 500×; (b) magnification (5000×) of white marked area in Figure 7a; EDS
differential measurement of marked spots is shown in Figure 8.
 
Figure 8. EDS differential measurement of the organic particle in Figure 7. Graph #1 shows titanium
as the core material of this implant, with characteristic peaks at 0.452 KeV (La), 4.508 KeV (Lb), and
4.932 KeV (Kb). Graph #2 shows the spectrum of the particle with additional signals of the titanium
background. The subtraction of X-ray quanta from the background material reveals the elemental
composition of the impurity, which is carbon (characteristic Ka peak at 0.277 KeV) and oxygen (Ka
peak at 0.523 KeV).
The SEM images with higher magnification revealed systematic contamination with multiple
(>100) organic particles (5–60 μm) on exposed parts of the implant, as seen on the micro-threads next
to the implant shoulder (Figure 6) and near the implant’s apex (Figure 7).
In order to receive information about the particles’ elemental composition, EDS measurement
was performed with a spot focused on the foreign material, where background material was always
detected as well, and another spot focused in direct proximity, where only the implant’s core material
was detected (spot #1 and #2 in Figures 6b and 7b, respectively). Using a software application, it
was possible to subtract the signals of the core material so that the differential measurement revealed
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more precise information about the elemental composition of the foreign material. Figure 8 shows the
differential EDS measurement of the particle in Figure 7, with a clear signal of carbon as the major
element in this impurity.
One larger area at the implant shoulder showed numerous particles (5–40 μm) (Figure 9) with
significant signals, not only of carbon but also of fluorine, as seen in the differential EDS analysis
(Figure 10). The texture and elemental composition of the foreign material suggest that these particles
are most likely remnants of polytetrafluoroethylene (PTFE), used at different implant production stages.
 
(a)  (b) 
Figure 9. Possible remnants of polytetrafluoroethylene (PTFE), AS Implant (Cumdente); (a) green
marked area of Figure 5 in 500× shows a larger area of impurities; (b) magnification (5000×) of white
marked area in the left image; EDS differential measurement of the marked spots is shown in Figure 10.
 
Figure 10. EDS differential measurement of the particles in Figure 9 with significant X-ray quanta of
carbon and fluorine. Note that the quantitative information provided by the EDS analysis does not
always reflect the precise stoichiometric relationship of the particle’s chemical elements.
The second group compared the Straumann Standard Plus SLA Tissue Level Implant with an
implant of the same geometry from Bioconcept, both made of commercially pure grade 4 titanium,
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which is a composition of 99% titanium, 0.50% iron (maximum), oxygen 0.40% (maximum), carbon
0.085 (maximum), hydrogen 0.015% (maximum), and nitrogen 0.05% (maximum), according to the
ASTM F67 specification. The SEM imaging of the Straumann implant could not detect any organic or
inorganic contaminants (Figures 11 and 12).
 
Figure 11. SEM mapping, Standard Plus SLA implant (Straumann); Magnification of red marked area
is shown in Figure 12.
 
Figure 12. Surface of Standard Plus SLA implant (SEM 2500×); red marked area in Figure 11 with the
typical texture of a sandblasted and acid-etched titanium surface, free of foreign materials.
While the Straumann implant can be rated as clean at the micron level, the analysis of the
Bioconcept implant revealed several impurities, although the full-size image showed no systematic
larger contamination (Figure 13). With higher magnification, approximately 20 small organic particles
(10–20 μm) were found on the implant’s surface, one particle showing additional signals of sulfur
(Figure 15).
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Figure 13. SEM mapping, Tissue Level Implant (Bioconcept); red marked area—see magnification in
Figure 15, blue marked area—see magnification in Figure 14.
 
(a)  (b) 
Figure 14. Metal particle on the surface of the Bioconcept implant; (a) blue marked area in Figure 13,
SEM 500×; (b) magnification (5000×) of white marked area in the left image (a) showing bright metal
impurity (8 μm) and 2 points of EDS spot measurement (#1 =metal particle, #2 = core material).
Surprisingly, one metal particle of 8 μm was found on the Bioconcept implant, seemingly entirely
composed of iron, as the qualitative and quantitative elemental analysis and differential measurement
of this particle revealed (Figures 14 and 16).
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(a)  (b) 
Figure 15. Bioconcept implant with organic particles (10–15 μm); (a) red marked area in Figure 13,
SEM 500×; (b) magnification (5000×) of white marked area in the left image (a); arrows indicate
two embedded metal particles (0.5–1 μm) showing significant iron signals in the subsequent EDS
differential measurement.
 
Figure 16. EDS differential measurement of the metal particle in Figure 14, revealing iron as the major
element of the impurity.
The third group compared the NobelActive implant from Nobel Biocare with the Dental Implant
from Biodenta. Both implants have an anodized surface with a characteristic titanium oxide layer.
The area analysis of the NobelActive implant showed calcium and phosphorous signals in addition to
titanium and oxygen. Within the scope of this analysis, neither inorganic nor organic particles were
detected on the Nobel Biocare implant (Figures 17 and 18).
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Figure 17. SEM mapping: NobelActive Internal RP implant (Nobel Biocare); red marked area—see
magnification in Figure 18.
 
Figure 18. Surface of the NobelActive Internal RP implant (2500×); magnification of red marked area
in Figure 17 with the typical texture of an anodized titanium surface, free of foreign materials.
While the full-size SEM image of the Biodenta implant exposed no significant organic
contamination (Figure 19), the area analysis of the core material showed, in addition to calcium,
phosphorous, titanium, and oxygen, high levels of magnesium in the EDS (Figure 20) that were not
seen on the Nobel Biocare implant.
Significant traces of aluminum were detected in three areas of exposed threads and can be seen
as bright particles (5–10 μm) in Figure 21. The graph in Figure 22 shows the correspondent EDS
differential measurement of metal particles in Figure 20a.
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Figure 19. SEM mapping: Dental Implant (Biodenta); yellow arrows indicate spots with aluminum as
shown in Figure 21. Magnifications of the blue and red marked areas are shown in Figure 23.
 
Figure 20. EDS area analysis of the implant’s core material (Biodenta).
 
(a)  (b) 
Figure 21. Aluminum-containing particles (5–10 μm) on the surface of the Biodenta implant; location
shown using yellow arrows in Figure 19; (a) SEM 5000×with 2 points of EDS spot measurement shown
in Figure 22; (b) impurities with similar size in close proximity to particles shown in the left image (a).
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Figure 22. EDS differential measurement of the metal particle in Figure 20 (a), showing significant
X-ray quanta of aluminum. The lack of oxygen signals indicates that these particles were not made of
aluminum oxide.
These aluminum-containing particles must be rated as inorganic impurities as they are not
comparable with sharp-edged aluminum oxide particles, used for blasting procedures of other
implants. Apart from this, it is noticeable that the approximately 3 μm thick oxide layer was damaged
at several exposed locations of the Biodenta implant (Figure 23).
 
(a)  (b) 
Figure 23. Damaged oxide layer of the Biodenta implant, SEM 1000×: (a) magnification of the blue
marked area in Figure 19 showing the damage at the exposed implant thread; (b) magnification of
the red marked area in Figure 19 demonstrates the large-area irregularity of the oxide layer at the
implant apex.
3.2. Documentation of Clinical Results
None of the copy-cat manufacturers’ websites contained any information regarding published
clinical trials of the implant systems. No manufacturers responded to the email requesting scientific
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documentation regarding clinical performance. No manufacturers presented such documentation.
The PubMed database search identified no papers regarding the Bioconcept or Cumdente system,
but two papers for the Biodenta system. The two Biodenta papers were, however, in vitro trials that
evaluated the company’s CAD/CAM (computer-aided design/computer-aided manufacturing) system,
not the clinical outcome of the implants [7,8]. Broadening the search by deleting “dental implants”
and only using the respective company name did not identify any publications for the Cumdente
system but one additional paper for the Biodenta system [9]. However, this paper did not report on
the clinical outcome of implants. No clinical documentation of implant outcome was noticed for the
Bioconcept system.
The OsseoSpeed implant has a very solid clinical documentation verifying excellent clinical results
for up to 7 years in clinical function [10–14]. Similar excellent clinical results apply to the SLA implants
from Straumann [4,15–18] and the TiUnite implants from Nobel Biocare [5,19–22], where these two
implant systems have been documented for more than 10 years in numerous studies.
4. Discussion
In general, the implants OsseoSpeed (Astra Tech–Dentsply Implants), Standard Plus SLA Implant
(Straumann), and NobelActive (Nobel Biocare) showed—within the scope of this analysis—a surface
free of foreign materials in the SEM. The Cumdente AS Implant with a similar geometry compared to
the Astra Tech OsseoSpeed implant demonstrated a surface with substantial organic contaminants
and most likely remnants of Teflon. The Straumann look-alike implant from Bioconcept exposed
numerous organic particles and two small particles containing significant amounts of iron. The Nobel
Biocare look-alike implant from Biodenta showed high levels of magnesium and small particles with
aluminum on the surface. These particles, with a diameter of 5 to 10 μm, and organic contaminants
with a similar size, are small enough for phagocytosis by macrophages that would be theoretically
possible for particles without a chemical bonding to the implant surface.
It may, therefore, be said that the original implants were cleaner than the correspondent look-alike
devices. The price range for the look-alike implants indicated that the definition of a copy-cat product
or look-alike implant is not necessarily based on a low price.
To the knowledge of the present authors, no defined thresholds have been published in peer
reviewed journals until now, with respect to what may represent “acceptable” levels of impurities
and what must be regarded as “unacceptable impurities”. However, the non-profit CleanImplant
Foundation (www.cleanimplant.org) has presented a consensus statement on surface impurities signed
by Luigi Canullo (Rome, Italy), Jaafar Mouhyi (Marrakesh, Morroco), Michael Norton (London, UK),
and four of the authors of this paper Tomas Albrektsson, Florian Beuer, Dirk Duddeck, and Ann
Wennerberg [23]. In this consensus statement, surface anomalies and remnants of blasting materials
were not considered clinically relevant, in contrast to the metal particles of tungsten, nickel, iron,
chromium, copper, tin or antimony found on the surfaces of some implants. Single organic particles
smaller than 50 μm in diameter were considered less vicious than numerous particles, with a maximum
of 30 particles along the circumference of the implant. Major plaque-like organic contaminants
exceeding the size of 50 μm and PTFE particles, presumably originating from Teflon baskets used
during implant production, were considered unacceptable.
Other foreign bodies routinely seen adjacent to implants such as titanium particles [24–26] or the
accidental presence of cement in the bone-to-implant interface that, according to some investigators,
may be found in 59% of cemented implants [27], may combine to cause peri-implantitis [28].
Impurities on sterile packaged implants—caused by metal particles and contaminations with
organic substances such as thermoplastic materials, synthetic polymers, or polysiloxanes—are
technically avoidable, as this paper demonstrated. The academic discussion as to what extent
implant pollution is acceptable normally ends quickly when dental professionals know about such
contamination of an implant system and the next patient for an implant therapy is their partner or
child. We should avoid using sterile packaged implants with verifiable impurities and therewith
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follow the well-established “precautionary principle” as an evolution of the ancient medical principle
of “primum non nocere”.
From a clinical point of view, it is obvious that Astra Tech–Dentsply Implants, Straumann, and
Nobel Biocare have solidly documented clinical results reported in hundreds of scientific papers. On
the other hand, a long history of clinical documentation representing high-quality efforts in the past is
no guarantee for a high level of production quality and a clean surface at present, accentuating the
need for periodic reviews by independent institutions. With respect to the look-alike systems, none of
them had any properly documented clinical reports available. The absence of clinical documentation
of look-alike systems may indicate either that they see themselves as identical to the implants they
have copied or that they see implants as commodity products where all implant systems will work
well clinically. The possibility first mentioned was critically analyzed in this paper comparing the
cleanliness of different implant systems. The second possibility that implants are commodity products
may be criticized against the knowledge of numerous implant systems that have been withdrawn from
the market due to the unforeseen clinical problems over longer times of follow-up [29].
In essence, our hypothesis was verified in that the major implant systems displayed cleaner
surfaces than those of their respective look-alike implants. However, whether the relative lack of
cleanliness of look-alike implants indicates that they have an impaired clinical function in comparison
to the major systems remains uncertain. Having said this, oral implants are placed in human beings
and, therefore, it seems strongly advisable to present clinical results in peer-reviewed journals for
every oral implant system to be used clinically. In this regard, the look-alike implants are clearly
inferior to the major documented oral implant systems and none of the look-alike systems investigated
had any clinical documentation of their own, which must be regarded as a major shortcoming. Since
differences obviously exist between the major systems and the respective look-alike implants, clinicians
using the latter devices must inform their patients of this fact and that the implants placed are totally
un-documented with respect to clinical outcome.
5. Conclusions
In contrast to the original implants of market-leading manufacturers, the analyzed look-alike
implants showed significantly more impurities, underlining the need for periodic reviews of the
production quality by independent institutions. Multiple organic particles and remnants of PTFE
(Cumdente), organic particles containing sulfur, particles containing iron (Bioconcept) or impurities
with aluminum (Biodenta)—all particles small enough for possible phagocytosis—expose patients to
unknown risks. In addition to the results of SEM/EDS analysis, the lack of clinical documentation of
the analyzed look-alike implants raises concerns.
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Abstract: Purpose: Bacterial biofilms are a major problem in the treatment of infected dental and
orthopedic implants. The purpose of this study is to investigate the cleaning effect of an electrolytic
approach (EC) compared to a powder-spray system (PSS) on titanium surfaces. Materials and
Methods: The tested implants (different surfaces and alloys) were collated into six groups and treated
ether with EC or PSS. After a mature biofilm was established, the implants were treated, immersed in
a nutritional solution, and streaked on Columbia agar. Colony-forming units (CFUs) were counted
after breeding and testing (EC), and control (PSS) groups were compared using a paired sample
t-test. Results: No bacterial growth was observed in the EC groups. After thinning to 1:1,000,000,
258.1 ± 19.9 (group 2), 264.4 ± 36.5 (group 4), and 245.3 ± 40.7 (group 6) CFUs could be counted in
the PSS groups. The difference between the electrolytic approach (test groups 1, 3, and 5) and PSS
(control groups 2, 4, and 6) was statistically extremely significant (p-value < 2.2 × 10−16). Conclusion:
Only EC inactivated the bacterial biofilm, and PSS left reproducible bacteria behind. Within the limits
of this in vitro test, clinical relevance could be demonstrated.
Keywords: dental implant; biofilm; infection; perio-prosthetic joint infection; periimplantitis;
electrolytic cleaning
1. Introduction
Growing numbers of inserted dental implants correlate to an increasing number of infected
implants [1]. Periimplantitis (PI) is defined as an inflammatory process affecting both periimplant soft
and hard tissue. Craterlike bone defects, ongoing bone loss, pus, and bleeding on probing (BoP) are
clinical parameters that have to be present to justify the diagnosis of PI [2,3]. PI correlates to bacterial
biofilms growing on implants or abutments [4]. In view of the various definitions of PI and the lack of
agreement in the dental community about an acceptable threshold of bone loss, there is no consensus
on when pathology starts and how PI can be diagnosed precisely. Hence, there is no consensus about
prevalence data [5–7]. A proper treatment modality is lacking [8]. Whether the bacterial biofilm is
the single causal factor or only correlates to PI [9] is still a matter of discussion. This debate about
etiology is not merely an academic question, but may influence the success rate of therapy, because of
possible differences in specimen susceptibility and uncorrectable surgical or mechanical obstacles. In
any event, biofilm needs to be removed to prevent progression of disease, or to treat PI successfully.
As implant surfaces exposed to the oral cavity are immediately colonized by bacteria, the surfaces
need to be re-osseointegrated for good long-term results [10].
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Infection of plates or other orthopedic devices, or endoprostheses caused by polymicrobial
biofilms, is a major challenge. The average infection rate of implants in the shoulder, knee, and hip
is less than 2% in most treatment centers [11,12]. A recent meta-analysis demonstrates an overall
cumulative incidence of endoprosthetic joint infection across all studies of 0.78% [13]. It has been
reported that, in the United States, more than 1 million implants placed in shoulders, knees, and hips
need to be replaced every year due to infections [14]. A systematic review showed a reinfection rate
of 7.6% (95% CI 3.4–13.1) of hip and knee replacements [15]. Polymicrobial biofilm on orthopedic
implants shows high resistance to immune defense, and will result in local inhibition of granulocyte
activity around the implant. This effect is referred to as frustrated phagocytosis, which leads to
degranulation, reduced ingestion ability, and production of oxygen radicals in the granulocytes [16].
The standard treatment protocol for infected orthopedic implants is replacement in a one- or two-stage
procedure, with a success rate of 80−90% [17,18]. Even early infections within the first 30 days after
implantation that are treated by aggressive debridement and long-time antibiotics yield success rates
of only 71% [19,20].
In most cases, all treatment modalities fail to cure infected implants, requiring replacement of the
implant or causing at least an inadequate failure rate and immense costs. Therefore, it is necessary to
search for another approach to decontaminate infected implants.
Several ablative methods to remove biofilms, such as mechanical debridement with curettes,
brushes, lasers, cotton pellets, cold plasma, or air-powder sprays, combined or not combined with
disinfecting or antibiotic agents, have been discussed. Re-osseointegration of formerly infected dental
implant surfaces was reported in animal studies for between 39% and 46% of the surface [21]. There is
no evidence of whether and to what percentage re-osseointegration occurs clinically. A recent review
of the literature demonstrated the equality of all published methods, and no method seemed able to
achieve stable results over time [22]. Follow-up revealed recurrence of the disease in up to 100% for
some methods after one year [8]. A powder-spray system (PSS) is commonly used to clean implant
surfaces. Erythritol (size 14 μm) or glycine (size 25 μm) particles are accelerated by air pressure (2 bar).
When the particles impact at an angle of 30–60◦ at an ideal working distance of 3−5 mm, the kinetic
energy of the powder removes biofilm, according to the manufacturer’s manual. Several animal studies
investigating re-osseointegration after cleaning with a PSS proved incomplete re-osseointegration [21].
Improvement of periimplant parameters, such as BoP, probing depth, and pus was clinically proven
after the PSS, but re-osseointegration was not proven. Furthermore, the PSS failed to demonstrate
superiority over any other treatment modality [23–25]. Possible reasons for this incomplete cleaning
efficacy might be craterlike bone defects, with limited access and thus an improper working angle and
distance of the device, the macro- and micro-design of implant surface, and oversized particles for
much smaller bacteria hidden in the microstructure of textured implants. In an in vitro test, implants
contaminated with E. coli were treated with a continuous current of 0−10 mA. Two implants were
loaded as either cathode or anode, resulting in reduced numbers of bacteria on both implants. On
anodic implants, a current of more than 75 mA caused complete killing of the bacteria [26]. Zipprich et
al. loaded the implant as a cathode, and a platinum-coated titanium acted as the anode [27]. In this
in vitro trial, the implants were exposed to a sodium-iodine solution buffered by lactic acid to avoid
alkalization of the salt solution [27]. Hydrolytic splitting of water produces hydrogen cations as long as
the implants are loaded. These hydrogen cations penetrate the biofilm, and after an electron has been
taken from the implant surface, hydrogen forms between the implant surface and the biofilm. The
hydrogen bubbles remove the biofilm. While all the other discussed methods for removing a biofilm
are ablative, the electrolytic approach presented here works under the biofilm, directly on the implant
surface, regardless of surface characteristics or alloy. Our results support the finding that the potassium
iodine solution allows a higher current than the previously published sodium chloride solution [27].
This results in higher hydrogen production and a possible direct bactericidal effect. A cooperating
working group examined the exact working mode of this method and proved its effectiveness in killing
bacteria [28]. The current gold standard in dentistry is to remove biofilm with a PSS. These positive
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preliminary results for an electrolytic approach (EC) encouraged the authors to compare the cleaning
effect of air-powder-water spray as an accepted method of cleaning contaminated implant surfaces
with the new electrolytic approach in vitro.
2. Materials and Methods
2.1. Null Hypothesis
The null hypothesis is that the electrolytic approach works equally as well as PSS cleaning.
2.2. Preparation of Test Implant and Grouping
For the study, test implants were designed and produced by the authors to be as close as possible
to clinical reality in implant and orthopedic surgery. The test specimens were made of grade 4 and 5
titanium, and consisted of a test and a carrier part (Figure 1). The design of the test part was similar to
a standard, parallel-threaded dental implant (∅ 4.0 mm/L = 11.0 mm pitch = 0.6 mm) with different
surface modifications. The carrier part was machined to serve as the electricity conductor and to fix
the test specimen in the experimental set-up without influencing the area of interest of the test area.
Furthermore, the test and carrier part could be separated at a predetermined breaking point to avoid
bacterial contamination of the test area during handling.
 
Figure 1. The structure of test implants.
Six groups of implants (n = 12 per group, 72 in total) were investigated. Ten per group were
treated (60 in total), while two served as negative controls and were not treated (12 in total):
Group 1: titanium grade 4 + sandblasting and acid-etching + electrolytic cleaning;
Group 2: titanium grade 4 + sandblasting and acid-etching + air-powder-water spray cleaning;
Group 3: titanium grade 5 + sandblasting and acid-etching + electrolytic cleaning;
Group 4: titanium grade 5 + sandblasting and acid-etching + air-powder-water spray cleaning;
Group 5: titanium grade 4 + anodic oxidation + electrolytic cleaning;
Group 6: titanium grade 4 + anodic oxidation + air-powder-water spray cleaning.
Groups 1, 3, and 5 (test group) were treated with an electrolytic treatment, and groups 2, 4, and 6
(control group) were treated with a PSS.
2.3. Saliva Collection
In order to ensure a diversity of microorganisms, saliva was collected from three volunteers
(different ages, 2 male, 1 female, healthy, no medication or drugs). The collected saliva (3 mL) was
pooled, centrifuged to spin down any large debris and cells (2600 g for 10 min), and the liquid
supernatant was mixed with 0.5 L nutrition solution culture (Bacto Tryptic Soy Broth, Becton Dickenson,
Heidelberg, Germany), and incubated under 37 ◦C on the rocking device for 48 h, as previously
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described [29]. The solution was then filled into tubes (1.5 mL, Eppendorf Safe-Lock Tubes, Eppendorf,
Hamburg, Germany) and frozen at −18 ◦C to provide identical samples for all further tests.
2.4. Establishing the Biofilm
To breed the biofilm on the implants, the required bacterial samples were thawed and bred with
300 mL nutrition solution in a beaker at 37 ◦C for 24 h. The carrier parts of the sterilized implants were
masked to reduce bacterial contamination and fixed on a base plate. The experimental set-up was then
immersed in the beaker with the culture medium to initiate formation of the biofilm. The beaker was
placed in the rocking incubator for 14 days at a temperature of 37 ◦C. Previous tests with daily checks
with a scanning electron micrograph (SEM) had demonstrated that 14 days were necessary to achieve
a mature, multilayer biofilm (Figure 2). Every two days, the bacterial culture medium was replaced
with freshly prepared nutritional solution.
 
Figure 2. Progredient formation of biofilms on different surfaces.
2.5. Electrolytic Cleaning (Test Group)
The implants in groups 1, 3, and 5 were cleaned by an electrolytic process. Figure 3 shows the
construction of the electrolytic chamber. After demasking of the biofilm-coated test implant with
a customized ejector, the implant was mounted on the bottom of the electrolytic chamber with a
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customized connector. The test implant served as the cathode. The connector had an inner titanium
sleeve (titanium grade 4) covered by an insulating polyetheretherketone (PEEK) carrier. The inner
titanium sleeve was connected to the electric source, and the PEEK carrier masked the carrier part of the
test implant for only three quarters. This design was chosen to guarantee that it was possible to separate
the test specimen using a customized tool, without touching the PEEK carrier, which was not been
cleaned during the electrolytic procedure. The connector was mounted in a polytetrafluoroethylene
(PTFE) socket to ensure stability of the electrolytic chamber.
After the cathode was fixed, the glass cylinder of the chamber was mounted, and 35 mL of
electrolyte (sodium iodide (200 g/L), potassium iodide (200 g/L), L(+)-lactic acid (20 g/L), and water
(800 g/L)) was poured into the chamber. Fresh electrolyte was used for each test.
The anode (titanium grade 4) was coated with platinum to prevent passivation of its surface. The
anode was fixed in a hollow PTFE tube to ensure direct contact of the platinum-plated part with the
electrolyte (∅ 5.0 mm/L = 4.0 mm). After the other end of the PTFE tube had been mounted in the cap
of the chamber, the anode and cathode were connected to a voltage source (PeakTech 6060, PeakTech,
Ahrensburg, Germany).
A voltage of 6 V was applied for 5 minutes, resulting in a current of up to 1100 mA.
After the cleaning process was finished, the cap of the chamber was removed, and the used
electrolyte was poured into a beaker. The biofilm floated as a visible layer on the fluid in the
beaker, and was pipetted with some fluid to prove the vitality of the collected bacteria (waste from
electrolytic cleaning).
 
Figure 3. The assembly of the powder-water spray device. PEEK = polyetheretherketone, FPM =
fluorine rubber, PTFE = polytetrafluorothgylene.
2.6. Air-Powder-Water Spray (PSS) Cleaning (Control Group)
The implants in groups 2, 4, and 6 were treated by a PSS (BA 8000, Mectron GmbH, Cologne,
Germany). To ensure a reproducible and comparable cleaning effect, a test apparatus was assembled,
as shown in Figure 4. The aim was to reproduce the working angle and distance according to the
manufacturer´s operating manual (45◦ and 10 mm). The test implants were mounted on a sterile PEEK
carrier (Figure 4, in orange), which masked three quarters of the carrier part and was then fixed in
a PTFE connecting bar (Figure 4). The holder provided the same working angle and distance for all
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the tested implants. The holder and its fixed handpiece were moved manually along the implant axis
while the test implant rotated, being driven by a motor around its axis (40 rpm) to ensure proper and
repeatable cleaning of the implants (Figure 4). Sterile water (Aqua ad injectabilia, Braun, Melsungen,
Germany) and aminoacetic acid powder (glycine powder, Mectron GmbH, Cologne, Germany) were
used with an air pressure of 2 bar being applied for 60 s. The waste liquid produced during the
cleaning process was collected in a beaker to prove the vitality of the removed biofilm (waste from
air-powder-water cleaning).
 
Figure 4. The structure of the electrolytic chamber.
2.7. Rinsing and Test Sample Incubation
After cleaning, the test and control implants were rinsed with air-water spray for 5 seconds
(distance of 5 cm) and dried with oil-free air. The test parts were then broken off at the predetermined
breaking point in a sterile manner, transferred to Eppendorf tubes filled with 1.5 mL nutritional
solution, and incubated at 37 ◦C for 24 h. Ehrensberger et al. demonstrated that no additional colonies
grew when incubation time was extended 18 h. [30]
2.8. Analysis of the Bacterial Growth
The solution in each Eppendorf tube was pipetted, transferred and streaked with an L-spatula on
blood agar (Columbia Blood Agar-VWR, BDH Chemicals, Leuven, Belgium). The plate was incubated
at 37 ◦C for 24 h.
The rest of the contents of the Eppendorf tube was gradually diluted in six steps to 1:1,000,000.
Each step was also spread on a blood agar plate and treated as described above. In total, seven dilution
steps were bred (210 in test group, 210 in control group, 420 in total).
The change in the plate condition was photographed after 24 h. The number of colony-forming
units (CFUs) were counted using the software ImageJ (version 1.51u, National Institutes of Health,
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Bethesda, MD, USA). The difference between the two Poisson rates has been applied to evaluate the
difference in bacterial growth.
2.9. Sterility of the Experimental Set-Up (Positive Control)
To prove the sterility of the different experimental set-ups, the air-powder-water spray was
directed to blood agar plates (two per group, six in total). The sterility of the nutritional solution was
proved by breeding it at 37 ◦C for 24 h, and then spreading it on a blood agar plate. The agar plates
were incubated at 37 ◦C for 24 h, and then CFUs were counted.
2.10. Quality of Biofilm (Negative Control)
To prove the quality of the biofilm, two test implants from each group (12 in total) served as the
negative control and were not cleaned. After biofilm formation, the nutritional solution was rinsed
away with sterile water. One implant per group (six in total) was rinsed with sterile water (Aqua ad
injectabilia, Braun, Melsungen, Germany) and dried in air for 24 h. The usual fixation in ethanol was
not done, to avoid washing-out of the matrix. The samples were gold-coated and examined using a
Philips SE XL30 (LaB6 cathode) scanning electron micrograph (SEM) with 20 kV power and a spot size
4 to check biofilm formation and quality. One implant per group (six in total) was incubated in an
Eppendorf tube with 1.5 mL nutritional solution and bred at 37 ◦C for 24 h. In anticipation of floating
bacteria, the nutritional solution was spread on blood agar and bred at 37 ◦C for 24 h. Colony forming
units (CFUs) were then counted (Figure 5).
 
Figure 5. Bacterial growth with the nutritional solution of the negative control (not treated). Dilution
grade 1:1,000,000.
2.11. Vitality of Bacteria after Cleaning
To prove the vitality, the waste from both cleaning methods (electrolytic and PSS) was spread on
blood agar and bred at 37 ◦C for 24 h. Then CFUs were counted.
2.12. Counting Colonies
The number of colonies that had grown on the blood agar plates were manually counted using
the ImageJ (version 1.51u) software.
2.13. Statistics
The number of colonies that had grown on the blood agar plates after a dilution to 1:1,000,000
where manually counted and processed by the ImageJ (version 1.51u) software.
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Continuous variables are reported as mean ± standard deviation. All groups were tested for
normality by the Shapiro-Wilk test. Comparisons between the two cleaning methods were performed
with the paired sample t-test. Comparisons between the surface and material groups for AirFlow were
performed with the Kruskal-Wallis test.
A two-sided p-value of ≤0.05 was considered statistically significant. Statistical analysis was
performed with R (R Foundation for Statistical Computing, Vienna, Austria).
3. Results
3.1. Quality of Biofilm (Negative Control)
The formation of a mature layer of biofilm completely covering the surface of all six tested implants
was demonstrated upon checking by scanning electron micrograph (SEM). Six implants were not
treated, but were incubated as described. CFUs could not be counted because the blood agar plate was
totally covered with a closed layer of bacteria.
3.2. Colony-Forming Unit Count
In groups 1, 3, and 5 (test groups, electrolytic cleaning), 210 blood agar plates were evaluated.
Not a single CFU could be counted on any blood agar plate. Neither dilution (Figure 6) nor alloy nor
surface had any influence on this observation.
 
Figure 6. Bacterial growth after electrolytic cleaning. Dilution grade 1:1.
The cultivation of the waste liquid collected from the electrolytic cleaning process also showed no
bacterial growth.
In the control groups (2, 4, and 6; PSS; 210 agar plates), the growth of bacteria was observed on
every agar plate with any dilution grade (Figure 7), irrespective of dilution, alloy, or surface. CFU
counting was not possible in the first five steps of dilution (from 1:1 to 1:100,000), because the bacteria
grew over the whole agar plate. CFU counting was possible at a dilution of 1:1,000,000. In all PSS
groups, more than 200 CFUs were documented (group 2 = 258.1 ± 19.9, group 4 = 264.4 ± 36.5, group
6 = 245.3 ± 40.7) (Table 1). The cultivation of the collected waste liquid always showed bacterial growth.
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Figure 7. Bacterial growth after air-powder-water spray cleaning. Dilution grade 1: 1,000,000.
Table 1. Colony-forming unit (CFU) counts per grade of titanium, surface, dilution, and
cleaning method.
Cleaning Method Electrolytic PPS Electrolytic PPS Electrolytic PPS
Material & Surface
Group 1:
Ti Grade 4 +
SAE
Group 2:
Ti Grade 4 +
SAE
Group 3:
Ti Grade 5 +
SAE
Group 4:
Ti Grade 5 +
SAE
Group 5:
Ti Grade 4 +
AO
Group 6:
Ti Grade 4 +
AO
Dilution ∅ CFU ∅ CFU ∅ CFU ∅ CFU ∅ CFU ∅ CFU
1:1 0 na 0 na 0 na
1:10 0 na 0 na 0 na
1:100 0 na 0 na 0 na
1:1000 0 na 0 na 0 na
1:10,000 0 na 0 na 0 na
1:100,000 0 na 0 na 0 na
1:1,000,000 0 258.1 ± 19.9 0 264.4 ±36.5 0 245.3 ± 40.7
The difference between the electrolytic approach (test groups 1, 3, and 5) and PSS (control groups 2, 4, and 6) was
statistically extremely significant (p-value < 2.2 × 10−16). In control groups 2, 4, and 6 (PSS), no difference in cleaning
efficacy could be detected (p-value = 0.3465) when comparing the different implant materials and surfaces. In test
groups 1, 3, and 5 (electrolytic approach), no colony-forming units (CFUs) were detected. Therefore, there were no
differences between the different implant materials and surfaces.
3.3. Sterility of Experimental Set-Up (Positive Control)
No sign of bacterial growth was observed on the blood agar after PSS was sprayed directly onto
blood agar plates. No sign of bacterial growth was observed on the blood agar after the nutritional
solution was bred. This indicates that the air-powder-water spray system and the prepared nutritional
solution were free from bacterial contamination.
4. Discussion
The application of voltage to reduce bacterial load has been described several times in the literature.
Ehrensberger et al. [30] evaluated the influence of cathodic voltage-controlled electrical stimulation
(CVCES) to eradicate methicillin-resistant S. aureus (MRSA) from titanium surfaces in vitro and in
Long-Evans rats. The application of −1.8 V for 1 h reduced MRSA CFU counts by 87% in bone and
88% in titanium, compared to the open-circuit potential in vitro, and by 97% in titanium in vivo. No
histological changes were detected in the rat model. CVCES increased the interfacial capacitance
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(from 18.93 to 98.25 μF/cm2) and decreased the polarization resistance (from 868.25 to 108 Ω/cm2).
Because of the negative charge of the titanium surface and the negative surface charge of S. aureus,
attachment of the biofilm may be influenced. Furthermore, it has been discussed that the electric field
on polarized electrodes generates anions by electrolytic splitting, which disrupts and pushes away
the biofilm [24,31,32]. The major reaction at the cathode is the reduction of water or the reduction
of oxygen:
Reaction 1: 2H2O + 2e−→ H2 + OH−
Reaction 2: O2 + 4− +2H2O → 4 OH−
Blenkinsopp et al. proposed an altered transport of ions within the biofilm [33]. Portinga et al.
demonstrated an extended attachment of bacteria to the biofilm after donation of their free electrons
to the matrix. Free electrons on the cathode might disturb this adherence [31,34], To summarize, the
antimicrobial effects seem to be related to voltage-dependent surface properties of the titanium.
Several authors [26,35,36] have reported that loading two contaminated dental implants (one as
anode and the other as cathode) in NaCl as electrolyte significantly reduces the number of bacteria. The
downside of the published method is that toxic chloric and hypochlorous acid are reaction products,
and the pH in the periimplant area decreased or increased significantly.
Zipprich et al. [27] introduced an electrolytic approach to remove biofilm from explanted implants
by using a mixture of sodium iodide, potassium iodide, and water buffered by L(+)-lactic acid.
Schneider et al. [28] investigated the underlying mechanism of this method of electrolytic cleaning.
Several disinfecting agents, such as triiodide and hydrogen peroxide, were generated on the implant
surface loaded as the cathode. The authors proved in an in vitro test that the major effect in removing
the biofilm was the generation of hydrogen on the implant surface, which pushed away the biofilm
mechanically. Based on these findings, the authors decided to prove the effectiveness and efficiency
of this approach in this in vitro test. It is very difficult to perform a controlled in vitro study on a
“real” biofilm in real periimplantitis cases, because its three-dimensional structure is destroyed while
the implant is removed, and anaerobic bacteria would not survive this process. The nutritional and
biological conditions of an in vivo biofilm will differ from biofilms used in this in vitro test. Such
samples may harbor different mixtures of bacteria. This pitfall compromises all in vitro studies done
on periimplant biofilms. On the other hand, it was demonstrated that microbiota associated with
periimplantitis are quite variable and inconsistent [4].
Different methods of growing biofilms have been published. Most of the articles used single-species
biofilms with very little relation to real periimplant biofilms. S. aureus is a colony-forming bacterium
associated with infected dental or orthopedic implants, and was bred for several days on titanium
surfaces [30,37]. Mohn used E. coli, which is not associated with periimplantitis [26]. Other authors
harvested intraoral subgingival plaque and exposed titanium plates in a nutritional solution for seven
days [38]. John et al. cultivated biofilms by exposing titanium plates fixed on splints for 48 hours in
the oral cavity of two specimens [39]. In preparation for this study, we were not able to reproduce
the claims of these authors to achieve a mature biofilm covering the complete implant surface in the
published timeline, when using a model with intraoral bacteria. It took 14 days to achieve a multilayer
mature biofilm covering the whole implant surface (Figure 2).
To imitate micro- and macrostructure, we decided to use lifelike test implants. To carry such
implants in the mouth for several days to accumulate bacteria would be unacceptable for humans.
Consequently, we had to develop a realistic extraoral model to breed a biofilm. A single-species model
was used, and did not form a complete monolayer of bacteria nor a multilayer biofilm. To achieve the
most realistic diversity of microorganisms, the saliva was collected and pooled from three volunteers,
bred extra-orally, and frozen to ensure the same biota for all the tests. In preparation for this study, we
found out that it takes 14 days to achieve the expected quality and thickness of biofilm. In vitro, it
could have been demonstrated that a cold plasma device can clean heling abutments more effectively
than conventional cleaning [40].
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No published method was able to remove all bacteria from implant surfaces in the clinical setting.
Moreover, bacteria will re-colonize implant surfaces exposed to the oral cavity within a matter of
hours [10]. The theory that elimination of the biofilm will cure periimplantitis is an attractive one [4].
Clinically, it may be necessary to remove the bacteria and extracellular matrix in a way that will allow
re-osseointegration of formerly infected surfaces.
We were able to demonstrate that no bacteria could be cultivated in the nutritional solution and
powder used for a PSS, thus proving the sterility of the experimental set-up. The vitality of the bred
biofilm was proved visually by SEM and by CFU counting after its cultivation on blood agar plates.
As different titanium alloys and surface modifications are used in dental and orthopedic surgery, we
tested titanium grades 4 and 5, as well as acid-etched, sandblasted, and anodized implant surfaces.
Their effectiveness in the removal of bacteria was compared to a standard method (PSS).
The results were unequivocally clear. It was not possible to breed bacteria after the implants
had been cleaned by the electrolytic approach. Every implant cleaned by the air-powder-water spray
contained so many bacteria that all the blood agar plates were totally overgrown with a lawn of bacteria.
A single CFU could only be counted after dilution to 1:1,000,000. The waste collected while using the
PSS contained vital bacteria, and breeding them on blood agar plates demonstrated their vitality.
In conclusion, the air-powder-water spray does not sufficiently remove the biofilm. This might
explain why, in a recent review, a re-osseointegration rate of only 39%−46% was possible in animal
models [21]. Considering the angle of threads, the micro-texture of the implants combined with
oversized particles, and craterlike bone defects, it is more possible to follow the manufacturer´s manual
(working distance of 3–5 mm and an angle of 30–60◦) and to clean the microstructure properly. The
electrolytic approach sterilized all the tested implants, irrespective of alloy or surface. No vital bacteria
were detectable. For this reason, the null hypothesis had to be rejected.
The electrolytic approach seems to be a promising method for treating infected dental and
orthopedic implants.
5. Conclusions
In this study, it was proven that electrolytic cleaning of lifelike dental implants contaminated with
vital oral biofilms sterilizes the implant surfaces. One of the gold-standard methods of cleaning by
air-powder-water spray failed to achieve an adequate result. Clinical testing is necessary to prove the
clinical impact of these findings in dentistry and orthopedic surgery.
Author Contributions: Conceptualization, C.R., P.W., D.H., F.K. and H.Z.; methodology, C.R., P.W., D.H., F.K.,
M.S and H.Z.; software, C.R.; validation, C.R., P.W., D.H., F.K., M.S. and H.Z.; formal analysis, C.R., M.S. and H.Z.;
investigation, C.R., D.H. and H.Z.; resources, H.Z.; data curation, C.R., P.W., M.S. and H.Z.; writing—original draft
preparation, C.R., M.S. and H.Z.; writing—review and editing, C.R., P.W., D.H., F.K., M.S. and H.Z.; visualization,
C.R., P.W., M.S. and H.Z.; supervision, C.R. and H.Z.; project administration, C.R and H.Z.; funding acquisition,
M.S., H.Z.
Funding: This research was funded by by Zyfoma GmbH, Weiterstadt, Germany.
Acknowledgments: The authors Schlee and Zipprich declare themselves as holding patents on the described
technology, and to have financial interests. We appreciate Ümniye Balaban from the Institute for Biostatistics and
Mathematical Modeling Center of Health Sciences, Hospital and Department of Medicine of the Goethe University
for her support with the statistics. We appreciate Charlotte zur Megede and Jana Weiler for support in collecting
the data.
Conflicts of Interest: The authors M.S. and H.Z. declare themselves as holding patents on the described technology,
and to have financial interests. M.S. was involved in the design of the study, analysis and interpretation of the
data, writing and the decision to publish this data.
References
1. Sendyk, D.I.; Chrcanovic, B.R.; Albrektsson, T.; Wennerberg, A.; Zindel Deboni, M.C. Does Surgical Experience
Influence Implant Survival Rate? A Systematic Review and Meta-Analysis. Int. J. Prosthodont. 2017, 30,
341–347. [CrossRef]
117
J. Clin. Med. 2019, 8, 1397
2. Lang, N.P.; Berglundh, T. Periimplant diseases: Where are we now?—Consensus of the Seventh European
Workshop on Periodontology. J. Clin. Periodontol. 2011, 38, 178–181. [CrossRef]
3. Berglundh, T.; Armitage, G.; Araújo, M.G.; Avila-Ortiz, G.; Blanco, J.; Camargo, P.M.; Chen, S.; Cochran, D.;
Derks, J.; Figuero, E.; et al. Peri-implant diseases and conditions: Consensus report of workgroup 4 of
the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
J. Periodontol. 2018, 89, S313–S318. [CrossRef]
4. Mombelli, A.; Décaillet, F. The characteristics of biofilms in peri-implant disease. J. Clin. Periodontol. 2011, 38,
203–213. [CrossRef]
5. Mombelli, A.; Müller, N.; Cionca, N. The epidemiology of peri-implantitis. Clin. Oral Implants Res. 2012, 23,
67–76. [CrossRef]
6. Derks, J.; Tomasi, C. Peri-implant health and disease. A systematic review of current epidemiology.
J. Clin. Periodontol. 2015, 42, S158–S171. [CrossRef]
7. Coli, P.; Christiaens, V.; Sennerby, L.; de Bruyn, H. Reliability of periodontal diagnostic tools for monitoring
peri-implant health and disease. Periodontology 2000 2017, 73, 203–217. [CrossRef]
8. Esposito, M.; Grusovin, M.G.; Worthington, H.V. Treatment of peri-implantitis: What interventions are
effective? A Cochrane systematic review. Eur. J. Oral Implant. 2012, 5, S21–S41.
9. Canullo, L.; Montegrotto Group for the Study of Peri-implant Disease; Schlee, M.; Wagner, W.; Covani, U.
International Brainstorming Meeting on Etiologic and Risk Factors of Peri-implantitis, Montegrotto (Padua,
Italy), August 2014. Int. J. Oral Maxillofac. Implants 2015, 30, 1093–1104. [CrossRef]
10. Fürst, M.M.; Salvi, G.E.; Lang, N.P.; Persson, G.R. Bacterial colonization immediately after installation on
oral titanium implants. Clin. Oral Implants Res. 2007, 18, 501–508. [CrossRef]
11. Zoubos, A.B.; Galanakos, S.P.; Soucacos, P.N. Orthopedics and biofilm—What do we know? A review.
Med. Sci. Monit. 2012, 18, RA89–RA96. [CrossRef]
12. Cargill, J.S.; Upton, M. Low concentrations of vancomycin stimulate biofilm formation in some clinical
isolates of Staphylococcus epidermidis. J. Clin. Pathol. 2009, 62, 1112–1116. [CrossRef]
13. Hexter, A.T.; Hislop, S.M.; Blunn, G.W.; Liddle, A.D. The effect of bearing surface on risk of periprosthetic
joint infection in total hip arthroplasty: A systematic review and meta-analysis. Bone Joint J. 2018, 100-B,
134–142. [CrossRef]
14. Gilson, M.; Gossec, L.; Mariette, X.; Gherissi, D.; Guyot, M.H.; Berthelot, J.M.; et al. NIH consensus conference:
Total hip replacement. NIH Consensus Development Panel on Total Hip Replacement. JAMA 1995, 273,
1950–1956.
15. Rowan, F.E.; Donaldson, M.J.; Pietrzak, J.R.; Haddad, F.S. The Role of One-Stage Exchange for Prosthetic
Joint Infection. Curr. Rev. Musculoskelet. Med. 2018, 11, 370–379. [CrossRef]
16. Zimmerli, W.; Sendi, P. Pathogenesis of implant-associated infection: the role of the host. Semin. Immunopathol.
2011, 33, 295–306. [CrossRef]
17. Biring, G.S.; Kostamo, T.; Garbuz, D.S.; Masri, B.A.; Duncan, C.P. Two-stage revision arthroplasty of the hip
for infection using an interim articulated Prostalac hip spacer: A 10- to 15-year follow-up study. J. Bone Joint
Surg. Br. 2009, 91, 1431–1437. [CrossRef]
18. Sia, I.G.; Berbari, E.F.; Karchmer, A.W. Prosthetic Joint Infections. Infect. Dis. Clin. North Am. 2005, 19,
885–914. [CrossRef]
19. Byren, I.; Bejon, P.; Atkins, B.L.; Angus, B.; Masters, S.; McLardy-Smith, P.; Gundle, R.; Berendt, A. One
hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant
retention): antibiotic duration and outcome. J. Antimicrob. Chemother. 2009, 63, 1264–1271. [CrossRef]
20. Helou, O.C.; Berbari, E.F.; Lahr, B.D.; Eckel-Passow, J.E.; Razonable, R.R.; Sia, I.G.; Virk, A.; Walker, R.C.;
Steckelberg, J.M.; Wilson, W.R.; et al. Efficacy and safety of rifampin containing regimen for staphylococcal
prosthetic joint infections treated with debridement and retention. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29,
961–967. [CrossRef]
21. Tastepe, C.S.; Van Waas, R.; Liu, Y.; Wismeijer, D. Air powder abrasive treatment as an implant surface
cleaning method: A literature review. Int. J. Oral Maxillofac. Implants 2012, 27, 1461–1473.
22. Claffey, N.; Clarke, E.; Polyzois, I.; Renvert, S. Surgical treatment of peri-implantitis. J. Clin. Periodontol. 2008,
35, 316–332. [CrossRef]
118
J. Clin. Med. 2019, 8, 1397
23. De Almeida, J.M.; Matheus, H.R.; Rodrigues Gusman, D.J.; Faleiros, P.L.; Januário de Araújo, N.; Noronha
Novaes, V.C. Effectiveness of Mechanical Debridement Combined With Adjunctive Therapies for Nonsurgical
Treatment of Periimplantitis: A Systematic Review. Implant Dent. 2017, 26, 137–144. [CrossRef]
24. Del Pozo, J.L.; Rouse, M.S.; Mandrekar, J.N.; Steckelberg, J.M.; Patel, R. The electricidal effect: Reduction
of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current.
Antimicrob. Agents Chemother. 2009, 53, 41–45. [CrossRef]
25. Schwarz, F.; Becker, K.; Sager, M. Efficacy of professionally administered plaque removal with or without
adjunctive measures for the treatment of peri-implant mucositis. A systematic review and meta-analysis.
J. Clin. Periodontol. 2015, 42, 202–213. [CrossRef]
26. Mohn, D.; Zehnder, M.; Stark, W.J.; Imfeld, T. Electrochemical Disinfection of Dental Implants—A Proof of
Concept. PLoS ONE 2011, 6, e16157. [CrossRef]
27. Zipprich, H.; Ratka, C.; Schlee, M.; Brodbeck, U.; Lauer, H.C.; Seitz, O. Periimplantitistherapie: Durchbruch
mit neuer Reinigungsmethode. Dentalmagazin 2013, 31, 14–17.
28. Schneider, S.; Rudolph, M.; Bause, V.; Terfort, A. Electrochemical removal of biofilms from titanium dental
implant surfaces. Bioelectrochemistry 2018, 121, 84–94. [CrossRef]
29. Tian, Y.; He, X.; Torralba, M.; Yooseph, S.; Nelson, K.E.; Lux, R.; McLean, J.S.; Yu, G.; Shi, W. Using DGGE
profiling ro develop a novel culture medium suitable for oral microbial communities. Mol. Oral Microbiol.
2010, 25, 357–367. [CrossRef]
30. Ehrensberger, M.T.; Tobias, M.E.; Nodzo, S.R.; Hansen, L.A.; Luke-Marshall, N.R.; Cole, R.F.; Wild, L.M.;
Campagnari, A.A. Cathodic voltage-controlled electrical stimulation of titanium implants as treatment for
methicillin-resistant Staphylococcus aureus periprosthetic infections. Biomaterials 2015, 41, 97–105. [CrossRef]
31. Poortinga, A.T.; Smit, J.; Van Der Mei, H.C.; Busscher, H.J. Electric field induced desorption of bacteria from
a conditioning film covered substratum. Biotechnol. Bioeng. 2001, 76, 395–399. [CrossRef]
32. Van Der Borden, A.; Van Der Mei, H.; Busscher, H. Electric block current induced detachment from surgical
stainless steel and decreased viability of Staphylococcus epidermidis. Biomaterials 2005, 26, 6731–6735.
[CrossRef]
33. A Blenkinsopp, S.; Khoury, A.E.; Costerton, J.W. Electrical enhancement of biocide efficacy against
Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 1992, 58, 3770–3773.
34. Poortinga, A.; Bos, R.; Busscher, H. Measurement of charge transfer during bacterial adhesion to an indium
tin oxide surface in a parallel plate flow chamber. J. Microbiol. Methods 1999, 38, 183–189. [CrossRef]
35. Sahrmann, P.; Zehnder, M.; Mohn, D.; Meier, A.; Imfeld, T.; Thurnheer, T. Effect of low direct current on
anaerobic multispecies biofilm adhering to a titanium implant surface. Clin. Implant Dent. Relat. Res. 2014,
16, 552–556. [CrossRef]
36. Sandvik, E.L.; McLeod, B.R.; Parker, A.E.; Stewart, P.S. Direct Electric Current Treatment under Physiologic
Saline Conditions Kills Staphylococcus epidermidis Biofilms via Electrolytic Generation of Hypochlorous
Acid. PLoS ONE 2013, 8, e55118. [CrossRef]
37. Salvi, G.E.; Fürst, M.M.; Lang, N.P.; Persson, G.R. One-year bacterial colonization patterns of Staphylococcus
aureus and other bacteria at implants and adjacent teeth. Clin. Oral Implants Res. 2008, 19, 242–248. [CrossRef]
38. Koban, I.; Holtfreter, B.; Hübner, N.-O.; Matthes, R.; Sietmann, R.; Kindel, E.; Weltmann, K.-D.; Welk, A.;
Kramer, A.; Kocher, T. Antimicrobial efficacy of non-thermal plasma in comparison to chlorhexidine against
dental biofilms on titanium discs in vitro - proof of principle experiment. J. Clin. Periodontol. 2011, 38,
956–965. [CrossRef]
39. John, G.; Schwarz, F.; Becker, J. Taurolidine as an effective and biocompatible additive for plaque-removing
techniques on implant surfaces. Clin. Oral Investig. 2015, 19, 1069–1077. [CrossRef]
40. Stacchi, C.; Berton, F.; Porrelli, D.; Lombardi, T. Reuse of Implant Healing Abutments: Comparative
Evaluation of the Efficacy of Two Cleaning Procedures. Int. J. Prosthodont. 2018, 31, 161–162. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution






Is Complete Re-Osseointegration of an Infected
Dental Implant Possible? Histologic Results of a Dog
Study: A Short Communication
Markus Schlee 1,2, Loubna Naili 3, Florian Rathe 1,4, Urs Brodbeck 5 and Holger Zipprich 6,*
1 Private Practice, Forchheim, Germany; markus.schlee@32schoenezaehne.de (M.S.);
florian.rathe@32schoenezaehne.de (F.R.)
2 Department of Maxillofacial Surgery, Goethe University, 60590 Frankfurt am Main, Germany
3 Private Practice, Kirchbachstraße 186, 28211 Bremen, Germany; lnaili@students.uni-mainz.de
4 Private Practice and Department of Prosthodontics, Danube University, 3500 Krems, Austria
5 Private Practice, 8051 Zürich, Switzerland; ursbrodbeck@bluewin.ch
6 Department of Prosthodontics, Goethe University, 60590 Frankfurt am Main, Germany
* Correspondence: zipprich@em.uni-frankfurt.de; Tel.: +49-69-6301-4714; Fax: +49-69-6301-3711
Received: 6 November 2019; Accepted: 9 January 2020; Published: 16 January 2020
Abstract: Complete reosseointegration after treatment of periimplantitis was never published yet.
This short scientific communication reports about results of a randomized controlled preclinical study.
An electrolytic approach was compared to a classical modality (ablative, cotton pellets soaked with
sodium chloride solution and H2O2. For electrolytic cleaning a complete reosseointegration was
achieved in several cases serving as a proof of concept.
Keywords: periimplantitis; electrolytic cleaning; augmentation; air flow; re-osseointegration;
dog study
1. Introduction
Ligature-induced inflammation and bone loss in a dog model was introduced to imitate
periimplantitis in humans and preclinically study different treatment approaches. Schwarz et al. [1]
compared bone defects in 24 patients with advanced periimplantitis to ligature-induced bone defects
at 30 implants in five beagle dogs. Defect morphology was similar in both entities. The authors
concluded that the dog model would be an appropriate model for simulating periimplantitis in
humans. Seong at al. reported the possibility of spontaneous healing after ligature removal in dogs [2].
The authors claimed that further clarification of differences between the forced acute bone loss induced
by ligatures and the chronic process in clinical periimplantitis would be necessary. Nevertheless,
the dog model provided valuable insights into the etiology and pathogenesis of periimplantitis [3]
and may be a reasonable model for studying whether re-osseointegration of implant surfaces covered
by bacterial biofilms is possible. Based on animal studies, re-osseointegration is feasible, although
unpredictable, as it varies between studies and depends on implant surface characteristics and defect
morphology [4,5].
In this preclinical randomized and controlled trial, electrolytic cleaning (EC) versus classical
cleaning (CC, rubbing a gauze strip soaked in H2O2 (3%), followed by a strip soaked in saline (0.9%))
was employed to prove whether complete re-osseointegration is possible in a dog model. This approach
was chosen on the basis of previous studies [5]. A custom-made pilot series device and the pilot
electrolyte (sodium and potassium iodine) of the in vitro study of Ratka et al. [6] were used in this
study. The aim of this short scientific communication is to share histologic results and to prove whether
complete re-osseointegration is possible when EC has been used as a decontamination technique.
J. Clin. Med. 2020, 9, 235; doi:10.3390/jcm9010235 www.mdpi.com/journal/jcm121
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2. Experimental Section
The study was approved by the Internal Review Board of the University of São Paulo
(2013.1.1193.58.3 by CEUA (Comissão de Ética no Uso de Animais)). No sample size calculation
could be done because this was the first in vivo trial and no data were available. To have a high
chance of achieving significance, we used a large number of dogs compared to existing literature (8
dogs). Two months after extraction (T1) of all premolars and the first molars in the left and right
mandible, 4 implants per quadrant were placed (Figure 1). It was planned to place two different
brands of implants: 48 BL implants (BL SLA® 3.3 × 8.0 mm, Straumann, Basel, Switzerland) and 16
Nobel Active implants (NA TiUnite® 3.5 × 8.5mm, Nobel Biocare, Kloten, Switzerland). In view of the
expected bone defects, the inter-implant distance was at least 6 mm (Figure 1). In addition to the study
implants, extra implants were placed, provided there was sufficient space and the study implants
would not be impeded. Ligatures were pushed into the sulcus at T2 (4 months) and removed at T3
(7 months). A hygiene program was set up, and the implants were treated at T4 (8 months) by either
CC or EC in a randomized manner with the use of sealed envelopes. The mode of action of EC has been
described before [6,7]. In summary, the implants were negatively loaded with a current of around 5 V,
and rinsed with an electrolyte which passed an anode inside a spray-head (Figure 4c). Sodium iodine
(200 g/L), potassium iodine (200 g/L), and L (+)-lactic acid (20 g/L) were used as the electrolyte [6]
and an early prototype of a spray-head (Figure 4c) as the source of current (5 min, 400 mA) in the
present study. The current directs anions and cations to the electric field. While the anions at the
anode form an iodine disinfecting solution, the cations penetrate the biofilm, take an electron from
the implant surface, and the emerging hydrogen bubbles (H2) lift off the bacterial biofilm. The CC
implants were treated by rubbing a gauze strip soaked in H2O2 (3%), followed by a strip soaked in
saline (0.9%, Braun Melsungen, Germany). All sites were augmented with autogenous bone harvested
from the ramus area of the lateral mandible (Micross Safescraper, Zantomed, Duisburg, Germany),
covered with a collagen membrane (Bio-Gide, Geistlich, Wohlhusen, Switzerland), and the flap was
coronally advanced to cover the augmented area without tension. One implant per dog (2 Nobel,
4 Straumann) was randomly selected and not treated to serve as a negative control. The animals were
sacrificed for histologic evaluation at T5 (11 months). Standardized x-rays were taken at T1, 2, 4, and 5.
Bleeding on probing (BoP) as well as an assessment of pocket depth (PD) at T2, 4, and 5 (Figure 2) were
performed. Preparation of samples followed the technique introduced by Donath [8], and staining was
done with Stevenel’s blue or Toluidine blue. Bone gain was assessed using a digital tool (NDP.view
2.5.19, (Hamamatsu Photonics KK, Shizuoka, Japan)) and analyzed histomorphometrically.
Figure 1. Allocation of implant positions.
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Figure 2. Timetable of the dog study.
3. Results
Sixty-five implants were finally placed (Table 1). Fourteen TiUnite® implants and 43 SLA®
implants were treated (EC & CC) and eight implants (2 TiUnite® and 6 SLA®) were left untreated.
Two implants could not be placed due to the required distances (Figure 1). All implants displayed
massive horizontal bone loss before treatment, in most cases merging with neighboring defects
(Figures 3 and 4), which left a site that was difficult to augment. Forty-eight implants were exposed
during healing whereas nine EC (5 TiUnite® and 4 SLA®) and eight CC (3 TiUnite® and 5 SLA®)
implants stayed covered until T5. Complete re-osseointegration could be demonstrated for implants
treated by CC in one implant and for four TiUnite® and six SLA® implants treated by EC (Figures 5–8).
The median bone gain for implants which healed submerged was 1.58 ± 0.76 in the case of EC and
1.19 ± 0.29 in the case of CC. The boxplot appears in Figure 9.
Table 1. Allocation of implant positions.
Dog Quadrant Straumann Nobel Straumann Not Treated Nobel Not Treated Total Not Placed
1 right 2 1 3 1
left 3 1 1 5
2 right 3 1 4
left 3 1 1 5
3 right 3 1 4
left 2 1 1 4
4 right 3 0 1 4
left 3 1 4
5 right 3 1 4
left 3 0 1 4
6 right 3 1 1 5
left 3 1 4
7 right 2 1 3 1
left 2 1 1 4
8 right 3 1 4
left 2 1 1 4




J. Clin. Med. 2020, 9, 235
 
Figure 3. Massive horizontal bone loss results in merging bone defects and massive resorption of the
whole ridge.
 
Figure 4. (a) Infected site prior to treatment, (b) reflected flap indicates a complex merged defect
morphology, (c) electrolytic cleaning with a spray-head, (d) augmented site before collagen membrane
was applied.
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Figure 5. Histologic evaluation of healing after electrolytic cleaning (EC) (SLA® surface). The arrows
indicate the bony crest before treatment. Complete coverage of the formerly exposed implant surface
was achieved.
Figure 6. Histologic evaluation of healing after classical cleaning (CC) (SLA® surface). The arrows
indicate the bony crest before treatment. Bone-to-implant contact was achieved but full regeneration
could not be achieved in any implant.
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Figure 7. Histologic evaluation of healing after CC (TiUnite® surface). The arrows indicate the
bony crest before treatment. A small amount of new bone-to-implant contact was achieved. No
re-osseointegration could be achieved on major parts of the implant surface.
Figure 8. Histologic evaluation of healing after EC (TiUnite® surface). The arrows indicate the bony
crest before treatment. Bone-to-implant contact was achieved as more crestal than the neighboring
bone level.
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Figure 9. Bone gain for submerged implants at T5 in CC (8 implants) and EC (9 implants) groups
display higher bone gain for the EC group.
4. Discussion
The results of this preclinical study may differ from results gained with the final devices used
for this technique. Nevertheless, they may serve as proof of principle. As submerged healing was
sought, the high number of exposures was an undesirable result. This may correlate with the fact that
most of the defects were horizontal and required vertical augmentation. Furthermore, uneventful
healing was not possible because of dogs biting on the surgical sites. Implants exposed to the platform
cannot regenerate completely and were therefore excluded from statistical evaluation. This limits
the meaningfulness of the study. Consequently, we were not able to prove the superiority of one
of the treatment modalities in regenerating bone in contact with the implant surface because of the
sample size.
Nevertheless, 17 implants were not exposed. When comparing bone regeneration in EC and CC in
these cases, EC tended to be superior based on median, without reaching significance. Eight implants
in the EC group achieved complete re-osseointegration, but none in the CC group. To the best of
the authors’ knowledge, complete regeneration has never before been described in the literature.
This paper does not investigate the reasons for this observation. In the context of previous literature,
it may be assumed that EC in contrast to CC removes the bacterial biofilm and other remnants to an
extent that makes complete re-osseointegration possible [6,7]. The latter was proven through histology
(Figures 5–8). Re-osseointegration is defined as new bone in direct contact with the formerly infected
implant surface. Soft tissue thickness correlates to bone level. Thus bone regeneration to the platform
cannot be expected in the case of exposure if the shoulder of the implant was visible [9]. If chewing
forces were applied to the implant, complete regeneration also cannot be expected, even if the site
stayed covered. Interestingly, complete regeneration was only possible in the EC group—even under
these circumstances.
The regenerative potential of horizontal bone defects with no walls is worse than for contained,
multi-walled defects [4,7]. In this animal study we observed massive horizontal bone loss and merging
defects resulting in a severely resorbed ridge (Figure 3). In humans, an inter-implant distance of 3 mm
is usually sufficient to maintain an interdental bone peak in the case of bone loss around implants [10].
We used an inter-implant distance of 6 mm and yet the defects still merged. This might be an indication
that ligature-induced periimplantitis in a dog model behaves differently to periimplantitis in humans.
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Considering our findings, dog models might be inappropriate for investigating the amount of bone
generation. Fewer implants per ridge are suggested for future dog studies.
5. Conclusions
As a proof of concept, complete re-osseointegration was proven after electrolytic cleaning
and augmentation.
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Abstract: Early marginal bone loss (MBL) is a non-infective remodeling process of variable entity
occurring within the first year after implant placement. It has a multifactorial etiology, being influenced
by both surgical and prosthetic factors. Their impact remains a matter of debate, and controversial
information is available, particularly regarding implants placed subcrestally. The present multicenter
prospective clinical study aimed to correlate marginal bone loss around platform-switched implants
with conical connection inserted subcrestally to general and local factors. Fifty-five patients were
enrolled according to strict inclusion/exclusion criteria by four clinical centers. Single or multiple
implants (AnyRidge, MegaGen, South Korea) were inserted in the posterior mandible with a one-stage
protocol. Impressions were taken after two months of healing (T1), screwed metal-ceramic restorations
were delivered three months after implant insertion (T2), and patients were recalled after six months
(T3) and twelve months (T4) of prosthetic loading. Periapical radiographs were acquired at each time
point. Bone levels were measured at each time point on both mesial and distal aspects of implants.
Linear mixed models were fitted to the data to identify predictors associated with MBL. Fifty patients
(25 male, 25 female; mean age 58.0± 12.8) with a total of 83 implants were included in the final analysis.
The mean subcrestal position of the implant shoulder at baseline was 1.24 ± 0.57 mm, while at T4,
it was 0.46 ± 0.59 mm under the bone level. Early marginal bone remodeling was significantly
influenced by implant insertion depth and factors related to biological width establishment (vertical
mucosal thickness, healing, and prosthetic abutment height). Deep implant insertion, thin peri-implant
mucosa, and short abutments were associated with greater marginal bone loss up to six months
after prosthetic loading. Peri-implant bone levels tended to stabilize after this time, and no further
marginal bone resorption was recorded at twelve months after implant loading.
Keywords: abutment height; subcrestal implants; marginal bone loss; implant insertion depth;
vertical mucosal thickness; biological width
1. Introduction
A complex cascade of biological events occurs after implant insertion. In this type of surgery,
wound healing response after surgical trauma is conditioned by the presence of foreign material in the
host bone. According to studies by Donath [1,2], a foreign material inside the human body may elicit
J. Clin. Med. 2019, 8, 1168; doi:10.3390/jcm8081168 www.mdpi.com/journal/jcm129
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four types of host response: rejection, dissolution, resorption, or demarcation. Demarcation, which
represents a protective reaction aiming to separate a foreign body impossible to dissolute or resorb
from healthy tissue, usually results in fibrous encapsulation. However, when biocompatible material
is surrounded by bone in a protected environment (with neither infection nor micromovements),
bone encapsulation usually occurs, forming a robust bone-to-implant interface, which can be used for
clinical purposes: the osseointegration phenomenon [3]. The majority of osseointegrated implants
show successful long-term clinical outcomes due to the establishment of steady-state bone remodeling
activity. However, the condition of foreign-body equilibrium may be compromised by various factors
at different times. The main clinical sign of imbalance between bone apposition and resorption is
a marginal bone loss (MBL) [4]. Marginal bone stability around dental implants has always been
considered one of the main criteria for defining implant success [5].
Early MBL is a non-infective remodeling process of variable entity occurring within the first
year after implant placement. It has a multifactorial etiology, being influenced by both surgical
factors (insufficient crestal width and/or implant malpositioning, bone overheating during implant
site preparation, implant crest module characteristics, excessive cortical compression) and prosthetic
variables (type of implant/abutment connection, entity and location of implant/abutment microgap,
number of abutment disconnections, abutment height, residual cement, early loading) [6–9]. Early
MBL represents an adaptive response of peri-implant marginal bone to the combined effect of these
factors and has been considered to have an important prognostic value for predicting long-term
implant success. A recent study on implants positioned at the crestal level suggested that early MBL
>0.44 mm in the first six months after prosthetic loading is a risk indicator for peri-implant bone loss
progression [10].
Modifications of horizontal and vertical relationships between implant-abutment junction (IAJ)
and bone crest have been suggested to influence the entity of early MBL. The horizontal displacement
of the microgap location far from the bone crest using an abutment narrower than the implant
neck (platform switching) has been demonstrated to be effective in reducing early MBL [11,12].
Conversely, controversial information is available regarding implants placed subcrestally. Some
authors recommended placement of the implant platform 1 or 2 mm below the alveolar crest to better
maintain marginal bone levels [13,14]. However, other studies reported an increased extension of
inflammatory infiltrate due to deep positioning of the IAJ, resulting in greater MBL compared to
implants placed equicrestally [15,16].
Therefore, the primary aim of the present multicenter prospective clinical study was to analyze
factors potentially influencing early MBL around platform-switched implants with conical connection
inserted subcrestally, up to 15 months after implant placement.
2. Material and Methods
2.1. Study Protocol
This multicenter prospective clinical study was reported in strict adherence to the criteria of
the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) checklist. All
procedures were performed per the recommendations of the Declaration of Helsinki, as revised in
Fortaleza (2013), for investigations with human subjects. The study protocol was approved by the
relevant Ethical Committee (Regione Calabria, Sezione Area Nord, No. 46/2016), and was recorded
in a public register of clinical trials (www.clinicaltrials.gov-NCT03077880). All eligible patients were
thoroughly informed of the study protocol (including surgical and prosthetic procedures, follow-up
visits, potential risks involved, and possible therapeutic alternatives), and signed an informed consent
form. Patients authorized the use of their data for research purposes.
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2.2. Selection Criteria
Any partially edentulous patient requiring implant therapy for fixed prosthetic rehabilitation in the
posterior mandible was eligible for this study, subject to the following inclusion and exclusion criteria.
General inclusion criteria were: (I) age >18 years; (II) good general health; (III) patient willing and
fully capable to comply with the study protocol; (IV) written informed consent given.
Local inclusion criteria were: (I) presence of keratinized mucosa with a minimum buccolingual
width of 4 mm; (II) bone crest with at least 6 mm width and 8 mm height above the mandibular canal
in the site when the implant was planned; (III) healed bone crest (at least 6 months elapsed from
tooth extraction); (IV) no grafted bone; (V) full mouth plaque score (FMPS) <25% and full mouth
bleeding score (FMBS) <20%; (VI) implant insertion torque (IT) >20 Ncm; (VII) presence of the opposing
dentition; (VIII) subcrestal positioning. Exclusion criteria were: (I) history of head or neck radiation
therapy; (II) uncontrolled diabetes (hemoglobinA1c >7.5%); (III) immunocompromised patients (HIV
infection or chemotherapy within the past 5 years); (IV) present or past treatment with intravenous
bisphosphonates; (V) patient pregnancy or lactating at any time during the study; (VI) psychological or
psychiatric problems; (VII) alcohol or drugs abuse; (VIII) participating in other studies, if the present
protocol could not be properly followed.
All patients, selected consecutively between April 2016 and October 2017, were treated
independently by four operators (T.L., S.S., E.B., and C.S.) in four private offices. Data collection was
performed by a single independent examiner (F.B.).
All patients received oral hygiene instructions and underwent deplaquing 1 week before surgery.
Cone beam computed tomography (CBCT) was performed to analyze available bone volume and to
plan implant insertion.
2.3. Surgical and Restorative Procedures
All patients were administered with antibiotic prophylaxis (amoxicillin 2 g) one hour before
surgery. A mid-crestal incision was performed under local anesthesia, preserving an adequate quantity
of keratinized tissue on both buccal and lingual sides. A full-thickness buccal flap was elevated, and
vertical mucosal thickness of the undetached lingual flap was measured with a periodontal probe at the
center of the programmed implant site, as described elsewhere [17]. The lingual flap was subsequently
elevated, and implant site preparation was performed under abundant irrigation of cold saline solution
following the manufacturer’s recommendations for subcrestal placement. Platform-switched implants
with conical connection (AnyRidge, MegaGen, Gyeongbuk, South Korea) were inserted under bone
level, and peak IT values were recorded by the surgical motor (Implantmed, W&H, Burmoos, Austria).
Implants were immediately connected to healing or transepithelial abutments (Octa, MegaGen,
Gyeongbuk, South Korea), adapting their length to the site-specific soft tissue vertical thickness.
Flaps were sutured with single stitches and Sentineri technique using synthetic monofilament [18].
Patients were prescribed post-surgical antibiotic therapy (amoxicillin 1 g twice a day) for six days, and
nonsteroidal anti-inflammatory drugs (ibuprofen 600 mg), when necessary. Sutures were removed
10–14 days after surgery. Patients were instructed not to use removable prostheses during the entire
healing period.
After two months of healing, implants were clinically and radiographically evaluated, and
final impressions were taken. Prosthetic abutments height was chosen, adapting their length to
the site-specific soft tissue vertical thickness. After functional and aesthetic try-in, screw-retained
metal-ceramic rehabilitations were delivered.
Periodontal status was assessed using the modified plaque index (mPI) and modified sulcus
bleeding index (mSBI) at prosthesis delivery and after 6 and 12 months of functional loading [19].
The mean of the four values recorded for each implant (mesial, distal, buccal, and lingual) was
subsequently analyzed.
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2.4. Radiographic Measurements
Digital radiographs were taken using a long-cone paralleling technique with a Rinn-type film
holder at the time of implant placement (baseline—T0), at impression taking (2 months after implant
placement—T1), at prosthetic restoration delivery (3 months after implant placement—T2), and after 6
and 12 months of prosthetic loading (T3 and T4, respectively) (Figure 1).
Figure 1. Summary of the visits.
The distance between IAJ and bone crest was measured at each time interval, on both mesial and
distal aspects of the implant. A positive value was assigned when the bone crest was coronal to the
IAJ, whereas a negative value was assigned when the bone crest was apical to the IAJ.
Any radiograph showing signs of deformation or poor image quality was immediately repeated.
All measurements were taken by a single calibrated examiner (F.P.), on a 30-inch led-backlit color
diagnostic display, using measuring software (Image J 1.52a, National Institutes of Health, USA)
(Figure 2). Each measurement was repeated three times at three different time points, as proposed by
Gomez-Roman and Launer [20]. Examiner calibration was performed by assessing ten radiographs,
with a different author (F.B.) serving as a reference examiner. Intra-examiner and inter-examiner
concordances were 91.9% and 85.2%, respectively, for linear measurements within ±0.1 mm.
 
Figure 2. Bone level measurement.
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2.5. Predictor and Outcome Variables
Primary predictor variables and their respective period of activity were evaluated as follows:
(i) vertical mucosal thickness (thick >2 mm vs. thin ≤2 mm; from T0 to T4); (ii) implant insertion
torque (>50 Ncm vs. ≤50 Ncm; from T0 to T1); (iii) depth of implant insertion (mm; from T0 to T4);
(iv) healing abutment height (long ≥3 mm vs. short <3 mm; from T0 to T2); (v) number of abutment
disconnections (zero vs. multiple; from T0 to T4); (vi) prosthetic abutment height (long ≥3 mm vs.
short <3 mm; from T2 to T4); (vii) type of prosthetic restoration (single crown vs. short-span bridge;
from T2 to T4). The influence of the following patient-related variables, possibly correlated with the
predictor and outcome variables, were also evaluated from T0 to T4: (i) age; (ii) gender; (iii) smoking
status (smoker vs. no smoker); (iv) periodontal status (periodontal health vs. chronic periodontitis).
Primary outcome (dependent variable):
• early MBL (up to 12 months from prosthetic loading).
Secondary outcomes:
• implant failure: implant mobility or implant removal due to progressive marginal bone loss.
Implant stability was tested by tightening abutment screws (35 N/cm) at prosthesis delivery.
• any complication or adverse event.
2.6. Statistical Analysis
Statistical analysis was performed using R software version 3.5.3 (nlme package; version 3.1.140).
Early MBL at each time point was defined as the difference between the depth of implant insertion at
the time and depth of implant insertion at baseline.
The means of mesial and distal early MBL at each follow-up were compared using a t-test for
paired data. No significant differences were found (T1: Toss = 0.413, d.f. (degrees of freedom) = 82,
p = 0.68; T2: Toss = 0.002, d.f. = 82, p = 1; T3: Toss = –0.143, d.f. = 82, p = 0.89; T4: Toss = –0.027,
d.f. = 82, p = 0.98), hence the mean between mesial and distal MBL was used as a primary outcome in
subsequent analysis.
Linear mixed models were fitted to the data to identify predictors associated with MBL. Since not
all variables were active at all time-points, four different models were estimated. First, a global model
(Model A) was built, considering all four follow-up time points. Preliminary models with only one
covariate at a time, plus time and peri-implant bone level at T0, were estimated to select the covariates
to be included in the final multivariable model. Only covariates with p < 0.05 entered the final model.
Covariates taken into account were those that might have affected the primary outcome over the
whole follow-up period: age, gender, smoking status, periodontal status, vertical mucosal thickness,
and multiple abutment disconnections. Time was considered a continuous variable measured in
months, and was modeled using a linear spline function with one knot at T3, as indicated by graphical
preliminary exploratory analyses. Subsequently, models considering different follow-up times were
estimated:
• Model B: T1
• Model C: T1, T2
• Model D: T2, T3, T4
In these models, in addition to the covariates used in Model A, other independent variables active
only at specific time points were added (implant insertion torque in Model B; healing abutment height
in Model C; prosthetic abutment height and type of prosthetic restoration in Model D).
In models C and D, time was used as a categorical variable. Time was not included in Model B
as only one MBL measurement was involved. Covariate selection was performed using preliminary
models, as explained above.
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The random-effects structure of each model was evaluated using the Likelihood Ratio Test. For all
models, the most suitable structure was random intercept on the subject and random intercept on the
operator, except for Model B, in which only random intercept on the operator was included.
3. Results
3.1. Demographics and Clinical Outcomes
Of a total of 228 patients evaluated for eligibility, 55 consecutive patients (T.L. 20; S.S. 9; E.B. 6;
C.S. 20) fulfilled all inclusion/exclusion requirements and were enrolled in the present study. Included
patients (27 male, 28 female; mean age 57.3 ± 12.6, age-range 32–85) were treated between June 2016
and March 2017 with the insertion of a total of 91 implants in the posterior mandible. Two implants
in two patients were not placed subcrestally (negative value of the mean between mesial and distal
measurements). Three implants in three patients failed to osseointegrate and were removed before
taking impressions (primary failure rate of 3.3%). Two patients (three implants) were lost at 6-month
follow-up (one patient of T.L. was jailed, and one patient of C.S. moved abroad). Finally, fifty patients
(25 male, 25 female; mean age 58.0 ± 12.8, age-range 32–85), with a total of 83 implants that received
single or short-span screwed metal-ceramic restorations, completed all phases of the study and were
included in the final analysis. The final sample was balanced in terms of age and gender distribution.
Complete demographics and characteristics of the included patients are summarized in Table 1.
Table 1. Characteristics of the included patients.
Total %
Age
Male 56.2 ± 13.8 -






Non Smoker 43 86
Periodontal Status
Periodontal Health 37 74
Chronic Periodontitis 13 26
No complications or adverse effects were recorded, and no additional implants were lost.
All 83 implants were functioning satisfactorily 6 months and 12 months after prosthetic loading.
Although slight increases in mPI and mSBI values were recorded at 15-month follow up, no significant
differences were recorded between T3 and T4.
3.2. Marginal Bone Level Changes
The mean subcrestal position of the implant shoulder at T0 was 1.24 ± 0.57 mm under bone level,
while at T4, it was 0.46 ± 0.59 mm. At the end of the follow-up period, out of a total of 83 implants, the
platform of 63 implants remained subcrestal (75.9%), four resulted in equicrestal (4.8%), and 16 resulted
in supracrestal (19.3%).
The pattern of marginal bone resorption over time was the following: mean MBL at T1 was
0.5 ± 0.34 mm. An additional mean MBL of 0.18 ± 0.22 mm was registered at T2. A further increase in
mean MBL of 0.11 ± 0.20 mm occurred at T3, while complete marginal bone stabilization was observed
at T4 (mean MBL compared to T3 = 0.00 ± 0.19 mm). Marginal bone levels at the different time-points
are represented in Figure 3.
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Figure 3. Marginal bone variations at different time points. MBL: marginal bone loss.
Results of preliminary linear mixed models analyzing factors possibly influencing MBL from
T0 and T4 are reported in Table 2. From T0 to T4, no significant relationships between early MBL
and patient age, gender, smoking status, periodontal status, and multiple abutment disconnections
were demonstrated. By contrast, implant insertion depth and presence of thin peri-implant mucosa
demonstrated significant negative influence upon early MBL from T0 to T4 (p < 0.01 and p = 0.01,
respectively). Complete results of the multivariable analysis are reported in Table 3.
Table 2. Preliminary univariable linear mixed models, analyzing factors possibly influencing marginal
bone loss from implant insertion to 12-months after prosthetic loading.
MBL (mm) Std. Error d.f. t-Value p-Value
Age 0.00 0.00 49 −0.49 0.63
Gender −0.02 0.08 49 −0.21 0.83
Smoking Status 0.12 0.10 49 1.15 0.26
Periodontal Status −0.02 0.09 49 −0.25 0.80
Multiple Abutment
Disconnections
0.03 0.08 30 0.43 0.67
MBL: marginal bone loss; Std: standard; DF: degrees of freedom. Adjusted for time effect and depth of
implant insertion.
Table 3. Multivariable linear mixed models, analyzing factors influencing marginal bone loss from
implant insertion to 12-months after prosthetic loading.
MBL (mm) Std. Error d.f. t-Value p-Value 95% CI
Vertical Mucosal
Thickness
0.24 0.08 30 2.91 0.01 0.07; 0.41
Depth of Implant
Insertion
−0.23 0.07 30 −3.37 <0.01 −0.37; −0.09
MBL: marginal bone loss; Std: standard; DF: degrees of freedom; CI: confidence interval. Adjusted for time effect.
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MBL variability within patients and operators was evaluated by a random-effects model and,
from T0 to T1, was observed to be 0.25 mm (0.19; 0.34) and 0.21 mm (0.13; 0.35), respectively.
Preliminary linear mixed models analyzing factors possibly influencing MBL within specific
time frames showed no significant associations between implant insertion torque and MBL (from T0
to T1; p = 0.62) or between type of prosthetic restoration (single crown vs. short-span bridge) and
marginal bone levels (from T2 to T4; p = 0.92). Conversely, healing abutment height (from T0 to T2)
and prosthetic abutment height (from T2 to T4) had a significant influence on early MBL. In particular,
short healing and prosthetic abutments (<3 mm height) were correlated with greater MBL (p < 0.01 for
both variables). Results of multivariable analysis analyzing factors influencing MBL within specific
time frames are reported in Table 4.
Table 4. Multivariable linear mixed models, analyzing factors influencing marginal bone loss within
specific time frames.








T2–T4 −0.44 0.07 29 −6.42 <0.01 −0.58; −0.3
MBL: marginal bone loss; Std: standard; DF: degrees of freedom; CI: confidence interval; T0: baseline; T1: 2-month
visit; T2: 3-month visit; T4: 15-month visit. Adjusted for time effect, depth of implant insertion, and vertical
mucosal thickness.
4. Discussion
The present multicenter prospective clinical study showed that platform-switched implants
with internal conical connection placed subcrestally presented a reduction in marginal bone levels
during the first year of function. Thoroughly analyzing this result, early MBL occurred in the first six
months after prosthetic loading. At 15-month follow-up, peri-implant marginal bone levels remained
unaltered (difference T4–T3: 0.00 ± 0.19 mm). This finding is in accordance with previous studies on
subcrestal implants, showing that MBL mainly occurs in the first period of function [14,21], followed
by stabilization of marginal bone levels or even slight marginal bone gain [22].
In the present investigation, a statistically significant positive correlation was demonstrated
between the depth of implant insertion and early MBL (p < 0.01), confirming a tendency shown in
previous studies [22,23]. To be exact, our statistical model suggested that a 1-mm depth increase
below the mean implant position at T0 (1.24 mm subcrestal) led to a greater MBL of 0.23 mm at
T4. However, from a clinical point of view, it should be underlined that implants with deeper
apico-coronal positioning at T0 (>1.5 mm under bone level) resulted in a more subcrestal position at
T4, when compared with implants placed more superficially at baseline (<1.5 mm under bone level)
(Table 5). Further studies are needed to establish the ideal insertion depth for subcrestal implants,
balancing the amount of MBL with the biological shield offered by the presence of bone coronal to the
implant shoulder.
Table 5. Bone loss variations in groups with different implant insertion depth.
Insertion Depth N◦ Of Implants Mean Depth At T0 Mean Depth At T4
>1.5 mm 20 2.01 ± 0.48 mm 0.94 ± 0.76 mm
<1.5 mm 63 1.00 ± 0.34 mm 0.31 ± 0.42 mm
T0: baseline; T4: 15-month visit.
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General variables, such as age, gender, periodontal status, and smoking habits, appeared not to
play a significant role in influencing MBL during the first months of healing. Even if smoking and
history of periodontitis are well-known risk factors for the long-term success of implant therapy, their
action is time-dependent and often is not predictive for early bone loss after 1-year follow-up [24,25].
Additionally, the one abutment-one time protocol did not have a significant protective action on MBL in
comparison to multiple abutment disconnections (three times, in the present study), in agreement with
a recent prospective study [26]. This outcome is also consistent with a recent meta-analysis concluding
that favorable changes in peri-implant marginal bone level associated with the one abutment-one time
protocol should be viewed with caution as its clinical significance remains uncertain [27].
In the present study, the greatest MBL occurred within two months after implant insertion
(mean 0.5 ± 0.34 mm), likely due to bone remodeling following surgical trauma and biological width
establishment around one-stage implants.
In our sample, variations in implant insertion torque (>50 Ncm vs. ≤50 Ncm) did not influence
MBL during the early healing period. This finding is in accordance with some previous clinical
trials [28,29] and is in contrast with other studies, showing a negative impact of high torques on
marginal bone stability [30–32]. However, the relationship between insertion torque and cortical
compression, possibly leading to marginal bone resorption, is strictly dependent upon some crucial
factors, which were not always adequately controlled in the aforementioned studies: implant crest
module design, implant diameter, and cortical bone thickness around implants [6,33,34]. In the
present investigation, detrimental distribution of compressive forces to cortical bone following implant
insertion was reduced by the subcrestal positioning of implants (not compressing the most coronal
part of the cortical bone) and by the crest module design of the fixture used in this study, the platform
of which was significantly narrower than the wider part of the implant body (3.3 mm vs. 4.3 mm).
Conversely, all investigated variables involved in biological width establishment (vertical mucosal
thickness, healing abutment height, and prosthetic abutment height) had a significant influence
on marginal bone remodeling. Biological width is the three-dimensional space necessary for the
establishment of a soft tissue barrier around dental implants once they become exposed to the oral
cavity [35]. Peri-implant soft tissue can be divided into two main zones: a coronal epithelial portion
and a more apical fiber-rich connective tissue [35,36]. Recently, the biological width around two-piece
dental implants placed at the crestal level has been measured in human histologic studies. Vertical
dimensions varied from 3.26 to 3.6 mm, representing the minimum space required to create an optimal
seal and protect the underlying tissue from external agents [37,38]. When vertical space is insufficient
for biological width establishment, the healing process includes marginal bone resorption.
In the present study, thin vertical mucosal thickness (≤2 mm), short healing abutments (<3 mm),
and short prosthetic abutments (<3 mm) were significantly associated with greater marginal bone
resorption (Figure 4). These data are in accordance with numerous clinical trials and a meta-analysis
conducted with implants placed at crestal level [17,39–43], even if this matter has been widely debated.
In clinical practice and also in the present study, abutment height is adapted to site-specific soft tissue
thickness, with the consequence that short abutments have usually been selected in the presence of
thin peri-implant mucosa. This condition could represent a confounding factor when analyzing the
real influence of both factors on MBL. Recent studies conducted on separate groups (thick mucosa
with long and short abutments; thin mucosa with long and short abutments) indicate that MBL during
biological width establishment around dental implants placed at crestal level is influenced by abutment
height irrespective of vertical mucosal thickness [9,44].
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Figure 4. Marginal bone remodeling at different time points estimated by the statistical model: pattern
of thick (green) and thin (pink) peri-implant mucosa in the entire sample. MBL: marginal bone loss.
Very few data on these topics are present in literature for subcrestal implants. Some authors
suggested adapting the vertical position of implants in relation to soft tissue thickness in order to
prevent early MBL [45,46]. The rationale behind this proposal is that subcrestal implant placement
could provide additional space for biologic width formation, from the bone crest to the implant
platform, resulting in reduced marginal bone remodeling in the presence of thin peri-implant mucosa.
However, further clinical and histological studies are necessary to confirm this hypothesis.
Some limitations must be considered when interpreting the outcomes of the present study. These
results are not to be generalized for all types of implants: fixtures with a flat-to-flat connection placed
subcrestally showed persistent acute inflammation at the microgap between implant and abutment,
resulting in increased MBL [15]. The platform-switched conical connection is currently to be considered
the pattern of choice to minimize marginal bone remodeling when planning subcrestal implant
placement [47].
Another limitation is the use of periapical radiographs to assess marginal bone levels: this method,
allowing evaluation of only mesial and distal aspects of peri-implant bone, reduces sensitivity in
detecting marginal bone changes.
Moreover, thresholds adopted in the present study to define an abutment as short or long (long:
≥3 mm height; short: <3 mm height) were arbitrary. Future studies should confirm the suitability of
these values to define abutment length for implants placed subcrestally.
Finally, the present study collected data from a limited pool of patients in a specific site (posterior
mandible): therefore, further trials are needed to generalize these results to a broader population and
different areas of the mouth.
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5. Conclusions
Early marginal bone remodeling around platform-switched implants with conical connection
inserted subcrestally was significantly influenced by implant insertion depth and factors related to
biological width establishment (vertical mucosal thickness, healing, and prosthetic abutment height).
Deep implant insertion, thin peri-implant mucosa, and short abutments were associated with greater
marginal bone loss up to six months after prosthetic loading. Peri-implant bone levels tended to
stabilize after this time, and no further marginal bone resorption was recorded at twelve months after
implant loading.
The outcomes of this study should be confirmed and generalized by further clinical trials with
greater numerosity and conducted in different areas of the mouth.
Finally, further investigations are needed to establish the ideal insertion depth for subcrestal
implants, balancing the amount of MBL with the biological shield offered by the presence of bone
coronal to the implant shoulder.
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Abstract: Background: Early peri-implant bone loss has been associated to long-term implant-
prosthetic failure. Different technical, surgical, and prosthetic techniques have been introduced to
enhance the clinical outcome of dental implants in terms of crestal bone preservation. The aim of
the present cohort study was to observe the mean marginal bone level around two-part implants
with gingivally tapered abutments one year after loading. Methods: Mean marginal bone levels and
change were computed following radiological calibration and linear measurement on standardized
radiographs. Results: Twenty patients who met the inclusion criterion of having at least one
implant with the tapered prosthetic connection were included in the study. The cumulative implant
success rate was 100%, the average bone loss was −0.18 ± 0.72 mm, with the final bone level sitting
above the implant platform most of the time (+1.16 ± 0.91 mm). Conclusion: The results of this
cohort study suggested that implants with tapered abutments perform successfully one year after
loading and that they are associated with excellent marginal bone preservation, thus suggesting that
implant-connection macro-geometry might have a crucial role in dictating peri-implant bone levels.
Keywords: bone loss; convergence; clinical study
1. Introduction
Long-term dental implant survival has been extensively documented under different conditions,
so that contemporary clinical dentistry has been focusing on means to achieve predictable implant
success. Most of the authors agree on the fact that minimal marginal bone loss should be observed
one year within the implant loading, as this quantity is a predictor of the long-term implant survival
and success [1]. The extent of post-loading bone remodeling has been mainly related to two different
phenomena: (1) The microbial infiltration at the implant-abutment (IA) micro-gap—with consequent
inflammation and bone demineralization [2]; (2) the implant-abutment (IA) design [3].
The most accounted risk factor for marginal bone loss has been long considered the inflammatory
infiltrate at the IA gap [4]. The understanding of the complex biological events impacting the cervical
bone surrounding submerged implants begun with the fundamental animal histometric study by
Ericsson [5] who typified the inflammatory infiltrate as a consistent finding in matching IA interfaces.
This circumscribed inflammation resulted in a round connective demarcation wall that ultimately
leads to bone demineralization and resorption [2,6,7]. Different studies indicated less marginal bone
resorption around mis-matching implants (implants with a platform switching connection—PS)—when
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compared to matching implants—as well as a different organization of the connective tissue fibers [8].
Several theories have been proposed to explain this clinical manifestation, such as the shifting of
the inflammatory infiltrate away from the bone, the additional room for protective connective tissue
proliferation, or, best, the creation of a geometrical stop for biological width apical establishment.
In fact, in matching implants, the fixture first thread is also the first topographic point where the
rehabilitation turns from a smaller to a wider diameter, creating a mechanical retention for connective
tissues. In short, marginal bone loss should be inevitable, at least to this extent [9]. In PS implants, the
implant-abutment discrepancy acts equally, but at a more coronal level—at the platform level—where
the connective fibers are retained. It could be hypothesized that the rehabilitation macro-geometry
dictates soft and hard tissue position, independent of the effect of the inflammatory infiltrate produced
by the gap [10,11].
The gingivally convergent abutment was developed with the idea of maximizing the available
space for soft tissues, which is occupied by the bulky metal shoulder in divergent abutments [12].
The sloping profile of gingival convergent abutments would allow tissue to slide coronally in the early
phases of healing, creating a thick connective seal above the IA gap.
What is really bearing the brunt of preserving marginal bone levels? Is it either the relative
location of the implant-abutment (IA) junction or is it the connection macro-geometry?
The specific aim of this cohort study was to investigate the clinical and radiological outcome of
implants with a convergent implant-abutment connection one year after loading.
2. Materials and Methods
This study was a retrospective, non-interventional analysis of consecutive patients treated with
dental implants with a gingivally convergent abutment connection (Shelta XA, Sweden & Martina,
Via Veneto 19, 35020, Due Carrare, Padova, Italy). This study was based on patients consecutively
treated on a routine basis at one specialistic center (BORG, Carrer de la Mare de Déu de Sales, 67 08840
Viladecans, Barcelona, Spain) during the period from 2016 to 2018.
2.1. Inclusion and Exclusion Criteria
The medical records of patients who had at least one two-part implant rehabilitated with a
convergent abutment with a one-year follow-up were reviewed. Patients were included if presenting a
complete set of follow-up radiographs and intra-oral digital photographs. All implants were placed at a
slightly sub-crestal level. Patient records were excluded if they did not present for bi-annual follow-up
visits, if they had been rehabilitated with overdentures or full-arch prosthesis or if the implants had
been placed with simultaneous guided bone regeneration.
2.2. Data Collection and Analysis
Data were directly entered into an Excel spreadsheet and then converted to a .csv file format
in order to be read by the software for statistical analysis. The following population describing the
variables were collected: Age, gender, implant characteristics (diameter, length), implant location
(tooth number and anterior/posterior, maxillary/mandibular), type of implant-supported prosthetic
restoration (single crown or partial bridge), and follow-up time.
2.3. Radiologic Marginal Bone Level Evaluation
Routine peri-apical radiographs obtained via the long-cone paralleling technique with a loop film
holder (Rinn, Dentsply Australia Pty Ltd, Pacific Hwy, St Leonards NSW 2065, Australia) were used to
measure the marginal bone levels. Radiographs were standardized by means of individual resin bites.
The distance between the implant–abutment connection and the first bone-to-implant contact (fBIC) on
mesial and distal surfaces was recorded. The scale was calibrated by the width of the dental implant
achieving a unique pixel/mm ratio (Figure 1). Radiographic bone levels were calculated at the moment
of prosthetic transfer connection (impression taking), at loading, and every six months after loading.
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The mean marginal bone level for each implant was computed merging mesial and distal variations.
The marginal bone change was defined as the difference between the last follow-up and the baseline
MBL value, with negative values denoting a loss in bone height.
Figure 1. The picture is a schematic representation of the calibration performed on the software
to achieve bone level linear measurements. The scale was set and calibrated by the width of the
dental implant.
All measurements were performed by a single examiner (SM). The intra-examiner reproducibility
was evaluated using the intraclass correlation analysis from the measurements in 10 patients, which
revealed a strong correlation coefficient of 0.982 for MBL radiological measurements. Measurements
were performed via the OsirisX software (Pixmeo SARL, 266 Rue de Bernex, CH-1233 Bernex,
Switzerland).
2.4. Dichotomous Outcomes
• Implant failure was identified with eventual implant mobility or persistent infection, and whenever
the implant presented signs and symptoms that led to the implant removal.
• Survival and success rates (SRs and CSRs, respectively) for implants, were calculated according to
the criteria defined by Buser et al. in 1997 [13]. Successful implants were those showing a mean
radiological peri-implant bone resorption within 1.5 mm during the first year of loading, and less
than 0.2 mm/year during the following years.
2.5. Statistical Analysis
Descriptive and longitudinal statistics was performed on the R free software version 3.5.1
(02-07-2018). The longitudinal nonparametric analysis on marginal bone levels was implemented on
the ld.f1 function within the package nparLD. This non-parametric method exhibits a competitive
performance for small sample sizes and outliers. In the per-implant analysis, the ANOVA-type statistic
(ATS) was calculated for the global alternatives with ‘time’ as the fixed su-plot factor. A p value < 0.05
has been used as a cut-off for significance and a robust analysis of variance and a Spearman’s correlation
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coefficient has been performed. A further mixed effect model (function lmer within package lme4) was
used to control for crossed random effects posed by patients contributing with more than one implant.
This formula expects that there is going to be multiple responses per patient, and these responses will
depend on each subject’s baseline level. This effectively resolved the non-independence that stemmed
from having multiple responses by the same subject.
3. Results
3.1. Study Population
In total, 20 patients received 36 implants. The mean age at the implant insertion was 56.2 ± 10.2 years
(Table 1). Of the 20 patients, 65.0% were female and 35.0% were male. Of the 36 implants, 24 (66.6%)
were placed in the maxilla and 12 (33.3%) were placed in the mandible. Implant diameters ranged
from 3.8 mm to 5.0 mm—the mode being 4.2 mm diameter (70%)—and implant lengths ranged from
8.5 mm to 15 mm. Sixteen implants (44.4%) were splinted. Implants were more frequently placed in
upper premolar positions (60%). Abutment heights ranged from 4 mm to 6 mm.
Table 1. Demographic data and clinical characteristics.
Male Female Total
Number of Patients 7 13 20
Number of Implants 9 27 36
Mean Age 56.2 ± 10.2
Age Range 39–76
3.2. Survival and Adverse Events
At the last follow up, all 36 implants were healthy, stable and there were no reported failures;
thus, the implant had a cumulative survival rate of 100%. No failure, defined as signs and symptoms
that led to the implant removal, could be recorded. Therefore, the cumulative success rate was 100%.
The average follow-up period was 1.5 years after loading.
3.3. Bone Levels
All the implants were radiographically examined by one author alien to the treatment procedure
(SM) with the OsiriX DICOM viewer (Pixmeo SARL, 266 Rue de Bernex, CH-1233 Bernex, Switzerland).
The mean marginal bone level was +1.39 ± 0.91 mm at the moment of the prosthetic-transfer
connection for definitive impression-taking (considered as the study baseline, Figure 2). One year after
loading, the mean marginal bone level reached +1.16 ± 0.911 mm (Figure 2) with an average overall
change of −0.18 ± 0.72 mm, occurring above the platform level at large (Figure 3). The change over
time was significant (p value = 0.01) when the implant was modeled as the first cluster of analysis and
the time was set as the only sub-plot factor (Table 2). The fitness of the model has been confirmed also
with the mixed-effects model considering the random effect posed by patients contributing with more
than one implant. The mean amount of bone resorption to be expected one year after loading was
normally distributed (Figure 4).
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Figure 2. Box-plot of the mean marginal bone levels at the baseline and one year after loading.
 
Figure 3. Radiographic appearance of the marginal bone levels at adjacent implants loaded with
tapered abutment at loading (left) and one year after (right).
Table 2. Mean marginal bone level (MBL) in function by year, mm (per implant analysis) and
statistical significance of time-effect according to the Behrens-Fisher test and the ANOVA results for
implant-related factors.
Time-point Mesial MBL Distal MBL Mean MBL Delta MBL p-value
Mean MBL in function by year, mm (per implant analysis) and statistical significance of time-effect.
Overall
Baseline 1.47 ± 0.87 1.30 ± 1.01 1.39 ± 0.91
1-year 1.28 ± 0.98 1.04 ± 0.92 1.16 ± 0.91 −0.18 ± 0.72 0.01
Mandible
Baseline 0.90 ± 0.76 0.55 ± 0.87 0.72 ± 0.77
1-year 0.76 ± 0.67 0.47 ± 0.61 0.61 ± 0.60 −0.10 ± 0.29 0.19
Sub-plot factor analysis for “Mandible vs. Maxilla relative treatment effect” <MBL ~ jaw p-value 6.58 × 10−7
Maxilla
Baseline 1.72 ± 0.81 1.63 ± 0.89 1.68 ± 0.72
1-year 1.51 ± 1.02 1.29 ± 0.92 1.40 ± 0.93 −0.22 ± 0.84 0.06
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Figure 4. Density plot of the mean marginal bone change frequency distribution one year after loading
in the entire cohort. The plot exquisitely shows a bell-shaped curve denoting a predictable amount
of marginal bone resorption for the implant-abutment studied: most of the observations converged
around zero.
The categorical data describing the implant-related factors and position (diameter, length, abutment
height, jaw) were modeled on the multiway test. The implant diameter and length did not appear to
affect the marginal bone, however, there was a relative significant effect given by the abutment height
(p value < 0.05) in the mixed model: Longer abutments showed better marginal bone preservation
at a one-year evaluation (Table 3). To investigate the question about which of the three abutment
height categories differed, multiple comparisons with the Bonferroni adjustment were applied.
The relationship held only for abutments longer than 5 mm; still, the linearity could not be confirmed.
Implants placed in the mandible and in the maxilla did not differ in terms of 1-year marginal bone
loss, however, the first bone-to-implant contact at implants placed in the mandible was significantly
lower than that of the maxilla most of the times (p value < 0.001).
Table 3. Mean marginal bone level (MBL) by implant abutment-height by year.
Sub-plot factor analysis for “Abutment Height treatment effect” <MBL ~ abutment height p-value 0.05
Time-point mesial MBL distal MBL mean MBL delta MBL p-value
4 mm
Baseline 1.31 ± 0.96 0.97 ± 0.98 1.15 ± 0.94
1-year 1.08 ± 0.91 0.77 ± 1.03 0.93 ± 0.93 −0.20 ± 0.83 0.36
5 mm
Baseline 1.54 ± 0.86 1.52 ± 1.03 1.53 ± 0.92
1-year 1.34 ± 1.08 1.16 ± 0.86 1.25 ± 0.94 −0.20 ± 0.70 0.17
6 mm
Baseline 1.80 ± 0.69 1.43 ± 0.80 1.62 ± 0.70
1-year 1.87 ± 0.35 1.53 ± 0.56 1.70 ± 0.43 0.08 ± 0.34 0.05
3.4. Secondary Outcomes: Soft Tissues
Peri-implant soft tissues appeared healthy and thick at each visit after loading (Figure 5). At the
provisional prosthesis loading, 96% and 95% of the 36 implants had a papilla index >2 for the mesial
and distal side, respectively. At the last follow up, 97% and 94% of the implants had a papilla index >2
for the mesial and distal side, respectively.
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Figure 5. Clinical appearance of vestibular and inter-proximal soft tissues around adjacent implants
loaded with tapered abutment.
4. Discussion
In the present study, the one-year healing around two-part implants with a gingival convergent
abutment profile was evaluated. In 90% of the implants analyzed, the radiological bone level extended
coronal to the IA border, at the abutment level. It is suggested that bone preservation may occur coronal
to the IA connection of two-part implants loaded with convergent abutment profile as a consequence
of advantageous macro-geometry, independent of the effect of the inflammatory infiltrate at the gap,
and of the establishment of biologic width after prosthesis connection.
Results derived from animal studies showed that marginal bone resorption of about 2 mm occurred
around two-part implants [14,15]. However, Welander et al. [16] suggested that osseointegration could
occur coronal to the IA junction of two-part implants when the fixture was placed 2 mm sub-crestally.
A number of factors, according to prevalent literature, might influence the first-year marginal bone
loss, such as neck configuration, surgical trauma, occlusal overload, mucositis, micro-gap colonization,
biologic width formation, and flapless or flapped procedures [17–19]. The stability of the marginal
bone levels might be determined by other factors, different from those acting during the healing phase.
One of these factors is represented by the apico-coronal location of the implant head in respect to
the bone crest [20]. In a recent systematic review, it was assessed that the effect of the sub-crestal
implant positioning compared with equi-crestal position on the bone and soft tissues around dental
implants with platform switching design: The authors reported that platform switch implants placed
in a sub-crestal position had shown less marginal bone resorption when compared to implants placed
with their head at the crest level [21].
The radiographic observation of post-loading bone remodeling generally coincided with the level
of the first thread, and some authors suggested that this would be a consequence of the soft tissue’s
attempt to sit on top of the dental implant creating a mechanical protective seal [22].
Davarpanah [23] also observed that bone resorption around the implants placed at the supra-crestal
level was less than that of the implants placed at the crestal level. However, it is true that when
the thread is moved in a coronal direction, the implant platform is moved upward as well. For this
reason, it would be impossible to demonstrate the relative influence of each contributing factor on
bone resorption. Flores-Guillen et al. [24] compared submerged and trans mucosal platform switch
implants and found that there were no differences at a five-year evaluation in terms of marginal
bone loss achieving a mean value of −0.73 ± 0.81 mm. Therefore, the cumulative screening literature
suggested that platform switching or, more in general, connection macro-geometry is more critical
than the relative position of the platform crest module in determining early bone remodeling.
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The recent systematic review by Messias et al. suggested that reporting the marginal bone change
is insufficient for the correct evaluation of the implant performance: The authors recommended to
report the crestal bone levels, in particular where no data is provided relative to the healing period [25].
Furthermore, reporting at which level the crestal bone is in an intimate contact with the implant
seemed reasonable and more convenient for describing the effect of the IA macro-geometry on the
marginal bone. In the present study, the overall bone change was −0.18 ± 0.72 mm one year after
loading, occurring above the platform level, in any case. In fact, the one-year mean bone level was
+1.16 ± 0.91 mm with a significant difference between the lower and upper jaw. The mean bone gain
from the baseline to the last follow-up occurred in 33.0% of the implants analyzed, which is twice
the frequency observed by Flores-Guillen et al. in the platform switch implants in the same given
period [24].
Few studies evaluated the tissue response around the tapered convergent abutments [26]. The use
of the tapered abutments, not only could improve the peri-implant bone level, but also diminish
the sulcus length. In fact, it has been suggested that the biological phenomenon of the peri-implant
bone preservation would be related with the circular connective tissue fibers stabilization around the
abutment and the presence of a shallow sulcus [27]. In the present study, the cumulative implant
success rate was 100%, with no implant showing any sign or symptom of mucositis or prosthetic
complication. Peri-implant mucosa appeared healthy-pink, thick, and firm at each visit after loading.
The plausible biologic explanation should be sought in the wound healing process that starts after
the abutment connection: The convergent abutment would create a housing effect that protects the
surrounding biological structures maintaining tissue stability over time.
The multiway analysis conducted on this study displayed a significant relative effect of the
abutment height on the marginal bone loss: Implants with longer abutments (>5 mm) appeared to have
minimal bone resorption. It has been hypothesized that an abutment with a height <2 mm does not
provide sufficient soft tissue for establishing the peri-implant biologic width [28]. The establishment of
the peri-implant biologic width follows the implant placement and connective tissue attachment to the
abutment. Long abutments might be associated with a thicker gingival biotype, which in turn would
be more effective at preventing inflammatory infiltration.
The present cohort study has different limitations that should be taken into account. First, the
study design was retrospective, and a single-cohort, thus reducing the meaningfulness and external
validity of the results. The implant was chosen as the first cluster of analysis which does not guarantee
independence between implants, however the mixed effect model applied took the random effect posed
by patients into account, not revealing any significant discrepancy with the fixed effect model. It must
be remarked that the radiographic artifact of a stable first bone-to-implant contact does not necessarily
imply histologic osseo-integration. However, the imaging accuracy of digital radiography is high with
a precision of 0.1 mm or less. Still, the clinical relevance of such small entities is questionable and
difficult to repeat among different operators [29]. Furthermore, the present study is a single cohort
study without an internal control group.
5. Conclusions
Overall, the present study showed that implants rehabilitated with tapered abutments yielded
excellent hard- and soft-tissue outcomes. In particular, after one year of loading, marginal bone
levels consistently appeared above the implant platform, at the abutment level, with minimal bone
change. It was suggested that the implant-connection macro-geometry might dictate peri-implant
bone levels. Therefore, further prospective randomized trials are strongly recommended to support
the present findings.
Author Contributions: All of the authors contributed with the investigation, supervision, writing, review, and
editing of the study. The study conceptualization must be acknowledged to S.M., U.C., E.M., X.V., and X.R. Data
curation, data visualization, and analysis must be acknowledged to S.M., E.G., X.V., and X.R.
Conflicts of Interest: The authors declare no conflict of interest.
150
J. Clin. Med. 2019., 8, 1305
References
1. Oh, T.J.; Yoon, J.; Misch, C.E.; Wang, H.L. The causes of early implant bone loss: Myth or science? J. Periodontol.
2002, 73, 322–333. [CrossRef] [PubMed]
2. Piattelli, A.; Vrespa, G.; Petrone, G.; Iezzi, G.; Annibali, S.; Scarano, A. Role of the micro-gap between implant
and abutment: A retrospective histologic evaluation in monkeys. J. Periodontol. 2003, 74, 346–352. [CrossRef]
[PubMed]
3. Jung, Y.C.; Han, C.H.; Lee, K.W. A 1-year radiographic evaluation of marginal bone around dental implants.
Int. J. Oral Maxillofac. Implants 1996, 11, 811–818. [PubMed]
4. Astrand, P.; Engquist, B.; Dahlgren, S.; Gröndahl, K.; Engquist, E.; Feldmann, H. Astra Tech and Brånemark
system implants: A 5-year prospective study of marginal bone reactions. Clin. Oral Implant. Res. 2004,
15, 413–420. [CrossRef] [PubMed]
5. Ericsson, I.; Persson, L.G.; Berglundh, T.; Marinello, C.P.; Lindhe, J.; Klinge, B. Different types of inflammatory
reactions in peri-implant soft tissues. J. Clin. Periodontol. 1995, 22, 255–261. [CrossRef] [PubMed]
6. Canullo, L.; Quaranta, A.; Teles, R.P. The microbiota associated with implants restored with platform
switching: A preliminary report. J. Periodontol. 2010, 81, 403–411. [CrossRef] [PubMed]
7. Canullo, L.; Pellegrini, G.; Allievi, C.; Trombelli, L.; Annibali, S.; Dellavia, C. Soft tissues around long-term
platform switching implant restorations: A histological human evaluation. Preliminary results. J. Clin.
Periodontol. 2011, 38, 86–94. [CrossRef]
8. Buser, D.; Wittneben, J.; Bornstein, M.M.; Grütter, L.; Chappuis, V.; Belser, U.C. Stability of contour
augmentation and esthetic outcomes of implant-supported single crowns in the esthetic zone: 3-year results
of a prospective study with early implant placement postextraction. J. Periodontol. 2011, 82, 342–349.
[CrossRef]
9. Östman, P.O.; Hellman, M.; Sennerby, L. Ten years later. Results from a prospective single-centre clinical
study on 121 oxidized (TiUnite™) Brånemark implants in 46 patients. Clin. Implant Dent. Relat. Res. 2012,
14, 852–860. [CrossRef]
10. Finelle, G.; Papadimitriou, D.E.V.; Souza, A.B.; Katebi, N.; Gallucci, G.O.; Araújo, M.G. Peri-implant soft
tissue and marginal bone adaptation on implant with non-matching healing abutments: Micro-CT analysis.
Clin. Oral Implant. Res. 2015, 26, e42–e46. [CrossRef]
11. Rodríguez, X.; Navajas, A.; Vela, X.; Fortuño, A.; Jimenez, J.; Nevins, M. Arrangement of Peri-implant
Connective Tissue Fibers Around Platform-Switching Implants with Conical Abutments and Its Relationship
to the Underlying Bone: A Human Histologic Study. Int. J. Periodontics Restor. Dent. 2016, 36, 533–540.
12. Canullo, L.; Tallarico, M.; Pradies, G.; Marinotti, F.; Loi, I.; Cocchetto, R. Soft and hard tissue response to an
implant with a convergent collar in the esthetic area: Preliminary report at 18 months. Int. J. Esthet. Dent.
2017, 12, 306–323. [PubMed]
13. Buser, D.; Mericske-Stern, R.; Bernard, J.P.; Behneke, A.; Behneke, N.; Hirt, H.P.; Belser, U.C.; Lang, N.P.
Long-term evaluation of non-submerged ITI implants. Part 1: 8-year life table analysis of a prospective
multi-center study with 2359 implants. Clin. Oral Implant. Res. 1997, 8, 161–172. [CrossRef]
14. Hermann, J.S.; Cochran, D.L.; Nummikoski, P.V.; Buser, D. Crestal bone changes around titanium implants.
A radiographic evaluation of unloaded nonsubmerged and submerged implants in the canine mandible.
J. Periodontol. 1997, 68, 1117–1130. [CrossRef] [PubMed]
15. Hermann, J.S.; Schoolfield, J.D.; Schenk, R.K.; Buser, D.; Cochran, D.L. Influence of the size of the microgap
on crestal bone changes around titanium implants. A histometric evaluation of unloaded non-submerged
implants in the canine mandible. J. Periodontol. 2001, 72, 1372–1383. [CrossRef] [PubMed]
16. Welander, M.; Abrahamsson, I.; Berglundh, T. The mucosal barrier at implant abutments of different materials.
Clin. Oral Implant. Res. 2008, 19, 635–641.
17. Qian, J.; Wennerberg, A.; Albrektsson, T. Reasons for marginal bone loss around oral implants. Clin. Implant.
Dent. Relat. Res. 2012, 14, 792–807. [CrossRef]
18. Sanz-Sánchez, I.; Sanz-Martín, I.; Carrillo de Albornoz, A.; Figuero, E.; Sanz, M. Biological effect of
the abutment material on the stability of peri-implant marginal bone levels: A systematic review and
meta-analysis. Clin. Oral Implant. Res. 2018, 29 (Suppl. 18), 124–144. [CrossRef]
19. Albrektsson, T.; Buser, D.; Sennerby, L. Crestal bone loss and oral implants. Clin. Implant. Dent. Relat. Res.
2012, 14, 783–791. [CrossRef]
151
J. Clin. Med. 2019., 8, 1305
20. Schwarz, F.; Hegewald, A.; Becker, J. Impact of implant-abutment connection and positioning of the machined
collar/microgap on crestal bone level changes: A systematic review. Clin. Oral Implant. Res. 2014, 225, 417–425.
[CrossRef]
21. Valles, C.; Rodríguez-Ciurana, X.; Clementini, M.; Baglivo, M.; Paniagua, B.; Nart, J. Influence of subcrestal
implant placement compared with equicrestal position on the peri-implant hard and soft tissues around
platform-switched implants: A systematic review and meta-analysis. Clin. Oral Investig. 2018, 22, 555–570.
[CrossRef] [PubMed]
22. Khayat, P.G.; Hallage, P.G.; Toledo, R.A. An investigation of 131 consecutively placed wide screw-vent
implants. Int. J. Oral Maxillofac. Implant. 2001, 16, 827–832.
23. Davarpanah, M.; Martinez, H.; Tecucianu, J.F. Apical-coronal implant position: Recent surgical proposals.
Technical note. Int. J. Oral Maxillofac. Implant. 2000, 15, 865–872.
24. Flores-Guillen, J.; Álvarez-Novoa, C.; Barbieri, G.; Martín, C.; Sanz, M. Five-year outcomes of a randomized
clinical trial comparing bone-level implants with either submerged or transmucosal healing. J. Clin.
Periodontol. 2018, 45, 125–135. [CrossRef] [PubMed]
25. Messias, A.; Nicolau, P.; Guerra, F. Titanium dental implants with different collar design and surface
modifications: A systematic review on survival rates and marginal bone levels. Clin. Oral Implant. Res. 2019,
30, 20–48. [CrossRef] [PubMed]
26. Cocchetto, R.; Canullo, L. The “hybrid abutment”: A new design for implant cemented restorations in the
esthetic zones. Int. J. Esthet. Dent. 2015, 10, 186–208. [PubMed]
27. Rodríguez-Ciurana, X.; Vela-Nebot, X.; Segalà-Torres, M.; Calvo-Guirado, J.L.; Cambra, J.; Méndez-Blanco, V.;
Tarnow, D.P. The effect of interimplant distance on the height of the interimplant bone crest when using
platform-switched implants. Int. J. Periodontics Restor. Dent. 2008, 29, 141–151.
28. Galindo-Moreno, P.; León-Cano, A.; Ortega-Oller, I.; Monje, A.; Suárez, F.; ÓValle, F.; Spinato, S.; Catena, A.
Prosthetic Abutment Height is a Key Factor in Peri-implant Marginal Bone Loss. J. Dent. Res. 2014,
93, 80S–85S. [CrossRef]
29. De Bruyn, H.; Vandeweghe, S.; Ruyffelaert, C.; Cosyn, J.; Sennerby, L. Radiographic evaluation of modern
oral implants with emphasis on crestal bone level and relevance to peri-implant health. Periodontol 2000,
62, 256–270. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution





Improvement of Quality of Life with
Implant-Supported Mandibular Overdentures and
the Effect of Implant Type and Surgical Procedure on
Bone and Soft Tissue Stability: A Three-Year
Prospective Split-Mouth Trial
Ron Doornewaard 1,*, Maarten Glibert 1, Carine Matthys 1, Stijn Vervaeke 1, Ewald Bronkhorst 2
and Hugo de Bruyn 1,2,*
1 Department Periodontology & Oral Implantology, Dental School, Faculty Medicine and Health Sciences,
Ghent University, De Pintelaan 185, 9000 Ghent, Belgium; maarten.glibert@ugent.be (M.G.);
carine.matthys@ugent.be (C.M.); stijn.vervaeke@ugent.be (S.V.)
2 Section Implantology & Periodontology, Department of Dentistry, Radboudumc, Philips van Leydenlaan 25,
6525 EX Nijmegen, The Netherlands; ewald.bronkhorst@radboudumc.nl
* Correspondence: ron.doornewaard@ugent.be (R.D.); hugo.debruyn@radboudumc.nl (H.d.B.)
Received: 13 May 2019; Accepted: 28 May 2019; Published: 31 May 2019
Abstract: In fully edentulous patients, the support of a lower dental prosthesis by two implants could
improve the chewing ability, retention, and stability of the prosthesis. Despite high success rates of
dental implants, complications, such as peri-implantitis, do occur. The latter is a consequence of
crestal bone loss and might be related to the implant surface and peri-implant soft tissue thickness.
The aim of this paper is to describe the effect of implant surface roughness and soft tissue thickness
on crestal bone remodeling, peri-implant health, and patient-centered outcomes. The mandibular
overdenture supported by two implants is used as a split-mouth model to scrutinize these aims.
The first study compared implants placed equicrestal to implants placed biologically (i.e., dependent
on site-specific soft tissue thickness). The second clinical trial compared implants with a minimally
to a moderately rough implant neck. Both studies reported an improvement in oral health-related
quality of life and a stable peri-implant health after three years follow-up. Only equicrestal implant
placement yielded significantly higher implant surface exposure, due to the establishment of the
biologic width. Within the limitations of this study, it can be concluded that an implant supported
mandibular overdenture significantly improves the quality of life, with limited biologic complications
and high survival rates of the implants.
Keywords: bone loss; dental implant; overdenture; implant survival; peri-implantitis; implant surface;
soft tissue; split-mouth design; oral health-related quality of life; patient-reported outcome measures
1. Introduction
Edentulousness is widely spread worldwide. According to the WHO the prevalence in the
elderly population is 26% in the USA and between 15% and 78% in European countries. Among
the edentulous population, a strong negative impact of poor oral conditions on daily life has been
described. Edentulism could lead to diet changes where food rich in saturated fats and cholesterol
are preferred. Besides diet changes, edentulousness is an independent risk factor for weight loss and
could lead to social handicaps related to communication [1].
The support of a dental prosthesis by two implants could improve the chewing ability, retention,
and stability of the prosthesis, which could lead to higher satisfaction and health-related quality of life.
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Dental implants have been used since the early sixties to replace missing teeth by fixed or removable
prostheses. Nowadays, this yields a predictable treatment outcome with success over 95% after 10 years
of function [2].
To measure the improvement in health-related quality of life, the Oral Health Impact Profile
(OHIP) is a widely used tool to assess currently applied dental procedures. It has also been used
for evaluating the quality of life in more invasive surgical interventions in oral surgery [3]. The tool
consists of a questionnaire to measure the impact of medical care on functional and social wellbeing [4].
Allen and McMillan reported significant improvement in satisfaction and health-related quality of life
for patients who received implant-retained prostheses compared to those who received conventional
dentures [5]. A panel of experts published a consensus statement where they described overwhelming
evidence for a 2-implant supported overdenture as the first choice of treatment for the edentulous
mandible instead of a conventional denture [6].
A recent review focusing on the Patient-Reported Outcome Measures (PROMs) showed compelling
evidence to support that the fully edentulous patients experience higher satisfaction with an
implant-supported overdenture in the mandible compared to a conventional denture [7]. These findings
were confirmed by several other recent systematic reviews and meta-analyses [8–10].
De Bruyn and co-workers also concluded that patient satisfaction is highly individual and
satisfaction with an implant-supported overdenture is never guaranteed. Hence, the decision to
propose an implant-supported overdenture should be based on proper individual assessment [7].
Despite the improvement of the patient’s quality of life and high survival and success rates of
dental implants in patients with overdentures, dental implants are not free of complications. The most
common complications following implant therapy are peri-implant mucositis (bleeding on probing and
inflammation of the peri-implant soft tissues), and peri-implantitis (clinical and radiographic bone loss
with or without suppuration). To detect inflammatory changes around the implant, several biologic
parameters (plaque, bleeding, and suppuration) must be monitored during the patient’s follow-up
visits [11].
According to the latest consensus report of the “World Workshop on the Classification of
Periodontal and Peri-implant Diseases and Conditions”, the main clinical characteristic of peri-implant
mucositis is bleeding on gently probing [12]. Erythema, swelling, and/or suppuration may also be
present [13]. There is strong evidence from animal and human experimental studies that plaque
is the etiological factor for peri-implant mucositis [11,14–18]. Peri-implantitis is described as a
plaque-associated pathologic condition occurring in tissues around dental implants, characterized
by inflammation in the peri-implant mucosa and subsequent progressive loss of supporting bone.
Peri-implantitis sites exhibit clinical signs of inflammation, bleeding on probing, and/or suppuration,
increased probing depths and/or recession of the mucosal margin in addition to radiographic bone
loss [19]. Peri-implantitis is a consequence of crestal bone loss. Two recent consensus meetings
highlighted the influence of implant material, shape and surface characteristics on the occurrence and
progression of peri-implantitis. However, evidence for these suggestions is weak and future long-term
studies are necessary to analyze these potential risk factors [20,21]. Beside these implant factors also
other important factors like surgical, prosthetic, patient-related factors and foreign body reactions may
contribute to crestal bone loss [21].
The composition and the topography of the implant surface have been a matter of debate during
the last decades. Both composition and topography have their influence on implant surface roughness.
The implant surface roughness is expressed in a Sa value. This three-dimensional value expresses an
absolute difference in the height of each point compared to the arithmetical mean of the surface [22].
In the early years of implant dentistry two types of implant surfaces were used, the machined/turned
surface (Sa = 0.5–1 μm) and the microporous titanium plasma-sprayed surface (Sa > 2 μm). The first
one is smooth and the latter could be described as a rough implant surface. Surface modification
was done to enlarge the surface, resulting in a greater bone-to-implant contact area. Implant surface
modifications were done by sandblasting, acid-etching, anodic oxidation or hydroxyapatite coating.
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These techniques resulted in a moderately rough implant surface (Sa = 1–2 μm), which is nowadays the
most used surface roughness. Beside the higher bone-to-implant contact [23], a lower clinical failure
rate [24] and a higher removal torque was observed compared to the smooth implant surfaces [25].
Hence, the surface modification made it possible to load the implant earlier or even immediately
after the surgery. The resulting surface enlargement allowed shorter implants to be used, without
jeopardizing the prognosis and with a reduced necessity for bone grafting procedures [2]. Beside
the aforementioned benefits, related to faster integration, rough implant systems have been linked
to increased bacterial adhesion [26]. The applied model in the latter study does not always mimic
the clinical reality. However, A Cochrane systematic review suggested limited evidence that smooth
surfaces had a 20% reduced risk of being affected by peri-implantitis over a three-year period [27,28].
This finding led to the commercial production of hybrid dental implants, combining the best of both
systems. Hybrid dental implants have a minimally rough coronal part to decrease biofilm formation in
the soft tissue crevice and a moderately rough implant body to enhance bone healing and speed up the
osseointegration. These hybrid surfaces combine the effect of both surface roughnesses in the same
implant. A short-term study indicated that the moderately rough and smooth coronal part showed the
same crestal bone remodeling in the initial healing phase [29]. However, long-term studies to describe
clinical parameters and peri-implant health are not yet available.
Some patient-related factors, such as certain metabolic syndrome components, medical conditions
and/or the use of medication are known to have an effect on implant treatment outcome. Systematic
reviews reveal that hyperglycemia has an increased risk for peri-implantitis [30,31], although the risk
for more implant failures is comparable with the one observed in healthy patients. [32]. There is
inconsistent and controversial evidence about the association with cardiovascular diseases [31]. Another
meta-analysis revealed that there was no difference in implant survival rate between patients with
and without osteoporosis. However, increased peri-implant bone loss was observed [33]. The intake
of bisphosphonates, related to the treatment of osteoporosis, was not associated with an increased
implant failure rate [34]. On the other hand, the same systematic review revealed an increased risk
for implant failure with the intake of certain selective serotonin reuptake inhibitors and proton pump
inhibitors [34]. Patients that are periodontally compromised are at higher risk for implant failure and
crestal bone loss when compared with periodontally healthy subjects [35].
Another patient factor related to the failure of integrated implants is smoking. De Bruyn and
Collaert described in a large retrospective study significantly higher failure rates of dental implants
in smokers compared to non-smokers, both before and after functional loading, especially in the
maxilla [36]. These findings are in agreement with a large meta-analysis of 18 studies showing an
odds-ratio of 2.17 for implant failures in smokers were compared to non-smokers [37]. Besides implant
failure smokers are more prone to peri-implant bone loss [38,39].
Also, biologic variances between patients could influence crestal bone loss around dental implants.
Especially, soft tissue dimensions could play an important role in bone remodeling. The effect of
peri-implant mucosal tissue thickness on the crestal bone loss was described in an animal study
suggesting a certain minimal width of peri-implant mucosa may be required, and that bone resorption
may take place allowing a stable soft tissue attachment [40]. The latter was confirmed in a human
clinical trial, when there was a soft tissue thickness of 2 mm or less, crestal bone loss up to 1.45 mm
may occur [41].
More recently Vervaeke and co-workers concluded that the initial bone remodeling was affected
by the thickness of the peri-implant soft tissue [42]. They suggested that bone loss directly after implant
placement, due to crestal bone remodeling, precludes the biologic width re-establishment and can be
controlled by adapting the vertical depth position of the implant in the bone in relation to the soft
tissue thickness at the time of implant placement. Hence, in thin tissues, a deeper subcrestal position
in the bone may prevent partial exposure of the crestal part of the implant. Although crestal bone
remodeling is a given fact after implant placement, related to the surgical trauma from periosteal
elevation, as well as the drilling procedure, it is from a preventive point of view important to have
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the bone covering the implant as much as possible. Initial crestal bone loss, resulting in the absence
of bone contact, can predict a future bone loss in patients prior to the disease. Galindo-Moreno and
co-workers concluded that 96% of implants with a marginal bone loss above 2 mm at 18 months had
lost 0.44 mm or more at six months post loading [43]. A critical long-term study where implants were
placed in the partially edentulous mandible, indicated that bone loss in patients with thin (<2 mm)
and a thick mucosa (>2 mm) was identical, when the implants were installed subcrestally to anticipate
on the biologic width re-establishment [44].
Another subject of debate is the predictive value of biologic parameters around dental implants.
Bleeding on probing, suppuration, plaque formation and probing pocket depth are the most widely
used clinical parameters to describe health and/or disease around dental implants. These biologic
parameters are most of the times included in the definition of peri-implantitis. However, a largely
critical review showed the absence of a correlation between bone loss and the biologic parameters mean
probing pocket depth and mean bleeding on probing. The authors also reported inconsistency and
incompleteness in reporting on these parameters in the literature, which could affect decision-making
in clinical practice [45].
Hence, the aim of this paper is to describe, by means of two prospective clinical split-mouth cohort
studies, the effect of implant surface roughness and surgical implant depth positioning on crestal
bone remodeling, peri-implant health, and patient-centered outcomes. The mandibular overdenture
supported by two dental implants is used as a split-mouth model to scrutinize these aims.
2. Experimental Section
2.1. Patient Population and Surgical/Prosthetic Procedures
This paper includes two prospective split-mouth studies. Both studies included edentulous
patients in need of a two-implant supported overdenture in the lower jaw. The same inclusion and
exclusion were used for both studies. Inclusion criteria include: (1) Total complete edentulism for at
least four months and (2) presence of sufficient residual bone volume to install two implants of 3.5 to
4.0 mm diameter and 8 to 11 mm length. Patients were excluded if they were: (1) Younger than 21,
(2) suffered from systemic diseases, (3) current smokers and (4) had general contraindications for oral
surgery (full dose head and neck radiation, intravenous administrated bisphosphonates, and ongoing
chemotherapy). All patients were treated at the Ghent University Hospital by the same surgeon
between January 2013 and September 2014. Twenty-six patients (study 1) received two moderately
rough dental implants (Astra Tech Osseospeed TX™, Dentsply implants, York, PA, USA). The control
implant was installed equicrestally (group 1), according to the manufacturer’s guidelines with the
rough implant surface completely surrounded by bone. The vertical position of the test implant
(group 2) was adapted to the soft tissue thickness, allowing at least 3 mm space for biologic width
establishment [42].
Another 23 patients (study 2) received two dental implants with a difference in implant surface
roughness of the coronal part of the implant (Figure 1). All 46 implants were biologically guided taking
the soft tissue thickness into account whereby care was taken to ensure a 3 mm soft tissue seal in contact
with the abutment. All patients received one moderately rough implant (group 3) (Sa = 1.3 μm) (DCC,
Southern implants, Irene, South Africa) and one test implant (group 4). The latter was a hybrid dental
implant with a minimally rough coronal neck of 3 mm (Sa = 0.9 μm) combined with a moderately
rough body (Sa = 1.3 μm) (MSC, Southern implants, Irene, South Africa).
Although two different brands were used in both studies, all 98 implants installed in the 49 patients
were identical at the level of the abutment-implant connection. Implants had the same integrated
platform-shift with a smooth implant bevel, the same internal deep conical connection and a similar
macro design of the micro-threads on the implant neck.
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Figure 1. Placement of an implant with a moderately rough surface (A) and a hybrid implant with a
minimally rough coronal neck (B).
Implants were immediately restored if primary stability was achieved (insertion-torque > 25 Ncm).
Implants were restored either with locator abutments (study 1) or definitive titanium abutments
(Compact Conical Abutments; Southern Implants, Irene, South Africa) and a healing cap with a
standard abutment height of 4 mm (study 2).
Before surgery, all patients received new removable dentures in the mandible and maxilla to
achieve a correct occlusion, appropriate teeth position, and appropriate smile line. The removable
dentures were adapted after surgery to connect with the implants by one experienced prosthodontist.
The surgical and prosthetic procedures have been described previously by Vervaeke and co-workers [46]
and Glibert and co-workers [29].
The clinical trial has been conducted in full accordance with the Helsinki Decleration (1975)
as revised in 2000. All patients were thoroughly informed and signed written informed consent.
The study protocol was approved by the ethical committee of the Ghent University Hospital.
2.2. Clinical and Radiographic Examination
Follow-up visits were planned at 1 week, 1, 3, 6, 12, 24, and 36 months after surgery. After soft
tissue healing was fully established, three months after surgery, peri-implant health was monitored and
probing pocket depths, bleeding on probing and plaque scores were assessed on four implants sites:
Midmesial, middistal, midbuccal, and midlingual. The bleeding- and plaque scores were measured
on a dichotomous scale (0 = absence of bleeding on probing/absence of plaque; 1 = bleeding on
probing/plaque). From the site level scores both for bleeding and plaque mean scores on implant level
were calculated.
Digital peri-apical radiographs were taken at baseline (implant placement), at 3, 6, 12, 24,
and 36 months using a guiding system in order to obtain the X-rays perpendicular to the film.
The radiographic measurements were calibrated using the length of the implant, the distance between
the threads or the diameter of the implant. Bone levels were determined as the distance from a reference
point, which corresponds with the lower edge of the smooth implant bevel at the implant-abutment
interface, to the most crestal bone-to-implant contact point. The baseline bone-to-implant contact levels
are assessed from the implant-abutment interface. The baseline from the four experimental groups
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was logically comparable. Bone loss was determined by the difference of the bone level directly after
implant placement and the bone level at the follow-up visit.
If necessary, calculus and plaque were removed and oral hygiene was reinforced during follow-up
visits. Instructions with a (electric) toothbrush and interdental brushes were given based on the need,
preferences and dexterity or motoric skills of the patient.
To measure the change in oral health-related quality of life the Oral Health Impact Profile-14
questionnaire (OHIP-14) is assessed before surgery, 3, and 12 months after connection of the prosthesis
with the implants (Table 1). The questionnaire is based on 14 questions capturing seven domains:
Functional limitation, physical pain, psychological discomfort, physical disability, psychological
disability, social disability, and handicap. Of these seven domains, two questions need to be answered
on a Likert scale. Score 4 is indicating a highly negative answer to the question and 0 means that there
is no discomfort at all. The total score of the 14 questions can balance between 56 (maximally negative)
to 0 (maximally positive).
Table 1. OHIP-14 questionnaire divided per domain.
Domain 1: Functional Limitation
1 Have you had trouble pronouncing any words because of problems with your teeth, mouth, or denture?
2 Have you felt that your sense of taste has worsened because of problems with your teeth, mouth, or denture?
Domain 2: Physical Pain
3 Have you had painful aching in your mouth?
4 Have you found it uncomfortable to eat any foods because of problems with your teeth, mouth, or denture?
Domain 3: Psychological Discomfort
5 Have you been self-conscious because of your teeth, mouth, or denture?
6 Have you felt tense because of problems with your teeth, mouth, or denture?
Domain 4: Physical Disability
7 Has been your diet been unsatisfactory because of problems with your teeth, mouth, or denture?
8 Have you interrupt meals because of problems with your teeth, mouth, or denture?
Domain 5: Psychological Disability
9 Have you found it difficult to relax because of problems with your teeth, mouth or denture?
10 Have you been a bit embarrassed because of problems with your teeth, mouth, or denture?
Domain 6: Social Disability
11 Have you been a bit irritable with other people because of problems with your teeth, mouth, or denture?
12 Have you had difficulty doing your usual jobs because of problems with your teeth, mouth, or denture?
Domain 7: Handicap
13 Have you felt that life, in general, was less satisfying because of problems with your teeth, mouth, or denture?
14 Have you been totally unable to function because of problems with your teeth, mouth, or denture?
2.3. Statistics
Outcomes are reported with descriptive statistics (mean, SD, median, range, and 95% CI) and
boxplots. All analyses concern pair-wise comparisons within patients. For continuous variables paired
t-tests were applied, for dichotomous variables the McNemar test was used. The 95% confidence
intervals are given to show the precision of an estimate of a certain effect.
The sample size for both studies was calculated using SAS Power and Sample size calculator for
related samples based on an effect size of 1 mm and a standard deviation of 0.60, with the level of
significance set at 0.05 andβ= 0.80. The effect estimation was based on findings Vervaeke et al., 2014 [42].
For the OHIP-14 outcome, the impact of the change was assessed by calculating the “effect size”
with the following formula:
((mean-OHIP before surgery) − (mean-OHIP three months after connection))/SD before surgery
As proposed by Cohen 1977 an “effect size” of 0.2 could be interpreted as a small change, 0.6 as a
moderate change and > 0.8 as a large change.
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3. Results
3.1. Study Population
A sample size of 14 patients for each study was calculated. Hence, minimums of 20 patients
(= 40 implants) were consequently included to anticipate future dropouts.
Twenty-six patients in study I were initially treated with one equicrestally (group 1) and one
subcrestally (group 2) placed implant. In study II, 23 patients were initially treated with one implant
with a moderately rough implant neck (group 3) and one implant with a minimally rough implant
neck (group 4). In total four experimental treatment groups were assessed. After a follow-up of at least
three years, one patient was excluded, due to anatomical constraints requiring deviation of the surgical
protocol. Two patients were excluded after starting smoking and one did not respond to the follow-up
invitation. Hence, 45 patients with two implants each were available after a follow-up of three years
and none of the implants had failed (survival 100%). A flowchart of the patients’ distribution is shown
in Figure 2. The study population consisted of 24 men and 21 women with a mean age at implant
placement of 64 years (SD = 9.25, range = 43–85).
Figure 2. Flowchart of both study populations.
3.2. Mean Bone Level Difference
Table 2 shows the mean bone level and the corresponding changes of the four treatment groups at
baseline and after 6, 12, 24, and 36 months. Initially, the bone level of the implants in the four groups is
comparable and basically located at the implant crest. In the first six months bone remodeling was
0.7 mm for equicrestally placed implants and ranging from 0–0.3 mm in the other three subcrestally
placed groups. Over time no further statistically significant bone level changes occurred in all groups
(Figures 3–6). Figures 5 and 6 gives a schematic view of the bone remodeling over time, with the visible
implant surface exposure in the equicrestally placed implant group (group 1).
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Figure 3. Boxplots representing the bone level at subsequent time points for the equicrestally (group 1)
and subcrestally placed implants (group 2). * Outliers (≥3 × IQR above third quartile), ◦ suspected
outliers (between 1.5 × IQR and 3 × IQR above third quartile).
Figure 4. Boxplots representing the bone level at subsequent time points for the implants with a
moderately rough neck (group 3) and minimally rough neck (group 4). * Outliers (≥3 × IQR above
third quartile), ◦ suspected outliers (between 1.5 × IQR and 3 × IQR above third quartile).
Between groups the subcrestally placed implants of group 2 lost no bone at all. Groups 3 and
4 showed comparable bone remodeling. Hence, implant surface roughness did not affect initial nor
long-term bone remodeling (Figures 4 and 6).
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Figure 5. Schematic illustration of study 1, left equicrestally placed implant (group 1) and right
subcrestally placed implant (group 2); showing the bone level at baseline (A) and bone level after bone
remodeling (B).
 
Figure 6. Schematic illustration of study 2, left implant with a moderately rough neck (group 3) and
right implant with a minimally rough neck (group 4); showing the bone level at baseline (A) and bone
level after bone remodeling (B).
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Table 2. Mean bone level for each study group and the bone level difference between respectively
equicrestally versus subcrestally placed implants and implants with moderately rough versus minimally
rough neck; p < 0.05 indicates a statistically significant difference (paired t-test).
Bone Level
Group 1: Equicrestal Group 2: Subcrestal Paired Difference
Mean (SD) Median Min Max Mean (SD) Median Min Max Mean dif 95% CI p
Baseline 0.03 (0.09) 0.00 0.00 0.40 0.00 (0.00) 0.00 0.00 0.00 0.030 (−0.009,0.070) 0.123
6 months 0.72 (0.74) 0.59 0.00 2.45 0.04 (0.11) 0.00 0.00 0.45 0.678 (0.360,0.996) <0.001
12 months 0.78 (0.81) 0.54 0.00 2.92 0.03 (0.10) 0.00 0.00 0.36 0.746 (0.397,1.096) <0.001
24 months 0.69 (0.70) 0.51 0.00 2.61 0.04 (0.10) 0.00 0.00 0.30 0.644 (0.337,0.951) <0.001
36 months 0.59 (0.59) 0.44 0.00 2.25 0.04 (0.10) 0.00 0.00 0.36 0.549 (0.297,0.802) <0.001
Group 3: Moderately Rough Neck Group 4: Minimally Rough Neck Paired Difference
Mean (SD) Median Min Max Mean (SD) Median Min Max Mean dif 95% CI p
Baseline 0.01 (0.07) 0.00 0.00 0.30 0.02 (0.05) 0.00 0.00 0.22 −0.002 (−0.424,0.037) 0.902
6 months 0.33 (0.64) 0.00 0.00 2.74 0.27 (0.38) 0.18 0.00 1.60 0.064 (−0.118,0.245) 0.474
12 months 0.34 (0.68) 0.00 0.00 2.62 0.34 (0.53) 0.00 0.00 1.61 0.009 (−0.191,0.209) 0.926
24 months 0.36 (0.58) 0.00 0.00 1.75 0.37 (0.49) 0.23 0.00 1.60 −0.014 (−0.170,0.142) 0.853
36 months 0.51 (0.74) 0.22 0.00 2.84 0.45 (0.58) 0.26 0.00 1.95 0.066 (−0.114,0.246) 0.453
3.3. Biologic Parameters
On implant level only a statistically significant difference could be measured for the plaque score
at 24 months (p = 0.042), with significantly less plaque for the equicrestally placed compared with
subcrestally placed implants. However, at all other time points the plaque–and bleeding scores were
not statistically significantly different, indicative of peri-implant health (Table 3).
Table 3. Mean plaque and bleeding on probing on implant level at 6, 12, 24 and 36 month for each study
group and mean difference between respectively equicrestally versus subcrestally placed implants
and implants with moderately rough versus minimally rough neck; p < 0.05 indicates a statistically
significant difference (paired t-test).
Plaque
Group 1: Equicrestal Group 2: Subcrestal Paired Difference
Mean (SD) Mean (SD) Mean dif 95% CI p
6 months 0.44 (0.47) 0.52 (0.45) −0.083 (−0.221,0.055) 0.224
12 months 0.45 (0.39) 0.56 (0.44) −0.115 (−0.285,0.056) 0.178
24 months 0.42 (0.40) 0.51 (0.40) −0.091 (−0.178,−0.003) 0.042






Mean (SD) Mean (SD) Mean dif 95% CI p
6 months 0.38 (0.33) 0.40 (0.31) −0.025 (−0.144,0.094) 0.666
12 months 0.37 (0.31) 0.35 (0.31) 0.017 (−0.136,0.169) 0.818
24 months 0.57 (0.36) 0.52 (0.36) 0.054 (−0.030,0.137) 0.189
36 months 0.39 (0.41) 0.43 (0.38) −0.038 (−0.147,0.072) 0.481
Bleeding on Probing
Group 1: Equicrestal Group 2: Subcrestal Paired Difference
Mean (SD) Mean (SD) Mean dif 95% CI p
6 months 0.15 (0.22) 0.15 (0.22) 0.000 (−0.093,0.0933) 1.000
12 months 0.19 (0.18) 0.19 (0.18) 0.000 (−0.125,0.125) 1.000
24 months 0.23 (0.30) 0.20 (0.28) 0.023 (−0.090,0.136) 0.680






Mean (SD) Mean (SD) Mean dif 95% CI p
6 months 0.24 (0.31) 0.23 (0.24) 0.013 (−0.110,0.135) 0.834
12 months 0.20 (0.32) 0.23 (0.24) −0.033 (−0.189,0.122) 0.653
24 months 0.25 (0.29) 0.30 (0.37) −0.054 (−0.243,0.136) 0.551
36 months 0.08 (0.14) 0.07 (0.12) 0.013 (−0.084,0.109) 0.789
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For the probing pocket depth at implant level only at 24 months a statistically significant difference
between equicrestally placed compared to subcrestally placed implants could be observed (Table 4).
After three years all groups are comparable indicative of peri-implant health.
Table 4. Mean probing pocket depth on implant level at 6, 12, 24 and 36 months for each study group
and the mean difference between respectively equicrestally versus subcrestally placed implants and
implants with a moderately rough versus minimally rough neck; p < 0.05 indicates a statistically
significant difference (paired t-test).
Probing Pocket Depth
Group 1: Equicrestal Group 2: Subcrestal Paired Difference
Mean (SD) Min Max Mean (SD) Min Max Mean dif 95% CI p
6 months 1.88 (0.53) 1.00 3.25 2.01 (0.66) 1.00 3.75 −0.135 (−0.311,0.041) 0.125
12 months 1.70 (0.44) 1.00 2.50 1.83 (0.53) 1.00 2.75 −0.130 (−0.312,0.051) 0.149
24 months 2.30 (0.66) 1.50 4.50 2.57 (0.84) 1.25 4.50 −0.261 (−0.473,−0.048) 0.018






Mean (SD) Min Max Mean (SD) Min Max Mean dif 95% CI p
6 months 2.93 (0.71) 1.75 5.25 2.88 (0.65) 1.75 4.75 0.050 (−0.142,0.242) 0.592
12 months 2.65 (0.72) 1.75 4.75 2.68 (0.68) 1.75 4.50 −0.033 (−0.221,0.154) 0.709
24 months 2.48 (0.58) 1.25 3.50 2.34 (0.60) 1.00 3,25 0.143 (−0.114,0.401) 0.252
36 months 2.10 (0.68) 1.25 4.25 2.01 (0.58) 1.00 3.00 0.088 (−0.259,0.434) 0.603
3.4. Oral Health-Related Quality of Life
Based on 45 edentulous patients, receiving an implant-supported overdenture, the OHIP-14 index
reduced from 13.37/56 (SD 9.97) at baseline to 4.42/56 (SD 4.94) after three months of functional loading.
This result in a large effect size of 0.90, suggesting a strong improvement in oral health related quality
of life. Between 3 and 12 months, no further changes were observed, resulting in small effect size
(0.04), indicative of a very stable result over time (Figure 7). The reduction was statistically significant
for all seven domains after three months (Table 5). For functional limitation, physical disability and
handicap the effect size was moderate. For the other four domains, a large effect size was observed
and most expressed for physical pain with an effect size of 1.04. The latter is logically given the fact
that improved denture retention results in less mucosal irritation and consequently fewer complaints
related to pain suffering.
Figure 7. Boxplots representing the Oral Health Impact Profile-14 (OHIP-14) total score before surgery,
3 and 12 months after connection of the prosthesis with the implants. A score of 56 represents a maximal
negative appreciation. ◦ Suspected outliers (between 1.5 × IQR and 3 × IQR above third quartile).
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Table 5. Mean OHIP score and the mean difference for each of the seven domains before surgery and
three months after connection with the calculated effect-size.
Domain








functional limitation 2.30 (1.85) 1.14 (1.42) 1.16 (0.540,1.785) 0.001 0.63
physical pain 3.37 (2.06) 1.21 (1.55) 2.16 (1.440,2.886) <0.001 1.04
psychological discomfort 2.52 (2.35) 0.65 (1.43) 1.87 (1.034,2.687) <0.001 0.80
physical disability 2.12 (2.16) 0.44 (0.85) 1.68 (0.971,2.378) <0.001 0.78
psychological disability 2.21 (1.91) 0.58 (0.93) 1.63 (0.930,2.326) <0.001 0.85
social disability 1.67 (1.49) 0.16 (0.49) 1.51 (1.007,2.016) <0.001 1.01
handicap 1.42 (1.48) 0.26 (0.66) 1.16 (0.683,1.642) <0.001 0.78
4. Discussion
The current paper focuses on implant treatment outcome in patients, which were completely
edentulous in both jaws. Retention of the lower denture is a typical problem in this category of patients,
especially in the mandible as compared to the maxillary denture. The denture in the mandible is less
retentive because of a smaller crestal bone support, a more expressed degree of bone resorption, and
unfavorable distribution of occluding forces, as well as additional pressure of the tongue yielding
dislocating forces. Often this results in functional discomfort and pain, the latter because of the absence
of keratinized mucosa. In the maxilla, the denture is supported on the crest and on the hard structure of
the palate, which is covered by keratinized tissue. A vacuum present during mastication, between the
palatal coverage of the denture and the underlying tissues, improves the retention. Consequently, fully
edentulous patients have more complaints with mandibular dentures and an overdenture retained on
two implants has therefore been suggested as of minimal care in order to provide functional comfort [6].
Implant treatment in denture wearing patients can be used for split mouth studies as was the case in
the two clinical studies presented in the present paper. The focus was on implant type and surgical
procedure, defined as implant survival, crestal bone loss and biologic peri-implant health. The latter
is an important aspect because peri-implant diseases may jeopardize treatment outcome in the long
run and are often related to aesthetic appreciation. Additionally, the patient-centered outcome was
assessed by using a validated Oral Health Related Quality of Life questionnaire.
After three years of follow-up, no implant failures could be recorded in the present study and
all remaining patients remained fully functional. This 100% implant survival is in line with current
literature on implant overdenture therapy [47].
Initial bone remodeling is a healing phenomenon related to the surgical procedure mainly the
exposure of bone and periosteum during implant placement, as well as the depth placement in the bone.
Given the fact that implant survival with currently available dental implant systems is successful and
quite predictable, the research focuses on implant success. Implant treatment is considered a success
when high implant survival is combined with bone stability over time, because the latter reflects the
health of the peri-implant tissues. Indeed, worldwide consensus defined that peri implantitis, a disease
condition of the implant resulting in pocket formation between the implant and soft tissue, is always
preceded by the bone loss [12]. Additionally, soft tissue health also affects the aesthetic outcome,
especially in the partially edentulous patient. Although aesthetics was not the key issue in the present
paper, the study conditions tested may provide clinical guidelines that do affect aesthetics, as well as
peri-implant health outcomes.
In the present paper, minimal initial bone remodeling ranging from 0–0.7 mm was assessed.
After the physiological initial bone remodeling, no further bone loss could be observed up to three years
of function. The effect of soft tissue thickness and implant surface roughness on the crestal bone loss
was evaluated. The applied split-mouth study design corrects for inter-individual variability from the
estimates of the treatment effect [48]. The results showed that the initial bone remodeling was affected
by the originally present soft tissue thickness, but not by the implant surface roughness. After implant
164
J. Clin. Med. 2019, 8, 773
installation, a minimum of 3 mm soft tissue dimensions seems to be necessary for the re-establishment
of the so-called “biologic width”, indicative of the importance of the biologically guided implant
placement. These findings are in accordance with an earlier published systematic review, including
meta-analysis. There it is stated that implants placed with an initially thicker peri-implant soft tissue
have less radiographic marginal bone loss in the short term [49]. Additionally, an increased early bone
remodeling leads to implant surface exposure in patients with thin soft tissues, which increases the
risk of on-going bone loss as shown by Vervaeke and colleagues in a nine year follow-up. A greater
implant surface exposure increases the bacterial colonization of the implant surface, which could
enlarge the chance to induce peri-implantitis [50]. From a clinical point of view, it is highly suggested
that the surgeon adapts the surgical position of the implant in relation to the available pre-operative
soft-tissue thickness.
It is generally accepted that osseointegration of moderately rough implants is enhanced as
compared to minimally rough implants. This resulted in faster treatment protocols and reduced early
failures. More recently, it was suggested that a minimally rough implant surface yields less crestal
bone loss and less peri-implantitis on the long-term. A recent systematic review, including studies up
to 10 years, reported on the survival rate and marginal bone loss of implants with different surface
roughness. Implant survival was higher for moderately rough surfaces, but minimally rough surfaces
showed the least marginal bone loss [51]. This outcome is in contrast to the outcome presented in
another systematic review with meta-analysis. The latter evaluated the influence of the implant collar
surface on marginal bone loss and revealed less bone loss for the rougher implant systems. However,
10 out of the 12 included studies showed results with less than five years of function. The only study
with 10 years of follow-up showed less bone loss for the implants with a smooth collar compared to the
implants with a rough collar. Yet, the authors stated that the results of their systematic review needed
to be interpreted cautiously, due to several confounding factors [52]. Another systematic review with
meta-analysis, which included only studies with at least, a five-year follow-up showed significantly
less bone loss around smooth implant surfaces compared to moderately rough and rough implant
surfaces [38]. Recently Donati and co-workers published the results of a 20-year follow-up RCT to
evaluate the effect of a modified implant surface. In 51 patients at least one implant with a minimally
rough surface and one with a modified surface was installed. The difference in mean bone level change
between the two implant-systems was not statistically significant, and the moderate increase of implant
surface roughness has no beneficial effect on long-term preservation of the peri-implant marginal bone
level. A more detailed analysis of the paper revealed, however, that none of the 32 evaluated smooth
implants showed more than 3 mm bone loss, whereas 3 out of the 32 modified implants showed bone
loss between 3 and 6 mm. Only two smooth surface implants were diagnosed with peri-implantitis
compared with five implants with a modified surface [53].
The findings of our paper are in accordance with the paper of Donati and co-workers, concluding
that the surface roughness of the implant neck has no effect on bone level up to three years. The hybrid
implant system used in our study combines the benefits of faster osseointegration, due to the moderately
rough implant body, and the minimally rough surface around the implant neck suggests it is less
prone to develop peri-implantitis [54]. Additionally, several studies conclude the beneficial effect of
a smoother surface with a lower incidence of peri-implantitis and less bone loss on the long term.
A further long-term follow-up of the current study population will elucidate the latter.
Besides implant survival and bone level stability, also peri-implant health is considered a perquisite
for treatment success. Peri-implant health is defined on two levels. Plaque accumulation yields minor
inflammation of the soft tissue surrounding the implant- restorative interface, coined as mucositis.
It is diagnosed with bleeding of the tissues after probing the crevice between implant and mucosa.
In a recent consensus report, the diagnosis of peri-implantitis has been redefined as a combination of
probing pocket depths of at least 6 mm in combination with bleeding on probing or a bone level of at
least 3 mm apical of the most coronal portion of the intraosseous part of the implant [12]. In our study,
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no patients showed ongoing bone-loss in combination with bleeding and increasing probing pocket
depths. Hence, the incidence of peri-implantitis was 0.0%.
The absence of peri-implantitis was found despite a high plaque level. This could be explained by
the elderly, fully edentulous patient population. De Waal and colleagues revealed that edentulous
patients restored with implants showed more plaque compared to partially edentulous patients
restored with implants. However, the plaque in the fully edentulous patients harbours a potentially
less pathogenic peri-implant micro-flora [55,56].
Another explanation for the relatively high plaque scores could be the dexterity problems inducing
imperfect cleaning abilities in elderly patients. On the other hand, plaque is screened at a given
moment in time during the clinical inspection and this may be several hours after cleaning and not
necessarily reflects the overall hygiene of the patient over time.
This is the reason why the bleeding index is considered more useful. It reflects the degree of
inflammation as a result of the long-term plaque control and is less momentarily. The current study
revealed that high plaque score did not result in high bleeding scores.
The support of a mandibular overdenture by two implants has a significant positive effect on
the quality of life. The OHIP-14 score was calculated irrespective of the implant group because it is a
patient-related outcome variable. On all the seven domains measured with the OHIP-14 questionnaire a
statistically significant difference was measured, all in favor of the support of a mandible overdenture by
two implants. These findings are in accordance with a clinical trial reporting a significant improvement
in satisfaction and health-related quality of life when subjects who received two implants are compared
with subjects requesting a new conventional denture. Besides the improvement in the quality of life,
they reported that patients requesting implants reported that tooth loss and denture wearing problems
had a much greater impact in their quality of life than patients seeking conventional dentures [5].
5. Conclusions
Within the limitations of this study, it can be concluded that an implant supported mandibular
overdenture significantly improves the quality of life, with limited biologic complications and a high
survival rate of the implants. All seven domains of the OHIP-14 questionnaire significantly reduced
when the mandible overdenture is supported by two implants. No differences were observed in
crestal bone remodeling between minimally rough and moderately rough implant surfaces. However,
initial bone remodeling was affected by initial soft tissue thickness. Anticipating biologic width
re-establishment by adapting the vertical position of the implant in relation to the available soft tissue
thickness may avoid peri-implant bone loss. The biologic variance of the patient might be more
important compared to the configuration of the implant surface. Long-term follow-up of the study is
necessary to determine the influence of early implant surface exposure and implant surface roughness
on crestal bone loss, biologic parameters, mechanical complication, and implant survival.
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Abstract: Objectives: The present randomized clinical trial assesses the six-month outcomes following
surgical regenerative therapy of periimplantitis lesions using either an electrolytic method (EC) to
remove biofilms or a combination of powder spray and electrolytic method (PEC). Materials and
Methods: 24 patients with 24 implants suffering from peri-implantitis with any type of bone defect
were randomly treated by EC or PEC. Bone defects were augmented with a mixture of natural bone
mineral and autogenous bone and left for submerged healing. The distance from implant shoulder to
bone was assessed at six defined points at baseline (T0) and after six months at uncovering surgery
(T1) by periodontal probe and standardized x-rays. Results: One implant had to be removed at T1
because of reinfection and other obstacles. None of the other implants showed signs of inflammation.
Bone gain was 2.71± 1.70 mm for EC and 2.81± 2.15 mm for PEC. No statistically significant difference
between EC and PEC was detected. Significant clinical bone fill was observed for all 24 implants.
Complete regeneration of bone was achieved in 12 implants. Defect morphology impacted the
amount of regeneration. Conclusion: EC needs no further mechanical cleaning by powder spray.
Complete re-osseointegration in peri-implantitis cases is possible.
Keywords: periimplantitis; electrolytic cleaning; augmentation; air flow; re-osseointegration;
classification of bone defects
1. Introduction
Increasing numbers of inserted dental implants cause an increasing number of infected implants [1].
Mucositis is a reversible inflammatory process limited to peri-implant soft tissue. Peri-implantitis
(PI) is defined as an inflammatory process affecting peri-implant hard as well as soft tissue. Typical
cup-shaped progressive bone defects, pus, and bleeding on probing (BoP) are clinical parameters
which have to be verified simultaneously to justify the diagnosis of PI [2,3]. Mucositis and PI are
correlated with bacterial biofilms colonizing the surfaces of implants or abutments [4]. In view of the
difficulty in differentiating pathologic bleeding from bleeding caused by improper probing, as well
as the discordance in the dental community about the acceptable threshold of bone loss, there is no
consensus about when pathology starts and how PI can be diagnosed precisely. Hence, prevalence data
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vary from author to author [5,6]. Based on these data, up to 100 million dental implants may be infected
worldwide. As implant surfaces, which are exposed to the oral cavity, are immediately colonized by
the individual microbiome, the surfaces need to be re-osseointegrated for positive long-term results [7].
Treatment and replacement of implants cause immense costs and discomfort. Therefore, it is necessary
to find more effective approaches to decontaminating infected implants.
Several methods, all of which are ablative for removing biofilms have been discussed. For example,
mechanical debridement by hand or ultrasound-driven curettes, brushes, lasers, pellets, cold
plasma, or air-powder sprays in conjunction with or without disinfection or antibiotic agents.
Re-osseointegration of between 39% and 46% of treated implant surfaces was reported in a review [8].
Re-osseointegration in humans has not yet been proven. A review of the literature demonstrated
that none of the assessed methods was superior to any other in removing the biofilm and no
method was able to achieve a stable result over time [9]. Up to 100% relapse of the disease for
some methods was demonstrated after one year, and evidence for the superiority of any treatment
modality is lacking [10]. Powder spray systems (PSS) are commonly used to treat PI. Small particles
(erythritol or glycine) are accelerated by air pressure and remove the biofilm when impacting the
implant surface. Several animal studies investigating re-osseointegration after cleaning by PSS proved
incomplete re-osseointegration [8]. Clinical parameters like BoP, pocket depth (PD), and pus improved.
Furthermore, PSS failed to prove superiority to any other treatment modality [11–13]. Possible reasons
for this limited efficacy might be craterlike bone defects with compromised access, thus improper
working angle and distance of the device, macro- and micro-design of the implant surface, and particles
too large for much smaller bacteria hidden in the microstructure of textured implants.
In an in vitro test, two bacterially contaminated implants were embedded in an electro-conductive
gelatin block and were loaded with a continuous current of 0-10 mA – one acting as a cathode, the other
as an anode. A reduction of bacteria was proved. This approach dramatically changed the pH at
both implants [14]. Zipprich et al. covered implants with a mature biofilm, loaded them as cathode,
and flooded the implants with a buffered potassium iodine solution which had passed an anode.
Complete removal of the biofilm was demonstrated by SEM analysis [15]. The mode of action was
investigated by a collaborative working group [16]. In an in vitro test, Ratka et al. used EC versus
PSS to treat implants with different surfaces and alloys covered with a mature biofilm. In contrast to
PSS, no bacteria could be cultivated in the EC groups. The difference was extremely significant [17].
Based on these findings, an electrolytic device was developed by the authors to remove the biofilm in a
clinical setting.
The aim and endpoint of this controlled clinical trial was to compare the effectiveness of two
processes of decontamination in terms of bone level changes.
2. Materials and Methods
2.1. Legal
The study was registered (BfArM DA/CA99, DIMDI 00010977) and approved by the
“Ethik-Kommission der Bayerischen Landesärztekammer” (BASEC_No. DE/EKBY10) with the
registration code 17075.
2.2. Sample Size Calculation
The data presented in this study were collected for a proof of principle study assessing the
bacterial load before and after the treatment. This article describes the six-month results of the proof of
principle study. Based on previous in vitro tests using a paired t-test with a power of 90% and a level
of significance of 5%, a sample size of 12 per group was calculated. The sample size calculation was
done using G*Power 3.1 (Heinrich Heine University of Düsseldorf).
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2.3. Devices and Mode of Action
For the electrolytic approach (EL) the implant has to be loaded negatively with a voltage and a
maximum current of 600 mA. This is achieved by a device (GS1000, GalvoSurge Dental AG, Widnau,
Switzerland) providing the voltage and pumping a sodium formiate solution through a spray-head,
which has to be pressed into the implant by finger pressure to achieve an electrical contact (Figure 1).
Driven by a peristaltic pump, a sodium formiate solution passes an anode inside the spray-head and
then covers the implant with a “film” of liquid (Figure 2). The current splits the water into hydrogen
anions and cations. The cations penetrate the biofilm and take an electron from the implant. Hydrogen
bubbles lift the biofilm off the implant surface.
 
Figure 1. Composition of the spray-head. (1) Implant (loaded as a cathode); (2) spray head; (3) tube for
electrolyte; (4) spiral-like threaded isolator; (5) connector (loaded as a cathode); (6) anode; (7) shower
head (exit of electrolyte); (8) control unit and voltage source. Application of Figure 1: The spray-head
(2) has to be pressed on containment of the implant (1) manually. The electrolyte will be pumped
through the tube (3) and passes the spiral of the treaded isolator (4), reaches the anode (6), and will be
sprayed by the shower head (7) onto the exposed implant surface. A second pathway branching off
from the threaded isolator to the implant connector (5) pumps electrolyte in the implant containment
(1). The positive current path derives from the voltage source (8), passes metallic conductors to the
anode. The negative current path derives from the voltage source (8), passes metallic conductors to the
connector (5), to the implant (1), which acts in the electrolytic process as the cathode.
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Figure 2. Spray-head during cleaning process.
2.4. Patient and Sample Selection, Randomization
24 patients with at least one titanium implant and diagnosed with periimplantitis (definition
according to Berglund et al.) [3] were included in the study. If more than one implant was affected,
one implant was chosen randomly. The patients were allocated to test group (EC) or control group
(PEC) after randomization by using sealed envelopes immediately before surgery.
2.5. Inclusion Criteria
Patients older than 18 years, capable of understanding and signing an informed consent, smoking
fewer than 10 cigarettes per day, without uncontrolled periodontitis, BoP < 20%, Plaque Index < 20%,
no allergy to the drugs or materials used, and not pregnant or nursing were suitable to be enrolled in
the study.
In contrast to most of the literature, the bone defects were not limited to intraosseous defects.
All implants were included independently of their bone defect morphology, three-dimensional implant
position, e.g. implant axis, inter-implant distance, etc.
2.6. Procedures and Measurements
Selected patients were instructed and motivated regarding proper oral hygiene and, if necessary,
underwent periodontal treatment. Standardized photos were taken (occlusal, buccal, lingual view)
and repeated in all appointments listed below. Suprastructures were removed 14 days before
surgery. The implants were cleaned by powder spray (Nozzle, EMS, Nyon, Switzerland) and rinsed
with chlorhexidine (Chlorhexamed forte, GlaxoSmithKline, Munich, Germany) to reduce soft tissue
inflammation in line with standard procedures in periodontal therapy. A cover screw was placed.
As a result of this pretreatment, in most cases the soft tissue grew over the implant, leaving a crestal
fistula. PD and BoP were assessed at six defined points (m, mb, b, db, d, dl) (Figure 3) using a
periodontal probe with a 1 mm scale (PCPUNC 15, HuFridy, Chicago, IL, USA). A crestal incision with
releasing incisions was performed to enable a flap to be reflected so that access to the implant could
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be gained. Buccal and, in the mandible, additional lingual periosteal incisions were made so that the
tissues could be mobilized over the implant. The granulation tissues were removed and, if applicable,
tartar or cement remnants were removed mechanically by the use of curettes (DSC13/14, HuFridy,
Chicago, IL, USA) and/or ultrasonic devices (Dentsply Sirona, Bensheim, Germany). This is necessary
because the EC process can only work if the electrolyte is in direct contact with the conductive implant.
The distance from implant platform to the most apical position of bone (P-B) was assessed as described
in (Figure 3) at the same six points as PD and BoP were measured using the described periodontal
probe. In the EC group, the spray-head was pressed into the implant and the GS1000 control unit
started. The current was applied 5 s after the peristaltic pump was started and the electrolytic spray was
initiated. The cleaning process took 120 s. In the PEC group, the implants were treated according to the
manufacturer’s manual by a powder spray (Airflow Plus powder, Airflow, EMS, Nyon, Switzerland)
for 60 s followed by the treatment described for the EC group. After cleaning, the implants were
rinsed with sterile saline and augmented with a mixture of autogenous bone harvested from the
ramus area (Micross Safescraper, Zantomed, Duisburg, Germany) and Bio-Oss (Geistlich, Wohlhusen,
Switzerland) in a 50:50 ratio. In cases with non-supporting infrabony defects, tenting screws were used
for space maintaining (Umbrella-Screw, Ustomed, Tuttlingen, Germany). After placement of a collagen
membrane (Bio-Gide, Geistlich, Wohlhusen, Switzerland) the flap was coronally advanced to cover
the site passively. The 6-0 propylene monofilaments (Medipac, Kilis, Greece) were removed after two
weeks, and wound healing was documented. A VAS (pain, acceptance) assessment was also done by
the patients. When no exposure was present at the time of suture removal the patients were checked
again four weeks later, then scheduled six months after surgery for second-stage surgery. In the case of
exposure, the patients were instructed to brush the area carefully and rinse the site with chlorhexidine.
These sites were checked monthly.
Figure 3. Bone defects were assessed at six defined points from implant shoulder to the most coronal
position of the bone.
During the period of healing (six months) the patients were supervised, and exposures or infections
were documented. After six months, second-stage surgery was performed. The implants and the
surrounding bone were exposed and P-B was assessed under direct vision at the previous points.
In cases with exposures, no second-stage surgery was necessary and P-B was assessed by bone sounding
under local anesthesia using the described periodontal probe with sufficient pressure. Furthermore
infections, BoP, and recessions were documented. For all implants, suprastructures were replaced,
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photographs were taken, and a standardized x-ray in the right-angle position was performed. Sutures
were removed after 14 days, if applicable. Bone levels at baseline and after six months were assessed
by two examiners using software (DBS Win, Dürr, Bietigheim-Bissingen, Germany). The examiners,
not knowing the aim of the study, were calibrated until their results correlated adequately as measured
by Cohen’s Kappa (κ ≥ 0.6). In addition, the measurements had to reach 90% agreement for ±0.5 mm
as well as exact agreement in 75% of the radiologic measurements before assessment of the x-rays in
this study.
Schwarz et al. [18] introduced a classification describing typical peri-implant bone defect anatomy.
For clinical purposes, however, a classification providing information about the healing potential of a
defect would be more helpful for the practitioner. Therefore, we hereby introduce the RP Classification
differentiating the regenerative potential (RP) of a bone defect based on the risk-chance ratio of
treatment. We assessed intrabony defects (RP1), intrabony defects with dehiscence defects (RP2) and
horizontal bone defects (RP3) (Figure 4) and correlated them to total and median bone fill. Complete
regain of bone is dependent on the type of implant. In most of the implants 1 mm remodeling occurs
within the first year. It cannot be expected that these implants will re-osseointegrate up to the platform.
Implants with a polished neck osseointegrate to the border rough-polished. They are placed at this
level very often. More coronal re-osseointegration cannot be expected [19,20].
Therefore, we define bone-to-implant contact with a P-B < 1 mm as complete bone fill. Implants
with polished necks are counted as complete bone fill, if the bone fill reaches the border rough-polished
being visible at T2 after flap removal.
All the surgical procedures and clinical assessments such as PPD, recessions and BoP were
performed by the first-named author.
Figure 4. RP Classification of peri-implant bone defects based on risk-chance ratio of treatment.
2.7. Statistics
Quantitative values are presented as mean and standard deviation, and minimum and maximum,
as well as quartiles. Gaussian distribution of data was assessed using the Saphiro-Wilk test.
Comparisons were performed with the Mann-Whitney U test or t-test, as appropriate. The homogeneity
of variance was verified by Levene’s test before the t-tests. The level of significance was set at α = 0.05
and all tests were two-sided. The statistical analysis was performed using R 3.6.1 with the package car
3.0-3. R. The package used is available from CRAN at http://CRAN.R-project.org/.
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3. Results
The distribution of gender and age was homogeneous (12f/12m; mean age 57.13 y) and there were
four smokers (3 EC, 1 PEC) < 10 cigarettes per day. All the sites were infected, BoP was positive, pus
drained from pockets, and all sites probed deeper than 5 mm at baseline (Table 1). PD was 6.64 mm in
the EC and 7.02 mm in the PEC group. No significant difference was assessable (Fisher’s exact test,
p > 0.999). Thus, the entity was considered to be homogeneous.
Table 1. Qualitative baseline data indicating homogenous data.
General Information Specific Information n/Mean Years Percentage
gender female 12 50.00%
male 12 50.00%
age female 59.2 y
male 51.4 y
jaw maxilla EL 4 16.67%
maxilla PEL 8 33.33%
mandible EL 8 33.33%
mandible PEL 4 16.67%
maxilla total 12 50.00%
mandible total 12 50.00%




Nineteen sites were exposed at suture removal, 15 after six months. Nevertheless, no implant
was lost during the healing phase. One implant from the PEC group had to be removed after six
months because of infection, incomplete bone regeneration, and the presence of infection. Compliance
of this female patient was poor, and the implant was placed far too lingually in a compromised axis.
The addition of these factors led to the recommendation to remove this implant.
The quality of regained bone was assessed by visual inspection with a microscope (24x
magnification), bone sounding with high pressure, and interpretation of x-rays. Complete and
solid bone in direct contact with the implant was confirmed.
Bone gain was assessed at six months as a difference between P-Bbaseline and P-B6 months (ΔP-B)
at the six defined points. There was no statistical significant difference either between the specific
points or the median. Bone gain and differences between the EC and PEC groups are visualized
in Table 2. Bone gain was 2.71 ± 1.70 mm in the EC group and 2.81 ± 2.15 for PEC. The difference
(Δ PEC-EC) was not statistically significant (0.10 mm, p-value 0.87). The related boxplots are displayed
in Figures 5 and 6.
The implants in the study population consisted of different implant brands and designs.
Their distribution is displayed in Table 3. According to our definition, complete bone fill was
achieved if ΔP-B was less than 1 mm. This was observed in nine implants (37.5%). In two cases with a
polished implant shoulder (Camlog, Altatec, Wimsheim, Germany), the bone fill reached the border
rough-polished (ΔP-B < 2). If those cases are accepted as complete bone fill, a total of 12 implants
(50%) accomplished complete bone fill. The distribution of the different defect morphologies and
regenerative potential was four implants RP1, 11 implants RP2, and nine implants RP3. Complete
regain of visible and probable bone up to the implant shoulder was achieved in all the RP1 implants.
Six implants in RP2 cases and only two implants in RP3 achieved complete bone fill. Median bone
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gain related to defect morphology was 4.02 ± 0.96 mm in RP1 cases, 2.64 ± 1.58 mm in RP2 and
2.34 ± 1.58 mm in RP3 (Table 4).
Table 2. Bone gain and differences between EC and AFL group.
Location EC Group [mm] PEC Group [mm]
Differences
AEL-EL p-Value
db 3.00 ± 1.67 2.50 ± 2.10 −0.50 0.52
b 3.25 ± 1.63 2.83 ± 2.94 −0.42 0.71
mb 3.17 ± 1.61 3.00 ± 2.12 −0.17 0.83
ml 2.58 ± 1.84 3.13 ± 2.25 0.55 0.53
l 2.29 ± 1.79 2.96 ± 1.86 0.67 0.38
dl 1.96 ± 1.57 2.46 ± 1.83 0.50 0.48
Median 2.71 ± 1.70 2.81 ± 2.15 0.10 0.87
Figure 5. Boxplot indicating the distribution of the assessment points in EC and PEC.
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Figure 6. Boxplot indicating the merged distribution of the assessment points in EC and PEC.
Table 3. Allocation of different implant types.
Type of Implant Number
Astra TX 5
Astra EV 2
Straumann tissue level 2
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Table 4. Bone gain in relation to RP class.
RP Class Bone Gain
RP1 4.02 ± 0.96
RP2 2.64 ± 1.58
RP3 2.34 ± 1.58
In one case 1.5 mm bone grew over the top of the implant and 1.5 mm clinically hard and mature
bone had to be removed to get access to the implant (Figures 7 and 8) [21]. In two cases, (both RP3) the
implants were covered by tartar. In one case, complete bone fill was gained. In the other case, P-B
improved slightly.
Figure 7. (a). A raised flap displays granulation tissue. (b). Deep peri-implant RP1 bone defect.
(c). The spray-head is in place. The film of electrolyte is guided by a sponge. Hydrogen bubbles appear
as a result of the process. (d). Defect augmented by a mixture of autogenous and natural bone mineral.
(e). Healed defect after six months. (f). Solid bone overgrew the implant.
Figure 8. (a). The defect at baseline looks much less severe than in clinical reality. (b). Augmented
defect. (c). Six months of healing.
4. Discussion
4.1. Design of Study
The study was designed as a randomized and controlled trial. As none of the current treatment
modalities was superior to any other and all of them failed to prove long-term stability and
re-osseointegration in a clinical setting [10], they were unsuitable to serve as a control method.
None of these methods was considered ethical to use. After lengthy discussion with the ethics
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committee, we decided to investigate whether additional ablative methods are beneficial to the
outcome of the electrolytic approach. For this purpose, we cannot compare the results of this study
directly with current treatment modalities. Furthermore, this RCT investigated changes in bone level
clinically while most of the published articles focus on the change in clinical parameters. In view of
the different endpoints, the data presented in this article cannot be compared directly with existing
literature. After six months of healing after second-stage surgery, we will have the chance to assess
clinical data (PPD, BoP, secretion) and compare them to existing literature.
The definition of success in the therapy of periimplantitis is a matter of debate. Carcuac et al.
approached this question by assessing three outcomes: 1. further marginal bone loss ≤ 0.5 mm,
2. outcome 1 + PD ≤ 5 mm, and 3. outcome 2 + BoP and/or suppuration on probing (SoP) = negative.
According to this definition they were able to achieve 69.4%, 55.4% and 33.1% success in an RCT
investigating resective surgery [22]. Assuming that elimination of a pocket should resolve the problems,
these results are disheartening. In an RCT, after cleaning of the implant surface with plastic curettes
and chlorhexidine gel in cases with intrabony defects, Schwarz et al. showed PD changes after four
years from 7.1 mm to 4.6 mm when using Bio-Oss and a collagen membrane [23]. BoP reduced from 79
to 28%. Defect configuration seems to have a major effect on PD reduction. Schwarz et al. proved that
circumferential intrabony defects exhibit a significantly higher reduction of PD compared to intrabony
fenestration defects [24]. Roccuzzo et al. followed 24 patients (two dropouts) with intrabony defects in
a case series for seven years. Implants were treated by mechanical debridement and application of
EDTA and chlorhexidine gel followed by augmentation with Bio-Oss Collagen. The survival rate was
83.3% for SLA implants and 71.4% for TPS. PD was reduced from 6.6 ± 1.3 to 3.2 ± 0.7 mm in SLA,
and 7.2 ± 1.5 to 3.4 ± 0.6 mm in TPS. BoP changed from 75.0 ± 31.2% to 7.5 ± 12.1% (SLA), and from
90.0 ± 12.9% to 30.0 ± 19.7% (TPS). The authors described successful therapy as PD ≤ 5 mm, negative
BoP and no further bone loss. Success was achieved in two of 14 (14.3%) of the TPS and in seven of 12
(58.3%) of the SLA implants [25]. These results are difficult to understand as BoP, according to the
definition of peri-implantitis, should have been 100% at baseline. It is not known whether non-infected
implants with bone loss were enrolled in the study. This demonstrates the difficulty of using the
parameter of BoP as a tool for diagnosing peri-implantitis, as discussed by Coli et al. [26].
4.2. Our Results
The potential of the electrolytic approach has previously been demonstrated in various in vitro
tests [15–17,27]. We did not focus on intrabony defects, like the cited studies, but accepted all kinds of
defects in our data. Therefore, because of the use of different endpoints, it is not possible to compare
our data directly with the studies cited above. Achievement of re-osseointegration can be proved only
histologically. In an animal study [27], we proved that complete re-osseointegration could be achieved
after the use of EC, whereas with conventional cleaning, the bone filled the defect partially, but was
never in direct contact with the implant. Clinically, bone fill cannot be equated with re-osseointegration,
although this can happen with high probability after EC. The quality of the gained bone was evaluated
by visual inspection, assessment of x-rays, and/or mechanical bone sounding of the most crestal
position of the bone at the six predetermined points. Mature and solid bone in direct contact with
the implant was detected. This still does not prove re-osseointegration. It may be stated, however,
that we achieved complete bone fill (according to this definition) in all intrabony defects (RP1 cases).
Complete bone fill was achieved in 50% of all cases – a number which, to the best knowledge of the
authors, has not yet been quoted in the literature. In cases with exposure, no flap was raised after six
months. The P-B distance could not be assessed under direct visual control. The potential bias seems
to be negligible. Former studies demonstrated that even probing with 0.5 N completely lateralizes
the peri-implant tissues [28]. In the study bone sounding was performed with high pressure under
local anesthesia.
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Published clinical studies focus on the change in radio-opalescence in x-rays. We will compare
radiologic data in a further follow-up as well as PD and BoP assessments and answer the question of
the long-term stability of the EC approach.
The exposure rates (15 sites at suture removal) were much higher than is usual in the hands of the
author compared to simultaneous implant placement and augmentation. This happened even though
a strict initial phase was applied in order to reduce infection and inflammation. It will be necessary to
investigate this issue more closely in future and possibly adapt surgical techniques. Whether the soft
tissues could be compromised by the former peri-implant infection is merely a matter of speculation.
Our in vitro data clearly prove the potential of EC for removing bacterial [17]. No data are
available regarding whether periimplantitis impacts the healing potential of surrounding soft tissue.
The number of exposures exceeds the number of exposures in cases of simultaneous implantation and
augmentation according to the author’s experience. This requires further studies.
Powder spray has to impact at an angle of 30–60◦ and a working distance of 3–5 mm according
to the manufacturer’s manual. Owing to micro- and macrostructure as well as defect anatomy,
this prerequisite may not always be met. In our study, we compared EC with a combination of EC
and powder spray in order to assess whether additional mechanical debridement enhances outcomes.
Our data support previous in vitro results, namely that EC alone is able to clean the implant surface
and regain a surface onto which bone grows [17].
Tartar had to be removed in two cases before EC cleaning. It was clearly visible that the surfaces
of the implants were damaged by the curettes and the ultrasonic device. Our data prove that regain of
bone above the former bone level and clinical reattachment of bone are nevertheless possible.
One implant had to be removed because of various factors (reinfection, malpositioning of the
implant, and compliance of the patient). Which of these obstacles was causative for the decision
is unclear. This raises the question of which implants should be treated or removed and leads to
discussion about the etiology of the individual disease and the regenerative potential of this special
defect. It is still a matter of discussion whether the bacterial biofilm is the only causal factor or whether
bone loss caused by surgical, mechanical, or patient-related reasons, and bacterial colonization happens
secondarily on the exposed surfaces [29]. This debate about etiology is not only an academic question.
The success rate of possible treatments correlates with specimen susceptibility and uncorrectable
surgical or mechanical obstacles. The number of implants included in the present study was too
small to draw statistically significant conclusions about correlations between defect morphology
and outcome. Conspicuously, all implants with completely preserved bone walls but intrabony
defects (RP1) healed with complete bone fill of the defect. Only two out of nine cases with a vertical
component (circumferential bone loss; RP3) achieved complete bone fill. Our data support the results
of Schwarz et al. who stated that defect morphology has a major impact on healing [24]. We clearly
state that the data from this study are too weak because of the sample size to justify the validity of the
suggested RP classification. Initially, we did not plan to discuss the data in this way, but the results
showed clear differences without reaching significance. Further studies are necessary to validate the
RP classification. We treated all implants with the diagnosis of peri-implantitis. Implants placed with a
bad axis, insufficient buccolingual inclination, and inter-implant distance < 3 mm were not excluded.
Bone gain was smaller compared to perfectly placed implants according to the clinical impression of
the authors. Statistical analysis was not performed because of small sample sizes. Further studies are
recommended to clarify this issue. For treatment, planning a classification of bone defects to forecast
treatment results would be helpful. Therefore, we herewith introduce a new classification focusing on
risk-chance ratio: The Regenerative Potential (RP) Classification. Cup-shaped defects with complete
bone walls surrounding the defect have the highest healing potential [24]. If more walls are missing
and/or additional risk factors are present, removal of the infected implant may be considered. Further
studies are necessary to develop a clear decision tree for determining which implants should be treated
or removed and when electrolytic cleaning is helpful for long-term success.
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5. Conclusions
Electrolytic cleaning of contaminated implants achieves an implant surface where complete
re-osseointegration is possible. This was attained in 50% of the cases. Additional mechanical cleaning
by the use of powder spray devices does not improve the results further. The amount of regeneration
depends on the regenerative potential of the bone (multiwall craterlike defects perform better than
horizontal bone loss). Further confounding factors could not be identified owing to the limited sample
size of 24 patients.
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Abstract: The prevalence of implant biological complications has grown enormously over the last
decade, in concordance with the impact of biofilm and its byproducts upon disease development.
Deleterious habits and systemic conditions have been regarded as risk factors for peri-implantitis.
However, little is known about the influence of local confounders upon the onset and progression of
the disease. The present narrative review therefore describes the emerging local predisposing factors
that place dental implants/patients at risk of developing peri-implantitis. A review is also made of
the triggering factors capable of inducing peri-implantitis and of the accelerating factors capable of
interfering with the progression of the disease.
Keywords: peri-implantitis; peri-implant endosseous healing; dental implantation; dental implant;
alveolar bone loss
1. Introduction
Implant dentistry, as a scientific discipline, has grown rapidly over the last four decades with
the aim of facilitating early and effective osseointegration affording successful long-term outcomes.
Over these years, the onset of complications has been neglected as representing only isolated events.
Nowadays, however, due to the increase in prevalence of such problems, one of the major endeavors
in this field is the prevention and efficient management of biological complications referred to as
peri-implant diseases [1,2].
According to the bacterial theory, peri-implantitis by definition is a chronic inflammatory
condition associated with a microbial challenge [3]. Nevertheless, in some cases there may be
immunological reasons behind marginal bone loss [4–6] not primarily related to biofilm-mediated
infectious processes [7]. Accordingly, a change from a stable immune system, seen during maintained
osteointegration, to an active system may lead to the rejection of foreign bodies [7]. In this regard,
implant surfaces types, surface wear, or contaminated particles may enhance these immunological
reactions [8].
The conversion process from peri-implant mucositis mirrors the progression from gingivitis to
periodontitis, with the constant formation of plaque features in the peri-implant tissues, characterized
by erythema, bleeding, exudation, and tumefaction. At histological level, the establishment of B-
and T-cell-dominated inflammatory cell infiltrates has been evidenced [9]. However, the clinical and
histopathological characteristics during the conversion process are still not fully clear. Following
conversion, peri-implantitis progresses in a nonlinear and accelerated manner [10].
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The epidemiology of peri-implantitis varies widely depending on the given case definition.
There has been important controversy regarding the threshold defining physiological peri-implant
bone loss. As such, unspecific ranges have been observed in meta-analyses with heterogeneous case
definitions. In 2012, the VIII European Workshop of Periodontology underscored that the diagnosis of
peri-implantitis should be given on a longitudinal basis of overt progressive bone loss with clinical signs
of inflammation [11]. In this regard, a threshold of ≥2 mm of peri-implant bone loss could be accepted
for the diagnosis of peri-implantitis. More recently, the American Academy of Periodontology and the
European Federation of Periodontology have jointly proposed a case definition based on a threshold of
≥3 mm [12]. Recent meta-analytical data have suggested the prevalence of peri-implantitis to be 18.5%
at patient level and 12.8% at implant level [13], though the prevalence at patient level ranges widely
between 1 and 47% [14]. Regardless of the diagnostic criteria proposed, peri-implantitis has been
shown to be a site-specific condition. In contrast to periodontitis, which manifests with generalized
loss of support, peri-implantitis commonly progresses conditioned by factors predisposing to biofilm
accumulation which, under susceptible conditions, triggers a complex inflammatory response.
Strong evidence suggesting an increased risk of peri-implantitis has been obtained in subjects
with poor personal- and professional-administered oral hygiene measures, and in individuals with a
history of periodontitis [15,16]. Even though other factors and deleterious habits such as smoking [17]
or hyperglycemia [18] have been identified as potential risk factors, there is a need for further and
stronger evidence to validate their influence upon the development of peri-implantitis [3].
Moreover, in a site-specific condition, attention should focus on those factors which locally
might be predisposing for the onset and progression of the disease [19]. Accordingly, the 2017 World
Workshop identified evidence linking peri-implantitis to factors that complicate access to adequate
oral hygiene, that is, those local conditions that predispose certain implants to develop disease [12].
2. Significance of Terminology for Reaching Consensus
As mentioned above, peri-implantitis and periodontitis occur more frequently under certain
systemic conditions and in the presence of deleterious habits. For instance, it is known that major
periodontal disease risk factors such as smoking and diabetes alter the epigenetics by downregulating
the genic expression of bone matrix proteins that could influence the pathway from peri-implant
mucositis to peri-implantitis by suppressing specific transcription factors for osteogenesis, or by
activating certain transcription factors for osteoclastogenesis [20,21]. Hence, these systemic conditions
may increase the risk of suffering peri-implant diseases.
On the other hand, emerging data point to the influence which certain local factors might have
upon the onset and development of disease, since they induce plaque accumulation. These are the
so-called predisposing factors. Terminologically, a predisposing factor is a condition that places the
given element (dental implant)/individual (patient) at risk of developing a problem (peri-implantitis).
In this regard, it is also of interest to underscore that a triggering factor, if not controlled after diagnosing
and arresting (or not arresting) the problem (peri-implantitis), represents a perpetuating element that
maintains the problem after it has become established [22]. Accelerating factors are therefore defined
as those conditions that do not play a role in the onset of a problem (peri-implantitis) but can influence
its progression.
3. Are Dental Implants Predisposed to Develop Biological Complications?
The evolution of dental implants and their incorporation to routine practice to restore function
and aesthetics of lost or failing dentition have been described as one of the most revolutionary and
innovative developments of the twentieth century. In fact, early dental implants were developed with a
minimally rough surface microdesign. At that stage in modern implant dentistry, the osseointegration
process proved slower and less effective. Long-term findings reported that these implants moreover
tended to fail more frequently in the maxilla compared with the mandible. In addition, mean marginal
186
J. Clin. Med. 2019, 8, 279
bone loss using primitive implant–abutment connections was shown to be 1.5 mm, with an annual
progressive bone loss of 0.1 mm [23,24].
With the development of new technology, the vast majority of commercial implants now have
modified (moderately rough) surfaces with the primary aim of securing earlier osseointegration [25].
The incorporation of more biologically acceptable connections may be able to restrict inflammatory
infiltration and thus minimize physiological bone loss. Indeed, a clinical study showed that 96% of
the implants with a marginal bone loss of >2 mm at 18 months had lost 0.44 mm or more at 6 months
postloading [26]. Thus, early healing dictates the long-term life of dental implants and the occurrence of
biological complications, as it can be assumed that the establishment of a more anaerobic environment
results in greater susceptibility to progressive bone loss.
Advances in the knowledge of bone biology and translational medicine summed to the
development of novel armamentaria allow the clinician to minimize physiological bone remodeling.
In this regard, excessive physiological bone remodeling (loss) may create a niche for the harboring of
periopathogenic microorganisms that can lead to the development of implant biological complications.
4. Peri-Implant Monitoring: Diagnostic Accuracy of Clinical Peri-Implant Parameters
The prompt diagnosis of peri-implant disease is crucial to achieve favorable therapeutic
outcomes. While the nonsurgical treatment of peri-implant mucositis is effective, the management
of peri-implantitis proves more challenging [27]. Along these lines, it is worth mentioning that the
severity and extensiveness of the lesion are crucial factors for successful and maintainable outcomes.
Peri-implantitis develops with progressive bone loss and signs of inflammation. As such,
in order to secure an accurate diagnosis, the classical signs of inflammation (i.e., warmth, reddening,
tumefaction) and an increased probing depth compared to baseline (assuming a measurement error)
must be present [12] (Figure 1; Figure 2), as evidenced by clinical (Table 1) and preclinical studies.
Interestingly, during the progression of ligature-induced experimental peri-implantitis, all the clinical
parameters are worse due to the degree of inflammation present [28–31].
In this sense, it should be mentioned that disagreement persists concerning the sensitivity of
bleeding on probing (BOP) and suppuration as diagnostic criteria. For instance, a human study
showed the probability of positive BOP at a peri-implant site with a probing depth of 4 mm to be
27% [32]. The odds for positive BOP was seen to increase 1.6-fold per 1 mm of further probing
depth. It has been further evidenced that BOP might be influenced by patient-related factors such as
smoking [32]. In fact, understanding of the morphological differences of the periodontal apparatus
compared with the peri-implant tissues supports the possibility that the former responds differently
to mechanical stimulation. This might explain the poorer sensitivity in the detection of peri-implant
diseases compared with periodontal diseases. Likewise, suppuration has been reported in about
10–20% of all peri-implant sites [28,33–36]. Hence, suppuration does not seem to exhibit high sensitivity
in the diagnosis of peri-implantitis.
  
Figure 1. Bleeding on probing and increased probing pocket depth are clinical signs of peri-implantitis.
The final diagnosis should be based on the correlation of the clinical data to the radiographic findings.
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Figure 2. Bleeding on probing and increased probing pocket depth are clinical signs of peri-implantitis.
The final diagnosis should be based on the correlation of the clinical data to the radiographic findings.
When bone loss is advanced, implant removal is often the most predictable option for dealing
with peri-implantitis.
In sum, clinical monitoring of peri-implantitis using a periodontal probe is indicated at each
maintenance visit, with the purpose of preventing major biological complications. Nevertheless,
the definite diagnosis should be based on the radiographic findings compared to baseline.
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5. Local Predisposing Factors
5.1. Significance of Soft Tissue Characteristics
The characteristics of the periodontal soft tissues and their association to periodontal conditions
have been the subject of debate [41–45]. Based on the existing literature, it seems that attached
keratinized gingiva is beneficial in patients with deficient oral hygiene. In contrast, patients with
adequate personal- and professional-administered oral hygiene measures do not benefit from attached
keratinized gingiva. In fact, movable mucosa facilitates the penetration of biofilm into the crevice,
which would trigger the activation of neutrophils and lymphocytes [43]. Hence, in patients not
adhering to adequate hygiene, the presence of keratinized attached gingiva might play a pivotal role
in the prevention of the disease, in particular in the presence of subgingival restorations.
The influence of keratinized mucosa around dental implants has not been without controversy
(Table 2). Early findings indicated that a lack of keratinized mucosa was not associated with less
favorable peri-implant conditions [46]. More recent data have shown a wide band of keratinized
mucosa to favor improved scores referred to as plaque index, modified gingival index, mucosal
recession, and attachment loss [47]. Likewise, it has been demonstrated that the presence of keratinized
mucosa around dental implants has a positive impact upon the immunological features, with a negative
correlation to prostaglandin E2 levels [48]. This is due in part to a reduced inflammatory condition as a
consequence of less discomfort during personal-administered oral hygiene. In fact, two recent clinical
studies have shown the presence of ≥2 mm of keratinized mucosa to be crucial for the prevention of
peri-implant diseases in erratic maintenance compliers [49] (Figure 3; Figure 4).
Figure 3. Comparative plot showing the clinical and radiographic differences between <2 mm versus
≥2 mm of peri-implant keratinized mucosa in erratic maintenance compliers [49]. Note: * stand for
the outliers
 
Figure 4. Representative case of an erratic maintenance complier with inadequate
personal-administered oral hygiene presenting with healthy clinical and radiographic peri-implant
conditions in the presence of 2 mm of keratinized and attached mucosa.
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Thus, a lack of keratinized mucosa in patients with inadequate oral hygiene could be regarded
as a predisposing factor for peri-implant diseases, since it is associated with more recession, less
vestibular depth, and more plaque accumulation, which, in turn, may be predisposing to inflammation
(i.e., peri-implantitis).
5.2. Surgical Predisposing Factors
5.2.1. Significance of Implant Malpositioning as an Iatrogenic Factor: Critical Bone Dimensions
In the 2017 World Workshop on the classification of Periodontal and Peri-Implant Diseases and
Conditions, implant malpositioning was suggested to be a predisposing factor for peri-implantitis
due to the limited access for adequate oral hygiene often associated with these implant-supported
restorations. If fact, a retrospective study associated implant malpositioning (OR = 48), occlusal
overload (OR = 18.7), prosthetic problems (OR = 3.7), and bone grafting procedures (OR = 2.4)
with peri-implantitis [54]. An early survey of cases reported in the literature as corresponding to
peri-implantitis, following evaluation by a group of independent experts in the field, agreed that >40%
of the implants diagnosed with peri-implantitis presented with a too-buccal position, with perfect
interexaminer agreement (k = 0.81) [55]. This is in contrast to a four-year clinical study which found
implants with residual buccal dehiscence defects to be more prone to develop peri-implantitis [56].
A comprehensive understanding of bone biology is crucial to conceive implant positioning,
in particular, too-buccal positioning, as a predisposing factor for peri-implantitis. In a healed ridge,
the alveolar process is composed of cortical bone at the outer side, while cancellous bone is featured
in the inner structure. The cortical bone receives a blood supply branched from the outside through
blood vessels of the periosteal surface, and from the inside from the endosteum [57]. When an implant
is inserted with an open-flap procedure, elevation of the periosteum eliminates the periosteal blood
supply from the outside. The same process occurs from the inside, since insertion of the implant
interrupts the endosteal blood supply. This phenomenon of avascular necrosis is well known in bone
biology [58] (Figure 5). A recent study has demonstrated that the critical buccal bone thickness for
preventing marked physiological buccal–lingual bone resorption is 1.5 mm. In the absence of this
thickness, more pronounced peri-implantitis may occur as a consequence of the microrough surface
exposed to the oral cavity-facilitating surface contamination and the chronification of peri-implant
infection [59] (Figure 6).
Likewise, apico-coronal implant positioning might dictate the long-term stability of the
peri-implant tissues (Figure 7). Based on the hypothesis that too-apical implant positioning may
favor the establishment of a microbial anaerobic environment, it is advised that implants be placed
within the apico-coronal safety threshold. A recent retrospective analysis has validated this idea.
Kumar et al., in nonsplinted single implants in function for at least five years, demonstrated that
implant placement at a depth of ≥6 mm from the cementoenamel junction of the adjacent teeth
is more commonly associated with peri-implantitis (OR = 8.5) [60]. Similarly, it should be noted
that other factors could increase bone loss in these scenarios such as the type of implant–abutment
connection (external vs internal vs conical) [61], number of abutment connection/disconnection [62],
or the increased difficulty in removing cement remnants in case of cemented restorations [63].
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Figure 5. A critical buccal bone thickness of 1.5 mm is essential for preventing excessive physiological
and pathological bone loss as a consequence of early avascular necrosis leading to peri-implant bone
loss and thus to an increased risk of surface contamination.
 
Figure 6. Histological analysis with fluorescent dyes illustrating excessive bone loss as a consequence of
ligature-induced peri-implantitis. Note that the lack of fluorescence on the buccal side demonstrates the
severe vertical bone resorption that occurs after physiological bone remodeling due to the insufficient
critical buccal bone thickness (<1.5 mm).
   
Figure 7. Inadequate apico-coronal implant positioning may favor the establishment of a microbial
anaerobic environment that can be predisposing to progressive pathological peri-implant bone loss.
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The mesiodistal implant position could be regarded as a predisposing factor for peri-implant bone
loss, leading to peri-implantitis due to two main factors: (1) inadequate access for performing correct
oral hygiene; and (2) excessive physiological bone remodeling if no safety distance is ensured between
two adjacent dental implants or one implant with the adjoining dentition (Figure 8). Classically,
the recommendation was to leave 3 mm between dental implants [64]. Even though this is no longer
applicable to current implant dentistry due to advances in implant–abutment designs, a safety distance
must be observed in order to avoid avascular necrosis of the interimplant cortical bone, with sufficient
space to favor adequate personal oral hygiene.
   
Figure 8. Incorrect implant positioning predisposes dental implants to peri-implant diseases due to the
inability to perform correct oral hygiene.
5.2.2. Implant Insertion Torque and Its Interplay with the Hard Tissue Substratum
Implant placement in low-density bone can prove challenging. Thus, in order to ensure adequate
primary stability and reduce early osseointegration implant failures, adaptation of the drilling protocol
to the bone features has been recommended [65]. In fact, modifications in implant macrodesign, the use
of osteotome condenser drills, and underpreparation of the implant socket may increase primary
stability and osseointegration [65]. It is important to note that the connections between the trabecular
mesh give cancellous bone the capacity to bear loads [66]; atraumatic surgical procedures therefore
minimize the risk of bone loss. Thus, the use of drills to condense and densify trabecular bone might
disrupt the connectivity of the trabecular network, reduce the capacity of bone to transmit occlusal
forces, and result in weak bone that might not guarantee secondary stability due to higher bone
turnover [66]. In fact, excessive compression of peri-implant bone by using osteotomes or increased
torque may lead to 22–50% more crestal bone loss than conventional implantation [67,68] and also to a
41% reduction in the amount of bone-to-implant contact [69]. Such mechanical devices may damage the
canalicular network of the trabecular bone, leading to a change in fluid flow mechanisms, impairment
of mechanical stimulation, and delayed new bone formation [69]. Similar undesirable effects may be
caused by excessive torque [70], leading to bone compression and delaying bone healing [71] (Figure 9).
Areas with minimal bone-to-implant contact and therefore low strain seem to promote faster osteoblast
differentiation [66,71,72]. During the first weeks, bone in contact areas around the implant threading is
reabsorbed, and bone formation occurs earlier in contact-free areas [73].
The assessment of bone architecture is also relevant for implant drilling [74]. Larger
osteocyte necrosis areas were found in trabecular bone versus cortical bone (550 versus 1400 μm,
respectively) [65]. A similar increase in osteocyte damaged area was found when drilling speed was
raised from 500 to 1500 rpm (600 versus 1400 μm, respectively) [65]. When using a 1.6 mm drill,
a distance of 1050 μm of bone damage from the osteotomy center is expected, whereas the distance is
about 1400 μm if a 5 mm drill is used [74]. The larger the drill diameter, the greater the tangential speed
and centrifugal force, and therefore also the drilling power and energy transmitted to the bone. Lower
values of early bone area formation around 5 mm implants versus 3.75 mm implants were found,
and the use of large-diameter drills may be one of the underlying reasons [75]. Recently, simplified
protocols have been proposed to reduce drilling time. Some authors reported no detrimental effects
upon bone formation [75], but less bone formation was found in early stages in other studies [76].
It is important to note that simplified protocols might increase bone compression [76]. Moreover,
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the drill torque energy applied to the bone increases as the diameters of two consecutive drills increase.
This fact might elevate the bone temperature and consequently the area of bone damage [65]. Further,
other approaches, such as ultrasonic site preparation, have evidenced better preservation of the bone
microarchitecture, resulting in a faster healing response [77].
  
Figure 9. Implant removed four months after placement in the mandible. Note that the implant
macrodesign, together with a highly corticalized bone structure, have induced excessive bone loss
extending on the coronal portion of the implant and creating bone necrosis on the apical part. The severe
bone resorption in the coronal area might have been predisposing to peri-implantitis as a biological
complication if the implant had not been removed.
5.3. Significance of Prosthetic Design
Assuming the role of biofilm and its bacterial byproducts in the onset and progression of
peri-implantitis, it is conceivable that retentive prosthetic components may promote inflammation
(Figure 10). In this regard, Serino and Strom demonstrated that regardless of adequate oral hygiene of
the natural dentition in partially edentulous patients, prosthetic design plays a major role in plaque
accumulation around implant-supported prostheses. The authors found that adequate oral hygiene
could not be performed in 53 out of 58 implants, and that peri-implantitis therefore could be attributed
to deficient access for personal oral hygiene [78]. This is a typical scenario in hybrid prostheses, where
esthetic requirements are satisfied but long-term implant maintenance is jeopardized owing to poor
access for oral hygiene. Similarly, bone-level, implant-supported single crowns with an emergence
angle of over 30 degrees and a convex profile have been shown to be factors strongly associated
with peri-implantitis. This was not consistent with the findings in tissue-level implants [79]. Hence,
convexities and marked emergence profiles should be avoided in the design of single crowns. In any
case, patients should be comprehensively instructed to use interproximal brushes to remove food
debris or plaque within the implant surroundings [2].
  
Figure 10. A hybrid prosthesis does not facilitate adequate oral hygiene and favors plaque retention,
thereby triggering peri-implantitis.
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Into the bargain, conceiving that excessive early bone resorption is often associated with greater
late bone loss [26], prosthetic factors associated with minimal physiological bone loss should be
noted. In this sense, longer transmucosal abutments (>2 mm) [80] and internal connection (including
platform-switching [81] and Morse cone connections [82]) have demonstrated efficient preservation of
the peri-implant hard tissue levels.
6. Local Precipitant Factors
The literature describes a few factors (so-called precipitant factors) associated with the triggering
of inflammation within the peri-implant sulcus.
6.1. Residual Submucosal Cement
While screw-retained restorations do not necessarily outperform cement-retained prostheses,
the presence of residual cement has been shown to have a deleterious effect upon the peri-implant
tissues. Wilson et al. demonstrated the triggering role of residual cement, since 81% of the cases
developed peri-implantitis, with spontaneous resolution in 74% following mechanical removal of
the excess cement [63]. Likewise, Linkevicius et al. demonstrated the effect of residual cement upon
peri-implant tissue response. In this scenario, 85% of the cases developed peri-implant disease [83].
Similar findings were obtained by Korsch et al. in a later study affording further insight into the effect of
cement type upon the development of pathological complications. It was seen that while methacrylate
cement was present in 62% of the suprastructures, zinc oxide eugenol cement could not be detected [84].
As a matter of fact, it was seen that the clinical and radiographic peri-implant conditions were generally
unfavorable for implant-retained suprastructures using methacrylate cement, irrespective of cement
excess [84]. In view of the significance of the presence of residual cement upon peri-implant tissue
stability, it is advisable to use radiopaque cement if needed, with the aim of promptly detecting and
removing it.
6.2. Residual Dental Floss
The remnants of floss in the peri-implant sulcus have also been regarded as a triggering factor
for peri-implantitis. Van Velzen et al. reported 10 cases with progressive peri-implantitis related
to floss remnants. Interestingly, in 90% of the cases, the inflammation resolved spontaneously after
mechanical removal of the floss remnants [85]. Thus, caution is required when providing personal oral
hygiene instructions involving the use of floss, and patients should be further encouraged to employ
interproximal brushes.
7. Local Accelerating Factors: Influence of Surface Topography upon Progressive Bone Loss
In the course of the evolution of implant dentistry, advances in the form of implant surface
modifications have led to stronger bone responses and higher implant survival rates [86]. Associations
have been reported between significantly greater crestal bone loss and different implant surfaces and
topographic features [86]. Furthermore, it has been suggested that surface roughness might have
some role in the incidence of peri-implantitis [87] (Figure 11). In contrast, other authors consider
that there are no available data confirming an association between implant surface features and
the initiation of peri-implantitis or the progression of established peri-implantitis [88]. Ligature
animal models have shown an increased risk of peri-implantitis with SLA implants in comparison to
machined implants [89], and with TiUnite implants in comparison to machined, SLA, and TiOblast
implants [31,90,91]. Similarly, another preclinical study noted significantly greater intrasurgical defect
depths, defect widths, probing depths, and radiographic bone loss with TiUnite implants than with
Straumann SLA or Biomet T3 implants [92]. Other factors apart from surface features might be relevant
in the initial phase; for example, the invaginating grooves and pits on the TiUnite surface might favor
bacterial adhesion and protect bacteria from shear forces [92]. Interestingly, a recent systematic review
failed to find a long-term association between different surface modifications. Hence, these data in
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humans suggest that it is possible to achieve very good long-term results with all types of moderately
rough implant surfaces [93].
 
Figure 11. Moderately rough topographic characteristics (RA~1.3 μm) may induce chronification
of the inflammatory condition by harboring pathogenic bacteria. This, in turn, may influence the
therapeutic outcome. Note the scanning electron microscopic features of the implant surface under
high magnification.
Furthermore, the management of established peri-implantitis is possible after surgical treatment,
but the therapeutic outcome is also influenced by the implant surface characteristics [90]. In a
randomized clinical trial on the effect of adjunctive systemic and local antimicrobial therapy in patients
with peri-implantitis, treatment success was reported in 79% of the implants with nonmodified
surface features, but in only 34% of the implants with modified surfaces [94]. Similarly, a three-year
randomized controlled trial found the surgical treatment of peri-implantitis to be effective, with stable
peri-implant marginal bone levels, but here again the nonmodified surfaces yielded significantly better
results [95].
Depending on the surface modification methods used, some remnants may persist on the surface
and have deleterious effects upon the clinical performance of the implant [87]. These particles and
others released from the surface as a result of corrosion and mechanical wear may have cytotoxic effects
and stimulate inflammatory reactions [8], leading to osteoclast activation and further peri-implant bone
loss. Likewise, it has been recently evidenced that titanium particles derived from implants containing
phosphate-enriched titanium oxide, fluoride-modified, and grit-blasted (GB) surface treatments are
able to activate CHK2 and trigger the recruitment of BRCA1 in oral epithelial cells. These are markers
for detecting activation of the DNA damage response. Accordingly, it can be inferred that titanium
particles released into a surgical wound may contribute to the disruption of epithelial homeostasis,
and potentially compromise the oral epithelial barrier [96].
8. Other Perspectives to Conceive Peri-Implantitis
Different perspectives to understand peri-implantitis have been further proposed. As such, it has
been advocated that peri-implant marginal bone loss might be related to a change in the foreign body
equilibrium between the host immune system and the implant device [97]. The biological behavior
of the bone cells is mediated by the interaction among immune cells (neutrophils, macrophages,
and lymphocytes) and the dental implant (or any kind of foreign body). Briefly, one of the very
first interplays around the foreign body is carried out by neutrophils for 24–48 h [98]. The insertion
of a dental implant induces a status of hypoxia in the surrounding bone that leads to neutrophil
accumulation in order to promote angiogenesis. Also, neutrophil cells may discharge proteolytic
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enzymes and reactive oxygen species during their function that can erode the implant surface and
release metal particles to the tissues [99]. After 48 h, the population of macrophages is higher around
the foreign body and these cells may lead the evolution of the immune response. In fact, these cells
promote osteoclastogenesis, matrix deposition, and bone anabolism [100], whereas macrophages’
absence might impair osteoblast viability and bone formation [101,102]. Neutrophil apoptosis is
mediated by macrophages during the shift between inflammatory phase to the healing phase. Also,
the polarization between macrophages M1 to M2 and the length of each phase may have clinical
effects, thereby an extended M1 phase may lead to a fibrous encapsulation of the fixture and implant
failure [103]. On the contrary, higher presence of M2 macrophages has been reported on commercial
pure implants [99,104], leading to bone deposition on the surface to isolate the fixture from the
surrounding bone.
In addition, macrophages can differentiate into osteoclasts during bone remodeling and
have phagocytosis capabilities until 5 μm of particle size [98]. Under presence of larger particles,
macrophages tend to fuse to become foreign body giant cells (FBGCs). FBGCs are more frequent
around the implant interface [105] than around healthy tissues and this fact might indicate the presence
of a foreign body reaction around the dental fixture or the allogenic material.
Hence, under this concept of foreign body reaction, osseointegration is a mild chronic
inflammatory and immunologically driven response where the bone–implant interface remains in
a state of equilibrium but susceptible to changes in the environment [7,106]. Macrophages, FBGCs,
and others approach this new bone barrier and if any disturbing factor occurs, a reactivation of the
immuno-inflammatory cells against the foreign body material takes place. The loss of the foreign body
equilibrium may thus stand as one of the reasons for this peri-implant bone loss [98].
9. Conclusions
Site-specific diseases are often attributable to local predisposing factors. In the case of
plaque-associated peri-implantitis, local contributors, including surgical and prosthetic factors, as well
as soft and hard tissue characteristics, may be predisposing factors to biofilm adherence around dental
implants, thus leading to inflammation. Moreover, two major precipitant or triggering factors can be
identified: residual cement and residual floss. In addition, current evidence seems to suggest that
certain surface topographies can further accelerate the process of peri-implantitis.
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Osseointegration of oral implants was initially discovered by Brånemark. The time for his
discovery has incorrectly been said to have been during the 1950s [1,2], but in reality, the year was
1962 [3]. Brånemark operated the first patient with oral implants in 1965, only three years after his
discovery. Osseointegration has meant a breakthrough for clinical results in oral and craniofacial
implants [4,5] and has been applied, if in relatively small numbers, for anchorage of orthopedic
implants in amputees [6]. The original definition of the term implied a direct contact, at the light
microscopic level of resolution, between bone tissue and load-bearing implants [7,8]. Hip and knee
arthroplasties do not present a direct bone anchorage, but instead display distance osteogenesis [9],
probably due to the substantial clinical trauma at insertion. Nevertheless, clinical results of orthopedic
implants have remained quite good, with 88% of operated hip replacements still in situ 25 years after
surgery [10].
In 1985, I started seeing a researcher who later became a good friend. “Tomas” said this man to
me in German, you must realize that osseointegration is but a “fremderkörperreaktion”—a foreign
body reaction. It took me too many years to realize that this researcher, the now late Karl Donath of
Hamburg University, was right [11,12]. Karl Donath was a pioneer. As happens to many pioneers his
work was forgotten when later American colleagues started discussing implants as foreign bodies well
into our new millennium and Donaths’ papers published 15–20 years earlier were not even quoted.
What is then an oral implant? Some colleagues of ours saw the implant as being the same as
the tooth it was replacing, exemplified in this volume in the paper by Monje and co-workers [13].
In fact, such a coupling between the tooth and the implant once lead to the assumption that since
teeth display a disease entitled periodontitis, then implants will display a similar disease that was
named peri-implantitis. The original reason for the alleged disease was bacterial attack, even if, at
least in the case of tooth disease, hereditary factors were also acknowledged. This is the background
to seeing marginal bone loss around oral implants as solely a disease phenomenon. This outlook
stands in clear contrast to orthopedic implants. In orthopedics marginal bone loss may be seen in a
pattern similar to an oral implant. However, the reason for marginal bone loss in a hip arthroplasty
is assumed to depend on a condition named aseptic loosening, i.e., something quite in contrast to
what is believed with respect to oral implants. Aseptic loosening has in recent studies, one of them
included in this volume [14], been shown to depend on immunological reactions. As summarized
by Harris [15], massive immune reactions triggering osteoclasts may lead to bone resorption around
hip arthroplasties.
It would in fact seem very easy to conclude that the pathology of an oral implant is as little related
to a tooth as is pathology of a hip arthroplasty to a normally functioning, pristine hip joint [16]. What
then is behind the different opinion displayed by some dental colleagues? To my dismay, I must
profess to clear guilt of the pioneering team of osseointegration of which I once was a member. When
we worked to find out why we had seen oral implant success in clear contrast to all others who at
the time had tried placing foreign devices in the oral cavity, we had several explanations. Among
those were using minimal surgical trauma and commercially pure titanium implants that we at the
time saw as being quite inert biologically, and presenting a simple wound healing phenomenon when
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placed in bone tissue [8,17]. Today we are aware of our misinterpretations. Trindade et al. [18,19]
published two papers in this volume with evidence that titanium is not at all inert; the material causes
clearly observable immune reactions in the tissue. Other biomaterials such as Poly-ether-ether-ketone,
covered by Han et al. [20] in this volume, displayed significantly greater immune reactions than did
titanium [19].
Another set of studies believed to prove that the presence of bacteria was the primary cause of
problems with bone loss around implants relate to ligatures placed around experimental implants. One
paper in this volume [21], summarized 133 such papers that generally reported a primary bacterial
response to be behind the observed bone loss around the implants. However, in a ligature study
conducted in a site where bacteria are usually absent, the tibia of research animals, Reinedahl and
co-workers [22] reported of strong immunological reactions to the ligatures and subsequent marginal
bone loss. Again, it seemed that the primary adverse reaction was immunological in nature and that
bacteria were not needed for marginal bone loss which does not exclude a secondary bacterial action
once the immune system has overreacted [23].
No, oral implants are not the same as a tooth. Neither does the primary bacterial theory explain
why bone is lost around oral implants. We need a lot more research, such as several papers published
in this volume of Journal of Clinical Medicine, to learn more about the true background of threats
to osseointegration [24–26]. We must recognize that marginal bone loss commonly represents a
complication to treatment; i.e., a condition, and not a disease. In addition, we can rejoice by the fact that
moderately rough oral implant failure rates at 10 years of follow up are in the range of only 1–3% [27],
that we see quite good clinical outcomes over 30 years of follow up [28] and that oral implants in case
studies have been successfully followed up in excess of 50 years of clinical function [23].
Osseointegration is but an immunologically based reaction [29], representing demarcation of the
foreign object [12], but if the immune system runs berserk the oral implant may be rejected from the
body as a secondary response [12]. When the immune system in this manner overreacts and decides to
reject the implant, at the same time the bacterial defense will go down, which explains the secondary
presence of bacteria in failing implants [30].
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Abstract: The aim of the present study is to evaluate the expression of microRNA (miRNA)
in peri-implant soft tissue and to correlate epigenetic information with the clinical outcomes of
the implants up to the five-year follow-up. Seven patients have been rehabilitated with fixed
screw-retained bridges each supported by implants. Peri-implant bone resorption and soft tissue
health parameters have been recorded over time with a five-year follow-up. Mini-invasive samples
of soft peri-implant tissue have been taken three months after implant insertion. miRNA have been
extracted from cells of the soft tissue samples to evaluate gene-expression at the implant sites by
microarray analysis. The epigenomic data obtained by microarray technology has been statistically
analyzed by dedicated software and compared with measured clinical parameters. Specific miRNA
expression profiles predictive of specific clinical outcomes were found. In particular, some specific
miRNA signatures appeared to be “protective” from bone resorption despite the presence of plaque
accumulation. miRNA may be predictors of dental implant clinical outcomes and may be used as
biomarkers for diagnostic and prognostic purposes in the field of implant dentistry.
Keywords: dental implants; micro-RNA; microarray; predictive biomarker; epigenomics
1. Introduction
Currently dental implants are widely used for fixed rehabilitation of partially or completely
edentulous patients and demonstrate predictable outcomes. However, the biological mechanisms
of possible complications and implant failure are not clear and are debated in the dental
scientific community.
In particular, the specific endogenous characteristic of the host (i.e., individual susceptibility)
may strongly affect the success of the rehabilitation. Modern innovative technologies using molecular
biomarkers may help in identifying individual susceptibility.
In a previous paper [1] we provided evidence that microRNA (miRNA) expression in peri-implant
tissue reflects the pathological processes occurring in peri-implant tissues.
miRNAs are small noncoding RNAs (ncRNAs) of approximately 22 nucleotides responsible for
specific regulation of gene expression in a post-transcriptional manner. They are the main regulator
of gene transcription and bear relevance in predicting clinical outcomes. Indeed, only less than 5%
of expressed genes producing messenger RNA is really translated into proteins while microRNAs
are fully functionally active in cell cytoplasm [2]. They have an important role in several biological
processes, such as development, cell proliferation, apoptosis and carcinogenesis [3,4].
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A major problem is currently represented by the lack of a predictive marker to personalize risk
after peri-implant surgery. Indeed, some authors have suggested peri-implant soft tissue biotype as a
risk indicator of peri-implants tissue disease [5,6]. However, this biomarker is rough and does not
reflect the multiple pathogenic mechanisms occurring in the peri-implant tissue hampering or favoring
the outcome of implant surgery. Conversely the accurate classification of patients in high or low-risk
categories is fundamental to set up follow-up procedures and therapies according to the real risk of
each subject. This is a pivotal step in the era of personalized medicine.
Molecular biomarkers are already extensively used in medicine to accurately classify each patient
according to their real risk of developing complications. This approach, referred to as personalized or
“theranostic” medicine, has been already well developed in oncology but is still under development in
dental science.
Molecular predictive biomarkers should reflect the pathogenic process modulating clinical
outcome in the target tissue of the diseases. Furthermore, the molecular alteration investigated may
occur years before the appearance of the related clinical consequence thus opening the possibility of
preventing adverse clinical outcomes before their onset.
At this regard, miRNAs are currently identified as predictive biomarkers for degenerative diseases,
because they do not undergo a post-transcriptional selection, being themselves the controllers of gene
transcription. Consequently, compared to genomic or transcriptomic biomarkers, miRNA expression
has by far a higher probability of being related with clinical variables representing a new tool for
predictive medicine.
On the other side, several factors, including the implant surface [7], might affect dental implant
success possibly through miRNA expression. Our research group demonstrated in vitro that osteoblasts
change their gene expression profile according to the type of implant surface in contact with them [8].
The role of miRNA in implant dentistry has been established. In a clinical trial, we demonstrated
that miRNA expressed by peri-implant tissues are related with the clinical outcome [2]. However, it
remains to be established the long-term predictivity of miRNA analysis in a long-term follow-up study.
The aim of the present study is to examine the predictivity of miRNA profiling to categorize
patients according to risk categories of developing more or less probably adverse consequences of oral
implants on a long-term basis.
In particular, the expression of micro-RNA (miRNA) in peri-implant soft tissue will be correlated
with the clinical outcomes of dental implants recorded up to the five-year follow-up.
2. Experimental Section
Between January 2013 and July 2014, 7 patients (4 women, 3 men; mean age: 64.6, range:
52–76) who were referred to the Division of Implant and Prosthetic Dentistry of the Surgical Sciences
Department (DISC) of the University of Genoa (Genoa, Italy) and that required the insertion of
two implants into an edentulous area were recruited if they met the following criteria: desire to be
treated with fixed prostheses supported by dental implants and good general health without any
contraindications for undergoing oral surgery and the related prosthodontic protocols.
Exclusion criteria included: an uncontrolled medical condition such as diabetes mellitus, immune
suppression, intravenous bisphosphonate medication, oro-facial cancer, chemotherapy or head and
neck radiotherapy, infarct during the preceding 6 months, heavy smokers (≥20 cigarettes/day).
Healing time since tooth extraction in the intended implant sites had to be longer than 1 year.
Post-extractive implants and implant sites that required a bone graft were excluded.
The present report was conducted in accordance with the Helsinki Declaration and was approved
by the local Scientific Ethical Committee of the University of Genoa.
Patients were instructed in detail on the planned clinical procedure and signed an informed
consent before being scheduled in the experimental protocol.
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Each patient of the sample received two adjacent implants: Osseotite implants (Biomet 3i,
Palmbeach Gardens, FL) with a dual acid-etched (DAE) surface in the apical portion and a machined
coronal part (hybrid implants), and Full Osseotite implants (Biomet 3i) completely DAE (DAE implants).
All the implants had identical macro- and micro-structure, external hexagon connection, a 4 mm
diameter, a 10–13 mm length (depending on available bone).
Implants were placed with a single-stage delayed loading approach and were assigned specific
codes for blinding.
The healing abutments remained in situ up to the 4-month follow-up appointment when
impressions of the implants were taken to fabricate the fixed prostheses. No bone nor soft tissue
grafting procedures were performed at the implant sites.
Patients were accurately instructed on the hygienic procedures to be followed and were prescribed
adequate dietary guidelines in order to ensure optimal recovery.
Screw-retained prostheses, provided with a metal framework and composite resin veneering
material, were delivered 5–6 months (mean 24 weeks) after surgery (Figure 1).
 
Figure 1. One of the patients included in the present research: (a) intraoral view of the bridge at the
five-year follow-up appointment; (b) occlusal view of the bridge at the five-year follow-up appointment;
(c) endoral radiograph three months after implant insertion; (d) endoral radiograph taken at the
five-year follow-up appointment.
Spontaneous bleeding, probing depth (PD), bleeding on probing (BoP), plaque index (PI), and
suppuration were recorded at 3 and 6 weeks and at 3-, 6- and 12-months post-surgery and then at the
five-year follow-up appointment. At the five-year appointment the fixed prostheses were unscrewed
in order to record the parodontal parameters. PD was recorded in four points for each implant (mesial,
distal, buccal and lingual) using a non-metallic probe. BoP was simultaneously evaluated in four
points for each implant (values from 0 to 4 for each implant). PI was measured at four points for each
implant using an erythrosine gel (values from 0 to 4 for each implant).
Technical and biological complications were also recorded.
Intraoral radiographs were taken at the time of implant placement and at 3-, 6- and 12-months
post-surgery and then at the five-year follow-up appointment. The implant–abutment interface was
used as the reference point for interproximal bone level measurements over time. Bone resorption (BR)
over the duration of the study was assessed from these reference points to the most coronal bone at the
mesial and distal aspects of each implant.
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The above-mentioned clinical parameters recorded at the five-year follow-up appointment were
statistically analyzed and differences between DAE and hybrid implants were evaluated by Student’s
t-test.
After 3 months from surgery, a sample of soft tissue containing both epithelium and connective
tissue was collected: a mini-invasive sample of soft tissue (diameter < 3 mm) surrounding each implant
was taken using a surgical blade to be histologically analyzed by miRNA microarray at the Department
of Health Sciences (DISSAL) of Genoa University.
MicroRNA microarray analysis is an innovative technology, which allows the evaluations of
thousands of genes in a single experiment. MicroRNAs (miRNA) have been extracted from cells of the
soft tissue samples to evaluate gene-expression at the implant sites by microarray analysis.
miRNA expression data was evaluated in the peri-implant tissue as previously reported [1]. The
expression of 1928 human miRNA was determined by using a commercially available microarray
(miRCURY LNATM, Exiqon, Vedbaek, Denmark).
The results of miRNA microarray have been compared with clinical parameters measured over
time for five years since miRNA analysis. The previously published paper reported correlation between
miRNA data and one-year outcomes (T0). The present paper reports the correlation between miRNA
data and clinical outcomes recorded at the five-year follow-up appointment (T1).
All clinical continuous variables recorded at the five-year follow-up have been turned into
categorical ones depending on the following criteria arbitrarily chosen by the authors:
• mean bone resorption (BR): normal/increased (normal ≤ 1 mm, increased > 1 mm)
• mean probing depth (PD): normal/increased (normal ≤ 3 mm, increased > 3 mm)
• mean plaque index (PI): low/high (low ≤ 1, high > 1)
• mean bleeding on probing (BOP): yes/no (yes ≥ 0.5, no < 0.5)
On the base of these parameters, several categories of implants (i.e., implants with normal BR vs.
implants with increased BR) have been determined.
In addition, implants with the contemporary presence of BOP, altered PD and bone resorption
were considered affected by peri-implantitis (PITI).
Implant sites were also divided in two categories according to the periodontal biotype: thin (TH)
and thick (TK). To evaluate the biotype, a periodontal probe was placed into the facial aspect of the
peri-implant mucosa. The peri-implant biotype was categorized as thin if the outline of the underlying
periodontal probe could be seen through the gingiva and thick if the probe could not be seen [9].
Relationship between miRNA and clinical events were tested by Genespring software (Agilent
technologies, Palo Alto, CA, USA).
3. Results
During the five-year follow-up, there were no dropouts and all the patients attended the five-year
recall appointment. No implant failure occurred resulting in an implant cumulative survival rate (CSR)
of 100%. No technical complications were detected, resulting in a prosthodontic CSR of 100%. All the
patients anecdotally reported to be satisfied with their implant rehabilitation.
Five patients presented a thin periodontal biotype and two a thick periodontal biotype.
Mean bone resorption at the five-year follow-up appointment was 1.98 mm (min: 0.7, max: 4 mm):
1.8 mm and 2.2 mm for implants with a machined coronal portion and DAE implants respectively.
No patient presented spontaneous bleeding or suppuration.
No statistically significant differences were found between hybrid implants and DAE implants for
the clinical variables recorded at the five-year follow-up.
Mean and median values of the other soft tissue health parameters are reported in Table 1.
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Mean 1.98 2.9 2.1 3.7
Median 2 3 2 4
Min 0.7 0 0 1
Max 4 4 4 6.5
P for DAE vs.
hybrid implants 0.1466 0.8641 0.5817 0.6215
An overall view of the miRNA alterations as related to clinical outcomes occurring in the five
years after surgery was performed using scatter plot (Figure 2) and volcano plot analyses (Figure 3).
 
Figure 2. Scatter plot analyses reporting the alteration of microRNA (miRNA) profile as related
to the outcome of the following clinical variables recorded at the five-year follow-up appointment:
(a) bone resorption (BR), (b) peri-implant probing depth (PPD), (c) bleeding on probing (BOP),
(d) peri-implantits (PITI).
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Figure 3. Volcano plot analyses reporting the number of significantly (<2-fold, p < 0.05) altered
miRNAs as related to the outcome of the following clinical variables recorded at the five-year follow-up
appointment: BR, PPD, BOP, PITI.
For each clinical variable, the predictor miRNAs were identified by volcano plot analysis (Table 2).
Table 2. Identity of miRNAs predictor of five-year clinical outcomes of dental implants.
Clinical Variable Predicted miRNA
Bone Resorption (BR) miR-33, miR-134, miR-200, miR-378
Bleeding on probing (BOP) let-7f miR-425, miR-548
Peri-implant pocket depth (PPD) miR-30, miR-197, miR-218, miR-548, miR-613
Perimplantitis (PITI) miR-517, miR-525, miR-624, miR-3128, miR-3658,miR-3692, miR-3912, miR-3920, miR-4683, miR-4690
BR: 48 miRNA were significantly (Figure 3) dysregulated at T0 in patients with altered BR (altered)
as compared to those with normal BR (normal) in the five years following implant surgery. Venn
diagram analyses indicated that in these patients among the miRNAs altered at T0, four were predictors
of BR in the following five years. These miRNAs are miR-33, miR-134, miR-200 and miR-378 (Table 2).
They play a regulatory role in cell proliferation, stem cell recruitment and differentiation, osteogenesis
and inflammation.
Hierarchical cluster analyses were used to classify patients according to their miRNA expression
profile as related to BR in the five years following implant surgery. Implants with a normal miRNA
expression level (yellow, red) are located in the left part of the cluster, while implants with a decreased
miRNA expression (blue) are located in the right part of the cluster. A severe alteration of miRNA
expression at three months occurs in patients with BR ≥ 2 mm at the five-year follow-up appointment
(Figure 4a). These findings were confirmed by unsupervised principal component analysis of variance
(PCA) of miRNA expression profile for each implant. Indeed, all implants that had a BR ≥ 2 mm in the
five years after surgery were located in a different quadrant as compared to other implants (Figure 4b).
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Figure 4. Hierarchical cluster (a) and principal component analysis of variance (b) analyses showing
the occurrence of miRNA alteration in implants with BR > 2 mm.
PD: 29 miRNA were significantly (Figure 3, volcano plot) altered at T0 in patients with PD increase
(increased) as compared to those having normal PD (normal) in the five years following implant surgery.
Venn diagram analyses indicated that among the 10 miRNA altered in these implants at T0 (see data
reported in Menini et al. [1] first year after surgery) five were predictors of PD increase in the following
five years. These miRNAs are miR-30, miR-197, miR-218, miR-548 and miR-613 (Table 2). They play a
regulatory role in the following biological functions: osteogenesis and cartilage homeostasis.
BOP: 66 miRNA were significantly (Figure 3, volcano plot) altered at T0 in patients with BOP
(yes) as compared to those without BOP (no) at five years following implant surgery. Venn diagram
analyses indicated that among the six miRNA altered in these patients at T0 (see data reported in
Menini et al. [1] first year after surgery) three were predictors of BOP increase in the following five
years. These miRNAs are let-7f, miR-425 and miR-548 (Table 2). They play a regulatory role in the
following biological function: inflammation.
PITI: 10 miRNA were significantly (Figure 3, volcano plot) altered at T0 in patients having PITI
(yes) as compared to those not having PITI (no) at five years following implant surgery. This condition
was not evaluated at T0 (at the one-year follow-up appointment only two implants in one single
patient presented PITI). These miRNAs are miR-517, miR-525, miR-624, miR-3128, miR-3658, miR-3692,
miR-3912, miR-3920, miR-4683 and miR-4690 (Table 2). They play a regulatory role in the following
biological functions: inflammation, cellular proliferation and cartilage homeostasis.
The number of altered miRNAs as related to BR, peri-implant probing depth (PD) and BOP
recorded at the five-year follow-up was dramatically increased (T1) as compared to T0 (Table 3). These
findings reflect the progressive recruitment of new pathogenic mechanisms during the progression of
the diseases.
Table 3. Number of altered miRNAs as related to BR, PD and BOP recorded at the one-year (T0) and at
the five-year follow-up (T1).
BR PD BOP
T0 7 10 6
T1 48 29 66
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The efficacy of miRNA as biomarkers predicting clinical outcome was compared with those of
periodontal biotype classified for each patient as thick (low-risk) or thin (high-risk). The ability of
periodontal biotype to predict the clinical outcome of dental implants in the following five years was
tested by chi square analysis (Figure 5). Of the patients with a thick biotype 33% underwent PITI,
while none of the patients with a thin biotype underwent PITI. These differences were not significantly
different (chi square = 2.727; chi square p-value = 0.0986; Fischer’s exact p-value = 0.2308). Conversely,
miRNA expression as focused on the cluster of PITI miRNA predictors (see Table 2 and Figure 6) was
able to predict PITI occurrence in all (100%) patients.
Figure 5. PITI occurrence as related to parodontal biotype.
 
Figure 6. Principal component analysis of variance showing differences in miRNA expression in
implants with or without PITI.
In fact, PCA of miRNA expression at T0 (Figure 6) distinguished between patients that would
develop PITI in the following five years (red dots) from those who would not develop PITI (yellow
dots) in a clear-cut manner, as highlighted by the lack of any overlap between the grouping circles. The
ability of miRNA profiling in predicting PITI was also statistically evaluated by k-nearest neighbors and
support vector machine algorithms. The sensitivity (percentage of patients with prediction) was 80%
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and 93% respectively; the specificity (percentage of patients with true prediction) was 100% and 93%
respectively. Accordingly, the accuracy of this test was >90% independently of the algorithm adopted.
The miRNA pattern was compared in patients undergoing plaque accumulation (high PI) between
those with or without BR. The aim of this approach was to identify miRNA protecting peri-implant
tissue from the adverse effect of plaque accumulation. Obtained results are reported in Figure 7.
 
Figure 7. Scatter plot (a) and volcano plot (b) analyses reporting the alteration of miRNA profile as
related to BR at the level of implants with high plaque index (PI).
Both scatter plot and volcano plot identified differences between these two groups of patients.
The miRNAs that protected peri-implant tissue from BR despite the presence of plaque deposits are
reported in Table 4.
Table 4. miRNA that were found to be “protective” from bone resorption despite the presence of plaque
deposits (high PI) and their fold variation. The fold change indicates the ratio of miRNA expression
intensity between the two categories of implants stratified according to differences in bone resorption
(increased vs. normal) next to implants with high PI.
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4. Discussion
miRNA are biomarkers of several diseases and in recent years, some studies have begun to focus
on the regulatory role of miRNAs in the inflammatory response [10,11].
miRNA are fundamental in controlling cell function and also influence osteoinductive pathways
and inflammation in several ways. On the other side, miRNA expression is influenced by many
factors and some authors have suggested that different implant surfaces may condition miRNA
expression [12,13].
However, studies investigating the role of miRNA in implant dentistry are still scarce. Some
in vitro studies are present [12,14] and studies focused on the differences of miRNA profiles between
periimplantitis and periodontitis [15].
A recent review [16] found only one clinical trial evaluating the role of miRNA expression in the
osseointegration of dental implants. This study was the investigation conducted by the present team
of authors [1] and the present paper reports follow-up data for the same patients’ samples.
Our previous study suggested that miRNAs play an important role in conditioning clinical
outcomes after implant insertion [1]. Specific miRNA profiles appeared to indicate lower susceptibility
to peri-implant tissue inflammation and bone resorption. These findings highlighted the remarkable
biological importance of miRNA expression in peri-implant tissue in determining the clinical outcome
of dental implant rehabilitations.
The present study with a five-year follow-up confirmed the potential role of miRNA in patients’
susceptibility to peri-implant disease and the potential role of miRNAs as predictors of clinical outcomes
of dental implants. In fact, miRNA expression at three months of healing was predictive of the clinical
variables recorded at five years of follow-up.
The miRNA mostly involved in the prediction of clinical outcomes was miR-548. Indeed, this
miRNA predicted PD and BOP (Table 2). This miRNA is an established regulator of the balance between
cell proliferation and apoptosis. This miRNA was found to be upregulated in patients undergoing these
adverse events; indeed this upregulation results in cell proliferation arrest and apoptosis activation,
two conditions fundamental in triggering degenerative diseases of the peri-implant tissue and to
hamper wound healing.
The definition and etiology of peri-implant disease are controversial [17]. In particular, a clear
link between plaque accumulation and bone loss has yet to be demonstrated [18,19]. The possible
etiological effect of plaque accumulation on peri-implant disease may be decreased or enhanced by
specific miRNAs.
Indeed, a specific miRNA expression profile was found in patients with normal BR at five years,
despite the presence of plaque accumulation ( 6,7 ), and miRNA expression analysis was far more accurate
than periodontal biotype in predicting PITI occurrence in the five years after implant surgery ( 5,6 ).
The present investigation shed light on possible biomarkers that may be predictable of dental
implants clinical outcomes. The variables that can compromise implant therapy are numerous
(systematic diseases, residual bone density and 3-D morphology, smoking, bruxism, regularity and
effectiveness of the follow-up etc.) and the miRNA can be considered a useful tool for only evaluating
the “predisposition” of the peri-implant tissues to a stable osseointegration process.
The integrated findings derived from clinical and laboratory analysis helped with understanding
the biological mechanisms affecting peri-implant tissue healing and maintenance. This will help
clinicians in the choice of a better treatment plan for a predictable success of dental implant
rehabilitations. In fact, specific miRNA expression profiles are predictive of specific clinical outcomes
in implant dentistry and may be used as diagnostic and prognostic tools, thus affecting therapeutic
strategies. These findings can be tools for a more personalized medicine approach in the treatment of
edentulous patients using dental implants.
Moreover, the possible identification of “protective” miRNA also discloses the possibility of
using miRNAs in future studies as therapeutic agents in implant dentistry. miRNAs might be used
218
J. Clin. Med. 2019, 8, 888
as possible drugs or coatings for implant surfaces, in order to improve healing and maintenance of
peri-implant tissues.
5. Conclusions
The results of the present clinical trial suggest that miRNA may be predictors of dental implants
clinical outcomes and may be used as biomarkers for diagnostic and prognostic purposes in the field
of implant dentistry.
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Abstract: Pocket probing depth (PPD) and bleeding on probing (BOP) measurements are useful
indices for the assessment of periodontal conditions. The same periodontal indices are commonly
recommended to evaluate the dental implant/tissue interface to identify sites with mucositis and
peri-implantitis, which, if not treated, are anticipated to lead to implant failure. The aim of the
present narrative review is to discuss the available literature on the effectiveness of probing at
dental implants for identification of peri-implant pathology. There is substantial clinical evidence
that PPD and BOP measurements are very poor indices of peri-implant tissue conditions and are
questionable surrogate endpoints for implant failure. On the contrary, the literature suggests that
frequent disturbance of the soft tissue barrier at implants may instead induce inflammation and bone
resorption. Moreover, over-diagnosis and subsequent unnecessary treatment may lead to iatrogenic
damage to the implant-tissue interface. Despite this, the recommendations from recent consensus
meetings are still promoting the use of probing at dental implants. For evaluation of implants, for
instance at annual check-ups, the present authors recommend a clinical examination that includes
(i) a visual inspection of the peri-implant tissues for the assessment of oral hygiene and the detection
of potential redness, swelling, (ii) palpation of the peri-implant tissues for assessment of the potential
presence of swelling, bleeding, suppuration. In addition, (iii) radiography is recommended for the
assessment of crestal bone level for comparison with previous radiographs to evaluate potential
progressive bone loss even if there is a need for more scientific evidence of the true value of the first
two clinical testing modes.
Keywords: dental implants; mucositis; peri-implantitis; diagnosis; over-treatment; iatrogenic damage
1. Introduction
The ultimate goals of the maintenance phase of implant treatment are to preserve the function
and the aesthetics of the rehabilitation as well as the stability /health of the peri-implant tissues for as
long as possible. From a research point of view, the goal is to monitor the treatment outcomes: implant
survival and success/failure. One evident problem is that the definitions of survival, success/failure
used in more recent publications do not necessarily reflect the patient/clinician perceived successful
maintenance of the function and aesthetics of the treatment. In other words, the definitions of disease,
which would motivate a clinical intervention to cure the disease, do not seem to reflect the clinical
reality. Thus, the first questions to be answered are “what should be considered pathology at a dental
implant?” and “what diagnostic tools are available?” With regards to the natural dentition, there
has been a wide agreement within the scientific community in relation to disease definitions and
available diagnostic tools [1]. Despite the recent World Consensus meeting in Chicago [1], a similar
consensus with regards to definition of pathologies and available diagnostic tools does not seem to
exist for peri-implant tissue conditions [2–5]. The controversy regarding the application of periodontal
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indices to dental implants is not a recent one [6]. The basis for the disagreement can be found in the
difference in the viewing of the peri-implant tissues. Can similar disease definitions and diagnostic
tools be used in natural dentition and in situations where the natural dentition has been replaced with
implant-retained restorations? The question is logical since there are no doubts that the periodontium
and the peri-implant tissues ought to be regarded as two very different entities [5,7,8].
Is it correct to assume that similar reactions to infection, occlusal trauma, trauma from probing
can be expected for the periodontium and the peri-implant tissues? Is there a similar pattern of
disease progression? And if these aspects differ between the two entities, is it correct to use similar
diagnostic tools? There is evidence in the literature that the peri-implant tissues are more susceptible
to inflammatory reactions, a phenomenon also confirmed immunohistochemically with increase of
inflammatory infiltrate in comparison to teeth [9] that lesions around implants and teeth have critical
histopathologic differences [10], and that there are differences in the onset and progression of the
periodontal and peri-implant diseases [11]. Becker and co-workers examined the differences and
similarities between peri-implantitis and periodontitis underlying disease mechanisms [12]. On the
basis of quantitative transcriptome analysis, peri-implantitis and periodontitis exhibited significantly
different mRNA signatures, supporting the hypothesis of peri-implantitis being a complex inflammatory
disorder with a unique pathophysiology. While in peri-implantitis tissue, the regulation of transcripts
related to innate immune responses and defense responses were dominating, in periodontitis tissues,
bacterial response systems prevailed [12]. Several authors questioned the role of infection as a principal
cause of peri-implant diseases. For instance, Koka and Zarb questioned whether peri-implantitis is
a disease entity at all. The Authors refuted the bacterial implications and suggested terms such as
osseoinsufficiency or osseoseparation to describe problematic implants [13]. Moreover, in a review
article, Qian and co-workers failed to find evidence that primary infection causes marginal bone
resorption around implants [14]. Osseointegration has been suggested to represent a foreign body
reaction to biomaterials and its long-term clinical function depending on a foreign body equilibrium
that, if disturbed, may lead to impaired clinical function of the implant [15]. Recently, dental implants
have been suggested having more in common to orthopaedic implants in terms of foreign body
reaction and failure pattern than to teeth [16]. Given these fundamental differences between the
periodontal and peri-implant tissues, can periodontal indices be used as reliable diagnostic tools for
peri-implant tissues?
2. The Risk of Using Surrogate Endpoints for Prediction of Fatal Events
In the most recent definition and diagnosis requirements for peri-mucositis and peri-implantitis,
the use of probing around dental implants has been recommended for the detection of presence of
bleeding on probing (BOP), of increases in pocket probing depth (PPD) or of presence of PPD equal or
more than 6 mm [17]. Thus, periodontal indices are recommended as biologic measures to distinguish
between health and disease conditions and as surrogate endpoints as substitutes for fatal events
(implant failures) in clinical trial designs. The underlying assumption is that an improvement in the
surrogates would benefit the patient and that it is equivalent to reducing the rate of implant losses [18].
Whenever surrogate endpoints (or biological markers) are used, the link between the surrogate and
the true clinical event is critical since the use of non-validated endpoints may be more harmful than
beneficial. A classic example in the field of medicine is the clinical investigation carried out on the
assumption that arrhythmia is a risk factor for acute myocardial infarction and that, as a consequence,
the suppression of arrhythmia would reduce the risk of death by infarction. The investigation had to
be stopped when it became clear that the antiarrhythmic agents successfully reduced the number of
arrhythmia episodes but increased the risk of dying by infarction. Clearly, the reduction of arrhythmia
was not a good surrogate of treatment benefit to the patient [19]. One can question whether the
high prevalence of periodontal diseases claimed in more recent years and the alarming possibility of
peri-implantitis becoming a major future health problem [20] is correct or whether it is based on the
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wrong choice of surrogate endpoints (biologic markers), and therefore cause unnecessary alarmism
and overtreatments which are of no benefit to the patients.
3. The Use of Periodontal Indices to Diagnose Peri-Implant Disease
A systematic review of peri-implantitis therapy published in 2010 showed that PPD, BOP and
clinical attachment level (CAL) were the most frequently reported surrogate markers for important
clinical events such as implant failure, despite the fact that these surrogate markers/endpoints had not
yet been validated [18]. Has anything changed in the last nine years? Has the use of periodontal indices
around dental implants been validated since then? Periodontal probing has been a common basic
diagnostic tool around teeth since investigations in the 1970s demonstrated that PPD measurements
around teeth provide information regarding the ability of the periodontium to withstand probe
penetration as a measure of the inflammatory conditions of the tissues. In case of an inflamed
periodontium, the tip of the probe penetrates the epithelium into the connective tissue, overestimating
the depth of the histological pocket. In case of a healthy gingiva, the tip of the probe fails to reach
the most apical cell of the epithelium due to the increased resistance of the periodontal tissues, thus
underestimating the depth of the histological pocket [21–23]. Ericsson and Lindhe confirmed this
finding in animals but also showed that in healthy soft tissues conditions, probe penetration was
more advanced at implants than at teeth and concluded that the differences between the attachment
structure of teeth versus peri-implant mucosa makes the conditions for PPD measurements at teeth
and implants different [24]. In contrast, Lang and co-workers reported that in healthy and mucositis
sites, the probe tip was located at the most apical cell of the junctional epithelium, whereas in the
case of ligature-induced peri-implantitis sites, the probe tip penetrated into the connective tissue.
They concluded that probing around implants represents a good technique for assessing the status
of peri-implant mucosal health or disease. The difference in results between the two studies was
attributed to the lower probing forces in the last study, which was 0.2 N versus 0.5 N [25].
More relevantly, on an evidence-based scale, investigations in humans failed to detect a positive
correlation between the presence of periodontal signs of inflammation (PPD, BOP) and peri-implant
bone loss. In a cross-sectional study by Lekholm and co-workers with a mean follow-up time of
7.6 years of 125 implants placed in 20 partially edentulous patients reported that 60% of the pockets
measured more than 4 mm and that 80% of the sites were positive for BOP despite a limited mean
bone loss of 0.07 mm annually. The microflora was periodontally non-pathogenic in nature in 94% of
the samples and soft tissue biopsies showed a healthy mucosa in 95% of the cases. Thus, bleeding of
the peri-implant tissues and deep pockets had no correlation to crestal bone loss or to the presence of a
pathogenic microflora or to histological changes indicative for signs of periodontitis [26]. These findings
were confirmed several years later by Dierens and co-workers, who reported of lack of correlations
between PPD or BOP and crestal bone loss around single implants functional for 16–22 years. PPD and
BOP were found to be of poor diagnostic value [27]. Recently also Winitsky and co-workers confirmed
these observations, reporting of a lack of correlation between radiographically-detected crestal bone
loss and periodontal indices such as PPD >6 mm and BOP in a 14–20 follow-up of 48 single anterior
maxillary implants with a survival rate of 96%. The authors concluded by raising the question of
whether PPD and BOP should be used as diagnostic measurements of implant health [28].
4. Evidences That Pocket Probing Depth Is a Poor Indicator of Ongoing Peri-Implant Pathology
The thickness of the healthy soft tissues surrounding implants has been reported to range between
1.85 and 5.75 mm in beagle dogs [29]. A clinical study showed values ranging from of 0.85 to 6.85 mm,
but even papillae of 7–9 mm were observed [30]. Often, deeper PPDs are found at implant sites
inserted in partially edentulous ridges compared to edentulous ridges [31]. Kan and co-workers
reported the interproximal thickness of healthy peri-implant mucosa to be roughly 6 mm (SD 1.2)
in maxillary anterior single implant with a mean functional time of 3 years [32]. Long-term clinical
investigations have clearly shown that the probing depth of healthy peri-implant mucosa is often more
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than 4 mm (60% to 63%) [26,28,33] and up and over 6 mm (15% to 23%) [27,28] and that successful
implants with over 18 years of function might have a history of PPD up to 9 mm [28,33]. From animal
and human studies, it is evident that PPD depends on the thickness of the soft tissue at the time
of implant placement and on the anatomical circumstances. For these reasons, there is no specific
pocket depth that can indicate disease conditions. This fact is acknowledged in the new classification
scheme for periodontal and peri-implant diseases and conditions, where in the peri-implant health
definition it is stated that “it is not possible to define a range of probing depths compatible with
peri-implant health” [1], and it is reflected in the fact that for the diagnosis of peri-implant health,
it is mentioned that probing depths depend on the height of the soft tissue at the location of the
implant [17]. Unfortunately, in the same paper, it is stated that in the absence of previous examination
data, diagnosis of peri-implantitis requires the presence of bleeding and/or suppuration on gentle
probing, probing depths ≥6 mm, and bone levels ≥3 mm apical of the most coronal portion of the
intraosseous part of the implant.
Obviously, in light of what was discussed so far, the recommendation of using a 6-mm deep
pocket (which appears to be an arbitrary choice) as one of the indicators of peri-implantitis appears to
be highly questionable.
In the same paper, it is stated that for the diagnosis of peri-implantitis among other parameters,
“an increased probing depth compared to previous examinations” is required.
The use of changes in PPD to establish a diagnosis of peri-implantitis has been questioned [5].
Schou and co-workers have shown in animal studies that PPD assessments could not distinguish
between peri-implant sites with or without crestal bone loss and that the only correct indication of
bone level stability was obtained by radiographs [34]. Furthermore, even mild inflammation was
associated with deeper probe penetration around implants in comparison to teeth with no correlation
to presence of bone loss [35]. In a more relevant 5-year clinical prospective investigation, Weber
and co-workers assessed the ability of several clinical parameters (Suppuration, PI. BOP, PPD, PAL,
mobility) to predict crestal bone loss as detected on radiographs in 112 ITI implants [36]. The authors
reported no bone changes between years one and five in comparison to increasing PPD values during
the five years. The cumulative predictive power of the six clinical parameters with regards to bone loss
was reported to range from 2.8% to 14.3%. It was concluded that “the low levels of correlation between
the individual and cumulative clinical parameters with radiographically measured bone loss, suggests
that these measures are of limited clinical value in assessing and predicting future peri-implant bone
loss”. Healthy peri-implant soft tissues have been reported in sites with increased PPD values by
Giannopoulou and co-workers in a 9-year follow-up of 61 maxillary anterior implants using clinical,
microbiologic and biochemical parameters, thus showing a very poor correlation between PPD changes
and the presence of pathology at the peri-implant tissues [37]. From the above discussed data, it appears
that an increase in probing depth around implants does not necessarily mean that loss of bone or clinical
attachment has occurred. Since the key parameter for establishing a diagnosis of peri-implantitis is
bone loss and since the latter cannot be properly identified by a specific, pre-established PPD value or
by changes in PPD, the use of probing for PPD assessments around implants does not appear to be a
validated diagnostic tool.
5. Evidences That Bleeding on Probing Is a Poor Indicator of Ongoing Peri-Implant Pathology
For the detection of pathology and consequent treatment needs, BOP is a key parameter, according
to the most recent recommendations, since BOP is used as a diagnostic parameter for the detection of
both peri-mucositis and peri-implantitis [17]. This recommendation assumes that healthy peri-implant
soft tissues do not test positive to BOP, whereas only diseased sites do (or, at least, that there is a
statistically significant clinical difference between healthy and diseased sites when it comes to BOP
positivity test). While Lang and co-workers’ Beagle dog investigation detected constant increases
in BOP from healthy peri-implant sites to ligature-induced peri-mucositis sites to ligature-induced
peri-implantitis [25], Ericsson and Lindhe’s Beagle dog investigation reported of the presence of
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BOP for the majority of the healthy peri-implant sites [24]. One investigation comparing teeth and
implants with respect to soft tissue healing revealed that peri-implant healing as determined by
crevicular molecular composition differs from periodontal healing and suggested that peri-implant
tissues represent a higher pro-inflammatory state [38]. Thus, the peri-implant soft tissues could be
considered to be in a state of subclinical chronic inflammation. In fact, cross-sectional studies have
shown that BOP can be detected at the majority of sites, showing stable peri-implant tissues.
With a definition of peri-implantitis as an association of BOP and any bone-level alterations at
implant sites occurring between the 1-year and the 5-year (up to 23 years) follow-up examinations,
Fransson and co-workers reported the presence of BOP in 93.9% of the 197 implants with “progressive”
bone loss and in 90.9% of the 285 implants with stable bone level [39].
Roos-Jansåker et al reported that peri-implant mucositis, diagnosed by BOP, was detected in
approximately 70% of functioning implants after 9 to 14 years. The prevalence of peri-implantitis,
defined as bone loss of at least 1.8 mm following the first year of function, combined with BOP and/or
pus, was 16% at patient level and 6.6% at implant level. Interestingly, 42.2% of the implants had stable
bone levels and still showed BOP or suppuration, and 8.4% of the implants showed bone level gain
even in the presence of BOP or suppuration [40]. A very poor correlation between presence of BOP and
presence of peri-implant diseases has been reported in several long-term clinical studies. Lekholm at al
reported the BOP of 80% around implants, showing an annual bone loss of 0.07 mm and a 95% healthy
mucosa at biopsies [26]. Dierens and coworkers reported 81% BOP around implants, showing stable
conditions for 16 to 22 years of function [27]. Winitsky and co-workers reported 71% BOP around
implants, showing stable conditions for 14 to 20 years of function [28]. French and co-workers, in a
large cohort study including 4591 Straumann implants from 2060 subjects evaluated up to ten-year
follow-up, reported that BOP was a common finding, detected in more than 40% of the implants during
the study. Despite the high prevalence of bleeding, less than 3% of implants exhibited more than 1 mm
crestal bone. The presented data indicated that minimal bleeding did not correlate with bone loss,
whereas profuse bleeding or suppuration did [41].
The type of implant, two-piece vs. one-piece, may affect the soft tissue bleeding response
to probing. The presence of a chronic infiltrate at the implant-abutment interface of two-piece
implants has been reported and has been attributed to the microgap between the implant and
the abutment [42,43]. In contrast, the connective tissue surrounding one-piece implants has been
reported to be inflammation-free, possibly due to the absence of a microgap [44]. This could partially
explain the high BOP prevalence detected at stable peri-implant sites in investigations on two-piece
implants [26–28,39,40] and the lower percentage of BOP (40%) detected at stable peri-implant sites
around one-piece implants. In case of one-piece implants, the presence of profuse BOP had a higher
correlation to crestal bone loss compared to the poor correlation of minimal BOP [41].
The type of abutment material has been demonstrated to have an effect on BOP values in a recent
systematic review, where increased BOP values over time were demonstrated for Ti when compared
to Zi abutments [45]. Implant position (anterior v posterior), gender and PPD have been shown to
be factors affecting the probability of a peri-implant site to be positive to BOP. In 112 patients, data
related to 1725 peri-implant sites showed that the probability to bleed on probing increases for implants
placed in anterior compared to posterior areas of the dentition, for implants placed in female patients
compared to male patients, and that for each mm increase in PPD, there is a corresponding 10% increase
in the probability of detecting BOP at the site [46].
Thus, BOP seems to depend on the implant type (two-piece/one-piece), the type of abutment
material, the implant position (anterior/posterior), the patient’s gender and the PPD of the probed site
without correlation to disease presence.
It has been shown that BOP can be detected in the majority of healthy peri-implant sites and
cannot therefore be reasonably used to distinguish between peri-implant health and disease.
The investigations that attempted to establish the validity of the use of BOP as a predictor of future
crestal bone loss around implants have failed to produce convincing result to justify the use of BOP as
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an appropriate diagnostic test. Jepsen and co-workers reported no difference in BOP between sites
with progressive peri-implant PAL loss (rather than progressive bone loss) or stable sites. The authors
pointed out that probing might provoke a nonspecific bleeding that is unrelated to the amount of
inflammation. Thus, BOP as a diagnostic test for progressive PAL loss had a sensitivity of 70% and a
specificity of 32%. In other words, BOP was of limited value in the implant-specific diagnosis when
examined as positive predictors for peri-implant attachment loss. However, BOP demonstrated a
higher negative predictive value and it was concluded that negative scores can serve as indicators of
stable peri-implant conditions [47]. Monje and co-workers found that the diagnostic accuracy of BOP
was not enough to distinguish healthy from peri-implantitis sites (defined as presence of inflammation
and 2 mm crestal bone loss). A visual sign, such as mucosa redness, was reported having a much better
diagnostic accuracy in monitoring the presence of pathology. For the clinical parameters investigated
(PPD, BPO, mucosa redness, PI), it was found that, as diagnostic tests, their specificity surpasses their
sensitivity in the detection of peri-implant diseases. The authors therefore concluded that the diagnosis
of peri-implant diseases cannot rely on a single clinical parameter but rather requires a combination.
More interestingly, it was pointed out that progressive radiographic bone loss must be cautiously
examined to reach definitive diagnosis and avoid overtreatment [48]. Weber and co-workers reported
that the cumulative predictive power of six clinical parameters (Suppuration, PI. BOP, PPD, PAL) with
regards to bone loss ranges from 2.8% to 14.3% and concluded that “these measures are of limited
clinical value in assessing and predicting future peri-implant bone loss” [36]. A recent systematic
review and meta-analysis demonstrated that for BOP-positive implants, there was a 24.1% chance of
being diagnosed with peri-implantitis, while for BOP-positive patients, there was a 33.8% probability
of being diagnosed with peri-implantitis. It was concluded that clinicians should be aware of the
considerable false-positive rate of BOP to diagnose peri-implantitis [49].
6. Mismatch between Known Clinical Facts and Recommendations from Consensus Meetings
It is interesting to note that review articles [5,49,50] and prospective studies [36,48] conclude that
periodontal indices are unreliable tools for examining implants. Yet, the consensus meetings that often
commission the reports keep recommending the use of periodontal indices around implants.
As discussed by Coli and co-workers, the efficacy of a diagnostic test is affected by the prevalence of
the disease in the investigated population [5]. With increases in the disease prevalence, the probability
that a person with a positive test result does in fact have the disease increases. Thus, two factors are of
importance in order to properly establish an accurate disease diagnosis and avoid high figures of false
positives. The first factor is the availability of a diagnostic test with high sensitivity and specificity.
This has not yet been proven to be the case for any of the periodontal indices usually applied around
dental implants. The second factor is the application of the diagnostic test to a population that has a
high prevalence of the disease. Studies using the presence of BOP and a pre-established amount of
crestal bone loss can result in high prevalence of peri-mucositis and peri-implantitis, however, if more
stringent values of crestal bone loss are applied, much lower prevalence values are presented [50].
Long-term clinical investigations on machined implants are showing that despite the presence of
several clinical parameters that would be considered indicative of pathology in the case of natural
dentition (BOP, increases in PPD, suppuration), peri-implant tissue conditions were generally stable for
over 18 years with only 2.5%–5% of implants showing progressive bone loss [27,28,33,51,52]. A review
including ten different publications on three brands of moderately rough surfaces with ten- year or
longer follow-up times reported a 2.7% peri-implantitis prevalence [7]. Jemt and co-workers reported
that the incidence of surgery related to peri-implantitis problems carried out at the Branemark clinic
was on an average 1.2% of followed-up patients per year (on an average, 1294 patients per year) during
an 8-years period [53]. Thus, long-term clinical studies on machined as well as on modern micro-rough
implant surfaces are indicative of a low 1.2%–5% prevalence of peri-implantitis and implant losses due
to peri-implantitis. With such low peri-implantitis prevalence figures and with clinical parameters
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with poor accuracy as diagnostic tests, the probability of a dental implant being correctly diagnosed as
suffering from peri-implant diseases appears to be very low and the risk of overtreatment very high.
Two investigations highlight the poor accuracy of periodontal indices causing overdiagnosis in
several cases and failing to correctly identify implants that will suffer crestal bone loss in the future.
In a follow-up study based on the population described by Fransson and co-workers [39,54], Jemt
and co-workers showed that 9 years after the initial diagnosis of peri-implantitis, 31% of the patients
presented with implants with bone loss >2mm/year or with implant failures, whereas 69% of them
showed no problems with their implants [55]. A total of 91.4% of the implants in the peri-implantitis
diagnosed patients showed no or smaller annual bone loss than <0.2mm during the 9 years from the
diagnosis. The authors reported a low prevalence of obvious bone loss at implants (>0.2 mm/year)
with a comparable distribution between “affected” and “not affected” implants. Hence, the definition
of peri-implantitis used in the Fransson and co-workers study [39], bone loss associated with BOP,
was shown to be a poor predictor of future bone loss and implant failure and, consequently, a poor
indicator of treatment needs. In a follow-up study based on the population described by Roos-Jansåker
and co-workers in 2006 [40], Renvert and co-workers reported that 12 years after the initial diagnosis
of peri-implantitis and surgical treatment, 23% of the patients presented with implants with further
bone loss ≥3 threads. In the remaining 77% of the subjects, bone gains (15%) or no further bone loss or
bone loss <3 threads were detected [56]. Out of the subjects that at the first examination did not have
peri-implantitis, 15% were diagnosed as having at least one implant with bone loss of ≥3 threads in the
21–26-year examination. For the 9–14 years examination, 58% of the individuals had been diagnosed
with mucositis. Of those, 14% were found to have developed peri-implantitis at the 21–26-year
examination. On the other hand, 22% of the patients without any sign of mucositis after 9–14 years had
developed peri-implantitis at a later stage. Thus, a diagnosis of mucositis established after 9–14 years
was not predictive for development of peri-implantitis after 21–26 years, nor was the diagnosis of
peri-implantitis after 9–14 years predictive of further bone loss at 21–26 years. It seems evident that
the use of a dichotomous diagnostic criterion (bleeding yes or no) for the definition of peri-mucositis
and the arbitrary choice of a defined bone loss in association with BOP (surrogate endpoints) for the
definition of peri-implantitis, does not capture the long-term true outcome (endpoint) in the form of
implant failure and could result in massive overtreatment of implant patients. In fact, patients treated
by oral hygienists and/or had experienced peri-implantitis surgery did not seem to show any more
favourable progression of bone loss as compared with non-treated patients [55,56].
7. The Risk of Iatrogenic Damage by Probing of Dental Implants
One important aspect that has not been debated in the literature and that has not yet been properly
tested is the fact that probing around implants could potentially result in trauma to the peri-implant soft
tissues with consequent inflammation, apical proliferation of the epithelium and consequent bone loss.
There is strong evidence in the literature that the mechanical disruption of the mucosal barrier around
an implant should be considered as a connective tissue wound resulting in epithelial proliferation to
cover the wound and in bone resorption to allow a connective tissue barrier of proper dimensions
to reform in order to re-establish a “biological width”. Repeated abutment dis/reconnections with a
consequent disruption of the peri-implant soft tissue barrier have been shown to cause crestal bone
resorption around dental implants in animal studies [57,58] and in short-term and long-term clinical
investigations, as confirmed in several meta-analysis reports [59–61]. Although this limited crestal
bone resorption does not seem to be clinically relevant, this established fact should at least raise the
doubt that regular peri-implant tissue probing assessments might repeatedly disrupt the soft tissue
barrier with consequent serious iatrogenic effects on the stability of the peri-implant tissues in the
long term.
Another serious aspect to be considered is the overdiagnosis and overtreatment caused by
the use of periodontal indices. In periodontology, it is well established that the presence of BOP
is not an indicator of future periodontal tissue loss, but rather that the absence of BOP is a good
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predictor of periodontal stability [62]. For this reason, during the active and maintenance phases of
periodontal treatment, 4-mm-deep or deeper sites showing BOP are treated by scaling and root planing.
This zero-tolerance approach certainly results in overtreatment in several cases but does not result in
damages to the periodontal tissues and is therefore accepted and recommended. The same approach
in the case of dental implants seems to be unjustified and potentially dangerous. As discussed above,
there is no evidence in the literature that the presence of BOP at an implant site is a sign of pathology
(peri-mucositis or peri-implantitis) with a consequent treatment needed. The zero-tolerance approach
to bleeding in the case of dental implants could not only result in overtreatment, but, in fact, in the
triggering and the establishment of a difficult-to-manage inflammation in the soft tissues and excruciate
into a foreign-body reaction.
Different techniques are used to achieve decontamination of the abutment/implant surfaces.
Calculus is removed by manual debridement, such as conventional or ultrasonic scaling, resulting
in the release of Ti particles in the surrounding tissues and in surface changes affecting the corrosion
resistance of the material [63–67]. Orthopaedic studies have shown that the presence of titanium
particles from wear of limb prosthesis could over-express pro-inflammatory cytokines, that are related to
the osteolysis process, culminating in bone loss around the implant and prosthesis failure [68]. A recent
review concluded that Ti particles and corrosion products from dental implants can have adverse effects
on biological tissue [69]. Titanium particles released by ultrasonic scaling on dental implants have been
shown to activate inflammatory responses in in vitro studies: activating the DNA damage response
pathway in oral epithelial cells [70] or resulting in an increased secretion of IL-1β, IL-6, and TNF-α
in cultured human macrophages [71–73], inducing bone resorption [71]. In vivo, titanium particles
have been found in soft and hard tissue biopsies retrieved from sites with peri-implantitis [74,75].
Peri-implantitis tissues have been shown to contain high concentrations of Ti compared to controls
from periodontitis tissues, leading to the conclusion that the high Ti content in peri-implant mucosa has
the potential to aggravate inflammation [76]. Furthermore, greater levels of dissolved titanium have
been detected in submucosal plaque around implants with peri-implantitis compared with healthy
implants, indicating an association between titanium dissolution and peri-implantitis [77].
Since Ti particles can be released from surfaces of dental implants because of mechanical wear
and because of contact to chemical agents and/or with substances produced by adherent biofilm
and inflammatory cells, Mombelli and co-workers suggested that rather than being the trigger of
disease, the observed higher concentration of Ti particles in inflamed peri-implant tissues could be the
consequence of the presence of biofilms and inflammation [78]. However, in a recent animal model, it
was shown that Ti particles induce an inflammatory response with consequent bone loss and that both
inflammation and bone loss can be inhibited by the use of blockers targeting specific inflammatory
cytokines. The specific role of inflammatory cytokines in the development of Ti particle-induced
peri-implantitis was therefore clearly demonstrated [79]. Another investigation using a different animal
model further confirms that Ti particles can induce inflammatory bone loss even in the absence of
a bacteria infection and that the inflammatory response can be inhibited by blocking macrophage
activity [80]. Thus, there is increasing evidence that dental implant degradation products released
by corrosion and/or abrasion during mechanical debridement can act as foreign bodies, initiating
the release of inflammatory mediators associated with bone resorption, as already described in the
case of orthopaedic implants [81]. Hence, non-surgical implant debridement, incorrectly triggered
by the detection of BOP at one otherwise healthy and stable implant site, could result in alterations
of the implant surface, with the release of Ti particles (at the time of debridement and/or as a later
consequence of the surface corrosion) and initiation of a foreign-body reaction.
8. Conclusions and Recommendations Regarding Evaluation of the Implant-Tissue Interface
Periodontal indices do not seem to be reliable indicators for appropriate diagnosis and treatment
needs around dental implants. Apparently, they do not provide better information than visual
inspection and detection of mucosa redness. Probing around dental implant is more uncomfortable
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for the patient compared to probing around teeth. Probing around implants could potentially create
a trauma in the peri-implant scar tissue that could become difficult to manage. All the information
gathered from probing (BOP, PPD, CAL) needs to be associated to the radiographic assessment of
crestal bone levels to establish a definitive diagnosis and avoid overtreatment. Therefore, it appears
to be more logical to avoid any risks of disturbing the peri-implant tissues with probing and instead
proceeding with a clinical examination that includes (1) a visual inspection of the peri-implant tissues
for the assessment of oral hygiene and the detection of potential redness, swelling, (2) palpation of the
peri-implant tissues for assessment of the potential presence of swelling, bleeding, and suppuration,
and (3) radiography for the assessment of crestal bone level for comparison with previous radiographs
to evaluate potential progressive bone loss even if there is a need for more scientific evidence of the
true value of the first two clinical testing modes.
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Abstract: This systematic review sought to analyze different experimental peri-implantitis models,
their potential to induce marginal bone resorption (MBR) and the necessity of bacteria for bone loss to
occur in these models. An electronic search in PubMed/Medline, Web of Science, and ScienceDirect
was undertaken. A total of 133 studies were analyzed. Most studies induced peri-implantitis with
ligatures that had formed a biofilm, sometimes in combination with inoculation of specific bacteria
but never in a sterile environment. Most vertical MBR resulted from new ligatures periodically
packed above old ones, followed by periodically exchanged ligatures and ligatures that were not
exchanged. Cotton ligatures produced the most MBR, followed by steel, “dental floss” (not further
specified in the studies) and silk. The amount of MBR varied significantly between different animal
types and implant surfaces. None of the analyzed ligature studies aimed to validate that bacteria are
necessary for the inducement of MBR. It cannot be excluded that bone loss can be achieved by other
factors of the model, such as an immunological reaction to the ligature itself or trauma from repeated
ligature insertions. Because all the included trials allowed plaque accumulation on the ligatures,
bone resorbing capacity due to other factors could not be excluded or evaluated here.
Keywords: osseointegration; dental implant; peri-implantitis; ligature-induced peri-implantitis;
aseptic loosening; systematic review
1. Introduction
Experiments that aimed to mimic peri-implantitis were first introduced in the early 1990s
in response to reports on progressive peri-implant bone loss around dental implants [1,2].
These experiments have mainly been based on the infectious model of explanation where bacteria
are the presumed cause of the phenomenon [2,3]. The view of peri-implantitis as a strictly infectious
condition, as suggested in the studies these models were based on, is currently a matter of debate.
Albrektsson and co-workers recently proposed that tissue responses to dental implants should be
viewed similarly to other biomaterials; primarily as an immune mediated inflammatory and foreign
body reaction (FBR), indicating that immunological reactions may be important also for MBR [4].
The initial, and most frequently used experimental peri-implantitis model was adopted from the
ligature-induced periodontitis model. In short, ligatures made of silk, cotton, stainless-steel wire,
or other materials, are placed around the neck of dental implants, usually in a sub-marginal position.
The ligatures are then allowed to accumulate plaque for a few months, after which a certain amount
of marginal bone resorption (MBR) can be expected. Previous authors have claimed that plaque
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accumulation is necessary for bone resorption to occur in response to ligation [2,5], but Baron et al.
pointed out a lack of validation for this claim in their review from year 2000 and concluded that other
factors, such as a foreign body reaction to the ligature may also trigger a peri-implant inflammatory
response [6]. The aims of the present review were to categorize (1) the models that induce experimental
peri-implantitis described in literature and (2) to verify whether the amount of vertical MBR varies
between different ligature techniques (exchanged or non-exchanged ligature), material and size of
ligatures, animals or implant surfaces used in these studies. With this information in mind, we then (3)
critically analyzed the attempts to validate the presence of bacteria containing biofilms as a cause of
MBR in ligature-induced peri-implantitis models.
2. Materials and Methods
The present study followed the PRISMA Statement for Transparent Reporting of Systematic
Reviews and Meta-analyses [7].
2.1. Search Strategies
An electronic search without time restrictions for publications in English was undertaken in
January 2018 in the following databases: PubMed/Medline, Web of Science, and ScienceDirect.
The following terms were used in the search strategies:
(((dental implant) OR oral implant)) AND (experimentally induced periimplantitis) OR
experimentally induced peri-implantitis) OR experimental periimplantitis) OR experimental
peri-implantitis) OR ligature induced periimplantitis) OR ligature induced peri-implantitis) OR
ligature) OR plaque induced periimplantitis) OR plaque induced peri-implantitis) OR plaque
accumulation) OR mechanical overload) OR bacterial inoculation)
An additional manual search of related journals was conducted. The reference list of the identified
studies and the relevant reviews on the subject were scanned for possible additional studies.
2.2. Inclusion and Exclusion Criteria
The inclusion criteria comprised in vivo studies performing experimentally induced
peri-implantitis. All animal species used for the experiments and all methods to induce peri-implantitis
were considered. Studies inducing periodontitis (around teeth) were not included, unless they were
also investigating peri-implantitis around implants. Studies evaluating only mucositis around implants
were excluded.
2.3. Study Selection
The titles and abstracts of all reports identified through the electronic searches were read
independently by the authors. For studies appearing to meet the inclusion criteria, or for which
there were insufficient data in the title and abstract to make a clear decision, the full report was
obtained. Disagreements were resolved by discussion between the authors and the authors rapidly
reached a consensus.
2.4. Data Extraction
Two review authors independently searched for trials aiming to validate the necessity of biofilm
in order to induce MBR by means of ligatures. They then independently extracted data using specially
designed data extraction forms. The data extraction forms were piloted on several papers, which were
modified as required before use.
From the studies included in the final analysis, the following data was extracted (when available):
Year of publication, animal species used in the experiments, number of animals, jaw receiving the
implants, number of extracted teeth (to make room for the implants), implants’ healing period,
study design (split design, inter-quadrant, other), implant characteristics (shape, dimensions, material,
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surface, bone/tissue level), number of implants per animal, number of surgery stages, time between
abutment connection and peri-implantitis induction, use or not of randomization, use or not of loading,
pre- and post-operative care (antibiotic, and plaque control method, timing, and duration), method
of induction of peri-implantitis (ligature, overload, bacterial inoculation, other), ligature (material,
size, exchange regimen, duration, control side protocol), diagnostic markers (clinical measurements,
mobility, microbiological sampling, radiographies, histometric measurements, histological evaluation,
other), peri-implant bone defect (time of registration, vertical MBR, horizontal MBR, measurement
method, development after ligature removal, number of lost implants). Contact with authors for
possible missing data was performed.
2.5. Analyses
Descriptive statistics were utilized to report the data. In order to standardize and clarify
ambiguous data, vertical MBR was reported for each publication. Vertical MBR was the continuous
outcome evaluated, and the statistical unit was the implant (the implants used in the animals).
The untransformed proportion (random-effects DerSimonian–Laird (1986) method) for vertical bone
loss was calculated [8] with consideration for the different implant surfaces, the different animal
species, the different methods to induce peri-implantitis and, when ligature was the method used,
the different regimen applied, i.e., application of only one ligature, exchange of ligatures over time,
and application of a new ligature on the top of an old one. Meta-regression was performed for the
outcome of vertical MBR, using the time period of peri-implantitis induction as covariate. Statistical
significance was set at p < 0.05. The data were analyzed using the software OpenMeta (Analyst)
(MetaMorph Inc., Nashville, TN, USA) [9].
3. Results
3.1. Literature Search
The study selection process is summarized in Figure 1. The search strategy in the databases
returned 3525 papers. A number of 745 articles were cited in more than one database (duplicates).
The reviewers independently screened the abstracts for those articles related to the aim of the review.
Of the resulting 2780 studies, 2642 were excluded for not being related to the topic or for not being
induced peri-implantitis animal studies. Additional hand-searching of journals and of the reference lists
of selected studies yielded 10 additional papers. The full-text reports of the remaining 148 articles led
to the exclusion of 15 because they did not meet the inclusion criteria. Thus, a total of 133 publications
were included in the review (see References S1).
3.2. Description of the Studies and Analyses
Regarding ligature-induced peri-implantitis; none of the included publications attempted to
validate the presence of a bacterial biofilm in order to achieve MBR.
Detailed data of the 133 included studies are listed in Tables S1 and S2. Dogs were the most
commonly used animal for the experiments (being the case of 94 studies) followed by monkeys
(26 studies), mice (8 studies), micro-/mini-pigs (3 studies), and rats (2 studies).
Concerning the method of peri-implantitis induction, most of the studies (n = 91) induced
peri-implantitis with the use of ligatures alone. Ligatures of cotton were used in 50 studies, silk in
31 studies, 3 metallic ligatures, one the resorbable suture Vicryl, one “dental floss”, and 5 studies used a
combination of ligatures of different materials. Thirteen studies applied a period of ligature and then a
period of plaque accumulation (or vice-versa), 8 studies compared two or more groups concerning the
method of peri-implantitis induction (ligature and/or overload and/or plaque accumulation), 5 studies
used cotton ligatures followed by inoculation of Porphyromonas gingivalis. Seven studies provided
a time of plaque accumulation alone, 4 studies exposed the implants to overload, 2 studies applied
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ligatures plus cyanoacrylate, 2 studies used bacterial inoculation alone, and 1 study immunized the
animals followed by an injection of lipopolysaccharides.
 
Figure 1. Study selection.
The implant healing period before the induction of experimental peri-implantitis was at average
96.0 ± 57.1 days (min–max, 0–365). Seventy-nine studies used bone-level implants, 46 tissue-level
implants, 5 studies used both types of implants, 2 studies installed the implants at the sub-crestal level,
and proper information was not provided in one study.
The ligature methods were of three different regimens: One ligature not replaced (n = 53),
exchange of ligatures (n = 43), and periodical replacement of ligatures on top of old ones (n = 11).
Information was not available in 4 studies. Only 30 studies provided information on ligature size,
varying from suture size 7–0 to 2–0 United States Pharmacopeia (USP). Other examples included
0.010 inch, 0.254 mm, and 1.58 mm. The duration of ligature placement time varied between 7 and
660 days, and some studies intercalated the use of ligatures between periods of plaque accumulation
or of plaque control.
Plaque control maintenance was performed in 111 studies, where the period varied between
“only once” to 2 years. Information about plaque control was not available in 8 studies. The plaque
control methods used varied considerably among studies and included one or a combination of two
or more of the following activities: Daily brushing with toothpaste, interdental brushing, electric
pencil brush, application of chlorhexidine, scrubbing with chlorhexidine, implant scaling with plastic
scaler, gentle mechanical cleaning of pockets, manual irrigation with syringe, dental water jet, flossing,
and curettage. The plaque control maintenance also varied considerably among studies concerning the
duration period, the number of maintenance periods, and timing (for example; after teeth extraction,
after implant installation, at abutment connection, and after ligature removal).
The studies usually made use of several diagnostic markers listed in Table S2, but the present
review focused on the analysis of the vertical MBR. Table 1 shows the estimated vertical bone loss in
relation to implant surface type, species, method of peri-implantitis induction, and ligature regimen,
according to the untransformed proportion using the DerSimonian–Laird method (1986) analysis [6].
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Only studies providing the number of implants used, mean value and standard deviation for bone
loss were included here (n = 35 of the 133 reviewed studies) because these values are necessary for
the analyses. Detailed data for these 35 studies are listed in Tables S3 and S4 and a reference list is
available in References S2.
Table 1. Estimated vertical bone resorption in relation to implant surface type, species, method of
peri-implantitis induction and ligature regimen.
Factor MBR (in mm) (95% CI), p-Value, SE Heterogeneity Number of Measurements * Included for
the Meta Regression (Number of Studies)
Surface
Turned 2.265 (1.786, 2.745), p < 0.001, 0.245 I2 = 99.5%, p < 0.001 29 (21)
Acid-etched 2.864 (2.491, 3.237), p < 0.001, 0.190 I2 = 94.72%, p < 0.001 12 (6)
SB 2.509 (1.555, 3.463), p < 0.001, 0.487 I2 = 98.03%, p < 0.001 6 (5)
SB+F 1.697 (-0.640, 4.034), p = 0.155, 1.193 I2 = 98.94%, p < 0.001 3 (2)
SBAE 2.175 (1.658, 2.693), p < 0.001, 0.264 I2 = 98.44%, p < 0.001 21 (10)
SBAE/HA-coated 2.700 (2.174, 3.226), NA, 0.268 NA 1 (1)
HA-coated 2.349 (1.254, 3.444), p < 0.001, 0.559 I2 = 98.58%, p < 0.001 12 (7)
HA-plasma 1.650 (1.410, 1.890), p < 0.001, 0.122 I2 = 0%, p = 0.683 2 (1)
CaP-plasma sprayed 0.469 (-0.010, 0.949), p = 0.055, 0.245 I2 = 75.67%, p < 0.043 2 (1)
TPS 2.184 (1.523, 2.844), p < 0.001, 0.337 I2 = 98.16%, p < 0.001 13 (9)
Cancellous 1.932 (1.432, 2.431), p < 0.001, 0.255 I2 = 0%, p = 0.990 4 (1)
Anodized 3.462 (3.273, 3.651), p < 0.001, 0.097 I2 = 16.1%, p = 0.311 4 (2)
Overall 2.295 (2.042, 2.548), p < 0.001, 0.129 I2 = 99.18%, p < 0.001 109 (35 **)
Species
Dog 2.389 (2.152, 2.626), p < 0.001, 0.121 I2 = 98.3%, p < 0.001 98 (30)
Monkey 1.649 (1.254, 2.044), p < 0.001, 0.202 I2 = 96.75%, p < 0.001 9 (4)
Rat 0.800 (0.393, 1.207), NA, 0.208 NA 1 (1)
Mouse 0.579 (0.549, 0.609), NA, 0.015 NA 1 (1)
Overall 2.295 (2.042, 2.548), p < 0.001, 0.129 I2 = 99.18%, p < 0.001 109 (35 **)
Method
Plaque 0.689 (0.507, 0.871), p < 0.001, 0.093 I2 = 66.17%, p = 0.007 7 (2)
Inoculation 0.800 (0.393, 1.207), NA, 0.208 NA 1 (1)
Ligature
Cotton 2.730 (2.478, 2.982), p < 0.001, 0.129 I2 = 97.88%, p < 0.001 66 (22)
Silk 1.683 (1.296, 2.070), p < 0.001, 0.197 I2 = 98.98%, p < 0.001 28 (8)
“Dental floss” 2.361 (1.675, 3.046), p < 0.001, 0.350 I2 = 86.05%, p = 0.007 2 (1)
Steel 2.607 (1.359, 3.856), p < 0.001, 0.637 I2 = 98.08%, p < 0.001 5 (2)
Overall 2.295 (2.042, 2.548), p < 0.001, 0.129 I2 = 99.18%, p < 0.001 109 (35 **)
Ligature regimen
Only one 2.000 (1.647, 2.352), p < 0.001, 0.180 I2 = 98.91%, p < 0.001 37 (13)
Exchange 2.303 (2.030, 2.576), p < 0.001, 0.139 I2 = 97.89%, p < 0.001 48 (14)
New on top 3.123 (2.409, 3.838), p < 0.001, 0.365 I2 = 98.66%, p < 0.001 20 (6)
Overall 2.395 (2.098, 2.620), p < 0.001, 0.133 I2 = 99.2%, p < 0.001 105 (33) ***
CI—confidence interval, SE—standard error, MBL—marginal bone loss, SB—sandblasted, SB+F—sandblasted +
fluoride modified, SBAE—Sandblasted/acid-etched, HA—hydroxyapatite, NA—not applicable (there is only one
study for this category), TPS—Titanium plasma-sprayed. * Some studies performed measurements of MBL in
different implant surfaces, and/or different time points, and/or different methods. ** The total number of studies is
always 35 for the factors “surface”, “species”, and “method”, even though the sum of the studies for all categories
under the same factor is higher than 35. The reason for this is that some studies performed measurements of
MBL in different conditions, as explained in the footnote “*” above. An exception is made for “ligature regimen”
(see footnote “***” below). *** The ligature regimen was not clearly informed in four measurements performed in
two studies.
4. Discussion
This systematic review presents a broad inclusion of experimental peri-implantitis studies
that were all based on the infectious model except for a few studies that exposed the implants to
overload. The infectious model of explanation for peri-implantitis stems from the traditional view
that osseointegration results from ordinary bone healing adjacent to an inert implant and where all
subsequent marginal bone loss is due to bacterial challenge [3,10]. Currently, it is becoming more and
more clear that osseointegration is an FBR of demarcation type that is dependent on local and systemic
factors [11–13]. Even though the demarcation type reaction serves a functional purpose by enabling
dental implants to carry chewing forces, its immunological purpose is to shield off the material and
limit its tissue damage. It has been well established that an FBR is initiated at the time of implantation
of all biomaterials and that its expression may vary between encapsulation, dissolution, resorption
or rejection, depending on the properties of the material or the trauma associated with its insertion.
Its expression type may also vary over time in response to changing local or systemic factors [14,15].
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Sub-marginal ligation remains the most commonly used means to induce experimental
peri-implantitis and provides a relatively rapid and effective MBR. Plaque accumulation alone on
the other hand, provides minimal or absent MBR as evident from the dog (n = 5) and monkey (n = 2)
studies which used that technique in the present review [16–22]. Prior to its introduction in dental
implant research in the early 1990s, the model had been used extensively in experimental periodontitis
studies [23]. While it has been realized that ligature-induced peri-implantitis may not completely mimic
the onset and progression of disease in humans [24], it is still generally regarded as a solely infectious
model as evident from repeated claims that bone resorption results from exposition to biofilm, not the
ligature per se [2,4,25]. The earliest studies on experimental peri-implantitis revealed that the infectious
model of explanation was adopted from studies on native tissues (experimental periodontitis), rather
than implanted material. For example, Lindhe et al. referred to a 1966 study on germ-free vs.
conventional rats to support the theory [2]. In the provided reference, Rovin et al. described an
increased inflammatory response in the gingival tissues of conventional rats compared to germ free
rats after ligation with USP 3-0 braided silk sutures. However, none of the rats lost any bone and
neither did the distance between the epithelial attachment and cemento-enamel junction vary between
these groups at any time interval until the termination of the experiment after 6 months of ligation.
Rovin et al. concluded that their specific rat type appeared unsusceptible to periodontitis [26]. We failed
to identify any experimental peri-implantitis studies that attempted to validate that ligatures cannot
induce MBR without the presence of a biofilm. As concluded in a previous review by Baron et al.,
it still “remains uncertain whether the peri-implant inflammatory response is really only the result of
increased plaque accumulation or if the thread itself, as a foreign body, also acts as a stimulus” [5].
In the present review dogs displayed more bone loss in response to ligation than monkeys,
which points to differences in their susceptibility to ligature-induced peri-implantitis. The time
required to achieve a certain amount of bone loss also varied greatly within the groups of dogs or
monkeys in single studies [27,28]. The difference in MBR between rodents and large animals in the
present review may be due to the small implants and ligatures used in rodents compared to dogs and
monkeys. One must also consider the small number of rodent studies (n = 2) included in the analysis.
Recently, different mouse strains and knock out models have been used to better understand why the
marginal bone resorption in response to ligation differs between animals [29,30].
The significant differences in the MBR that resulted from different ligature materials in the present
meta-analysis, may be due to differences between the FBRs provoked by these materials. They could
also be related to varying plaque carriage potentials for these materials, but this can hardly explain
why smooth stainless-steel ligatures induced more bone loss than twined silk. Consider also the
significant differences in MBR between different ligature regimens, with more bone loss generated
from regularly exchanged ligatures and new ligatures packed on top of old ones, as compared to only
one ligature. Studies that utilized the exchanged ligature technique in the present review typically
carried out the exchange every 3 weeks by first removing the old ligature and then pushing a new one
into the bottom of the existing peri-implant pocket. Assuming that an anaerobic flora exists in the
apical part of a lesion prior to ligature exchange, it is likely that the removal procedure will disrupt the
biofilm and also introduce air into the lesion (aeration is generally considered an important part of the
surgical treatment of an anaerobic infection). It would also take some time for a new anaerobic biofilm
to develop on the new, presumably clean ligature. This may indicate that a close proximity between
ligature and bone, is more critical for continuous bone loss to occur than the type and composition of
its bacterial flora. The general disregard of the ligature itself as a potential inducer of bone loss may
perhaps explain why details about ligature size, material, structure, and sometimes composition, were
left out in many studies. In fact, none of the included studies compared the effect of different ligature
types or regimens.
The addition of ligature around a dental implant introduces a new foreign body on another
foreign body. It is plausible to assume that the new foreign body will alter the biological response of
adjacent tissues to a type more specific for the introduced ligature material. Because bacteria were
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always present on the ligatures of the included studies, their isolated effect could not be evaluated
in the present review. However, the FBRs to some of the most common ligature materials have been
described elsewhere in the literature. Silk, for example, is commonly used in in vivo applications and
produced the least amount of marginal bone loss in the present review. Setzen et al. reported that
twined silk sutures, identical with those commonly used in the trials of the present review, produced a
relatively extensive foreign body reaction and the thickest fibrous capsule of 11 sterile suture materials
that were placed subcutaneously in a rabbit model [31]. Cotton on the other hand, has been shown
to induce intense FBRs and also produced the most vertical MBL in the present review. Even though
cotton is generally avoided in vivo, it has sometimes been used as a negative control in studies that
compared the FBR to different biomaterials [32]. From reports on iatrogenic injuries following surgery,
it is known that retained sterile cotton sponges can cause large lesions of foreign body type in both hard
and soft tissues, sometimes referred to as “cottonballomas”. For example, Kalbermatten et al. reported
a massive osteolytic process surrounded by a thin rim of bone next to a sterile cotton sponge that
had been left 25 years earlier during the stabilization of a femoral fracture [33]. The case exemplifies
the slow progression often seen in foreign body type lesions, as well as their potential to induce both
bone resorption and bone remodelling. Even microscopic remnants of sterile lint retained from cotton
sponges during routine surgery have been shown to cause considerable foreign body granulomas
with ingested lint particles visible within macrophages and foreign body giant cells after 4 weeks
in rats [34]. It is plausible that similar particles can disseminate from the cotton ligatures used to
induce experimental peri-implantitis, but their presence or eventual role does not appear to have
been investigated in experimental peri-implantitis models. Within the orthopedic field, macrophage
activation after phagocytosis or cell-surface contact with wear particles is considered the key causal
reason for aseptic implant loosening, which is the main cause for revision surgery over the mid- and
long-term [35,36].
The addition of bacteria on ligatures, as was the case in all reviewed studies, will obviously
alter the inflammatory reaction to the ligature and likely plays an important role in the initiation and
progression of MBR, i.e. it is an offer to bacteria to invade new space. Bacteria may however not be
the only cause, as indicated by the results of this meta-analysis and other cited literature. It therefore
remains uncertain whether a ligature-induced lesion represents clinical peri-implantitis better than
a man-made defect would, perhaps created at implant insertion and then allowed to accumulate
biofilm for a short time. A man-made defect would probably decrease animal suffering significantly,
considering that ligatures have sometimes been left in place for as long as 1 year to induce a few
millimeters of bone loss [37–39]. A few experiments with man-made defects have been reported.
For example, Takasaki et al. combined manually created bone defects with a shorter ligature period of
5 weeks [40].
It also remains uncertain as to what extent a ligature-induced lesion can represent clinical
peri-implantitis and until further validation has been provided, clinical conclusions from
ligature-induced peri-implantitis studies should be drawn with great care and the experimental
and clinical conditions should be treated as separate entities at all times.
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Abstract: The clinical value of ligature-induced experimental peri-implantitis studies has been
questioned due to the artificial nature of the model. Despite repeated claims that ligatures of silk,
cotton and other materials may not induce bone resorption by themselves; a recent review showed
that the tissue reaction toward them has not been investigated. Hence, the current study aimed to
explore the hard and soft tissue reactions toward commonly used ligature materials. A total of 60
dental implants were inserted into the femur (n = 20) and tibia (n = 40) of 10 rabbits. The femoral
implants were ligated with sterile 3-0 braided silk in one leg and sterile cotton retraction chord in
the other leg. The tibial implants were ligated with silk or left as non-ligated controls. All wounds
were closed in layers. After a healing time of 8 weeks, femoral (silk versus cotton) and proximal tibial
(silk versus non-ligated control) implants were investigated histologically. Distal tibial (silk versus
non-ligated control) implants were investigated with real time polymerase chain reaction (qPCR).
The distance from the implant-top to first bone contact point was longer for silk ligated implants
compared to non-ligated controls (p = 0.007), but did not vary between cotton and silk. The ligatures
triggered an immunological reaction with cell infiltrates in close contact with the ligature materials,
adjacent soft tissue encapsulation and bone resorption. qPCR further demonstrated an upregulated
immune response toward the silk ligatures compared to non-ligated controls. Silk and cotton ligatures
provoke foreign body reactions of soft tissue encapsulation type and bone resorption around implants
in the absence of plaque.
Keywords: ligature induced peri-implantitis; dental implant; marginal bone loss; osseointegration;
aseptic loosening
1. Introduction
Dental implant therapy is a well-documented treatment for edentulism with an overall success
rate of approximately 95% after 10 years [1]. A small degree of marginal bone resorption can often be
observed during the first year of implant loading, probably due to tissue adaptation to the foreign
material. Even though it is self-limiting in most cases, the marginal bone resorption sometimes
progresses to the extent that the osseointegration becomes threatened. In a systematic review on
implants with different surface types, Doornewaard et al., reported a 5% overall rate of implants with
≥3 mm of marginal bone loss after at least 5 years of function. They further indicated that smoking and
a history of periodontitis yielded more bone loss [2]. With regards to treatment need, Albrektsson et al.
reported that 2.7% of modern, moderately rough implants were either removed or subjected to other
surgical procedures due to progressive marginal bone resorption during 7 to 16 years of follow up. [3].
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In severe cases, continuous marginal bone loss may be locally detrimental to patients due to
significant peri-implant bone defects that may impede future implant revision. Hence, animal models
have been developed to study the onset and progression of marginal bone loss [4]. Such models have
generally been based on the theory of peri-implantitis, which defines all marginal bone loss after
osseointegration as solely a bacterial infection if coupled with bleeding from the peri-implant pocket in
response to pocket probing [5].
The infectious peri-implantitis theory has been criticized for being narrow and exclusive of
other potential causes for marginal bone resorption, such as poor implants, traumatic implantation
or change of marginal conditions over time in response to wear products [6–8]. Furthermore, the
marginal bone level has been shown to both increase and decrease around some implants over time,
indicating a dynamic foreign body response to implants that may not require treatment, rather than a
progressive infectious condition that demands intervention [9]. It has also been well-established that
other types of endosseous implants that function in presumably sterile environments, such as hip and
knee arthroplasties are equally susceptible to progressive bone loss and long-term failure (>10 years),
as are transmucosal dental implants [10,11]. Aseptic loosening, caused by an immunological response
to increasing amounts of wear debris at the bone-implant interface over time is believed to be the main
cause of such late prosthetic joint failures [12,13].
In animal studies, undisturbed peri-implant plaque accumulation has resulted in negligible or
absent marginal bone loss [14–16]. In order to speed up the process, a large majority of previous
experimental peri-implantitis studies have therefore utilized sub-marginal ligatures of cotton, silk
or other materials. Sub-marginal ligation has commonly resulted in significant bone loss after a few
months, especially when the ligatures were replaced or added to in number every few weeks [17]. The
ligature method aims to mimic infectious, clinical peri-implantitis and several authors have claimed
that the utilized ligatures merely act as carriers of bacteria, without capacity to induce bone resorption
by themselves [4,18,19]. In one of the very first ligature studies on implants, Lindhe et al. referred
to a study that used silk ligatures in the periodontal tissues (natural teeth not implants) of germ free
and conventional rats from 1966 to support this claim; however, none of the rats in either group lost
any bone in that study [20]. The validity of the claim was further questioned in a recent systematic
review by our group, in which we failed to identify any attempts to prove that ligatures cannot
induce peri-implant bone resorption by themselves. Along with previous reviews on the method, we
concluded that it remains unknown whether bone resorption can be induced by a foreign body reaction
to the ligature materials themselves or the tissue trauma that results from their insertion [17,21,22]. An
eventual capacity for ligatures to induce bone resorption in absence of bacteria would cast serious
doubt on the clinical value of the method, especially when considering that ligation is an artificial
manipulation that does not mimic any clinical condition, with the possible exception if someone
unintentionally leaves a retraction chord in a peri-implant pocket, which, however, must be regarded a
most unusual clinical error. Hence, a validation of the infectious model of explanation provided for the
ligature method is warranted.
The aim of the current study was to evaluate the capacity of aseptic ligatures to induce peri-implant
bone resorption in rabbits. We chose silk ligatures due to their common use in other small animals, i.e.,
rodents, as well as existing, relevant real time polymerase chain reaction (qPCR) data from one of these
studies [23] and an ongoing aseptic silk ligature trial on rats, by another group at our faculty. The hard
and soft tissue reactions against the silk ligatures were evaluated for tibial implants, with histological
methods and also selected qPCR markers in order investigate the immunological activity of adjacent
cells, as well as the local bone reactions. Furthermore, since no comparisons of different ligature
materials have been published previously according to our knowledge, a histological comparison
of silk and cotton ligatures was also performed on femoral implants. Our null hypothesis was that
marginal ligatures should not be able to induce marginal bone loss in the absence of a bacterial plaque,
as repeatedly claimed in previous ligature induced peri-implantitis studies [4,18,19].
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2. Experimental Section
2.1. Implants
The implants used (Ospol Regular, Malmö, Sweden) were turned/machined (diameter 4 mm and
length 8 mm) from rods of commercially pure titanium (grade 4) followed by an anodising process.
Surface Roughness
The implant surface roughness was characterized by white light interferometry, GBS, mbH,
Ilmenau, Germany and MountainsMap Imaging Topography software (version 7.0, Digital Surf,
Besancon, France). Three implants were measured on nine sites each: three tops, three valleys and
three flanks. Each measurement had a size of 350 × 224 μm. Errors of form and waviness were removed
with a Gaussian filter size of 50 × 50μm. Three parameters were selected to describe the surface, one
height descriptive parameter (Sa), one spatial parameter (Sds) and one hybrid parameter (Sdr).
Sa is the average height deviation over the surface calculated from a mean plane. Calculated in
μm.
Sds is the density of summits, expressed in number/mm2.
Sdr is the increase in surface area compared to a completely flat area reference. Expressed in %.
2.2. Animal Model and Surgical Procedure
Ten male Swedish lop-eared rabbits with weight between 3.65 to 4.95 Kg were used in this
experiment, with ethical approval (number 188-15) from the Regional Ethics Committee for Animal
Research of Malmö/Lund, Sweden. All experiments were carried out in accordance with the rules and
regulations of the Swedish Board of Agriculture. The number of the animals included in the study
was selected after power analysis performed with G*Power software (version 3.1.9.4, Department of
Psychology, University of Düsseldorf, Düsseldorf, Germany) to achieved a statistical power of 80%,
given an α-error of 0.05 and an effect size of 0.8.
General anesthesia was induced by intramuscular injection of ketamin (Ketaminol; Intervet,
Stockholm, Sweden) and dexmedetomidine (Dexdomitor; Orion Pharma Animal Health, Danderyd,
Sweden) followed by subcutaneous injection of buprenorfin (Temgesic; Indivior, Berkshire, Great
Britain).
The surgical site was shaved and cleaned with chlorhexidine ethanol solution 0.5 mg/mL
(Klorhexidinsprit; Fresenius Kabi, Uppsala, Sweden) and covered with a sterile surgical drape. After
injection of lidokain 10 mg/mL (Xylocain; Aspen Nordic, Ballerup, Denmark) at the surgical sites, the
femoral and tibial metaphyseal plates were exposed by incision and dissection of covering tissue layers,
including skin, muscle and periosteum on the medial side. A total of 60 implants (n = 60) were inserted
according to Figure 1; one in each condylar metaphyseal plate and two in each tibial metaphyseal plate,
with a center to center implant distance of 10 mm.
The implant insertion and ligature application technique are depicted in Figure 2. Osteotomies
were performed with burrs of increasing diameter up to 3.5 mm under constant irrigation with
physiological saline solution. After inserting the implants halfway, a single ligature loop of sterile 3-0
braided silk (Ethicon, Cincinnati, OH, USA) were tied with a surgical knot around the neck of the (i)
right femoral, (ii) right proximal and (iii) left distal tibia implants of all rabbits. The ligature was then
compressed between the implant neck and marginal bone, by finishing the fixture insertion. With
an identical procedure, the left femoral implants were ligated with non-impregnated cotton gingival
retraction cord (GingiKNIT non-impregnated; Kerr Dental, Bioggio, Switzerland). The right distal and
left proximal implants were inserted without ligatures and used as controls. Multi-layered wound
closure was performed with resorbable sutures in fascia and skin (Vicryl 3-0, Ethicon, Cincinatti, OH,
USA) at all sites in order to ensure a submerged and non-contaminated healing environment for
all implants.
247
J. Clin. Med. 2019, 8, 1248
Figure 1. Schematic drawing of implant and ligature placement.
Figure 2. (a) Ligature tied around the implant neck after half-way insertion of the implant. (b) Ligature
compressed against the bone by finishing the implant insertion. (c) Wound closure with interrupted
resorbable sutures in a layered fashion.
At 8 weeks, the rabbits were sacrificed with a lethal injection of intra peritoneal pentobarbital
(Euthasol; Virbac, Kolding, Denmark). Femoral- (n = 20) and proximal tibial (n = 20) implants were
resected en bloc and directly immersed in 4% buffered formaldehyde (Merck, Darmstadt, Germany)
for three days.
The distal tibia samples (tissues and implants) were harvested for gene expression analysis in the
following way:
(i) The soft tissue that adhered to the implant margin was removed by a 6 mm punch after removing
the cutis.
(ii) The implants were then unscrewed and the marginal bone trephined out using a 6 mm trephine.
These respective tissues were placed in RNA-later store in +4 ◦C overnight and then −20 ◦C
until processing.
2.3. Histology
2.3.1. Histological Sample Preparation
Following the formalin fixation, the femoral (n = 20) and distal tibia (n = 20) samples were rinsed in
tap water and then dehydrated in increasing concentrations of ethanol from 70% up to 99.9% (Solveco,
Rosersberg, Sweden). The next steps involved pre-infiltration in diluted resin and pure resin followed
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by embedment in light-curing resin (Technovit 7200 VLC; Heraeus Kultzer, Wehrheim, Germany). All
samples were divided in a similar direction i.e., in the center of the implant (in a longitudinal manner
of the implant) using the cutting and grinding system, i.e., the ExaktR equipment (Exakt Apparatebau,
Norderstedt, Germany). A central section of about 150–200 μm were cut. The samples were ground
with Silicon carbide wet grinding papers of 800–1200 grit (Struers ApS, Ballerup, Denmark) to a final
thickness of about 15 μm. The section surfaces were cleaned and dried prior to histological staining in
toluidine blue mixed with pyronin G.
Finally, the sections were glass cover-slipped using a routine glue (Pertex, Histolab Products AB,
Göteborg). The sample preparation related to the cutting and grinding procedure followed the routine
laboratory-guidelines as deduced by Donath et al. [24] and Johansson and Morberg [25,26]
2.3.2. Histological Analysis: Qualitative and Quantitative
The histological sections were qualitatively and quantitatively investigated in a light microscope
(L.M., Eclipse Nikon ME600, Nikon, Tokyo, Japan) by two of the authors: C.J. and D.R. Measurements
were performed with the NIS-Elements D 64-bit software (version 3.2, Nikon Metrology, SARL, Lisses,
France) using a 10× objective. Light microscopic (LM) images of the histological features were obtained
with a Nikon DS-Ri1 camera (Nikon Instruments Inc. Meville, NY, USA). The first implant-bone contact
was ascertained with a 40× objective.
The distance from the implant top to first bone contact was measured on both sides of each
implant (anterior and posterior) sides. The difference between the distances for control versus test
(silk ligatures) samples in the proximal tibia and for the cotton versus silk samples in the femur,
were analyzed using non-parametric Wilcoxon Signed Rank with the pair considered as the control
and test samples from the same rabbit. Statistical significance was set for p < 0.05. A level of 0.05
was selected for the α-error and the statistical significance was set for p < 0.025 after Bonferroni’s
adjustment for multiple calculations. A qualitative investigation of the marginal hard and soft tissues
was also performed.
2.4. Gene Expression Analysis—qPCR
The samples for the gene expression analysis originated from the soft tissues that were in direct
contact with the implant heads in the distal tibias and bone tissue that was adherent to the implants in
distal tibia and constituted four study groups (soft tissues specimens from implants with and without
ligature and bone specimens from implants with and without ligatures). A total of 32 samples (20 soft
tissues and 12 bone tissue) were analyzed. The soft tissues were cut with sterile, disposable tissue
punches of 6 mm diameter (1 punch per specimen) and dissected from the implant surface with a
curette (Miltex, Inc. York, PA, USA).
The specimens were immediately placed in separate sterile plastic tubes containing RNAlater
solution (Ambion, Inc., Austin, TX, USA), for fixation. The samples were then stored at 4 ◦C overnight
and further stored at −20 ◦C until processing.
2.4.1. mRNA Isolation
(This step is performed to purify the mRNA from the samples.)
mRNA isolation and qPCR amplification were performed at TATAA Biocenter,
Gothenburg, Sweden.
Before mRNA isolation and extraction, the samples were thawed on ice. The samples were
extracted using Qiazol (Cat.No 79306) and the RNeasy mini kit (Cat.No 74104) (Qiagen GmbH, Venlo,
Netherlands) according to manufacturer’s instructions.
Sample concentrations where determined using spectrophotometry (Dropsense, Trinean,
Pleasanton, CA, USA) and RNA integrity was analyzed using capillary electrophoresis (Fragment
Analyzer, Thermo Fisher Scientific, Waltham, MA, USA).
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After extraction, the RNA was cleaned of inhibitory factors using the RNeasy MinElute Clean up
kit (Qiagen GmbH, Venlo, Netherlands, Cat no. 74204).
2.4.2. Reverse Transcription (RT)
(This step produces complementary DNA (cDNA) to the mRNA isolated from the respective
samples.)
RNA was reverse transcribed in single 20 μL reactions on all 32 samples.
Samples where first normalized to 33.33 ng/μL to reach a quantity of 500 ng RNA per tube that
was loaded into the reaction. The RT was performed according to manufacturer’s instructions with
TATAA Grandscript cDNA synthesis kit Cat.No A103 (TATAA Biocenter AB, Gothenburg, Sweden),
with the following concentration: 1 μL RT enzyme, 4 μL reaction mix, 15 μL normalized sample RNA.
2.4.3. Assays Design and Validation
(This step is performed to create short DNA fragments that are later used to determine each
specific region of DNA to be copied, in this case the regions that encode the proteins of interest for the
study.)
Eleven assays where designed and validated by TATAA (according to SOP 009 ver 1.2 SOP 001
ver1.4) (Validation plan qPCR assay validation). A list of all assays can be found in Table 1. For
validation, a control genomic DNA (gDNA) from male rabbit (Zyagen) and a pool of all the cDNA
samples was used. Seven-point standard curves in 10-fold dilutions were run for all the assays, in
quadruplicates. The annealing temperature was set to 60 ◦C for all assays. PCR products; gDNA, cDNA,
selected standard point and NTC were then run on Fragment Analyzer using the DNF-910-33-DNA
35-1500bp kit (Thermo Fisher Scientific, Waltham, MA, USA) to check the product lengths and primer
specificity. The qPCR data for the assay validation was analysed with GenEx software (version 6,
MultiD Analyses AB, Göteborg, Sweden) to calculate the efficiencies and performance of the assays
with a confidence interval of 95%.
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2.4.4. Real-Time Quantitative Polymerise Chain Reaction (RT-qPCR)
(This final step monitors the amplification of the selected DNA segments in real time and enables
the researcher to quantify the amount of each DNA segment at the start of the reaction.)
The cDNA samples were diluted 10× to have enough volume and were then analyzed using
TATAA SYBR GrandMaster® Mix Cat. No. TA01-625 (TATAA Biocenter AB, Gothenburg, Sweden).
Five μl of TATAA SYBR Green Master Mix, 0.4 μL of Primer (forward & reverse), 2.6 μL of nuclease-free
water and 2 μL of cDNA templates were used for each reaction mix. All pipetting was performed by
a pipetting robot (EpMotion 5070, Eppendorf, Germany). Duplicate NTCs were included for all the
assays and cDNA samples were run in duplicate reactions. Universal ValidPrime assay, Cat No. A107P
(TATAA Biocenter AB, Göteborg, Sweden) was used to compensate for possible gDNA contamination.
The quantification was performed using the LightCycler 480 (Roche, Basel, Switzerland) and
detection was performed in the SYBR channel. Cq values were based on the second derivative
maximum threshold method. Inter-plate calibrator, IPC Cat. No. IPC250 (TATAA Biocenter AB,
Göteborg, Sweden) was run on each plate to be able to correct for inter-run differences. qPCR raw data
were pre-processed and analyses with GenEx software (version 6, MultiD Analyses AB, Gothenburg,
Sweden) and were thereafter imported in Qbase+ software (version 3.1, Biogazelle, Zwijnaarde,
Belgium) for calibrated normalized relative quantification of the gene expression. Three assays were
used as reference genes (ACTB, GAPDH and LDHA) and their quality as reference genes was assessed
with the GeNorm algorithm.
2.4.5. Statistical Analysis
The gene expression results were reported as calibrated normalized relative quantities (CNRQ).
Mean and 95% confidence intervals were reported for each assay for each group.
The difference in mean between the test (silk ligated implants) and the control (pristine Ti-implant)
groups in the soft tissue samples and between the test and control groups in the bone samples were
analyzed using non-parametric Wilcoxon Signed Rank. The test and control samples from the same
rabbit were considered as paired. The level of α-error was set to 0.05 and statistical significance was
adjusted according to Bonferroni´s method for multiple testing; therefore, it was set to p < 0.0027.
3. Results
3.1. Clinical Appearance at Sacrifice
The tissue harvesting procedure is shown in Figure 3. Uneventful healing and primary wound
closure were achieved in all cases. Dissection of the tissues revealed no pus or other signs of infection
around the implants. Exposure of the bone adjacent to the implants revealed small saucerization-like
defects around most ligated implants and sometimes callus formation lateral to the ligatures. Some
control implants presented with callus formation lateral to the implants, but no saucerization-like bone
defects were noted.
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Figure 3. (a) The soft tissue covering a tibial control implant (superior) and test implant (inferior) after
removal of skin and subcutaneous tissues. (b) A small saucerization-like defect (green arrow) visible
after removal of the silk ligature around the inferior implant and callus formation (black arrow) around
the superior control implant.
3.2. Histological Results
3.2.1. Histomorphometrical Results
One implant with a cotton ligature was excluded from the histomorphometrical analysis due
to a superior displacement of the ligature and unfavorable implant location that engaged the dorsal
femoral bone plate and showed non-union of the implant on that side. The distance from the implant
top to first bone contact was significantly longer for test implants ligated with silk compared to controls
(p = 0.007) (Figure 4). This difference was due to the combined effect of bone resorption inferior to the
ligatures in the test implants and also bone gain due to callus formation adjacent to protrusive implant
tops in some control implants. The difference between implants ligated with silk or cotton was not
statistically significant (p = 0.37).
Figure 4. Box-plot showing the distance from implant top to first bone-to-implant contact for implants
with silk ligatures (Silk) and pristine implants (Control).
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3.2.2. Qualitative Histological Results
Control Implants (No Ligature Involved)
Control samples are shown in Figure 5. The control samples demonstrated both periosteal and
endosteal new bone formation. The old cortical bone surfaces, observed in regions close to the implant,
were undergoing remodeling with bone forming and bone resorption areas present. Most control
sections demonstrated that the implant interface regions consisted of new formed bone with various
amounts of bone-to-implant contact (BIC) and active bone forming regions (bone tissue covered by
osteoid with osteoblasts visible) close to the implant. In some sections, multinucleated giant cells
(MNGCs) of various sizes could be observed in close vicinity to metal oxide debris and particles (most
likely detached from the bulk implant being anodized).
Figure 5. (a) A typical example of a control sample (no ligature involved) with darker stained periosteal
and endosteal new bone formation. (b) This figure illustrates seemingly an ongoing bone remodeling
region with clear demarcation between old bone (lighter stained) and younger bone (larger osteocytes
and a bit darker stained bone tissue). Possibly some macrophages can be observed in the region closer
to the implant.
Test Implants (Ligated with Silk or Cotton)
Silk samples are shown in Figure 6. The silk samples demonstrated soft tissue encapsulation
of the material with capsules of varying thickness and sometimes also distant bony encapsulation.
The capsules appeared both as a “loose” and a “tight” formation with macrophages of various sizes
as the dominating cell type. Possibly some plasma-cells were also part of the cell population in such
regions. One section demonstrated loosened single silk fibers in the soft tissue region appearing as being
encapsulated by a rather thick formation of macrophages of various sizes and shapes. The silk material
was not in contact with bone and a capsule formation separating bone and silk could sometimes be
observed. In five samples, MNGCs could be seen as long elongated rims that captured the silk material
(i.e., foreign body reaction). This rim of cells was involved in a soft tissue space that separated the
bone from the silk. The bone surfaces, at some distance away, showed signs of resorption but no
osteoclasts could be observed. Macrophages of various sizes and shapes were observed in the soft
tissue regions close to the implant surface. The silk material was most often located “above” the bone
surface, seemingly glued onto the implant, compared to cotton being “spread out”. One silk sample
demonstrated a shell/dome-like bone formation with marrow tissue at the periosteal side.
254
J. Clin. Med. 2019, 8, 1248
 
 
(a) (b) (c) 
  
 
(d) (e)  
Figure 6. Sample figures from different silk sections. (a) Survey figure of a typical section with a silk
ligature (arrows) above a partly resorbed cortical bone surface in the periosteal region. (b) In some
cases, the silk ligatures (in close contact to the implant) were surrounded by a thick cellular infiltrate
layer (arrows) dominated by macrophages of various sizes and shapes. Outside this formation, loose
connective tissue was formed. (c) The same section in higher resolution. (d) This figure illustrates
a rather large “dome-like” callus formation of the periosteal bone and it seems like the implant part
above the silk ligature is almost covered by new formed bone. (e) The arrows illustrate a large, elongated
multinucleated giant cell (MNGC) in intimate contact with the silk.
Cotton samples are shown in Figure 7. The majority of the sections of the cotton material could be
observed as “huge loosened regions” with the material encapsulated by soft tissue situated above the
periosteal bone surface. The capsule itself was often surrounded by bone trabecula and the interface
between the periosteal bone surface and soft tissue seemed to undergo resorption, with regions
of “mouse-eaten” bone; however, no osteoclasts could be observed. Cotton demonstrated a larger
diameter of the material than silk, with several separate “cotton rolls” visible both at a distance from
the implant and in close contact, compared to the silk. No active bone forming surface (i.e., osteoid
rim with osteoblasts) could be observed close to the soft tissue. Although the bone surface, in general,
seemed to be resorbed (“mouse-eaten” surface) no osteoclasts were visible, except in one cotton-section.
In higher magnification MNGCs could be observed in close vicinity to cotton. Macrophages were also
visible but seemingly in less amount (albeit not counted) compared to silk. Cotton seemed to have
a greater soft tissue area surrounding the material compared to silk, which possibly indicated a higher
degree of encapsulation of cotton compared to silk.
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(a) (b) (c) 
Figure 7. Three images from one cotton section with arrows showing the cotton ligature. (a) An
illustration of a typical section with cotton suture situated above the periosteal bone. (b) The periosteal
bone surface is separated from the cotton ligature by a soft tissue layer and the bone surface appears to
be resorbed (arrows), although no osteoclasts could be observed. (c) The amount of macrophages in the
soft tissue between the bone and the cotton seemed to be less compared to the silk sections. However,
macrophages were visible as being more spread out and “darker” compared to silk samples. None of
the cotton samples demonstrated a typical MNGC formation and the “encapsulation” of cotton was
often loosely arranged (arrows).
3.3. Gene Expression Results
The expression of a panel of genes in the soft tissue around titanium implants either left pristine
(control) or treated with a silk ligature placed around the implant neck (test) was evaluated with
RT-qPCR. The relative expressions of the selected markers are presented in Table 2 and Figure 8 for
soft tissue and in Table 3 and Figure 9 for bone tissue.
Table 2. Relative expression of the selected gene targets in the soft tissues around implants with silk
ligature versus the soft tissues around controls (no ligature involved).
Target Gene Relative Expression in Test versus Control 95% CI Low 95% CI High p-Value
NCF1 4.9 1.9 12.4 0.008
CD11β 2.8 1.5 5.4 0.016
CD4 2.3 1.7 3.1 0.016
VEGFα 1.6 1.0 2.5 0.05
TNFα 1.7 0.9 2.9 0.08
ARG1 2.4 0.9 6.5 0.11
IL8 0.5 0.2 1.2 0.11
FGF2 0.8 0.5 1.2 0.11
CD8 3.9 0.5 27.4 0.22
CD19 2.1 0.5 12.3 0.22
OC 1.7 0.7 4.2 0.25
C5aR1 1.3 0.9 2.0 0.31
TRAP 1.7 0.5 5.4 0.37
IL1β 0.7 0.2 2.5 0.58
IL6 0.8 0.3 2.5 0.58
ALPL 1.2 0.5 3.1 0.64
MCP1 0.9 0.3 2.8 0.84
CTSK 1.0 0.7 1.5 0.84
CI = confidence interval. p-value was calculated with Wilcoxon Signed Rank test, significance level was set to
p ≤ 0.0027 after Bonferroni´s adjustment for multiple testing. No gene showed significant difference in expression.
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Figure 8. Up and down regulation of the selected markers in the soft tissues around implants with silk
ligatures versus controls (no ligature).
Table 3. Relative expression of the selected gene targets in the bone around implants with silk ligature





95% CI Low 95% CI High p-Value
IL6 0.1 0.0 0.9 0.04
CTSK 0.7 0.5 1.0 0.04
OC 0.6 0.4 1.1 0.07
NCF1 3.5 0.8 15.2 0.07
MCP1 2.2 0.8 5.9 0.08
CD19 2.7 0.6 12.3 0.13
CD11β 2.6 0.6 12.2 0.14
TNFα 0.4 0.1 2.3 0.19
FGF2 0.6 0.2 1.6 0.19
IL1β 2.1 0.5 8.8 0.19
IL8 0.5 0.1 2.4 0.26
C5aR1 1.9 0.4 9.3 0.28
CD4 2.6 0.3 25.0 0.28
CD8 1.4 0.4 5.2 0.42
TRAP 2.2 0.1 40.0 0.46
VEGFα 1.8 0.2 20.4 0.49
ALPL 0.8 0.2 4.4 0.76
CI = confidence interval. p-value calculated with Wilcoxon Signed Rank test, significance level was set to p ≤ 0.0027
after Bonferroni´s adjustment for multiple testing. No gene showed significant difference in expression.
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Figure 9. Up and down regulation of the selected markers in the bone around implants with silk
ligatures versus controls (no ligature).
In the soft tissues near the silk ligature, several genes mediating reactions of immune cells were
more than two-folds up-regulated compared to the controls. Those were NCF1 (CNRQ 4.9), which
is specific for neutrophils, CD8 (CNRQ 3.9), which is a marker for T-lymphocytes, CD11β (CNRQ
2.8), a M1 macrophages marker, ARG1 (CNRQ 2.4), a marker for M2 macrophages, CD4 (CNRQ 2.3),
which is another gene specific for T-lymphocytes, and CD19 (CNRQ 2.1), which is associated with
B-lymphocytes. One gene, IL8, related to macrophages was two-folds down-regulated in the tests
versus the controls. None of the markers reached a level of significance of p ≤ 0.0025 in expression
between the tests and the controls, which was the adjusted p-value (Table 2, Figure 8).
In the bone surrounding the implants ligated with silk, six genes related to the immune response
were expressed more than two-folds compared to the bone surrounding pristine implants. Of those,
four were the same that were overexpressed in the soft tissues near the ligatures: NCF1 (CNRQ 3.5),
CD19 (CNRQ 2.7), CD11β (CNRQ 2.6) and CD4 (CNRQ 2.6). Other genes up-regulated in the bone of
the test samples were MCP1 (CNRQ 2.2), which is related to macrophage fusion, ILβ1 (CNRQ 2.1)
which is another gene related to M1 macrophages, and Triiodothyronine receptor auxiliary protein
(TRAP) (CNRQ 2.2), which is an osteoclast marker for bone resorption.
Three genes were instead two-folds or more down-regulated in the bone around the test implants
compared to the controls. They were IL6 (CNRQ 0.1), which is a cytokine related to inflammation,
but also to bone formation [1], TNFα (CNRQ 0.4), another cytokine related to inflammation, and IL8
(CNRQ 0.5), which is related to macrophages and that was down-regulated also in the soft tissues of
the test implants. None of these investigated genes in the bone reached a level of significant difference
in expression for p ≤ 0.0025 (Table 3, Figure 9).
4. Discussion
The current study described marginal peri-implant bone and soft tissue reactions to marginal silk
and cotton ligatures without plaque accumulation. Our findings present clear criticism to the present
interpretation of ligature models that they verify bacteria to be the initiating problem behind marginal
bone loss. In reality, previous claims that ligatures induce bone loss solely by plaque accumulation and
not by themselves are incorrect [4,18,26]. The present findings also raise questions as to what extent
potential clinical provocations may also induce bone loss. Consider for example apically displaced
cementum residues, unsuitable, lose or ill-fitting abutments or increasing amounts of wear debris
in peri-implant tissues over time. Indeed, wear particles of both cementum and titanium has been
found in abundance in human biopsies of peri-implantitis lesions [27]. Furthermore, the possible
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role of sterile Ti debris in the development of soft tissue inflammation and marginal bone resorption
was recently demonstrated by Wang et al., who showed marginal bone resorption around submerged
titanium implants in Sprauge Dawley rats and also demonstrated a role of M1 macrophages in that
process. [28]. Future studies may strive to provide more knowledge about potential aseptic causes for
marginal bone resorption, with the ultimate goal to prevent and treat such conditions.
As described by Donath et al., the body will always strive to alienate an implanted material by
rejection, dissolution, resorption, demarcation (i.e., fibrous or bony encapsulation) or a combination of
these reactions [29]. The type and extent of the immunological response has been shown to depend
on multiple factors, such as material type, surface characteristics, type of receiving tissue, degree of
surgical trauma, micromovement between material and host and other factors [7,29]. From studies on
osteoimmunology we know that focal bone loss is achieved by osteoclasts when activated by adjacent
inflammation, and that TNFα is likely the most significant inflammatory cytokine necessary to activate
the osteoclasts [30]. TNFα is expressed in the acute inflammatory response against many types of
provocations, such as surgical trauma or presence of infectious microorganisms, necrotic tissue or
certain foreign materials. Hence, bone resorption can be expected to occur from almost any type of
adjacent, pro-inflammatory provocation of a certain magnitude and may also be continuous if the
provocation is sustained or repeated. In experimental peri-implantitis, this is well-exemplified by the
rapid marginal bone loss that often occurs when ligatures are frequently exchanged and new ligatures
are pushed apically towards the bone, as compared to the frequent self-containing resorption that often
occurs from non-exchanged ligatures [17].
The extensive, macrophage-dominated infiltrates adjacent to the silk and cotton ligatures in the
present study demonstrates a stronger inflammatory reaction to the ligatures compared to non-ligated
control implants, which may likely explain the resorbed bone defects frequently found adjacent to
the ligatures. Macrophages can initiate bone resorption in different ways: indirectly by secretion of
pro-inflammatory cytokines that stimulate osteoclast generation and activation as described above [30]
or directly by the secretion of certain matrix metalloproteinases that can degrade bone matrix [31].
However, the present study demonstrated a late stage foreign body reaction, with fibrous encapsulation
of the ligatures, lack of up-regulation of the pro-inflammatory cytokine markers for TNFα, IL1β
and IL6 in the soft tissues around them and seemingly arrested bone resorption as evident by the
lack of osteoclasts in the resorbed bone defects adjacent to them. This late stage reaction was likely
due to the long healing time of 8 weeks and is consistent with the previous findings of Setzen et al.,
who reported a quite extensive inflammatory response to black braided silk sutures during the first
few weeks, followed by the thickest fibrous capsule formation compared to 10 other suture types
inserted subcutaneously in rabbits [32]. Recent findings by Nguyen et al. suggested that active bone
resorption occurs much earlier, even when plaque accumulation is allowed. In their recent experimental
peri-implantitis study in mice, high expression levels of TNFα and IL1 were observed during the first
2 weeks after application of plaque accumulating 5-0 silk-ligatures, followed by a subsequent decrease
back to baseline levels after 4 weeks. Simultaneously, the number of osteoclasts and rate of marginal
bone resorption both decreased towards the end of the study at 4 weeks [23]. The tissue reactions to
strictly bacterial assaults also share many similarities, and is perhaps best exemplified by the closed
confines of the periapical bone, when provoked by endodontic pathogens. As explained by Nair et al.,
the endodontic pathogens typically trigger an acute inflammatory reaction with simultaneous active
bone resorption, followed by a chronic stage, or equilibrium, with arrested bone resorption and a dense
fibrous capsule that shields off the inflammatory infiltrate from the bone while it continues to hold
back the infection [33]. New acute episodes may then be triggered years later, in response to changed
local or systemic circumstances.
In contrast to the complex combined assault of repeated mechanic tissue trauma, hostile ligatures
and hostile bacteria provided by classical experimental peri-implantitis, the present study demonstrated
the isolated capacity of silk and cotton ligature to initiate bone loss. While the distance from the
implant top to the first bone contact point varied significantly between silk and controls, the difference
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between silk and cotton was not significant. However, the fact that the soft tissue capsules that
separated the ligatures from the bone were thicker around cotton than silk, may indicate a more
consistent bone resorption against cotton. Future studies could benefit from a histomorphometrical
method, which unfortunately cannot be performed successfully on non-decalcified, resin-embedded,
cut-and-ground sections. The difference in bone loss between similar study subjects (the rabbits in our
study) conforms to the findings of traditional ligature induced peri-implantitis studies, where the time
to achieve a certain amount of bone loss has also varied greatly [34,35]. These differences are likely
due to both immunological differences between animals, as indicated by recent knock out models [36],
as well as methodological aspects such as possible variations in the distance between ligature and
bone at the time of ligation. The choice of a rabbit model in the present study makes it difficult to
compare the present results to those of previous studies that used different mammals as experimental
models, considering the great differences in the resulting bone loss for different animal species [17].
For example, Beagle dogs have shown >3 mm of bone loss after 10-weeks with ligatures [37], while
monkeys have sometimes required a year of regularly exchanged ligatures to induce 1 mm of bone
loss [15].
Another important difference between the present and previous studies was the simultaneous
implant and ligature insertion, as opposed to the few months of implant healing before ligation utilized
in the majority of previous studies. Jovanovic et al. demonstrated that the amount of marginal bone loss
and configuration of peri-implant pockets did not differ from ligation at implant placement compared
to a preceding 3 months implant healing time [38].
Although the impact of the ligature has often been overlooked in ligature induced peri-implantitis
studies, as evident from the fact that some authors have not specified any details about the type of
material used [39,40], information about the ligature materials can be found from other research fields.
The most commonly used ones are the organic materials cotton and silk. In surgery, cotton gauze
sponges are used to soak up fluids and maintain the surgical field, but are then carefully removed from
the tissues due to their capacity to provoke extensive foreign body reactions. When extensive, these
foreign body reactions can manifest themselves as tumor-like lesions referred to as cotton-ballomas
or gossypibomas. In some cases, these lesions have induced significant bone resorption and may
then mimic an osteolytic tumour such as a sarcoma [41,42]. A study on mice also showed that even
microscopic remnants of sterile cotton may induce foreign body reactions when left in a surgical
wound [43].
Silk, on the other hand, has been used as a suture material for over a century, and the black,
braided silk sutures used in the present study are made from fibroin, extracted from virgin Bombyx
mori silk in a process that separates the fibroin from a second, glue-like protein called sericin [44].
In addition to fibroin, the utilized suture type also contains a beeswax coating. It is unknown to what
extent this particular coating affects the immunological response, but it should be noted that beeswax
is the main ingredient of bone wax, a product used to stop osseous bleeding during surgery and well
known to arrest bone healing and induce significant foreign body reactions [45]. Older pre-1980s
silk sutures contained both fibroin and sericin and were known to induce considerable acute and
chronic inflammatory responses, as well as frequent late allergic reactions. Modern fibroin type silk
sutures very rarely induce allergy, but still elicit a relatively strong acute inflammatory reaction in
the early healing phase. Silk also undergoes slow proteolytic degradation, even though the sutures
are defined as non-resorbable [44,46]. Spelzini et al., compared two types of fibroin silk implants
with a polypropylene implant for fascial repair in mice and reported a somewhat stronger acute
inflammatory reaction to the silk implants, followed by a much stronger chronic inflammatory response
with progressive accumulation of chronic inflammatory cells up until 30 days that remained virtually
unchanged after 90 days. They also reported a high initial presence of polymorphnuclear neutrophil
(PMN) cells, which subsequently dropped in numbers with time but still remained in smaller numbers
after 90 days [46].
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The clinical significance of the PCR results of the present study must be considered in light of
the histological sections and the evident late healing stage and arrested bone resorption described
above. It must also be kept in mind that the PCR results only demonstrate the difference between
test (silk ligature) and control (no ligature) implants, and hence do not show the immunological
reaction to the Ti-implants that were identical for tests and controls. For example, CD11β was 2.8 times
upregulated in the present study but 13 times upregulated in response to Ti compared to sham after
28 days in a previous rabbit study, which suggests a pronounced immunological reaction dominated
by macrophages to Ti that was masked in the present study design [47]. Additional biopsies at
baseline or from untouched distant tissues at sacrifice may facilitate the interpretation in future studies.
Regarding the bone specimens, the small differences between tests and controls may in part be due to
the harvesting technique, considering that the entire implants + surrounding bone were harvested and
analyzed, while only a very small marginal portion of them was ever in contact with the ligatures.
With the above factors in mind, the more than two-fold upregulation of the soft tissue markers
NCF1, CD11β, and CD4, ARG1, CD8 and CD19 for silk ligated test implants compared to pristine
implants demonstrated a greater activation of the immune response in the test compared to the
controls that corresponded to the chronic inflammatory cell infiltrates present around the ligatures.
The upregulation of CD11β and ARG1 indicate a mixed M1/M2 phenotype of the macrophages in
this tissue. CD4 and CD8 upregulation indicate T-cell presence. T-cells play a key role in antigen
specific defense, but are also involved in foreign body reactions in absence of known antigens [48].
Their increased presence in the present study may correspond to the larger number of adherent
macrophages and MNGCs on the silk ligatures as compared to controls (Ti), as demonstrated by
Brodbeck et al., who described that lymphocytes (mainly CD8+ T-cells and CD4+ T-cells) “rosetted
around” biomaterial-adherent macrophages and MNGCs in a co-cell culture study [48]. The authors
further demonstrated that the presence of lymphocytes augmented macrophage adherence to
biomaterials as well as MNGC-fusion, when both cell types were present from the start of the
in vitro experiment [48]. However, a later study on T-cell deficient mice demonstrated a seemingly
normal foreign body response with adhesion and fusion of macrophages to an implanted material
even in absence of T-cells, which indicates that, while present, T-cells are probably not necessary
for a normal foreign body reaction to occur [49]. The prolonged neutrophil presence in soft tissue
indicated by upregulation of NCF1 further indicates a more pronounced foreign body reaction to the
silk ligatures than controls (no ligature involved). Recent studies demonstrate a long-term role of
neutrophils in foreign body reactions, as well as a capacity for them to regulate the long term reaction
toward an implant [50]. Jhunjhunwala et al., recently demonstrated a 30-500-fold increased neutrophil
presence in the peritoneal lavage of mice in response to sterile implanted microcapsules after 2 weeks,
which is much longer than the hours or few days they have previously been thought to survive at
a wound site. Jhunjhunwala et al. further demonstrated that the neutrophils became activated in
response to the implant, resulting in the secretion of different immunomodulatory cytokines and
chemokines and formation of extracellular traps (NETs) on the material surface [51]. The increasing
knowledge about the pivotal role of neutrophils in the regulation of foreign body reactions suggests
that a strong acute inflammation, associated with the implantation, can predispose an equally strong
chronic inflammation orchestrated by neutrophils and characterized by prolonged neutrophil presence
and frustrated phagocytosis in the very long run [50]. Beside the impact of material properties on the
long-term neutrophil response indicated in the present study, the eventual influence of other factors,
such as traumatic surgery and pre-existing disorders that influence the inflammatory response, such as
diabetes, may be considered in future studies [52–54].
The immunological reactions to aseptic provocations of dental implants remains largely unexplored
and future studies may focus on investigating the details in the immune response to different
provocations at different time points throughout the healing phase, as well as refining the methods for
such investigation.
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5. Conclusions
Within the limitations of the present study, it was demonstrated that aseptic marginal ligatures
made of silk and cotton triggered an immunological reaction in the peri-implant tissue of rabbits,
with abundant numbers of inflammatory cells in contact with the ligatures. Marginal bone resorption
was also evident adjacent to the ligatures, which rejected our null-hypothesis that ligatures cannot
induce bone resorption in the absence of a bacterial plaque. Future studies may aim to describe the
tissue reactions at both earlier and later time points, as well as further elucidate the details of the
immunological events responsible for bone resorption adjacent to aseptic marginal ligatures.
Author Contributions: Conceptualization, D.R., S.G., T.A., P.T. and A.W.; Data curation, S.G., P.H.J. and A.W.;
Formal analysis, D.R., P.H.J. and A.W.; Funding acquisition, A.W.; Investigation, D.R., S.G., T.A., P.H.J. and A.W.;
Methodology, D.R., S.G., T.A., P.T., C.B.J. and P.H.J.; Project administration, T.A., and A.W.; Supervision, T.A., P.T.,
C.B.J. and A.W.; Validation, C.B.J.; Visualization, D.R., S.G., C.B.J. and P.H.J.; Writing—Original Draft, D.R., S.G.,
C.B.J. and P.H.J.; Writing—Review & Editing, D.R., S.G., T.A., P.T., C.B.J. and A.W.
Funding: This study was funded by the Swedish Research Council grant number 2015-02971.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Moraschini, V.; Poubel, L.A.; Ferreira, V.F.; Barboza Edos, S. Evaluation of survival and success rates of dental
implants reported in longitudinal studies with a follow-up period of at least 10 years: A systematic review.
Int. J. Oral Maxillofac Surg. 2015, 44, 377–388. [CrossRef] [PubMed]
2. Doornewaard, R.; Christiaens, V.; De Bruyn, H.; Jacobsson, M.; Cosyn, J.; Vervaeke, S.; Jacquet, W. Long-Term
Effect of Surface Roughness and Patients’ Factors on Crestal Bone Loss at Dental Implants. A Systematic
Review and Meta-Analysis. Clin. Implant. Dent. Relat. Res. 2017, 19, 372–399. [CrossRef] [PubMed]
3. Albrektsson, T.; Buser, D.; Sennerby, L. Crestal bone loss and oral implants. Clin. Implant. Dent. Relat Res.
2012, 14, 783–791. [CrossRef] [PubMed]
4. Lindhe, J.; Berglundh, T.; Ericsson, I.; Liljenberg, B.; Marinello, C. Experimental breakdown of peri-implant
and periodontal tissues. A study in the beagle dog. Clin. oral implant res. 1992, 3, 9–16. [CrossRef]
5. Zitzmann, N.U.; Berglundh, T. Definition and prevalence of peri-implant diseases. J. Clin. Periodontol. 2008,
35, 286–291. [CrossRef] [PubMed]
6. Albrektsson, T.; Dahlin, C.; Jemt, T.; Sennerby, L.; Turri, A.; Wennerberg, A. Is marginal bone loss around oral
implants the result of a provoked foreign body reaction? Clin. Implant Dent. Relat. Res. 2014, 16, 155–165.
[CrossRef]
7. Albrektsson, T.; Chrcanovic, B.; Ostman, P.O.; Sennerby, L. Initial and long-term crestal bone responses to
modern dental implants. Periodontology 2000 2017, 73, 41–50. [CrossRef]
8. Frydman, A.; Simonian, K. Review of models for titanium as a foreign body. C.D.A. J. 2014, 42, 829–833.
9. Jemt, T.; Sunden Pikner, S.; Grondahl, K. Changes of Marginal Bone Level in Patients with “Progressive
Bone Loss” at Branemark System(R) Implants: A Radiographic Follow-Up Study over an Average of 9 Years.
Clin. Implant Dent. Relat. Res. 2015, 17, 619–628. [CrossRef]
10. Albrektsson, T.; Becker, W.; Coli, P.; Jemt, T.; Molne, J.; Sennerby, L. Bone loss around oral and orthopedic
implants: An immunologically based condition. Clin. Implant Dent. Relat. Res. 2019. [CrossRef]
11. Harris, W. Vanishing Bone—Conquering a Stealth Disease Caused by Total Hip Replacements; Oxford Press: Oxford,
UK, 2018.
12. Landgraeber, S.; Jäger, M.; Jacobs, J.J.; Hallab, N.J. The pathology of orthopedic implant failure is mediated
by innate immune system cytokines. Mediators Inflamm. 2014, 2014, 185150. [CrossRef] [PubMed]
13. Jiang, Y.; Jia, T.; Wooley, P.H.; Yang, S.Y. Current research in the pathogenesis of aseptic implant loosening
associated with particulate wear debris. Acta. Orthop. Belg. 2013, 79, 1–9. [PubMed]
14. Abrahamsson, I.; Berglundh, T.; Lindhe, J. Soft tissue response to plaque formation at different implant
systems. A comparative study in the dog. Clin. Oral Implants Res. 1998, 9, 73–79. [CrossRef] [PubMed]
15. Lang, N.P.; Bragger, U.; Walther, D.; Beamer, B.; Kornman, K.S. Ligature-induced peri-implant infection in
cynomolgus monkeys. I. Clinical and radiographic findings. Clin. Oral Implants Res. 1993, 4, 2–11. [CrossRef]
[PubMed]
262
J. Clin. Med. 2019, 8, 1248
16. Watzak, G.; Zechner, W.; Tangl, S.; Vasak, C.; Donath, K.; Watzek, G. Soft tissue around three different implant
types after 1.5 years of functional loading without oral hygiene: A preliminary study in baboons. Clin. Oral
Implants Res. 2006, 17, 229–236. [CrossRef] [PubMed]
17. Reinedahl, D.; Chrcanovic, B.; Albrektsson, T.; Tengvall, P.; Wennerberg, A. Ligature-Induced Experimental
Peri-Implantitis-A Systematic Review. J. Clin. Med. 2018, 7. [CrossRef] [PubMed]
18. Moest, T.; Wrede, J.; Schmitt, C.M.; Stamp, M.; Neukam, F.W.; Schlegel, K.A. The influence of different
abutment materials on tissue regeneration after surgical treatment of peri-implantitis—A randomized
controlled preclinical study. J. Craniomaxillofac. Surg. 2017, 45, 1190–1196. [CrossRef] [PubMed]
19. Carcuac, O.; Abrahamsson, I.; Albouy, J.P.; Linder, E.; Larsson, L.; Berglundh, T. Experimental periodontitis
and peri-implantitis in dogs. Clin. Oral Implants Res. 2013, 24, 363–371. [CrossRef]
20. Rovin, S.; Costich, E.R.; Gordon, H.A. The influence of bacteria and irritation in the initiation of periodontal
disease in germfree and conventional rats. J. Periodontal Res. 1966, 1, 193–204. [CrossRef]
21. Martins, O.; Ramos, J.C.; Baptista, I.P.; Dard, M.M. The dog as a model for peri-implantitis: A review.
J. Investig. Surg. 2014, 27, 50–56. [CrossRef]
22. Baron, M.; Haas, R.; Dortbudak, O.; Watzek, G. Experimentally induced peri-implantitis: A review of
different treatment methods described in the literature. Int. J. Oral Maxillofac. Implants 2000, 15, 533–544.
23. Nguyen Vo, T.N.; Hao, J.; Chou, J.; Oshima, M.; Aoki, K.; Kuroda, S.; Kaboosaya, B.; Kasugai, S. Ligature
induced peri-implantitis: Tissue destruction and inflammatory progression in a murine model. Clin. Oral
Implants Res. 2017, 28, 129–136. [CrossRef]
24. Donath, K.; Breuner, G. A method for the study of undecalcified bones and teeth with attached soft tissues.
The Sage-Schliff (sawing and grinding) technique. J. Oral Pathol. 1982, 11, 318–326. [CrossRef]
25. Johansson, C.B.; Morberg, P. Importance of ground section thickness for reliable histomorphometrical results.
Biomaterials 1995, 16, 91–95. [CrossRef]
26. Johansson, C.B.; Morberg, P. Cutting directions of bone with biomaterials in situ does influence the outcome
of histomorphometrical quantifications. Biomaterials 1995, 16, 1037–1039. [CrossRef]
27. Wilson, T.G.; Valderrama, P.; Burbano, M.; Blansett, J.; Levine, R.; Kessler, H.; Rodrigues, D.C. Foreign bodies
associated with peri-implantitis human biopsies. J. Periodontol. 2015, 86, 9–15. [CrossRef]
28. Wang, X.; Li, Y.; Feng, Y.; Cheng, H.; Li, D. Macrophage polarization in aseptic bone resorption around dental
implants induced by Ti particles in a murine model. J. Periodontal Res. 2019. [CrossRef]
29. Donath, K.; Laass, M.; Günzl, H.J. The histopathology of different foreign-body reactions in oral soft tissue
and bone tissue. Virchows. Arch. A 1992, 420, 131–137. [CrossRef]
30. Mbalaviele, G.; Novack, D.V.; Schett, G.; Teitelbaum, S.L. Inflammatory osteolysis: A conspiracy against
bone. J. Clin. Invest. 2017, 127, 2030–2039. [CrossRef]
31. Paiva, K.B.S.; Granjeiro, J.M. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.
Prog Mol. Biol. Transl. Sci. 2017, 148, 203–303. [CrossRef]
32. Setzen, G.; Williams, E.F., 3rd. Tissue response to suture materials implanted subcutaneously in a rabbit
model. Plast. Reconstr. Surg. 1997, 100, 1788–1795. [CrossRef]
33. Nair, P.N. Pathogenesis of apical periodontitis and the causes of endodontic failures. Crit. Rev. Oral Biol. Med.
2004, 15, 348–381. [CrossRef]
34. You, T.M.; Choi, B.H.; Zhu, S.J.; Jung, J.H.; Lee, S.H.; Huh, J.Y.; Lee, H.J.; Li, J. Treatment of experimental
peri-implantitis using autogenous bone grafts and platelet-enriched fibrin glue in dogs. Oral Surg. Oral Med.
Oral Pathol. Oral Radiol. Endod. 2007, 103, 34–37. [CrossRef]
35. Schou, S.; Holmstrup, P.; Jorgensen, T.; Stoltze, K.; Hjorting-Hansen, E.; Wenzel, A. Autogenous bone graft
and ePTFE membrane in the treatment of peri-implantitis. I. Clinical and radiographic observations in
cynomolgus monkeys. Clin. Oral Implants Res. 2003, 14, 391–403. [CrossRef]
36. Yu, X.; Hu, Y.; Freire, M.; Yu, P.; Kawai, T.; Han, X. Role of toll-like receptor 2 in inflammation and alveolar
bone loss in experimental peri-implantitis versus periodontitis. J. Periodontal Res. 2018, 53, 98–106. [CrossRef]
37. Albouy, J.P.; Abrahamsson, I.; Berglundh, T. Spontaneous progression of experimental peri-implantitis at
implants with different surface characteristics: An experimental study in dogs. J.Clin. Periodontol. 2012, 39,
182–187. [CrossRef]
38. Jovanovic, S.A.; Kenney, E.B.; Carranza, F.A., Jr.; Donath, K. The regenerative potential of plaque-induced
peri-implant bone defects treated by a submerged membrane technique: An experimental study. Int. J. Oral
Maxillofac. Implants 1993, 8, 13–18.
263
J. Clin. Med. 2019, 8, 1248
39. Hayek, R.R.; Araujo, N.S.; Gioso, M.A.; Ferreira, J.; Baptista-Sobrinho, C.A.; Yamada, A.M.; Ribeiro, M.S.
Comparative study between the effects of photodynamic therapy and conventional therapy on microbial
reduction in ligature-induced peri-implantitis in dogs. J. Periodontol. 2005, 76, 1275–1281. [CrossRef]
40. Machtei, E.E.; Kim, D.M.; Karimbux, N.; Zigdon-Giladi, H. The use of endothelial progenitor cells combined
with barrier membrane for the reconstruction of peri-implant osseous defects: An animal experimental study.
J. Clin. Periodontol. 2016, 43, 289–297. [CrossRef]
41. Abdul-Karim, F.W.; Benevenia, J.; Pathria, M.N.; Makley, J.T. Case report 736: Retained surgical sponge
(gossypiboma) with a foreign body reaction and remote and organizing hematoma. Skeletal Radiol. 1992, 21,
466–469.
42. Puvanesarajah, V.; Fayad, L.M.; Rao, S.S.; McCarthy, E.F.; Morris, C.D. Extremity gossypiboma mimicking
sarcoma: Case report and review. Skeletal Radiol. 2019, 48, 629–635. [CrossRef]
43. Sari, A.; Basterzi, Y.; Karabacak, T.; Tasdelen, B.; Demirkan, F. The potential of microscopic sterile sponge
particles to induce foreign body reaction. Int. Wound J. 2006, 3, 363–368. [CrossRef]
44. Altman, G.H.; Diaz, F.; Jakuba, C.; Calabro, T.; Horan, R.L.; Chen, J.; Lu, H.; Richmond, J.; Kaplan, D.L.
Silk-based biomaterials. Biomaterials 2003, 24, 401–416. [CrossRef]
45. Nooh, N.; Abdullah, W.A.; Grawish Mel, A.; Ramalingam, S.; Javed, F.; Al-Hezaimi, K. The effects of surgicel
and bone wax hemostatic agents on bone healing: An experimental study. Indian J. Orthop. 2014, 48, 319–325.
[CrossRef]
46. Spelzini, F.; Konstantinovic, M.L.; Guelinckx, I.; Verbist, G.; Verbeken, E.; De Ridder, D.; Deprest, J. Tensile
strength and host response towards silk and type i polypropylene implants used for augmentation of fascial
repair in a rat model. Gynecol. Obstet. Invest. 2007, 63, 155–162. [CrossRef]
47. Trindade, R.; Albrektsson, T.; Galli, S.; Prgomet, Z.; Tengvall, P.; Wennerberg, A. Osseointegration and foreign
body reaction: Titanium implants activate the immune system and suppress bone resorption during the first
4 weeks after implantation. Clin. Implant. Dent. Relat. Res. 2018, 20, 82–91. [CrossRef]
48. Brodbeck, W.G.; Macewan, M.; Colton, E.; Meyerson, H.; Anderson, J.M. Lymphocytes and the foreign body
response: Lymphocyte enhancement of macrophage adhesion and fusion. J. Biomed. Mater. Res. A 2005, 74,
222–229. [CrossRef]
49. Rodriguez, A.; Macewan, S.R.; Meyerson, H.; Kirk, J.T.; Anderson, J.M. The foreign body reaction in
T-cell-deficient mice. J. Biomed. Mater. Res. A 2009, 90, 106–113. [CrossRef]
50. Selders, G.S.; Fetz, A.E.; Radic, M.Z.; Bowlin, G.L. An overview of the role of neutrophils in innate immunity,
inflammation and host-biomaterial integration. Regen. Biomater. 2017, 4, 55–68. [CrossRef]
51. Jhunjhunwala, S.; Aresta-DaSilva, S.; Tang, K.; Alvarez, D.; Webber, M.J.; Tang, B.C.; Lavin, D.M.; Veiseh, O.;
Doloff, J.C.; Bose, S.; et al. Neutrophil Responses to Sterile Implant Materials. PLoS ONE 2015, 10, e0137550.
[CrossRef]
52. Laffey, J.G.; Boylan, J.F.; Cheng, D.C. The systemic inflammatory response to cardiac surgery: Implications
for the anesthesiologist. Anesthesiology 2002, 97, 215–252. [CrossRef]
53. Chrcanovic, B.R.; Albrektsson, T.; Wennerberg, A. Diabetes and oral implant failure: A systematic review.
J. Dent. Res. 2014, 93, 859–867. [CrossRef]
54. Chrcanovic, B.R.; Albrektsson, T.; Wennerberg, A. Reasons for failures of oral implants. J. Oral Rehabil. 2014,
41, 443–476. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution





Bone Immune Response to Materials, Part I: Titanium,
PEEK and Copper in Comparison to Sham at 10 Days
in Rabbit Tibia
Ricardo Trindade 1,*, Tomas Albrektsson 2,3, Silvia Galli 3, Zdenka Prgomet 4, Pentti Tengvall 2
and Ann Wennerberg 1
1 Department of Prosthodontics, Faculty of Odontology, The Sahlgrenska Academy, University of Gothenburg,
405 30 Gothenburg, Sweden; ann.wennerberg@odontologi.gu.se
2 Department of Biomaterials, Institute of Clinical Sciences, University of Gothenburg, 405 30 Gothenburg,
Sweden; tomas.albrektsson@biomaterials.gu.se (T.A.); pentti.tengvall@gu.se (P.T.)
3 Department of Prosthodontics, Faculty of Odontology, Malmö University, 205 06 Malmö, Sweden;
silvia.galli@mau.se
4 Department of Oral Pathology, Faculty of Odontology, Malmö University, 205 06 Malmö, Sweden;
zdenka.prgomet@mau.se
* Correspondence: ricardo.bretes.trindade@gu.se
Received: 9 November 2018; Accepted: 5 December 2018; Published: 7 December 2018
Abstract: Bone anchored biomaterials have become an indispensable solution for the restoration of
lost dental elements and for skeletal joint replacements. However, a thorough understanding is still
lacking in terms of the biological mechanisms leading to osseointegration and its contrast, unwanted
peri-implant bone loss. We have previously hypothesized on the participation of immune mechanisms
in such processes, and later demonstrated enhanced bone immune activation up to 4 weeks around
titanium implants. The current experimental study explored and compared in a rabbit tibia model
after 10 days of healing time, the bone inflammation/immunological reaction at mRNA level towards
titanium, polyether ether ketone (PEEK) and copper compared to a Sham control. Samples from the
test and control sites were, after a healing period, processed for gene expression analysis (polymerase
chain reaction, (qPCR)) and decalcified histology tissue analysis. All materials displayed immune
activation and suppression of bone resorption, when compared to sham. The M1 (inflammatory)/M2
(reparative) -macrophage phenotype balance was correlated to the proximity and volume of bone
growth at the implant vicinity, with titanium demonstrating a M2-phenotype at 10 days, whereas
copper and PEEK were still dealing with a mixed M1- and M2-phenotype environment. Titanium
was the only material showing adequate bone growth and proximity inside the implant threads.
There was a consistent upregulation of (T-cell surface glycoprotein CD4) CD4 and downregulation
of (T-cell transmembrane glycoprotein CD8) CD8, indicating a CD4-lymphocyte phenotype driven
reaction around all materials at 10 days.
Keywords: osseointegration; immune system; biomaterials; foreign body reaction; in vivo study
1. Introduction
Recent evidence suggests that biomaterials induce an immunomodulatory interaction with the
host, and materials such as titanium or bone substitutes seem not at all inert upon contact with host
bone [1]. The ultimate outcome of biomaterial implantation depends on the extent of the ensuing
foreign body reaction (FBR) and related immune and inflammatory mechanisms; current scientific
efforts are focusing on understanding this complex host reaction, in order to improve the behavior of
implanted biomaterials [2]. However, the precise mechanisms of osseointegration are today not fully
understood, especially the long-term immune recognition of implants.
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The present authors have explored some immunological mechanisms in a previously published
review [3], following the hypothesis that osseointegration is nothing but a special type of immune
driven foreign body reaction to the implanted material, ending up in bone demarcation at or near
the surface [4]. The main hypothesis was that implants are not biologically inert, meaning that
the immune/inflammatory system, in this case with emphasis on the immune system, is activated
when titanium interacts with host bone—A hypothesis that later was tested and verified in a recent
4 week experimental pilot animal study, where immunological markers representing macrophages,
complement, neutrophils, lymphocytes and bone resorption markers were compared in osteotomy
sites, with and without the presence of titanium implants [5]: Titanium sites, showed significant up-/or
down-regulation of immune (and inflammatory) markers after 28 days, i.e., at a time point well into the
bone remodeling phase The immune system was apparently activated through the complement system,
displayed M1 (inflammatory) - and M2 (reparative) -macrophages phenotypes, neutrophil cytosolic
factor 1 (NCF-1), and down regulation of markers related to osteoclastic activity. Comparatively,
at an earlier stage (10 days) only the M2-macrophage (reparative) phenotype was identified around
titanium, when compared to the sham site. From earlier studies immune complement is known to
become activated at a very early time point around titanium, and materials are then recognized as
foreign objects by inflammatory cells [6]. During bone healing, and after the acute inflammatory
phase, macrophages and their classically described polarization into M1 (inflammatory) and M2
(reparative) phenotypes dominate, and are considered to be central in the host reaction to implanted
biomaterials [7,8], but the precise in vivo mechanisms are still in need of a thorough clarification.
Macrophages are also intimately related to bone biology, interacting closely with osteoblasts during
bone formation (these macrophages are named Osteomacs), and also fusing into either osteoclasts or
material related multinucleated giant cells (named Foreign Body Giant Cells), determining a further
important role for macrophages when considering bone borne biomaterials [9].
In the earlier review [3], and pertaining the current manuscript, it was further hypothesized that
the reason why different materials may or not achieve osseointegration is probably related, to some
extent, to a persistent immune patrolling resulting in a modified inflammatory reaction around the
different materials. These two concepts—That materials are not biologically inert and that a specific
persistent immune-inflammatory balance or patrolling around different materials largely dictates
whether osseointegration occurs or not—Are fundamental to our understanding of longer-term host
reactions to materials in bone.
The aim of the present exploratory in vivo study is to test the hypothesis that different materials
trigger different early immune/inflammatory responses upon implantation in rabbit bone, and that
these different responses may be important for the establishment of osseointegration, or the ultimate
lack of it.
2. Materials and Methods
The current study consists of an experiment in the rabbit proximal tibia (metaphysis), comparing
bone healing on sites where osteotomies were performed and then either left to heal without the
placement of a material (sham site- Sh), or had one of the three test materials placed for comparison:
titanium (Ti), copper (Cu) or polyether ether ketone (PEEK). Each rabbit received one site of each
group (two sites per tibia): Sh, Ti, Cu and PEEK. Ti and PEEK were placed on the right tibia
and a Sham site was produced and Cu was introduced in the other osteotomy on the left tibia.
All implants were machined with a turning process, with a threaded 0.6 mm pitch height, 3.75 mm
width Branemark MkIII design. The Ti implants were made of commercially pure titanium grade IV.
Implant manufacturers: Ti and PEEK implants were produced by Carlsson and Möller, Helsingborg,
Sweden; Copper implants were produced by TL Medical Company, Molndal, Sweden.
The sham site also provokes an inflammatory reaction, which is still present at 10 days and is
used as a baseline to compare with the immune reaction elicited by each of the different materials.
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2.1. Surgical Procedure
This study was performed on 6 mature, female New Zealand White Rabbits (n = 6, weight
3 to 4 Kg), with the ethical approval from the Ethics Committee for Animal Research (number
13-011) of the École Nationale Vétérinaire D’Alfors, Maisons-Alfors, Val-de-Marne, France. All care
was taken to minimize animal pain or discomfort during and after the surgical procedures.
For the surgical procedures, the rabbits were placed under general anesthesia using a mixture
of medetomidine (Domitor, Zoetis, Florham Park, NJ, USA), ketamine (Imalgène 1000, Merial,
Lyon, France) and diazepam (Valium, Roche, Basel, Switzerland) for induction, then applying
subcutaneous buprenorphine (Buprecare, Animalcare, York, UK) and intramuscular Meloxicam
(Metacam; Boehringer Ingelheim Vetmedica, Inc., Ridgefield, CT, USA). A single incision was
performed in the internal knee area on each side and the bone exposed for osteotomies and insertion
of implants in the sites mentioned above. The surgical site was sutured with a resorbable suture
(Vicryl 3-0, Ethicon, Cincinnati, OH, USA) and hemostasis achieved. Following surgery, Fentanyl
patches (Duragesic, Janssen Pharmaceutica, Beerse, Belgium) were applied.
The osteotomies were produced with a sequence of increasing diameter twist drills, from 2 mm to
3.15 mm width, and a final countersink bur prepared the cortical part of the bone. The implants used
were 3.75 mm in diameter.
The rabbits were housed in separate cages and were allowed to move and eat freely. At 10 days,
the rabbits were sacrificed with a lethal injection of sodium pentobarbital (Euthasol, Virbac, Fort Worth,
TX, USA). The 6 animals had the implants removed through unscrewing. On 4 of those animals,
bone was collected with a 2 mm twist drill from the periphery of the Sh, Ti, Cu and PEEK sites on the
most distal portion, and then processed for Gene Expression Analysis through quantitative polymerase
chain reaction (qPCR). The 6 animals had the test sites then removed en bloc for histological processing.
2.2. Gene Expression Analysis—qPCR
The bone samples for gene expression analysis were collected from the distal side of the
osteotomies of all four groups (following the removal of the implant from the implant sites), with a
2 mm twist drill that removed both cortical and marrow bone in the full length of the osteotomy,
to enable the study of the 2 mm peri-implant bone area of each of the Sh, Ti, Cu and PEEK sites.
The samples were immediately transferred to separate sterile plastic recipients containing RNAlater
medium (Ambion, Inc., Austin, TX, USA), for preservation. The samples were then refrigerated first at
4 ◦C and then stored at −20 ◦C until processing.
2.3. mRNA Isolation
Samples were homogenized using an ultrasound homogenizer (Sonoplus HD3100, Brandelin,
Berlin, Germany) in 1 mL PureZOL and total RNA was isolated via column fractionalization using
the AurumTM Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad Laboratories Inc., Hercules, CA, USA)
following the manufacturer’s instructions. All the samples were DNAse treated using an on-column
DNAse I contained in the kit to remove genomic DNA. The RNA quantity for each sample was
analyzed in the NanoDrop 2000 Spectrophotometer (Thermo Scientific, Wilmington, NC, USA). BioRad
iScript cDNA synthesis kit (Bio-Rad Laboratories Inc., Hercules, CA, USA) was then used to convert
mRNA into cDNA, following the manufacturer’s instructions.
qPCR primers (Tataa Biocenter, Gothenburg, Sweden) were designed following the National
Center of Biotechnology Information (NCBI) Sequence database, including the local factors chosen
in order to characterize the immune, inflammatory and bone metabolic pathways (Tables 1 and 2).
All primers had an efficiency between 90 and 110%.
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Table 1. Gene sequences.
Primer Forward Sequence Reverse Sequence Accession nr/Transcript ID
NCF-1 TTCATCCGCCACATTGCCC GTCCTGCCACTTCACCAAGA NM_001082102.1
CD68 TTTCCCCAGCTCTCCACCTC CGATGATGAGGGGCACCAAG ENSOCUT00000010382
CD11b TTCAACCTGGAGACTGAGAACAC TCAAACTGGACCACGCTCTG ENSOCUT00000001589
CD14 TCTGAAAATCCTGGGCTGGG TTCATTCCCGCGTTCCGTAG ENSOCUT00000004218
ARG1 GGATCATTGGAGCCCCTTTCTC TCAAGCAGACCAGCCTTTCTC NM_001082108.1
IL-4 CTACCTCCACCACAAGGTGTC CCAGTGTAGTCTGTCTGGCTT ENSOCUT00000024099
IL-13 GCAGCCTCGTATCCCCAG GGTTGACGCTCCACACCA ENSOCUT00000000154
M-CSF GGAACTCTCGCTCAGGCTC ACATTCTTGATCTTCTCCAGCAAC ENSOCUT00000030714
OPG TGTGTGAATGCGAGGAAGGG AACTGTATTCCGCTCTGGGG ENSOCUT00000011149
RANKL GAAGGTTCATGGTTCGATCTGG CCAAGAGGACAGGCTCACTTT ENSOCUT00000024354
TRAP TTACTTCAGTGGCGTGCAGA CGATCTGGGCTGAGACGTTG NM_001081988.1
CathK GGAACCGGGGCATTGACTCT TGTACCCTCTGCATTTGGCTG NM_001082641.1
PPAR-γ CAAGGCGAGGGCGATCTT ATGCGGATGGCGACTTCTTT NM_001082148.1
C3 ACTCTGTCGAGAAGGAACGGG CCTTGATTTGTTGATGCTGGCTG NM_001082286.1
C3aR1 CATGTCAGTCAACCCCTGCT GCGAATGGTTTTGCTCCCTG ENSOCUT00000007435
CD46 TCCTGCTGTTCACTTTCTCGG CATGTTCCCATCCTTGTTTACACTT ENSOCUT00000033915
CD55 TGGTGTTGGGTGGAGTGACC AGAGTGAAGCCTCTGTTGCATT ENSOCUT00000031985
CD59 ACCACTGTCTCCTCCCAAGT GCAATCTTCATACCGCCAACA NM_001082712.1
C5 TCCAAAACTCTGCAACCTTAACA AAATGCTTTGACACAACTTCCA ENSOCUT00000005683
C5aR1 ACGTCAACTGCTGCATCAACC AGGCTGGGGAGAGACTTGC ENSOCUT00000029180
CD3 CCTGGGGACAGGAAGATGATGAC CAGCACCACACGGGTTCCA NM_001082001.1
CD4 CAACTGGAAACATGCGAACCA TTGATGACCAGGGGGAAAGA NM_001082313.2
CD8 GGCGTCTACTTCTGCATGACC GAACCGGCACACTCTCTTCT ENSOCUT00000009383
CD19 GGATGTATGTCTGTCGCCGT AAGCAAAGCCACAACTGGAA ENSOCUT00000028895
GAPDH GGTGAAGGTCGGAGTGAACGG CATGTAGACCATGTAGTGGAGGTCA NM_001082253.1
ACT-β TCATTCCAAATATCGTGAGATGCC TACACAAATGCGATGCTGCC NM_001101683.1
LDHA TGCAGACAAGGAACAGTGGA CCCAGGTAGTGTAGCCCTT NM_001082277.1
NCF-1, neutrophil cytosolic factor 1; CD68, macrosialin; CD11b, macrophage marker; CD14, monocyte
differentiation antigen CD14; ARG1, Arginase 1; IL-4, Interleukin 4; IL-13, Interleukin 13; M-CSF, colony stimulating
factor-macrophage; OPG, osteoprotegerin; RANKL, Receptor activator of nuclear factor kappa-B ligand; TRAP,
tartrate resistant acid phosphatase; CathK, cathepsin K; PPAR-γ, peroxisome proliferator activated receptor gamma;
C3, complement component 3; C3aR1, complement component 3a receptor 1; CD46, complement regulatory protein;
CD55, decay accelerating factor for complement; CD59, complement regulatory protein; C5, complement component
5; C5aR1, complement component 5a receptor 1; CD3, T-cell surface glycoprotein CD3; CD4, T-cell surface
glycoprotein CD4; CD8, T-cell transmembrane glycoprotein CD8; CD19, B-lymphocyte surface protein CD19;
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; ACT-β, actin beta; LDHA, lactate dehydrogenase A.
Table 2. Correspondence between studied gene expression and biological entities.
Biological Entity Gene
Neutrophil NCF-1
Macrophage CD68, CD11b, CD14, ARG1
Macrophage fusion IL-4, IL-13, M-CSF
Bone resorption OPG, RANKL, TRAP, CathK, PPAR-γ
Complement Activation: C3, C3aR1, C5, C5aR1 Inhibition: CD46, CD55, CD59
T-lymphocytes CD3, CD4, CD8
B-lymphocytes CD19
Reference genes GAPDH, ACT-β, LDHA
2.4. Amplification Process
Five μL of SsoAdvanced SYBR™ Green Supermix (Bio-Rad Laboratories Inc., Hercules, CA, USA)
and 1 μL of cDNA template together with 0.4 μM of forward and reverse primer were used in the qPCR
reaction. Each cDNA sample was performed on duplicates. The thermal cycles were performed on the
CFX Connect Real-Time System (Bio-Rad Laboratories Inc., Hercules, CA, USA). The CFX Manager
Software 3.0 (Bio-Rad, Hercules, CA, USA) was used for the data analysis.
Three genes (GAPDH, ACT-β, LDHA) were selected as reference genes using the geNorm
algorithm integrated in the CFX Manager Software. A quantification cycle (Cq) value of the chosen
reference genes (Tables 1 and 2) was used as control; hence the mean Cq value of each target gene
(Table 1) was normalized against the reference gene’s Cq, giving the genes’ relative expression.
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For calculation of fold change, the ΔΔCq was used, comparing mRNA expressions from the different
groups. Significance was set at p < 0.05 and the regulation threshold at ×2-fold change.
2.5. Decalcified Bone Histology
After removal of the implants from the studied Sh, Ti, Cu and PEEK sites on the
6 subjects, bone was removed en bloc and preserved in 10% formalin (4% buffered formaldehyde,
VWR international, Leuven, Belgium) during 48 h for fixation. Samples were decalcified in ethylene
diamine tetra-acetic acid (10% unbuffered EDTA; Milestone Srl, Sorisole, Italy) for 4 weeks, with weekly
substitution of the EDTA solution, dehydrated and embedded in paraffin (Tissue-Tek TEC, Sakura
Finetek Europe BV, Leiden, The Netherlands). Samples were sectioned (4 μm thick) with a microtome
(Microm HM355S, Thermo Fischer Scientific, Walldorf, Germany) and stained with hematoxylin-eosin
(HE) for histological analysis.
2.6. Statistical Analysis
The gene expression statistical analysis was performed using the t test built in the algorithm of
the CFX Manager Software 3.0 package (BioRad, Hercules, CA, USA). The gene expression analysis
was made pair wise, each material being evaluated against the Sham in each animal.
2.7. Surface Roughness
The surface roughness of each material was measured (following Wennerberg and Albrektsson
guidelines (2000)) [10], with a white light 3D optical Profilometer, gbs, smart WLI extended
(Gesellschaft für Bild und Signal verarbeitung mbH, Immenau, Germany) using a 50× objective.
MountainsMap®Imaging Topography 7.4 (Digital Surf, Besancon, France) software was used to
evaluate the data. Surface roughness parameters were calculated after removing errors of form and
waviness. A gaussian filter with a size of 50 × 50 μm was used. The measuring area was 350 × 220
μm for all measurements, 3 copper, 3 titanium and 3 PEEK implants were measured, each implant on
9 sites (3 tops, 3 valleys and 3 flanks).
In order to characterize the surface in height, spatial and surface enlargement aspects 4 parameters
were selected; Sa that describes the average height distribution measured in μm, Sds which is a measure
of the density of summits over the measured area, measured in 1/μm2, Ssk (skewness) a parameter
that describes the asymmetry of the surface deviation from the mean plane and Sdr which describes
the surface enlargement compared to a totally flat reference area, measured in %.
3. Results
3.1. Gene Expression Analysis
Each material (Ti, Cu and PEEK) was compared against the Sh site for gene expression
regarding the immunological reaction after 10 days of healing- and considering that the Sh site
itself, also produces an immune-inflammatory reaction. The results show that when comparing Ti
sites with Sh sites (Table 3 and Figure 1), ARG1 (M2-macrophage) is statistically significantly and
almost 2-fold upregulated, while CD4 (T helper lymphocytes) is 2-fold upregulated and close to
statistical significance. This indicates an activation of the immune system already at 10 days around
Ti, when compared to Sh. On the other hand, the downregulation of both C3aR1 (complement
component 3a receptor 1) and CD8 (T cytotoxic lymphocytes) was more than 2-fold and at a
statistically significant level around Ti compared to Sh, which further supports the notion of an
immunological involvement in the host response towards titanium, as it probably represents a
biological feedback effect following activation of complement factor C3 and T cells at an earlier
stage. Furthermore, peroxisome proliferator-activated receptor gamma (PPAR-γ) is significantly
downregulated, while RANKL (Receptor activator of nuclear factor kappa-B ligand) and OPG
(osteoprotegerin) showed a non-significant downregulation, indicating an environment around Ti
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where bone resorption is apparently suppressed. Macrophage colony-stimulating factor (M-CSF) is
significantly downregulated, indicating suppression of cell (macrophage) fusion around Ti at 10 days,
into either osteoclasts or foreign body giant cells (FBGCs).











Figure 1. Volcano plot comparing the gene expression of Ti versus Sh at 10 days. Downregulation
(vertical green line) and Upregulation (vertical red line) set a ×2 regulation. Statistical significance
(horizontal blue line) set at p < 0.05—Marker is significant when above blue line.
When comparing PEEK sites with Sh sites (Table 4 and Figure 2), even if not significantly,
ARG1 (M2-macrophages), NCF-1 (neutrophils), CD68 (M1-macrophages) and CD4 (T helper cells)
are upregulated 2-fold or more around PEEK when compared to Sh sites, indicating early immune
activation around PEEK. Downregulation of CD8 (T cytotoxic cell—Significant), complement factors
(C3aR1, CD55, CD59 and C5- the last two statistically significant), strongly adds to the notion of
immune system involvement in the host reaction towards PEEK implants. The downregulation
of PPAR-gamma, RANKL, OPG, TRAP (all statistically significant) and CATHK demonstrates the
suppression of bone resorption around PEEK implants after 10 days of insertion in the bone.
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Figure 2. Volcano plot comparing the gene expression of PEEK versus Sh at 10 days. Downregulation
(vertical green line) and Upregulation (vertical red line) set a ×2 regulation. Statistical significance
(horizontal blue line) set at p < 0.05—Marker is significant when above blue line.
Around Copper (Cu) implants, when compared to Sh (Table 5 and Figure 3) at 10 days,
ARG1 (M2 macrophage), NCF1 (neutrophils) and CD4 (T helper cells) are statistically significantly
upregulated. Furthermore, even if not reaching the statistical significance level of p < 0.05,
CD19 (B cells), C5aR1 (complement C5 receptor 1), CD68, CD14 and CD11b (the latter three are
M1-macrophage markers) are upregulated. These results demonstrate a strong immune activation
around Cu upon contact with host bone tissue.
C5, CD59, CD55, CD46 and C3aR1 (complement factors) are downregulated, suggesting a
feedback effect following complement activation (which is confirmed by C5aR1 upregulation).
CD8 (T cytotoxic cell) shows a tendency for downregulation around Cu.
The statistically significant downregulation of M-CSF, with the tendency for downregulation of
IL-4, even if both not reaching a 2-fold change, suggests that at 10 days of implantation, macrophage
fusion into either osteoclasts or FBGCs is suppressed around Cu—Similar to what was observed above
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around Ti. Additionally, as for Ti and PEEK, bone resorption is suppressed around Cu at 10 days,
when compared to Sh, since PPAR-gamma is statistically significantly downregulated and the other
bone resorption markers (RANKL, OPG, TRAP and CATHK) show a tendency for downregulation.



















Figure 3. Volcano plot comparing the gene expression of Cu versus Sh at 10 days. Downregulation
(vertical green line) and Upregulation (vertical red line) set a ×2 regulation. Statistical significance
(horizontal blue line) set at p < 0.05—Marker is significant when above blue line.
3.2. Decalcified Bone Histology
Decalcified histological sections of the four groups (Sham and the three different materials) were
analyzed at a tissue level. The Sh sites display some bone formation around the osteotomy site, which is
decreasing in size after 10 days, as the new bone fills in the osteotomy defect (Figure 4). Ti sites show
new bone formation and bone remodeling in the thread areas (Figure 5). Cu sites display no bone
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formation at the interface of the implant site, showing a division (from the implant area) of a first
layer of inflammatory cells with signs of cell lysis and some foreign body giant cells, followed by a
proliferative area with parallel aligned fibers to the implant site, which in turn is followed outwards
by an area of bone remodeling, more noticeable in areas closer to cortical bone, where osteoblasts and
osteoclasts can be observed remodeling the old bone (Figure 6). PEEK sites present very little new bone
formation/remodeling areas close to the implant interface, confined to areas in cortical bone proximity,
whereas most of the interface presents only a thin proliferative area parallel to the implant site, mostly
consisting of fibrous tissue and with very few calcified islands (Figure 7). The cellular components
have all been clearly identified, neutrophils, macrophages, osteoclasts, osteoblasts, and also foreign
body giant cells. However, quantification has not been performed, as it is not within the scope of the
present study.
 
Figure 4. The 10 days Sh site. Bone remodeling with new bone formation around the osteotomy site.
Defect is isolated from the marrow space. Scale bars, clockwise: 5 mm, 1 mm, 250 μm and 100 μm.
 
Figure 5. The 10 days Ti site. Bone remodeling and new bone formation around the implant site,
isolating it from the marrow space. Scale bars, clockwise: 5 mm, 500 μm and 50 μm.
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Figure 6. The 10 days Cu site. No bone on the immediate implant vicinity. FBGC, foreign body
giant cells; Oc, osteoclast actively remodeling old bone; Ob, Seam of osteoblasts producing new bone
(part of the remodeling); IO, Implant/Osteotomy. Reaction to Cu divided in 3 zones, representing the
3 phenomena around implant materials in the bone: From the implant surface Lytic/Inflammatory
area, Fibroproliferative area and Osteoproliferative area. The latter two represent an attempt to isolate
the material from the marrow cavity. No osseointegration is viable at this time point. Theoretically,
around Ti the same phenomena exist, but at a different balance, allowing for osseointegration, through
direct bon-to-implant contact. Inflammatory area is highly vascularized. Scale bars 5 mm (left) and
100 μm (right).
 
Figure 7. The 10 days PEEK. NB, new bone; forming only in the areas adjacent to cortical bone,
while most other interfacial tissue shows no bone formation. P, proliferative area; no visible calcified
tissue formation, but for some isolated calcified bone areas (CB, calcified bone). Scale bars, clockwise:
5 mm, 1 mm and 250 μm.
3.3. Surface Roughness
Table 6 shows the results on each material surface roughness analysis. The surface enlargement,
which is depending on both height and the density of the surface irregularities, was smallest for the
copper implants mostly depending on the lower height deviation compared to titanium and PEEK.
Titanium and PEEK had a frequency distribution close to zero, while copper implants had slightly
more peaks than pits. In terms of height deviation, titanium demonstrated the roughest surface.
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Table 6. Surface roughness analysis.
Surface Roughness Sa μm Mean Ssk Mean Sds 1/μm
2 Mean Sdr % Mean
Copper 0.40 1.2 0.28 47
Titanium 0.75 −0.02 0.25 66
PEEK 0.56 −0.23 0.31 69
Sa, describes the average height distribution measured in μm; Sds, a measure of the density of summits over the
measured area, measured in 1/μm2; Ssk (skewness), a parameter that describes the asymmetry of the surface
deviation from the mean plane; Sdr, describes the surface enlargement compared to a totally flat reference area,
measured in %.
4. Discussion
The present results demonstrate the immune system activation around Ti, PEEK and Cu once in
contact with host bone, after 10 days of implantation- this demonstrates that, eventually, all materials
render an immune activation, when in contact with bone.
Macrophage polarization, between M1-macrophage and M2-macrophage phenotypes, has been
highlighted as a determining factor in the foreign body reaction, i.e., how host tissues interact with
biomaterials [7,8]. M1-macrophages present a pro-inflammatory phenotype, while M2-macrophages
have been identified as anti-inflammatory cells, participating in wound healing—Namely in the healing
phase of acute inflammation—And also in chronic inflammation associated with immunological
diseases, such as Rheumatoid Arthritis and Psoriasis [11]. M1-macrophages are described as induced
by interferon-gamma (IFN-γ), while M2 macrophages are described as induced by e.g., IL-4 and
IL-13 [8].
One of the main findings in this study is the importance of the M1/M2-macrophage (M1/M2)
immunological balance in osseointegration already at this early stage: Titanium displays a
reparative/anti-inflammatory M2-macrophage (M2) phenotype (ARG1), whereas Cu and PEEK are
still dealing with a mixed pro-inflammatory M1-macrophage (M1) and M2 anti-inflammatory type of
reaction (CD68, CD14 and CD11b; ARG1, respectively). The early preferential polarization towards
a M2 phenotype around Ti, in the M1/M2 balance, probably explains the event of osseointegration
being successful around Ti and not around the other materials—A fact already hypothesized in our
previous work [3] and further discussed below.
Another important, and unpredicted, finding is the tilting towards the CD4 T-cell phenotype
and suppression of the CD8 T-cell phenotype around all materials, opening a window to further
understanding the immune reaction to biomaterials in the bone, by demonstrating the participation of
T-cells and indicating an early specific T-cell phenotype (discussed below).
The current results confirm the present authors’ previously published results comparing Ti and
Sh immune responses, where immune activation around Ti implants was demonstrated in a femur
study at 10 days and even more so at 28 days after implantation, i.e., outside the major inflammatory
period [12].
For the present experiment, Ti was chosen as an already studied material, and the results of
the previous study were confirmed, while PEEK was chosen for its perceived bio-inertness [13] and
Cu for its known induction of a stronger inflammatory reaction when in contact with tissues—As
demonstrated by Suska et al. 2008 in a rat soft tissue model [14]. As already mentioned, Ti displays
mostly a reparative type-2 phenotype (ARG1 and CD4), whereas around Cu (ARG1, NCF1, CD11b,
CD68, CD14, C5aR1, CD19) and PEEK (ARG1, CD68, NCF1, CD4) there is still a mixed environment,
with pro-inflammatory and anti-inflammatory/reparative elements, which may explain the different
bone tissue reaction towards the different materials at a tissue level (supported by the histological
findings in this study). Even if some of these markers are not expressed with a statistically significant
difference in value, most pass the ×2 threshold in regulation fold-change or are very close to that value;
hence, their interpretation is crucial to understand the biological events and the osteoimmunology in
relation to the studied materials.
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The three materials have shown up-regulation of ARG1, indicating a reparative type-2
anti-inflammatory reaction (M2- macrophages and ILC-2). PEEK and Cu also show a M1-macrophage
pro-inflammatory type of reaction, meaning that at 10 days the host tissue is not yet tilting the balance
towards a full reparative mode around Cu and PEEK, which may explain, at least in part, the results at
tissue level. Hence, the present results confirm the notion of macrophages being central in host reaction
to biomaterials, with a decisive role already at 10 days- it would be interesting to study how the
biological immune process develops at a later time point, whether it resolves, maintains or increases
around Cu and PEEK.
Furthermore, the results show activation of CD4+ T-cells around all materials at 10 days, whereas
the CD8+ T-cell phenotype is suppressed. These findings demonstrate the participation of T-cells
in the bone healing process around solid biomaterials, although it is not known whether solely
an innate or also an adaptive type of immune reaction is present—Classically, the host reaction to
biomaterials is perceived as an innate immunological process [5], hence indicating T-cell activity
through cytokines, rather than an antigen-antibody interaction. Furthermore, ARG1, which shows a
tendency for upregulation in the three materials compared to Sh, is also expressed by type-2 innate
lymphoid-cells (ILC-2) [15], supporting an innate immune mechanism. T-helper cells (CD4+) are
involved in the regulation of immune responses at many levels, such as interaction with macrophages
and the recruitment of neutrophils [16]. Regulatory T-cells (Treg) are also CD4+, and are responsible
for suppressing immune inflammatory responses to allow reparative processes, being important,
for instance, in halting some forms of autoimmune diseases [17]; hence, upregulation of CD4 most
probably indicates an immunologically driven reaction towards tissue repair and proliferation around
the studied materials, which has also been suggested by other authors [18].
The statistically significant upregulation of NCF1 around Cu and a similar upregulation around
PEEK (even if not statistically significant) already at 10 days, highlights the role of neutrophils in the
host-biomaterial interaction; however, in our previous study [5], Ti showed a statistically significant
upregulation of NCF1 only after 28 days of healing, which implies a stronger inflammatory reaction
around Cu and PEEK at an early stage that may further help dictate a soft tissue formation around
these materials, not enabling bone deposition at the implant surface. At an earlier stage in the healing
response, neutrophils participate in the inflammatory reaction, although changing phenotype at a
later stage in this response, which may be the result of either macrophages inhibiting neutrophil
apoptosis for continued neutrophil local performance, or the possible participation in the reparative
process, mainly through an enhancing effect on vascularization [19,20]. Vascularization is of particular
importance for the early development of tissue around the implants in an attempt to isolate these from
the marrow compartment during the foreign body reaction; this is especially important considering
that bone is a hypoxic tissue [21].
Complement factors seem mostly suppressed around all of the materials studied, at 10 days.
The complement system, however, is complex and self-regulated [22]. The results show that the
complement components are mostly downregulated, probably reflecting an inhibitory reaction to an
earlier complement activation during the initial healing phase- thus indicating the possible involvement
of the complement system from an early time point in the host reaction to implanted materials in
the bone.
Furthermore, bone resorption markers were downregulated around all three materials at 10 days,
when compared to Sh sites. This demonstrates a bone resorption suppression in the immediate implant
environment from an early stage, when compared to our previous study, where this was mostly
perceived at a later time point (28 days) around Ti [5]. Hence, a bone forming environment is already
being developed around materials from an early healing stage and within the inflammatory period.
Further studies including protein identification techniques are recommended to confirm the gene
expression outcomes presented here and rule out possible post-transcriptional or post-translational
changes in the biological response.
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Copper presents with extensive apoptosis around the surface; one would attribute this to the
toxicity of Copper ions, but the surface topography may play an important role in determining
the phenotype of Macrophages here: Copper compared to Sham shows an upregulation of ARG1,
indicating M2-macrophages already at 10 days (25 times up regulated in Cu, while Ti and PEEK
show a less pronounced increase in ARG1, even if also relevant). A possible conclusion is that the
chemical aspect of Copper surface is likely a major factor, given the apoptosis seen, but that the surface
topography also has to be considered, given that current evidence on M1/M2-macrophage polarization
has a clear link to surface topography [8], which relates to our results both on surface analysis and
gene expression analysis. Further studies are hence necessary to understand the role of both surface
topography and chemistry, which likely differs between different materials. The surface may play
a role in the macrophage phenotype, however, in the present study, Cu did not demonstrate an
exceptional roughness, rather similar to commercial Ti implants produced with grade 4 Ti. Therefore,
the topography may have had an influence but not likely a major one. Recent in vitro studies have
shown the effect of surface chemistry and topography in macrophage polarization. Zhang H et al.
have demonstrated the surface chemistry immunomodulatory effect of amine silanized titanium,
which reduced inflammation and promoted M2 polarization of macrophages [23], while Gao L et al.
have demonstrated a M1- to M2-macrophage switch, through surface release of IL-4 [24]. Regarding
surface topography, Shayan M et al. have demonstrated both in vitro and in a soft tissue in vivo
study, that implant surface nanopatterning is able to selectively polarize macrophages towards M2,
hence modulating the immune response to the selected biomaterial [25]. These studies concur with
the current bone tissue in vivo experimental results, which demonstrated that different materials
modulate the host immune response through the polarization of macrophages, where Ti promotes
an early shift to a M2-macrophage phenotype- with the inherent consequences observed at the tissue
level, and which may explain the clinical osseointegration seen around Ti implants in bone.
Decalcified histology of specimens from the four groups shows that only Ti develops a structured
thread infill of new bone, at 10 days. All the groups form an area of several cell layers clearly
isolating the implant material (or osteotomy site in Sh), although Cu and PEEK fail to produce
an adequate volume of osseous tissue, showing mostly soft tissue in the interfacial zone. In fact,
the present histological results support the published work by Osborne and Newesley (1980), indicating
contact osteogenesis around “well tolerated” biomaterials and distance osteogenesis around “less well
tolerated” biomaterials [26]. This difference can be explained by the above gene expression analysis,
where Ti shows a more reparative environment at such an early stage, when compared to PEEK
and Cu.
5. Conclusions/Summary
1. All three materials display immune/inflammatory system activation at 10 days;
2. A more favourable macrophage M1/M2 balance likely leads to a better osseointegration of Ti,
as compared to Cu and PEEK:
3. A clearer M2 anti-inflammatory/reparative regulation around Ti at 10 days;
4. A mixture of M1 and M2 (pro- and anti-inflammatory, respectively) regulation around Cu and
PEEK (more pronounced around Cu);
5. T-lymphocytes participate in the foreign body reaction to biomaterials at an early stage;
6. T-cells may act through a CD4+ phenotype (Thelper/Treg), suppressing the CD8+ Tcytotoxic type of
reaction at 10 days;
7. The up-regulation of the neutrophil specific factor NCF-1 around Cu and PEEK, indicates a higher
inflammatory activity and may in part contribute to an inferior osseointegration on materials
other than Ti;
8. Complement system seems predominantly downregulated around materials at 10 days, when
compared to the Sh;
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9. Bone forming environment (suppression of bone resorption) develops around all three implanted
materials at an early stage, and within the inflammatory period;
10. At tissue level, only Ti seems to lead to osseointegration; PEEK and Cu show little or no implant
related bone formation (respectively)—Which probably reflects the slightly more pronounced
immune activation around the latter materials at this early stage;
11. Surface topography may play a role in macrophage phenotype and on the ultimate tissue level
reaction to biomaterials, but further studies are needed.
The present results indicate that Ti osseointegration likely arises from a material-specific
inflammatory/immune process leading to a shorter pro-inflammatory period and earlier reparative
process, starting still within the inflammatory period and promoting bone apposition on Ti implant
surfaces. It is further confirmed that all materials trigger an immune activation, even by materials
like PEEK, previously considered as bio-inert. Different materials thus display different inflammatory
balances in their vicinity, partly controlled by the immune system. Longer-term studies are necessary
to better comprehend the immunobiology and tissue performance beyond the inflammatory period
around established and new biomaterials.
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Abstract: Osseointegration is likely the result of an immunologically driven bone reaction to materials
such as titanium. Osseointegration has resulted in the clinical possibility to anchor oral implants in
jaw bone tissue. However, the mechanisms behind bony anchorage are not fully understood and
complications over a longer period of time have been reported. The current study aims at exploring
possible differences between copper (Cu) and polyetheretherketone (PEEK) materials that do not
osseointegrate, with osseointegrating cp titanium as control. The implants were placed in rabbit
tibia and selected immune markers were evaluated at 10 and 28 days of follow-up. Cu and PEEK
demonstrated at both time points a higher immune activation than cp titanium. Cu demonstrated
distance osteogenesis due to a maintained proinflammatory environment over time, and PEEK failed
to osseointegrate due to an immunologically defined preferential adipose tissue formation on its
surface. The here presented results suggest the description of two different mechanisms for failed
osseointegration, both of which are correlated to the immune system.
Keywords: biomaterial; bone; osseointegration; immune; implant; healing; titanium; PEEK; Cu
1. Introduction
Osseointegration [1] is a central event for oral implant function. This specific bone reaction has
been described and studied at length for titanium and other materials. Technical innovations have
led to improvements of bone reactions, such as material surface topographical changes [2–4] that
have been vastly adopted by the oral implant industry, as well as different forms of chemical surface
modulations [5,6]. Such surface related innovations have resulted in improved clinical results and
widening of clinical indications [7,8]. However, the specific bone related control mechanisms that
lead to osseointegration are still in need of scientific analyses, as are the reasons for marginal bone
resorption. Generally speaking, the foreign body reaction (FBR) is accepted as the series of host
events that follow the introduction of a material into tissues. The host–biomaterial interaction [9]
depends on the type of material, clinical handling and on the tissue where the implant is placed
(e.g., bone, skin, and blood vessel), as well as the host specific conditions. The immune system has a
central role in the FBR [10–12] where the M1/M2-macrophage phenotype balance has been identified
as one of the main controlling factors at the cellular level [13]. Macrophages are thus able to shift
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between an M1-phenotype (proinflammatory) and an M2-phenotype (reparative/anti-inflammatory),
with obvious consequences for tissue reaction to biomaterials, and experimental modulation of this
balance has been studied to direct a favorable pathway for bone regeneration [14]. The current
authors have demonstrated an early M1/M2 shift around titanium, at 10 days of follow-up towards a
dominant M2 macrophage phenotype [15], in contrast to other materials such as polyetheretherketone
(PEEK) and Copper (Cu) that present mixed M1/M2 phenotypes at the same short term of follow-up.
Osseointegration is thus seen as the result of an FBR which in the long run may achieve a foreign
body equilibrium allowing for long term loading of implants [16]. However, the basis for the control
of bone metabolism around implants in health and disease remains largely unclear [17]. Particularly
the events taking place after the inflammatory period of initial healing and a possible immunological
regulation of bone metabolism are examples of important fields for further studies. Our group has
demonstrated that titanium activates the immune system when compared to a sham site at 10 and
28 days of follow-up [12]. In Part I of this series of studies (where the current work is Part II), the
importance of the specific immune response around different materials when compared to a sham site
was demonstrated at an early stage of 10 days [15]. The current study aims at comparing materials that
do not osseointegrate, i.e., test materials copper (known to induce a pronounced FBR in soft tissues [18])
and PEEK (considered a bioinert material [19]), to a material that osseointegrates, cp titanium (control)
at 10 and 28 days, in order to investigate and compare the respective immune modulation reactions
between the inflammatory (10 days) and postinflammatory (28 days) stages of bone healing.
2. Materials and Methods
The current study consists of an experiment in the rabbit proximal tibia (metaphysis), comparing
bone healing on sites where osteotomies were performed and one of three test materials were placed
for comparison: titanium (Ti), copper (Cu), or polyether ether ketone (PEEK), where Ti was a control.
All implants were turned with a threaded 0.6 mm pitch height, 3.75 mm width, and Branemark
MkIII design (Figure 1). The Ti implants were made of commercially pure titanium grade IV (98.55%
Ti, with specified maximum traces of elements Fe, O, N, H, and C for the remaining 1.45%).
 
Figure 1. Implant design with 3.75mm width and 8mm length. Representative image of titanium (Ti)
implant; copper (Cu) and polyetheretherketone (PEEK) implants with the same design.
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2.1. Surgical Procedure
This study was performed on 12 mature, female New Zealand White Rabbits (n = 6 for each
time point, 10 and 28 days, weight 3 to 4 Kg), with the ethical approval from the Ethics Committee
for Animal Research (No. 13-011) of the École Nationale Vétérinaire D’Alfors, Maisons-Alfors,
Val-de-Marne, France. The 6 animals at 10 days are the same used for Part I of this series of studies [12].
All care was taken to minimize animal pain or discomfort during and after the surgical procedures.
For the surgical procedures, the rabbits were placed under general anesthesia using a mixture of
medetomidine (Domitor; Zoetis, Florham Park, NJ, USA), ketamine (Imalgène 1000; Merial, Lyon,
France), and diazepam (Valium; Roche, Basel, Switzerland) for induction, then applying subcutaneous
buprenorphine (Buprecare; Animalcare, York, UK) and intramuscular meloxicam (Metacam; Boehringer
Ingelheim Vetmedica, Inc., Ridgefield, CT, USA). A single incision was performed in the internal knee
area on each side and the bone exposed for osteotomies and insertion of implants in the sites mentioned
above. The surgical site was sutured with a resorbable suture (Vicryl 3/0; Ethicon, Cincinnati, OH, USA)
and hemostasis achieved. Following surgery, Fentanyl patches (Duragesic; Janssen Pharmaceutica,
Beerse, Belgium) were applied.
The osteotomies were produced with a sequence of increasing diameter twist drills, from
2 mm to 3.15 mm width, and a final countersink bur prepared the cortical part of the bone.
The implants used were 3.75 mm in diameter, placed in an underprepared osteotomy to achieve
primary (mechanical) stability.
The rabbits were housed in separate cages and were allowed to move and eat freely.
At 10 and 28 days, the rabbits were sacrificed with a lethal injection of sodium pentobarbital
(Euthasol; Virbac, Fort Worth, TX, USA). The 6 animals at each time point had the implants removed
through unscrewing. On 4 animals at 10 days and 5 animals at 28 days, bone was collected with a
2 mm twist drill from the periphery of the Ti, Cu, and PEEK sites on the most distal portion, and then
processed through quantitative-polymerase chain reaction (qPCR). After this, at each time point, the
implant sites were removed en bloc for histological processing on the 6 animals.
2.2. Gene Expression Analysis—qPCR
The bone samples for gene expression analysis at 10 or 28 days were collected from the distal
side of the osteotomies of all three groups (following the removal of the implant from the implant
sites), with a 2 mm twist drill that removed both cortical and marrow bone in the full length of the
osteotomy, to enable the study of the 2 mm peri-implant bone area of each of the Ti, Cu, and PEEK sites.
The samples were immediately transferred to separate sterile plastic recipients containing RNAlater
medium (AmbionInc, Austin, TX, USA) for preservation. The samples were then refrigerated first at
4 ◦C and then stored at –20 ◦C until processing.
2.2.1. mRNA Isolation
Samples were homogenized using an ultrasound homogenizer (Sonoplus HD3100, Brandelin)
in 1 ml PureZOL and total RNA was isolated via column fractionalization using the AurumTM Total
RNA Fatty and Fibrous Tissue Kit (Bio-Rad Laboratories Inc.; Hercules, CA, USA) following the
manufacturer’s instructions. All the samples were DNAse treated using an on-column DNAse I
contained in the kit to remove genomic DNA. The RNA quantity for each sample was analyzed in the
NanoDrop 2000 Spectrophotometer (Thermo Scientific; Wilmington, DE, USA). BioRad iScript cDNA
synthesis kit (Bio-Rad Laboratories Inc.; Hercules, CA, USA) was then used to convert mRNA into
cDNA, following the manufacturer’s instructions.
qPCR primers (Tataa Biocenter; Gothenburg, Sweden) were designed following the NCBI Sequence
database, including the local factors chosen in order to characterize the immune, inflammatory, and
bone metabolic pathways (Tables 1 and 2). All primers had efficiency between 90% and 110%.
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Table 1. Gene sequences.
Primer Forward Sequence Reverse Sequence Accession No./Transcript ID
NCF-1 TTCATCCGCCACATTGCCC GTCCTGCCACTTCACCAAGA NM_001082102.1
CD68 TTTCCCCAGCTCTCCACCTC CGATGATGAGGGGCACCAAG ENSOCUT00000010382
CD11b TTCAACCTGGAGACTGAGAACAC TCAAACTGGACCACGCTCTG ENSOCUT00000001589
CD14 TCTGAAAATCCTGGGCTGGG TTCATTCCCGCGTTCCGTAG ENSOCUT00000004218
ARG1 GGATCATTGGAGCCCCTTTCTC TCAAGCAGACCAGCCTTTCTC NM_001082108.1
IL-4 CTACCTCCACCACAAGGTGTC CCAGTGTAGTCTGTCTGGCTT ENSOCUT00000024099
IL-13 GCAGCCTCGTATCCCCAG GGTTGACGCTCCACACCA ENSOCUT00000000154
M-CSF GGAACTCTCGCTCAGGCTC ACATTCTTGATCTTCTCCAGCAAC ENSOCUT00000030714
OPG TGTGTGAATGCGAGGAAGGG AACTGTATTCCGCTCTGGGG ENSOCUT00000011149
RANKL GAAGGTTCATGGTTCGATCTGG CCAAGAGGACAGGCTCACTTT ENSOCUT00000024354
TRAP TTACTTCAGTGGCGTGCAGA CGATCTGGGCTGAGACGTTG NM_001081988.1
CathK GGAACCGGGGCATTGACTCT TGTACCCTCTGCATTTGGCTG NM_001082641.1
PPAR-γ CAAGGCGAGGGCGATCTT ATGCGGATGGCGACTTCTTT NM_001082148.1
C3 ACTCTGTCGAGAAGGAACGGG CCTTGATTTGTTGATGCTGGCTG NM_001082286.1
C3aR1 CATGTCAGTCAACCCCTGCT GCGAATGGTTTTGCTCCCTG ENSOCUT00000007435
CD46 TCCTGCTGTTCACTTTCTCGG CATGTTCCCATCCTTGTTTACACTT ENSOCUT00000033915
CD55 TGGTGTTGGGTGGAGTGACC AGAGTGAAGCCTCTGTTGCATT ENSOCUT00000031985
CD59 ACCACTGTCTCCTCCCAAGT GCAATCTTCATACCGCCAACA NM_001082712.1
C5 TCCAAAACTCTGCAACCTTAACA AAATGCTTTGACACAACTTCCA ENSOCUT00000005683
C5aR1 ACGTCAACTGCTGCATCAACC AGGCTGGGGAGAGACTTGC ENSOCUT00000029180
CD3 CCTGGGGACAGGAAGATGATGAC CAGCACCACACGGGTTCCA NM_001082001.1
CD4 CAACTGGAAACATGCGAACCA TTGATGACCAGGGGGAAAGA NM_001082313.2
CD8 GGCGTCTACTTCTGCATGACC GAACCGGCACACTCTCTTCT ENSOCUT00000009383
CD19 GGATGTATGTCTGTCGCCGT AAGCAAAGCCACAACTGGAA ENSOCUT00000028895
GAPDH GGTGAAGGTCGGAGTGAACGG CATGTAGACCATGTAGTGGAGGTCA NM_001082253.1
ACT-β TCATTCCAAATATCGTGAGATGCC TACACAAATGCGATGCTGCC NM_001101683.1
LDHA TGCAGACAAGGAACAGTGGA CCCAGGTAGTGTAGCCCTT NM_001082277.1
NCF-1 (neutrophil cytosolic factor 1); CD68 (macrosialin); CD11b (MAC-1, macrophage marker); CD14 (monocyte
differentiation antigen CD14); ARG1 (Arginase 1); IL-4 (Interleukin 4); IL-13 (Interleukin 13); M-CSF (colony
stimulating factor-macrophage); OPG (osteoprotegerin); RANKL (Receptor activator of nuclear factor kappa-B
ligand); TRAP (tartrate resistant acid phosphatase); CathK (cathepsin K); PPAR-γ (peroxisome proliferator activated
receptor gamma); C3 (complement component 3); C3aR1 (complement component 3a receptor 1); CD46 (complement
regulatory protein); CD55 (decay accelerating factor for complement); CD59 (complement regulatory protein);
C5 (complement component 5); C5aR1 (complement component 5a receptor 1); CD3 (T cell surface glycoprotein
CD3); CD4 (T cell surface glycoprotein CD4); CD8 (T cell transmembrane glycoprotein CD8); CD19 (B-lymphocyte
surface protein CD19); GAPDH (glyceraldehyde-3-phosphate dehydrogenase); ACT-β (actin beta); LDHA (lactate
dehydrogenase A).
Table 2. Correspondence between studied gene expression and biological entities.
Biological Entity Gene
Neutrophil NCF-1
Macrophage CD68, CD11b, CD14, ARG1
Macrophage fusion IL-4, IL-13, M-CSF
Bone resorption OPG, RANKL, TRAP, CathK, PPAR-γ
Complement Activation: C3, C3aR1, C5, C5aR1; Inhibition: CD46, CD55, CD59
T lymphocytes CD3, CD4, CD8
B-lymphocytes CD19
Reference genes GAPDH, ACT-β, LDHA
NCF-1 (neutrophil cytosolic factor 1); CD68 (macrosialin); CD11b (MAC-1, macrophage marker); CD14 (monocyte
differentiation antigen CD14); ARG1 (Arginase 1); IL-4 (Interleukin 4); IL-13 (Interleukin 13); M-CSF (colony
stimulating factor-macrophage); OPG (osteoprotegerin); RANKL (Receptor activator of nuclear factor kappa-B
ligand); TRAP (tartrate resistant acid phosphatase); CathK (cathepsin K); PPAR-γ (peroxisome proliferator activated
receptor gamma); C3 (complement component 3); C3aR1 (complement component 3a receptor 1); CD46 (complement
regulatory protein); CD55 (decay accelerating factor for complement); CD59 (complement regulatory protein);
C5 (complement component 5); C5aR1 (complement component 5a receptor 1); CD3 (T cell surface glycoprotein
CD3); CD4 (T cell surface glycoprotein CD4); CD8 (T cell transmembrane glycoprotein CD8); CD19 (B-lymphocyte
surface protein CD19); GAPDH (glyceraldehyde-3-phosphate dehydrogenase); ACT-β (actin beta); LDHA (lactate
dehydrogenase A).
2.2.2. Amplification Process
Five microliters of SsoAdvanced SYBR™ Green Supermix (Bio-Rad Laboratories Inc.; Hercules,
CA, USA) and 1 μL of cDNA template together with 0.4 μM of forward and reverse primer were used
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in the qPCR reaction. Each cDNA sample was performed on duplicates. The thermal cycles were
performed on the CFX Connect Real-Time System (Bio-Rad Laboratories Inc.; Hercules, CA, USA).
The CFX Manager Software 3.0 (Bio-Rad, Hercules, CA, USA) was used for the data analysis.
Three genes (GAPDH, ACT-beta, and LDHA) were selected as reference genes using the geNorm
algorithm integrated in the CFX Manager Software. A quantification cycle (Cq) value of the chosen
reference genes (Tables 1 and 2) was used as control; hence the mean Cq value of each target gene
(Table 1) was normalized against the reference gene’s Cq, giving the gene’s relative expression.
For calculation of fold-change, the ΔΔCq was used, comparing mRNA expressions from the different
groups. Significance was set at p < 0.05 and the regulation threshold at ×2 fold-change.
2.3. Decalcified Bone Histology
After removal of the implants from the studied Ti, Cu, and PEEK sites on the 6 subjects of each
time point, bone was removed en bloc and preserved in 10% formalin (4% buffered formaldehyde;
VWR international, Leuven, Belgium) during 48 h for fixation. Samples were decalcified in Ethylene
diamine tetra-acetic acid (10% unbuffered EDTA; Milestone srl, BG, Italy) for 4 weeks, with weekly
substitution of the EDTA solution, dehydrated and embedded in paraffin (Tissue-Tek TEC; Sakura
Finetek Europe BV, Leiden, NL, USA). Samples were sectioned (4-μm-thick) with a microtome (Microm
HM355S; Microm International GmbH, Thermo Fischer Scientific, Walldorf, Germany) and stained
with Haematoxylin-Eosin (HE) for histological analysis.
2.4. Statistical Analysis
The gene expression statistical analysis was performed using the t-test built in the algorithm of
the CFX Manager Software 3.0 package (BioRad, Hercules, CA, USA).
3. Results
3.1. Gene Expression Analysis
3.1.1. Days
The gene expression analysis results at 10 days, comparing Cu and PEEK against Ti (control),
are displayed in the volcano plots (Figures 2 and 3) and data given in corresponding tables (Tables 3
and 4) with the numerical results expressed in fold-change (regulation, x-axis) and significance (p value,
y-axis). Data from 10 days have been published in Part I [15] of this study, if with another control.
At 10 days, Cu (vs. Ti, Figure 2 and Table 3) triggered an increased expression of ARG1 gene (around
14× fold-change). This probably translates to a much higher presence of M2 macrophages (reparative
phenotype) around Cu. NCF1 showed close to a 2× fold upregulation for Cu, and elicited an increased
participation of neutrophils at this early stage. Less increased markers, with approximately ×1.5
fold-change were observed for Complement (C3aR1), M1-macrophages (CD14) [20,21], B-lymphocytes
(CD19) and Th/Treg-lymphocytes (CD4). On the other hand, Cu displayed a downregulation in TRAP,
PPAR-gamma and OPG.
At 10 days PEEK (vs. Ti, Figure 3 and Table 4) showed less downregulation of the same bone
remodeling markers as Cu, TRAP, OPG, and PPAR-gamma, as well as the B cell marker CD19 and
macrophage fusion marker IL-4. Increased expression of NCF1 was observed for PEEK, probably
translating to an increased presence of neutrophils around this material (as also observed for Cu).
Table 3. Gene expression analysis of Cu compared to Ti (10 days).
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Table 3. Cont.









Minus values: downregulation; plus values: upregulation.
Figure 2. Volcano plot for gene expression of Cu compared to Ti (10 days). Downregulation (vertical
green line) and upregulation (vertical red line) set at ×2 regulation. Statistical significance (set at p <
0.05) when marker above horizontal blue line.
Figure 3. Volcano plot for gene expression of PEEK compared to Ti (10 days). Downregulation (vertical
green line) and upregulation (vertical red line) set at ×2 regulation. Statistical significance (set at
p < 0.05) when marker above horizontal blue line.
286
J. Clin. Med. 2019, 8, 814
Table 4. Gene expression analysis of PEEK compared to Ti (10 days).









Minus values: downregulation; plus values: upregulation.
3.1.2. 28 Days
At 28 days, Cu against Ti (Figure 4 and Table 5), showed upregulation around Cu of CD68 and
CD14, as well as ARG1 (macrophages of both M1-and M2- phenotypes), with M2 far more significant,
indicating an overall higher macrophage activation for Cu vs. Ti at 28 days, when compared to 10 days.
Complement markers C3aR1 and C5aR1 are also upregulated around Cu, as well as IL-13 (a macrophage
fusion marker). On the other hand, there was downregulation of bone remodeling markers TRAP,
CATHK, PPAR-gamma, and RANKL, as well as CD3 and CD4 (T lymphocytes), C3 complement factor,
CD59 (complement inhibitor), and IL-4 (the other macrophage fusion marker).
Figure 4. Volcano plot for gene expression analysis of Cu compared to Ti (28 days). Downregulation
(vertical green line) and upregulation (vertical red line) set at ×2 regulation. Statistical significance (set
at p < 0.05) when marker above horizontal blue line.
PEEK vs. Ti at 28 days (Figure 5 and Table 6), showed upregulation of most markers used, with the
exception of TRAP and CATHK, which are effector bone resorption markers that were downregulated.
This excessive upregulation indicates a wide and strong immune activation around PEEK compared
to Ti at 28 days. However, these results had a limitation in that only two out of the five rabbits used
in the study allowed enough mRNA extraction on PEEK samples for gene expression analysis (see
Discussion). Nevertheless, both subjects’ results were analysed separately for regulation (fold-change)
and showed similar responses compatible with that presented in the overall results. However, the
significance (p value) should not be taken in consideration here, since the low number of subjects
(only 2) renders impossible a statistical analysis.
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Minus values: downregulation; plus values: upregulation.
Figure 5. Volcano plot for gene expression analysis of PEEK compared to Ti (28 days). Only 2 subjects
to be interpreted with caution. Downregulation (vertical green line) and upregulation (vertical red line)
set at ×2 regulation. Statistical significance (set at p < 0.05) when marker above horizontal blue line.































Only 2 subjects to be interpreted with caution. Minus values: downregulation; plus values: upregulation.
It is interesting to note that Thelper/Treg (CD4) was upregulated for Cu at 10 days, but downregulated
at 28 days, which could indicate a shift in the presence of T lymphocytes between the two time points
and these cells’ participation in the biomaterial-associated healing process.
3.2. Comparative Analysis of Gene Expression: 10 vs. 28 Days
The comparison between Cu and PEEK when compared to Ti was divided by respective outcome
(Figures 6 and 7): macrophage, complement, neutrophils, lymphocytes, macrophage fusion and bone
metabolism. Data from 10 days have been published in Part I [15] of this study, if with another control.
Figure 6. Comparative analysis of gene expression between 10 and 28 days for Cu vs. Ti. Horizontal
red line: zero regulation mark; x-axis: time; y-axis: gene marker regulation (10 or 28 days). Intermittent
lines do not represent actual results at time points other than 10 or 28 days, but only highlight trend
from 10 to 28 days.
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Figure 7. Comparative analysis of gene expression between 10 and 28 days for PEEK vs. Ti. Horizontal
red line: zero regulation mark; x-axis: time; y-axis: gene marker regulation (10 or 28 days). Intermittent
lines: do not represent actual results at time points other than 10 or 28 days, but only highlight trend
from 10 to 28 days.
3.2.1. Cu vs. Ti (Figure 6)
Macrophages: The immune activation was clearly higher around Cu than Ti at both time points.
The M2-macrophage phenotype (ARG1) was reduced around Cu, but still upregulated when compared
to Ti. The M1 markers (combination of CD68, CD11b and CD14) were upregulated slightly around Cu
at both 10 and 28 days, i.e., Cu sustained a proinflammatory environment after the acute inflammatory
and beginning of the bone remodeling period.
Complement: The results show that C5 expression increased around Cu from 10 to 28 days, when
compared to Ti (both C5aR1 and C5 suffered a sharp increase in regulation while the CD59 (a C5
inhibitor) was sharply downregulated over time).
Neutrophils: There was a shift observed for NCF1 from upregulation at 10 days to downregulation
at 28 days. This likely indicates a change (reduction) in the presence of neutrophils around Cu.
Lymphocytes: The CD4 reduction (from up- to downregulated) at 28 days around Cu may
indicate a decrease in Thelper/Treg function, whereas effector Tcytotoxic (CD8) and B cells (CD19) remain
slightly upregulated.
Macrophage fusion: More pronounced IL4 downregulation and IL13 upregulation from 10 to
28 days.
Bone metabolism: The RANKL/OPG shunt reveals an obvious shift around Cu between 10 and 28
days. RANKL changes from upregulated to downregulated and the opposite for OPG, which becomes
upregulated at 28 days, meaning a suppression of osteoclastogenesis from 10 to 28 days.
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3.2.2. PEEK vs. Ti (Figure 7)
It should be noted at 28 days that the results for PEEK should be read with caution since it was
only possibility to retrieve mRNA from two of the five samples at 28 days. The possible reasons for
this will be discussed below. Data from 10 days have been published in Part I [15] of this study, if with
another control.
Macrophages: The macrophage activation around PEEK observed at 10 days and 28 days showed
increase in both M1 and M2 markers. This confirms that there was an elevated M1 activation at 28
days, as well as a strong increase in M2-phenotype.
Complement: The results indicate, after 28 days, a continued immune activation around
PEEK, especially pronounced for C3-related markers (C3, C3aR1, CD46, and CD55), and with slight
upregulation for C5-related markers.
Neutrophils: NCF1, the specific neutrophil marker, was at both time points upregulated for PEEK,
but showed a sharp increase at 28 days.
Lymphocytes: All lymphocyte markers increased from 10 to 28 days around PEEK. This was
especially evident for CD4+ Th/reg and CD19+ B cells.
Macrophage fusion: The results indicate a sharp increase in macrophage fusion markers around
PEEK, also with a possible contribution to a M2-macrophage phenotype (IL13- confirmed by the above
mentioned ARG1 upregulation at 28 days). M-CSF also contributes to bone/adipose tissue balance in
the osseous tissue, an important finding for PEEK and osseointegration in general, as discussed below.
Bone metabolism: The results suggest formation of adipose-like tissue around PEEK, as expressed
by the extreme upregulation of PPAR-gamma and by the upregulation of M-CSF. Suppression of
bone resorption was sustained over time—RANKL still shows at 28 days some upregulation, but was
overtaken by a sharp upregulation of OPG.
3.3. Histological Analysis
The histological analysis was performed at tissue level. At 10 days (Figures 8–10), Ti presents with
initial bone formation within the threads, represented by unorganized collagen proliferation, whereas
Cu presents mostly a lytic and cell infiltrate area on the implant surface, followed by a fibrous layer
and finally a new bone formation, away from the surface. At 10 days, PEEK demonstrated very little
initial bone tissue formation in some threads, but mostly adipose tissue surrounding the implant. Data
from 10 days have been published in Part I [15] of this study, if with another control.
At 28 days (Figures 11–13), Ti shows the bone within the threads maturing, while Cu demonstrates
a reduction of the cell infiltrate, but still a bone formation away from the implant surface, whereas
PEEK presents with mostly adipose tissue around the implant and the little bone tissue formed has not
matured (unlike Ti) and shows little calcification.
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Figure 8. Histological analysis of Ti (10 days). NB: New bone; CO: Contact osteogenesis. Collagen
proliferation and some initial calcification to form new bone in the threads. Scale bars: 5 mm and
500 μm.
 
Figure 9. Histological analysis of Cu (10 days). Lytic area next to the implant; Fb: fibroproliferative;
NB: New bone; DO: distance osteogenesis; Th: implant thread; V: blood vessel. New bone forming
away from the implant surface. Scale bars: 5 mm, 500 μm, and 250 μm clockwise from left.
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Figure 10. Histological analysis of PEEK (10 days). PI: PEEK implant; NB: New bone; Ad: Adipose
tissue. Some collagen proliferation in one thread, adipose tissue also on the implant surface. Scale bars:
5 mm, 1 mm, and 500 μm.
 
Figure 11. Histological analysis of Ti 28 (days). CO: contact osteogenesis. B: Bone. Formation of mature
bone within the implant threads. Scale bars: 5 mm and 500 μm.
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Figure 12. Histological analysis of Cu (28 days). DO: Distance osteogenesis; I: Inflammatory infiltrate;
F: fibrous tissue; B: Bone. Formation of bone away from the implant surface, with a reduction of the
infiltrate on the implant surface compared to 10 days. Scale bars: 5 mm and 500 μm.
 
Figure 13. Histological analysis of PEEK (28 days). Ad: Adipose tissue; V: blood vessels; NB: New
bone. Mostly adipose tissue proliferation and the bone tissue in the threads has not matured, nor
calcified substantially. Scale bars: 5 mm, 500 μm, and 250 μm.
4. Discussion
The osseointegration of materials for biomedical purposes has led to significant advances in
patient treatment. Oral implants have become common in clinical practice, and by large base their
success on osseointegration of materials such as titanium. Previous studies from the present authors
have demonstrated the activation of the immune system around a material placed in bone [12,15],
and it was hypothesized that the immune system has a regulatory function on the achievement
of osseointegration [11]. In the present experimental study, the bone immune reaction around the
materials polyetheretherketone (PEEK) and copper (Cu) was compared to titanium (Ti) as a control,
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at 10 and 28 days of implantation in rabbit tibia. The current study design aimed at comparing the
immune modulation of two materials with poor osseointegration (Cu and PEEK) against a material
that osseointegrates (Ti). The comparison between 10 and 28 days is important to understand the
evolution of the reaction between the inflammatory period (10 days) and the postinflammatory period
(28 days) of healing. Data from 10 days have been published in Part I [15] of this study, but with a
Sham (no biomaterial) site as a control.
At 10 days, both PEEK and Cu showed upregulation of markers indicating a higher and
different macrophage activity than was found around Ti (confirming the previous study [15]), namely
predominantly an M2-phenotype, but also an elevated M1-phenotype. This was more pronounced
around Cu than PEEK. At day 10, PEEK did not differ much from Ti, if with higher activation of the
immune system (neutrophils and macrophages). This was however observed for Cu, with a higher
overall immune activation. Both PEEK and Cu displayed some inhibition of bone resorption when
compared to Ti. It is worth noting that PEEK, commonly referred to as a bioinert material [22,23],
shows a higher immune activation than Ti at 10 days.
After 28 days of implantation the scenario changes for both PEEK and Cu. Cu shows, as
expected, a higher upregulation of the immune markers when compared to Ti, in all its innate
components (complement, neutrophils, and macrophages of both M1- and M2-phenotypes). However,
the macrophage fusion markers IL-4 and IL-13 expressions provide some contradictory indications
since IL-13 was upregulated and IL-4 downregulated. This could be hypothesized as a stage for
initial fusion into foreign body giant cells (FBGCs), but needs confirmation through further studies.
Such macrophage fusion is not likely to be guided towards osteoclastogenesis, since bone resorption
markers were widely downregulated, hence the macrophage behavior was probably directed towards
the formation of FBGCs. However, IL-13, also known to induce the M2-phenotype [24] and combined
with ARG1 upregulation, confirms, at 28 days, the elevated M2 phenotype activity around Cu and
PEEK compared to Ti, meaning a more pronounced host reparative effort for both materials, even if
proinflammatory markers are simultaneously upregulated. The downregulation of bone resorption
markers highlights the probable effort around Cu at 28 days, to build bone tissue around the implant
for a bony delimitation that, as the histology shows, clearly develops away from the surface of the
Cu implant.
PEEK, on the other hand, seems to suffer a vast transformation at 28 days, into a high immune
activation in the bone environment surrounding the implant, or rather fails to reduce that immune
activation when compared to Ti. Reasons for the high immune upregulation around PEEK at 28 days
are not well understood, although the current study results may offer an explanation regarding
the bone/adipose tissue balance, as developed below. As mentioned in the results section, the 28
days results for PEEK should be read with caution, since only two subjects out of the five used for
gene expression analysis actually enabled collection of enough mRNA to perform the PCR analysis.
The difficulty to extract sufficient mRNA from the tissues surrounding PEEK implants was probably
due to a low bone tissue formation adjacent to PEEK implants. Furthermore, the reasons behind
the classical claim of a supposed bioinertness of PEEK is either that only in vitro studies of it have
been presented or that in vivo studies have failed to analyze the immunological response; in contrast,
the present results indicate immune activation around PEEK that may persist over extended periods
of time.
Regarding the comparison between the two time points of 10 and 28 days, for Cu, the CD4
expression shifting over time from up- to downregulation, and the maintained upregulation of CD8
and CD19 at 28 days, demonstrates a shift in Thelper/Treg function whereas effector Tcytotoxic and B cells
remain slightly upregulated over time. B cells, not only osteoblasts, are known to produce OPG in
humans [25], which correlates with the increased gene expression of OPG at 28 days and adds another
regulatory mechanism of the immune system on bone effector cells, and consequently on the ultimate
anabolic/catabolic balance outcome of bone metabolism around implanted materials. It is important to
mention that this B cell mechanism is known to be regulated by T cells, and the production of OPG by
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B/plasma cells can reach 64% of total OPG in some mammals [26], thus the present results highlight the
immune regulation of bone metabolism around implanted materials.
The notion that Cu starts to enter the remodeling phase and bone production at 28 days, even if
at a distance as seen from the histological analysis, is further supported by the results for the above
mentioned bone metabolism, with a sharp shift in RANKL (upregulated at 10 days and downregulated
at 28 days) and in OPG (displaying the exact opposite trend) since RANKL induces osteoclastogenesis
and OPG is the decoy molecule that stops this process, the results indicate a shift to a bone reparative
environment around Cu at 28 days (through inhibition of the bone resorption inducive mechanisms).
As for the results of the two time point comparisons between PEEK and Ti, the M1-macrophage
activation at 28 days may impair bone formation at the PEEK implant surface, with a preferred fatty
tissue deposition during repair, as indicated by the upregulation of PPAR-gamma, which is produced
by differentiated macrophages [27] and in turn triggers the differentiation of adipocytes [28] at 28 days.
The upregulation of complement around PEEK, the sharp increase in NCF1 and the increase in
regulation from 10 to 28 days around PEEK for Th/reg and B cells demonstrates that over time a higher
immune activity is maintained around PEEK than Ti. This goes beyond the inflammatory period and
is most likely proinflammatory.
The upregulation at 28 days of macrophage fusion markers around PEEK indicates also other
possible interpretations, such as the M2-phenotype connection of IL-13 and the fact that M-CSF, besides
its role in macrophage fusion into either osteoclasts or FBGCs, is intimately related to adipose tissue
hyperplasia and growth (through proliferation) [29]. In the present study, the preferential adipose
tissue growth observed on PEEK surface is supported at 28 days by the concomitant sharp upregulation
of PPAR-gamma and M-CSF, and downregulation of TRAP and Cathepsin-K (bone resorption effectors),
clearly indicating a sharp imbalance towards adipose tissue formation instead of bone formation
around PEEK. It is important to note that in our previous study where Ti was compared to a Sham site
at 28 days, no significant differences regarding PPAR-gamma or M-CSF were observed between the
test and control [12], reinforcing the difference observed between PEEK and Ti at 28 days. Fat cell
degeneration has previously been described in bone tissue after trauma upon overheating [30].
Such bone/adipose tissue imbalance, tilting towards more adipose tissue formation, has also been
demonstrated in osteoporosis studies [31]. The present results after 28 days around PEEK support
the description of this new-found mechanism for bone biomaterials. The orchestration of this process
by the immune system has also been shown in literature [24], indicating a M1-macrophage chronic
inflammation presence in proliferating adipose tissue [32], as well as CD4+ Thelper/reg and CD19 B cells,
as demonstrated in our results with a shift from downregulation at 10 days to upregulation at 28 days.
The PPAR-gamma and M-CSF upregulation reaction likely overrules the OPG upregulation that would
suppress bone resorption and increase osteoblast differentiation around PEEK; it is known that bone
marrow mesenchymal stem cells (BMMSC) may either differentiate into osteoblasts or adipocytes [33],
and PEEK, as demonstrated by the current results, seems to induce immune regulated adipocyte
formation and proliferation in its vicinity.
5. Conclusions
Overall, at 10 and 28 days after implantation in rabbit tibia, both Cu and PEEK show a higher
immune activation than Ti. This more pronounced and extended immune reaction translates into a
prolonged inflammatory phase of the healing period, and may be the cause for the bone tissue failing
to form a layer in direct contact with these materials, as shown in the histological sections.
The current results demonstrate that, over time, different materials elicit a different immune
regulation of bone metabolism around implanted materials.
From a clinical orofacial perspective, it is fair to state that a fibrous tissue encapsulation or adipose
instead of bone tissue formation could also occur around clinically placed titanium implants, should
less ideal host conditions be present.
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The results from the current study suggest that osseointegration may fail by at least two
immunologically regulated mechanisms: (1) soft tissue encapsulation or (2) an imbalance in
bone/adipose tissue formation around the implanted material.
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Abstract: Metal release from total hip replacements (THRs) is associated with aseptic loosening
(AL). It has been proposed that the underlying immunological response is caused by a delayed
type IV hypersensitivity-like reaction to metals, i.e., metal allergy. The purpose of this study was
to investigate the immunological response in patients with AL in relation to metal release and the
prevalence of metal allergy. THR patients undergoing revision surgery due to AL or mechanical
implant failures were included in the study along with a control group consisting of primary THR
patients. Comprehensive cytokine analyses were performed on serum and periimplant tissue samples
along with metal analysis using inductive coupled plasma mass spectrometry (ICP-MS). Patient
patch testing was done with a series of metals related to orthopedic implant. A distinct cytokine
profile was found in the periimplant tissue of patients with AL. Significantly increased levels of the
proinflammatory cytokines IL-1β, IL-2, IL-8, IFN-γ and TNF-α, but also the anti-inflammatory IL-10
were detected. A general increase of metal concentrations in the periimplant tissue was observed in
both revision groups, while Cr was significantly increased in patient serum with AL. No difference in
the prevalence of metal sensitivity was established by patch testing. Increased levels of IL-1β, IL-8,
and TNF-α point to an innate immune response. However, the presence of IL-2 and IFN-γ indicates
additional involvement of T cell-mediated response in patients with AL, although this could not be
detected by patch testing.




Aseptic loosening (AL) of implants is the most common reason for revision surgeries in patients
with total hip replacements (THRs), representing close to 75% of all cases, with serious consequences for
patients and healthcare systems [1,2]. Although the etiology of AL is multifactorial and yet to be fully
understood, evidence suggest that the predominant cause of AL is due to a macrophage-driven chronic
inflammatory response initiated by implant wear [1,3–5]. This adverse tissue reaction is associated
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with the innate immune system and can lead to the bone degrading state of osteolysis, subsequently
resulting in implant failure by AL.
Cytokines are small messenger molecules that coordinate the immune response by regulating
inflammation and modulating cellular activities such as growth, differentiation and survival [6]. Key
mediators of osteolysis have been identified as pro-inflammatory cytokines like interleukin (IL)-1β, IL-6,
IL-8 and tumor necrosis factor (TNF)-α secreted by activated macrophages. In turn, these cytokines
are capable of inducing the differentiation of osteoclast precursor cells into mature, bone resorbing,
osteoclasts [1,7–11]. Interferon (IFN)-γ is another important immune regulatory cytokine implicated in
bone resorption but also in inflammation progression and cell mediated immunity [12,13].
Macrophages have been established as important mediators of ostolysis, but several other cell
types have also been identified in the periimplant tissue of failed implants, including lymphocytic
T cells [9,14–16]. T helper (Th) cells, a subtype of T cells, are important regulators of macrophage
function and the adaptive immune response, which given rise to the concept of implant-related metal
sensitivity. This concept is evolved around a delayed type IV T cell mediated hypersensitivity (DTH),
exemplified by allergic contact dermatitis to metal ions (metal allergy). Due to their small size, metal
ions are considered to be incomplete antigens, referred to as haptens, and must interact with peptides
or proteins to form an antigen able to mount DTH.
In support of the concept above, findings of elevated levels of metal particles and ions have been
shown to correlate with an increased prevalence of metal allergy in patients with failing implants [17–21].
Furthermore, some of the most commonly applied alloys for THR like stainless steel (FeCrNiMo),
cobalt chromium (CoCrMo) and titanium alloys (Ti6Al4V) contain known sensitizing metals [22].
Immunological studies of AL in THRs, have suggested the involvement of a Th1 cell response,
crucial for DTH, due to increased levels of Th1 cell specific cytokines like IFN-γ and IL-2 [4,23]. Previous
studies also suggest the involvement of a Th2 and Th17 cell response in AL, which are respectively
characterized by the production of IL-4, IL-17 and granulocyte-macrophage colony-stimulating factor
(GM-CSF) [24–26]. However, the causal relationship between immune reactions, metal release from
implants, and AL is still uncertain.
1.2. Aim
The aim of the present study was to determine and compare levels of THR relevant metals and
cytokine profiles from periimplant tissue and blood serum, and to investigate the prevalence of metal
allergy in patients undergoing revision surgery due AL, mechanical failure or undergoing primary THR
surgery. Periimplant tissue obtained from patients with AL showed a significantly different cytokine
profile suggesting the involvement of both innate and adaptive immunity in AL. No prevalence of
metal allergy was established in patients with failed implants despite elevated levels of metal ions in
the periimplant tissue.
2. Experimental Section
2.1. Patients and Samples
We conducted a prospective case study including three patient groups. This study was approved by
the Central Denmark Region Committee on Biomedical Research Ethics (Journal number: 1-10-72-90-13).
All patients gave their written informed consent before entering the study.
Criteria for inclusion in the AL (+) group were: revision (entirely or partial) due to aseptic
loosening, osteolysis, or unexplainable pain that could not be treated conservatively. The AL (−) group;
revision (entirely or partial) due to fracture, dislocation, or component failure. The Control group;
patients received a primary THR. Implant components are listed in Table 1.
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Table 1. Implant overview. Implant types and materials used for femoral, head, liner and acetabular
components are given for patients in the revision groups. In addition to the implant bulk material,
model names and surface finish is also listed. cpTi relates to commercially pure titanium and PS to
plasma sprayed coatings. FeCrNiMn is also referred to as Orthinox stainless steel.
Patient # Type Femoral Head Liner Acetabular
1 AL (+) MoP Ti-6Al-4V, ZMR®, uncemented,porous coating CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncommented, cpTi fiber mesh.
2 AL (+) MoP FeCrNiMn, Exeter®, cemented,polished. CoCrMo PE
cpTi, Duraloc®, uncemented,
porous coating.
3 AL (+) MoP CoCrMo, Lubinus®,cemented polished. CoCrMo PE
PE, Lubinus®, cemented,
all-polycup
4 AL (+) MoP FeCrNiM, Exeter®,cemented, polished. CoCrMo PE
Ti-6Al-4V, Mallory Head,
uncemented, PS.
5 AL (+) MoP Ti-6Al-4V, Bi-metric®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Mallory®Head,
uncemented, PS.
6 AL (+) MoM Ti-6Al-4V, Bi-metric®,uncemented, grit blasted. CoCrMo CoCrMo
CoCrMo, ReCap®, uncemented,
cpTI PS.
1 AL (−) MoP Ti-6Al-7Nb, CLS spotorno®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
2 AL (−) MoP Ti-6Al-7Nb, CLS spotorno®,uncemented, grit blasted. CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
3 AL (−) CoP Ti-6Al-4V, Biocontact®,uncemented, grit blasted. Ceramic PE
Ti-6Al-4V, Plasmacup®,
uncemented, plasmapore PS.
4 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished. CoCrMo PE
cpTi, Pinnacle®, uncemented
porocoat, porous coating.
5 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished CoCrMo PE
Ti-6Al-4V, Trilogy®,
uncemented, cpTi fiber mesh.
6 AL (−) MoP FeCrNiMn, Exeter®, cemented,polished CoCrMo PE
cpTi, Pinnacle®, uncemented
porocoat, porous coating.
Criteria for exclusion: infection (positive Kamme-Lindberg biopsies [27]), use of immunomodulating
medication, occupational metal exposure, known metal allergies towards implanted metals or secondary
osteoarthritis (fracture, inflammation). The mean age for the AL (+) group was 60.8 years with a gender
distribution of 4/2 (M/W). For the AL (−) group, the mean age was 73 years, and the distribution was 4/2
(M/W). The control group had a mean age of 62 years and a distribution of 5/3 (M/W). Tissue samples
for cytokine and ICP-MS analysis were snap-frozen in liquid nitrogen and stored at −80 ◦C for later use.
Serum obtained from patients blood samples were taken before the operation and stored at −80 ◦C for
later cytokine and ICP-MS analysis.
2.2. Cytokine Profile Analysis
Snap frozen tissue samples from group AL (+), group AL (−) and the control group were
mechanically disrupted and homogenized (Precellys®24 and Cryolys®—Bertin Technologies, Bie &
Berntsen A/S 2730, Herlev, Denmark) at 4 ◦C for 4 × 20 s in lysis buffer containing protease inhibitor
cocktail (REF 11836145001, Roche Diagnostics, Indianapolis, IN, USA). Homogenized tissue samples
were then spun for 10 min at 10,000 × G at 4 ◦C (Microcentrifuge 157MP—Ole Dich Instrumentmakers
ApS, Hvidovre, Denmark) and the protein concentration in the supernatant was estimated by Bradford
protein assay [28] using Coomassie blue (#1610436. Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Prior to cytokine analysis, total protein concentrations of the samples were adjusted to 0.5 mg/mL.
Cytokine analysis was performed using a validated V-PLEX electrochemiluminescence immunoassays
(Meso Scale Discovery, Rockville, MD, USA). A total of 11 cytokines divided on two separate kits were
analyzed. Proinflammatory Panel 1 contained; IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-γ and TNF-α
(catalog # K15049D-1), and cytokine panel 1 kit contained; IL-15, IL-17A, GM-CSF (catalog # K15050D-1).
Samples were analyzed in triplicates (MESO QuickPlex SQ 120—Meso Scale Discovery). Calibration
curves used to calculate cytokine concentrations were established by fitting to a 4 parameters logistic
model with a 1/Y2 weighting. Cytokine concentrations were calculated using the Discovery workbench
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4.0.12 software (Meso Scale Discovery). Serum samples were analyzed undiluted using the same
cytokine kits as used for the tissue.
2.3. Patch Testing
A special patch test series, provided by Smart Practice®(Phoenix, AZ, USA), was used in this
study. The patch contained prefabricated panels with metallic compounds associated with orthopedic
prostheses on Scanpor tape. Standard metal allergens included; nickel (II) sulphate NiSO4 (1.0 wt.%),
potassium dichromate (VI) K2Cr2O7 (0.054 wt.%) and cobalt (II) chloride CoCl2 (0.02 wt.%). In addition,
a customized panel with the following metals and corresponding titrations were included; vanadium
(IV) oxide sulfate hydrate VOSO4·H2O (0.36, 0.18, 0.06, 0.02 wt.%), vanadium (III) chloride VCl3 (0.24,
0.12, 0.013, 0.04 wt.%), manganese (II) chloride MnCl2·4H2O (0.24, 0.08, 0.06, 0.0057 wt.%), aluminum
(III) chloride AlCl3·6H2O (0.72, 0.38, 0.039 wt.%), ammonium molybdate (VI) (NH4)6Mo7O24 4H2O
(0.12, 0.013, 0.04 wt.%), titanium (IV) oxalate hydrate TiC4O8·H2O (0.32, 0.16, 0.08, 0.04 wt.%), titanium
(IV) dioxide TiO2 (0.24 wt.%), potassium titanium (II) oxide oxalate C4K2O9Ti·2H2O (2.4, 1.2, 0.6 wt.%),
ammonium titanium (II) lactate, solution Ti [(C3H4O3)2(NH4OH)2] (0.16, 0.08, 0.04 wt.%), ammonium
titanium (IV) peroxocitrate (NH4)4[Ti2(C6H4O7)2(O2)2]·4H2O (0.32, 0.16, 0.08, 0.04 wt.%). methyl
methacrylate C5H8O2 (2 wt.%), gentamycin sulfate (20 wt.%) and ferrous chloride FeCl2 (2 wt.%) were
tested by manually loading of a Finn chamber on Scanpor tape. Patches were applied on the upper back
and were occluded for 48 h. Readings were completed 96 h after application [29]. The patients were
instructed to remove the panels after 48 h, and not to shower, scratch or expose to sunlight. Reactions
were scored using the International Contact Dermatitis Research Group’s (ICDRG) criteria [30]. Only
definite +1, +2 and +3 reactions were regarded as positive.
2.4. ICP-MS (Serum)
Blood samples were sent to Vejle Hospital, Department of Clinical Biochemistry, Denmark, for
determination of chromium and cobalt levels before the surgery. The samples were analyzed by
ICP-MS instrument (iCAPq, Thermo Fisher Scientific Inc., Waltham, MA, USA). The samples were
diluted with 0.5% HNO3, gallium was added as an internal standard prior to analysis. The detection
limit was 10 nmol/L equivalent to 0.59 ppb (cobalt) and 0.52 ppb (chromium).
2.5. ICP-MS (Tissue and Serum)
Elemental analysis of tissues and titanium (Ti) analysis of blood was performed at the National
Food Institute at the Technical University of Denmark.
Elemental analysis in tissues: Tissue samples (0.1–0.5 g) were digested with a mixture of concentrated
nitric acid (4 mL; PlasmaPure, SCPScience, Courtaboeuf, France) and hydrogenperoxide (1 mL;
Merck, Darmstadt, Germany) in a microwave oven (Multiwave 3000, Anton Paar, Graz, Austria).
The concentration of aluminum (Al), vanadium (V), chromium (Cr), cobalt (Co) and nickel (Ni) was
determined using ICPMS (iCAPq, Thermo Fisher Scientific, Waltham, MA, USA) using rhodium as
an internal standard and external calibration. The ICPMS instrument was run in the kinetic energy
discrimination (KED) mode using helium as a collision cell gas. The limit of detection was estimated at
100 μg/kg for all elements.
Determination of Ti in tissue and blood: The acid digests of tissues were also subjected to Ti analysis.
Serum subsamples (200 μL) were diluted with 4.8 mL diluent solution consisting of 0.5% Triton X-100,
10% ethanol (both Merck) and 1% nitric acid (SCPScience) prior to the analysis of the concentration of
Ti using a triple quadrupole ICPMS (Agilent 8800 ICP-QQQ, Agilent Technologies, Yokogawa, Japan)
and using ammonia as a cell gas with determination of Ti after MS/MS mass shift from m/z 48 ≥ m/z 150
with scandium (Sc) as internal standard and external calibration. The data quality of Ti analysis was
assessed by the analysis of the reference material Seronorm (Sero, Oslo, Norway). The obtained value
7.2 μg/L was in good agreement with the reference value 6.8 μg/L. The limit of detection was estimated
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at 1 μg/L in serum samples and 20 μg/kg in tissues. All calibration standards and internal standards
were produced from certified single-element stock solutions (SCPScience).
2.6. Statistical Analysis
For group comparison the Kruskal-Wallis test was used, and if statistically significant,
the Mann-Whitney U test was used to compare between individual groups. By convention, to calculate
group medians, metal concentrations below the detection limit were assigned a value of one-half the
detection limit. Comparisons were made using the Mann-Whitney test. Contingency tables (patch test)
were analyzed using Fisher’s exact test. A significance level of p < 0.05 was considered statistically
significant. Matlab R2014a (8.3.0.532) with statistical toolbox (MathWorks Inc. Natick, MA, USA) was
used for statistical analysis. For graphical representation Prism 6.0 (GraphPad Software, San Diego,
CA, USA) was used.
3. Results
3.1. Cytokine Profile Analysis
3.1.1. Analysis of Cytokine Levels in Periimplant Tissue
Cytokine levels were measured in periimplant tissue obtained from revision or primary surgery
to identify a potential local immune response (Figure 1).
Figure 1. Cytokine profiles of periimplant tissue. Cytokines are shown in graph (a) and (b) with
different concentration scales. Except from IL-15 and IL-17, patients with aseptic loosening AL (+)
showed a statistically significant increase in the cytokine levels when compared with the control group.
Out of the statistically significant cytokines, IL-4 and TNF-α did not show any statistical significance
(NS) when comparing the two revision groups. IL-8 was found to be highly increased in patients with
AL. Results are expressed as the mean (±SEM). The Mann-Whitney U test was used for the statistical
analysis with a significance level of 0.05. p values are given by * p < 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
Altogether, 10 cytokines (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-15, IL-17A, IFN-γ and TNF-α) and
growth factor GM-CSF were analyzed (Figure 1a/b). We found a highly increased cytokine profile in
patients with AL, with a statistical significant increase of IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF,
IFN-γ and TNF-α when compared to the AL (+) and the control group. When compared to the AL (−)
group we found a statistically significant increase for all cytokines except from IL-4, IL-15, GM-CSF,
and TNF-α. Of note, IL-8 was highly increased and the most strongly associated cytokine with AL.
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3.1.2. Analysis of Cytokine Levels in Serum
An identical cytokine profile analysis was performed in serum to investigate a corresponding
systemic response (Figure 2). Cytokine levels in serum appeared 10–100 fold lower and although
IL-8 and IFN-γ seemed increased in the AL (+) group, no statistical differences could be established.
Together these results show a general increase of the investigated cytokine profile, in periimplant tissue
obtained from patients with AL, but also that cytokine levels in periimplant tissue are not necessarily
reflected in blood serum. Among other increased cytokines, IL-8 was established as the most potent
marker of AL.
 
Figure 2. Cytokine profiles in serum. Patients with aseptic loosening are represented as AL (+),
patients with dislocations are represented as AL (−) and the controls. Increased IL-8 and IFN-γ levels
appeared for the AL (+) group. Results are expressed as the mean concentration (±SEM). No statistically
significant differences could be established between the groups using the Mann-Whitney U test with a
significance level of 0.05.
3.2. Patch Test
All patient groups were subjected to a comprehensive patch test containing orthopedically relevant
metals and methyl methacrylate, the monomer of poly (methyl methacrylate) (PMMA) used as bone
cement in THR (Table 2). Positive and doubtful reactions to these metals are summarized in Table 2.
No statistical significant differences between either of the groups could be established. Few positive
test reaction were observed even for the metals used in the standard series (Cr, Co and Ni), only one
reaction to Ni and one to Cr were observed in all three groups. However, three positive reactions for
Ti and two positive skin reactions to V were observed in the (AL+) group. In fact, the two positive
reactions to V were observed in the same patient who had a positive reaction to Cr (Figure 3).
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Table 2. Skin reactions. Positive (+) and doubtful (+?) skin reactions to different metals and methyl
methacrylate. Patch test reactions were scored using the International Contact Dermatitis Research
Group’s (ICDRG) criteria [30]. Only definite +1, +2 and +3 reactions were regarded as positive. No
reactions were categorized as +2 and +3 reactions in this study and only compounds with either positive
(+1) or doubtful (+?) reactions are listed in the table. Prevalence of positive reactions was tested against
the control group using Fisher’s exact test with two tailed p values. No statistical significant differences
were found.
AL (+) (n = 6) AL (−) (n = 6) Control (n = 8)
Reactions
Metal compound (concentration) + (+?) + (+?) + (+?)
Al(III), AlCl3 (0.72%) 0 (0) 0 (0) 0 (1)
Ti(IV), TiC4O8 (0.32%) 0 (0) 1 (0) 2 (0)
Ti(II), C4K2O9Ti (2.4%) 0 (0) 0 (0) 0 (0)
V(III), VCl3 (0.24%) 1 (2) 0 (3) 0 (3)
V(III), VCl3 (0.12%) 1 (0) 0 (1) 0 (3)
V(III), VCl3 (0.013%) 0 (0) 0 (1) 0 (0)
V(III), VCl3 (0.04%) 0 (0) 0 (1) 0 (0)
V(IV), VOSO4 (0.36%) 0 (1) 0 (1) 0 (2)
V(IV), VOSO4 (0.18%) 0 (1) 0 (1) 0 (0)
Cr(VI), K2Cr2O7 (0.054%) 1 (0) 0 (0) 0 (0)
Mn(II), MnCl2 (0.24%) 0 (1) 1 (2) 0 (2)
Ni(II), NiSO4 (5.0%) 0 (0) 0 (0) 1 (1)
Methyl Methacrylate, C5H8O2 (2%) 0 (0) 0 (0) 0 (1)
Total reactions 3 (4) 2 (8) 3 (12)
 
Figure 3. Patch test. (A) Example of a positive (+) and a doubtful skin reactions (+?) to vanadium
and chromium in a patient from the AL (+) group. (B) Enlarged photograph of the skin reaction
to vanadium.
3.3. ICP-MS Analysis
3.3.1. Metal Concentrations in Periimplant Tissue
Periimplant tissue was analyzed for Al, Ti, V, Cr, Co and Ni by ICP-MS (Table 3). Raised median
concentrations of most metals could be observed in both revision groups, AL (+) and AL (−) as shown in
Table 3. Metals found at highest concentrations were, Al, Ti and Cr, although no statistically significant
differences could be established between the AL (+) and AL (−) group, however, a difference was
observed when compared to the control group. Despite the raised concentrations of Cr observed in the
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AL (+) group compared to the control group no statistical significant increase could be determined
(p = 0.074). These results clearly demonstrate the presence of metal release in the two revision groups.
Table 3. Elemental analysis. Metal concentrations (ppb) measured by ICP-MS in periimplant tissue
and blood serum. Titanium, chromium and cobalt were measured in blood serum. Values are
shown as group medians with interquartile range below. Statistics are based on medians using the
Wilcoxon-Mann-Whitney test with a significance level of 0.05. * Indicate significantly increased values
compared to the control group. Elemental analysis for Al, V and Ni was only carried out on tissue
samples and are therefore indicated as not available (N/A) for serum samples.
Metal
AL (+) n = 6 AL (−) n = 6 Control n = 10





























































3.3.2. Metal Concentrations in Serum
Serum samples were analyzed for Ti, Co and Cr by ICP-MS (Table 3). A statistical significant
increase of Cr concentrations in the AL (+) group was found, compared to the control group. No
statistical significant increase was observed between the two revision groups (p = 0.105). Nevertheless,
the highest concentrations of both Co and Cr was found in the AL (+) group. One patient in the control
group showed a high concentration of Ti and despite reanalysis, this sample still showed a high Ti
concentration, preventing it from being regarded as an outlier. All other Ti concentrations in the control
group were at the detection limit of the ICP-MS method. Furthermore, the results show that local metal
concentrations in the periimplant tissue can be highly increased compared to serum levels.
4. Discussion
The possibility of metal allergy leading to aseptic loosening has been debated in the literature for
many years [21,31–33]. Still, the long-term effect of internally released metals remains unknown and
so does the underlining immunological response lead to AL and implant failure [22]. In this study
we investigated the correlations between the immunological profile, metal allergy and metal released
from implants, in THR patients with AL.
We found that patients with AL had a cytokine profile with statistically significant increased levels
of the pro-inflammatory cytokines IL-1β, IL-6, and IL-8, but also Th1 associated cytokines, IL-2 and
IFN-γ, and the anti-inflammatory cytokine IL-10, when compared to patients with implant failures
due to mechanical causes. Despite a statistically significant and substantial metal exposure both locally
and systemically in THR patients, we were not able to prove any systemic effect by cytokine analysis
of serum or by positive patch testing. Based on the present study, a systemic effect cannot be ruled out
due to the low number of patients enrolled in this study. The findings are, however, in line with the
clinical observations, where the adverse effect to implants is predominantly observed locally rather
than systemically. A further limitation of this study was the clinical approach, where polyethylene
(PE) debris derived from the acetabular liner is most likely contributing the innate part of the cytokine
profile observed in the periimplant tissue.
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Cytokines play an important role in AL, not only as regulators of osteolysis, but also as important
identifiers of the occurring immune response. In our cytokine analysis we included IL-1β IL-2, IL-4,
IL-6, IL-8, IL-10, IL-15, IL-17A, GM-CSF, IFN-γ and TNF-α due to their implication in innate and
adaptive immunity and their function as osteolytic mediators (Figures 1 and 2). In addition to being
involved in the innate immune response, IL-1β, IL-6, IL-8, GM-CSF, and TNF-α have previously been
identified as mediators of osteolysis [14,34]. In accordance with these observations, we found elevated
levels of these cytokines in the periimplant tissue from the AL (+) group when compared to the control
group. When comparing the two revision groups, AL (+) and AL (−), no statistically significant
difference was seen for GM-CSF and TNF-α. However, levels of GM-CSF were very low and might
be considered without any biological effect. TNF-α is well-known as a strong inducer of osteolysis
and is the first proinflammatory cytokine produced in response to many wear particles and stimulates
macrophage production of IL-1β and IL-6 [35]. Although no statistically significance is seen for TNF-α
between the two revision groups, both IL-1β and IL-6 still showed a statistically significant increase in
the AL (+) group. In comparison, other investigators have found low levels of IL-1β and TNF-α in
periimplant tissue from patients with failed THRs due to osteolysis [36]. Moreover, they found that
IL-6 and IL-8 were consistent with failed implants, suggesting that IL-6 and IL-8 might be the primary
drivers of end-stage osteolysis, while IL-1β and TNF-α are critical mediators in the acute phase of
inflammation. Interestingly, these observations did indeed correspond well to our findings of IL-6 and
notably IL-8, which we found to be the strongest predictor of AL.
The main IL-8 secreting cells are macrophages, osteoblasts and osteoclasts. Studies have
shown that IL-8 holds multiple functions in AL and has been found to affect both neutrophils,
T cells, monocyte/macrophages and osteoclasts [37,38]. It has been demonstrated that wear particle
stimulation of osteoblasts and macrophages promotes IL-8 production, which in turn can lead to both
macrophage activation and induce phagocytosis [39]. Interleukin-8 also possess chemotactic properties
on neutrophils and T cells and could conceivably play a role in attracting such cells to the periimplant
tissue [37,40]. Moreover, IL-8 is shown to promote osteoclastogenesis and the formation of osteoclasts
that are capable of secreting IL-8 on their own. Thus, the high levels of IL-8 observed in patients with
AL is probably not only caused by an innate immune response but also in part by the osteolytic process
taking place in the patients with AL, which could explain the differences in IL-8 observed between the
AL (+) and the AL (−) group [40].
As indicators of DTH, IL-2 and IFN-γ levels were statistical significantly increased in the AL
(+) group compared to the AL (−), supporting the involvement of a Th1 cell response in AL. This is
consistent with other studies, showing lymphocyte reactivity to implant related metals and production
of Th1-specific cytokines (IFN-γ and IL-2), and even the generation of metal specific T cells [41,42].
Macrophages are capable of producing IFN-γ but abundant evidence suggests that T cells and natural
killer (NK) cells are the major sources of IFN-γ [3,43,44]. Accompanied by the increased levels of IL-2,
the increased IFN-γ levels found in patients with AL further support the involvement of a Th1 cell
response. Interferon-gamma possess both pro- and anti-inflammatory activities with the functional
outcome being dependent on secretion levels, pathogenesis and disease severity [13,44]. Some studies
show a protective effect of IFN-γ on osteolysis, possible by inhibiting the early differentiation of
osteoclasts, whereas others have shown that IFN-γ promotes osteoclast formation [13]. How IFN-γ
affects the progression of AL in this study is difficult to decipher but low levels of IFN-γ does not exert
the inhibitory effect on osteoclasts and seems to be limited to the early stage of osteoclast differentiation.
Furthermore, IFN-γ can promote osteoclast maturation in the late state of osteoclast formation leading
to a shift from the inhibitory effect towards a state of bone resorption [45].
In addition to the Th1 signature cytokines, we also observed an increase of IL-4, along with a
statistically significant increase of IL-10 when comparing the two revision groups.
Although the production of these cytokines are related to Th2 cells, IL-10 is also produced by
monocytes and regulatory T cells, acting as an anti-inflammatory cytokine, which could regulate
cell-mediated reactions involved in AL [46–48]. We were not able to detect any consistent cytokine
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profile at a systemic level in serum, underlining the difficulty of detecting AL based on the systemic
levels of cytokines. In fact, cytokines have a short half-life in serum due to their potent nature as
signaling molecules, which makes cytokines very challenging to use as biomarkers in serum [49].
In our analysis of Ti, Co and Cr in serum, we found a statistically significant increase of Cr in the
AL (+) group and Ti in the Al (−) group (Table 3). Furthermore, we did detect a correlation between
raised Ti concentrations in serum from patients with a stem component made from a Ti containing
alloy, which corresponds to the findings of other studies applying the ICP-MS method [50]. Metal
release, has previously been shown to increase in patients with poorly functioning implants [17]. From
a corrosion point of view, this could be explained by increased micro-motions of the implant leading
to fretting corrosion [20,51]. Fretting of the Ti6Al4V and the Orthinox SS alloys could contribute to
the statistically significant raise in Al, Ti, and Ni observed in the revision groups (Table 4) [52,53].
Highest concentrations of Co and Cr were detected in the AL (+) group. One patient in this group
had a MoM implant but no markedly increased in Co or Cr concentrations were detected in either
periimplant tissue or serum from this specific patient. Interestingly, relative low concentrations of
Co were found in tissue and blood samples compared to Cr concentrations. This observation has
previously been explained by a faster elimination of Co from both the tissue and blood than that of
Cr [54]. No upper limits are currently employed to describe critical metal release from implants, but an
upper limit of 7 ppb for Co and Cr in blood is often used as an action level for MoM implants [55].
Serum concentrations of this magnitude were not detected in this study. In general, our results confirm
previous metal concentrations reported in serum and periimplant tissue from patients with poorly
functioning implants [17]. A correlation between the metal content in periimplant tissue but not that
of serum has recently been made to a lymphocyte dominated response [56]. This emphasizes the
importance of the periimplant environment, in which we found highly raised metal concentrations.
Table 4. Alloy composition. Elemental composition of the different implant alloys found patient groups,













Aluminum (Al) 0.10 - 0.03 5.50–6.50 5.5–6.50
Carbon (C) 0.35 0.08 0.08 0.08 0.08
Chromium (Cr) 27–30 19.5–22 - - -
Cobalt (Co) Balance - - - -
Copper (Cu) - 0.25 0.10 - -
Iron (Fe) 0.75 Balance 0.50 0.25 0.25
Manganese (Mn) 1 2–4.25 - - -
Molybdenum (Mo) 5–7 2–3 - - -
Nickel (Ni) 0.50 9.0–11.0 - - -
Niobium (Nb) - 0.25–0.8 0.015 6.50–7.50 -
Nitrogen (N) 0.25 0.25–0.5 0.15 0.05 0.05
Oxygen (O) - - 0.40 0.20 0.13
Tantalum (Ta) - - Balance 0.50 -
Titanium (Ti) 0.10 - - Balance Balance
Tungsten (W) 0.20 - - - -
Vanadium (V) - - - - 3.5–4.5
In this study implants with different fixation strategies was used i.e. cemented implants and
different surface treatments for optimizing stability and osseointegration. Metal release and implant
performance is highly dependent on the micro/nano topography of the implant surface [57,58].
Cemented implants have been proved to increased initial stability and minimize micro-motions of
cemented parts leading to long survival rates [59]. The downside of this approach is the possible
formation of a crevice between the cement and implant, which can provide a highly corrosive
environment and lead to accelerated corrosion and subsequently implant failure by AL [60,61]. All
uncemented implants in this study had some form of increased roughness applied to their surfaces for
optimal osseointegration (Table 1). One of the costs of increasing the surface roughness on implant is an
increased functional surface area, which in turn will increase metal release. Especially titanium release
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has recently become a subject of concern and not only in implants used for THRs [62–65]. Another
debated strategy of improving osseointegration is the use of hydroxyapatite (HA) coatings, simulating
the bone chemistry and structure. However, recent studies suggest that the long-term effects are not
improved compared to other porous coatings or rough sandblasted surfaces [66,67].
Patch testing showed a diverse profile of test reactions across all groups making results difficult
to interpret (Table 2). Metals salts are well-known skin irritants and skin reactions may therefore,
in reality, be an irritant rather than an allergic reaction. On the other hand, a positive reaction can
only occur if the metal reaches the viable layers of the epidermis, and this might be a challenge for
some metals [68]. One patient in the AL (+) group had a positive reaction to Cr, which is higher than
expected considering that less than 1% of the general population are allergic to Cr [69]. Surprisingly,
we found positive reactions to Ti (IV) in the control group, which had not been exposed to Ti containing
implants. Although Ti allergy is considered very limited in THRs, in vitro studies of Ti particles suggest
that these can initiate innate and adaptive Th2 cell response [68,70]. Within the field of odontology
there is a growing concern of the innate immune response associated with Ti, which is believed to
cause osteolysis through macrophage secretion of IL1β, IL6, and TNFα [6,71]. A relative high number
of skin reactions to V were observed, although most of these were scored as doubtful, true allergy
cannot be ruled out. While larger cohort studies have found an increased prevalence of metal allergy
in THR patients our study was not powered to examine a possible association [21,72]. Nonetheless,
our findings indicate that metal allergy, as tested by patch test, is not likely to be a key driver of AL in
most patients.
5. Conclusions
Aseptic loosening of implants is a complex tissue response influenced by various factors. Metal
release from implants may generate DTH response capable of accelerating aseptic loosening of implants.
In this study, we report a distinct cytokine profile in periimplant tissues between patients with implant
failure due to AL, compared to mechanical causes, with statistically significant increased levels of
IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, GM-CSF, IFN-γ and TNF-α. In addition, raised metal concentrations
were found in blood and periimplant tissue from patients with failed THRs. Despite these observations,
we failed to detect any correlation between the prevalence of metal allergy and failed THRs or AL.
This work contributes to a better understanding of the immunologic nature of aseptic loosening and
suggests that the immunological events involved in AL are of both innate and adaptive character.
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Abstract: The etiology of peri-implant crestal bone loss is today better understood and certain factors
proposed in the past have turned out to not be of concern. Regardless, the incidence of crestal bone
loss remains higher than necessary and this paper reviews current theory on the etiology with a
special emphasis on traditional and innovative methods to assess the level of crestal bone around
dental implants that will enable greater sensitivity and specificity and significantly reduce variability
in bone loss measurement.
Keywords: Crestal bone loss; osseosufficiency; osseoseparation; peri-implantitis; photoacoustic
ultrasound; brain–bone axis; foreign body reaction; overloading; radiography; CBCT (cone beam
computerized tomography)
1. Introduction
Crestal bone loss (CBL) was relatively uncommon and non-progressing with the commercially
pure titanium implants with a machined surface introduced by Per-Ingvar Branemark. It was accepted
in the late 1980s and 1990s that 1 mm of CBL could be expected in the first year after implant placement
and then 0.2 mm of CBL on average might occur after that. In fact, an adage took hold that with
these implants, CBL to between the first and second thread is common after which time bone levels
remained remarkably stable for years.
Predictably, as the application of the initial wave of implants was so successful, an expansion
of clinical scenarios amenable to dental implant therapy took place. Following on, an expansion of
the clinical provider pool considered appropriate to place and restore implants took place. Finally,
“innovations” to the dental implant systems with the goal of fostering the expansion of clinical scenarios
and provider pool also took place. Unfortunately, despite the noblest of intentions, and indeed some
J. Clin. Med. 2019, 8, 166; doi:10.3390/jcm8020166 www.mdpi.com/journal/jcm315
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not so noble, the number of complications associated with dental implant therapy reported today is
high. Indeed, it is far higher than necessary, and puts patients at unnecessary, and hence unjustifiable,
risk for suboptimal clinical outcomes including implant loss, biological tissue loss, financial loss, and
psychological trauma.
Koka and Zarb first proposed the concept of osseosufficiency to describe the role of the
interplay between clinician, patient, and implant system inasmuch as promoting and perpetuating
osseointegration [1]. In this model, if the combination of the ingredients that clinician (skill, knowledge,
experience), patient (genetic, environmental, behavioral), and implant system (design, material) are
“enough” to promote and perpetuate osseointegration, a state of osseousufficiency is attained. If
the combination of ingredients is “not enough”, a state of osseoinsufficiency results. Although it is
commonplace to attribute implant loss as representing “implant failure”, this is clearly not the case
in most instances where implants are retrieved from jawbones, the main exception being when an
implant body fractures. To state that an implant failed implies that the implant was at fault for its
retrieval and assigns blame for the undesirable outcome to the one ingredient in the osseointegration
recipe that is the most predictable and by far, compared to patient and clinician, the least variable.
Conveniently, it is also the one element that is unable to defend itself in conversations about why
an implant was retrieved. Clearly, albeit an uncomfortable state of affairs, most complications in
implant therapy are clinician-dependent (inexperience, incompetence, or ignorance) and the remainder
are patient-dependent or a combination of clinician and patient factors. Therefore, throughout this
manuscript, the term “implant failure” will not be used. In the place of “implant failure”, terms like
“implant retrieval”, “implant removal”, or “implant loss” will be used to more accurately describe the
clinical outcome and to avoid inaccurate assignment of blame.
One manifestation of osseoinsufficiency that has significant clinical ramifications is peri-implant
CBL because it can lead to implant retrieval, osseous deformation, soft tissue deformation, esthetic
compromise, and a dissatisfied/upset patient who loses confidence in their clinical provider. Clearly,
prevention is better than cure when it comes to peri-implant CBL as effective and predictable methods
to restore lost bone remain elusive.
Crestal bone loss has been postulated to have a multi-factorial etiology [2] and can be considered
to occur early or late in the lifetime of a dental implant. Here, early means within the first year
after placement and CBL observed is a consequence of bone remodeling subsequent to surgical and
restorative procedures and early loading challenges undertaken by an implant and its associated
prosthesis [2,3]. Given the role of adaptive bone remodeling, early CBL is not necessarily influenced
by infection from oral microflora. Over the longer term, the cumulative effect of chronic etiological
factors that are immunological (foreign body reaction), environmental, including patient factors
such as motivation, smoking, bruxism, and infection/inflammation, and the influence of clinician
(surgeon/prosthodontist) may influence late CBL [2–5]. Given that other manuscripts in this
volume will address different etiological factors of CBL, in Section A, this manuscript will provide a
summary of current knowledge related to two common etiological factors, mechanical overloading
and periodontopathogens/perimplantopathogens/bacteria. It will also discuss the role of the immune
system through the foreign body reaction mechanisms that lie at the heart of osseointegration, and
describe how adverse immune reactions and a tantalizing new potential mechanism involving the
brain–bone axis may lead to CBL. In Section B, it will focus on a key and related issue of how CBL is
currently measured and how it can be improved in the future.
2. Section A. Selected Etiological Factors in Crestal Bone Loss
2.1. Overloading
After an implant body osseointegrates and is exposed to functional loading, Esposito et al.
reported that overload of the implant prosthesis may lead to implant loss. Furthermore, the report
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suggests that overload contributes to peri-implantitis and is one of the major determinants of late
implant retrieval [6].
There are a wide variety of experimental reports about overloading and implant therapy including
computer simulations, such as finite element analysis, and in vivo and in vitro experiment. However,
the results are inconclusive regarding the strength and validity of the evidence clearly linking
overloading to CBL. Here, we consider the clinical significance of overloading in peri-implant CBL.
What is ‘overloading’? ‘Overloading’ is difficult to describe but could be considered to be
the force level and/or nature of force application that exceeds the permissible or tolerable range
of the prosthetic and biological resistance to CBL. Each patient presents with a unique prosthetic
and biological resistance profile and reference ranges of permissibility are, as yet, unknown. Hence,
predicting who will be more or less susceptible to the effects of overloading is difficult. Most reports
draw a conclusion of overloading based on the findings of a complication (fracture of the prosthesis,
marginal bone loss etc.) as a post hoc event. Nevertheless, the complication is a result of distortion
between implant and marginal bone interface caused by stress applied to the structural components of
the implant prosthesis instead of the occlusal bite force itself.
Notationally, 0.1% deformation in volume is transcribed to 1000 με (microstrain). Frost et al.
divided the reaction of bone as a result of strain application into four phases or “windows” according
to the amount of distortion between bone and implant (Figure 1). (i) Disuse atrophy window (50–100
με). Bone resorption may result in this phase where the net effect of bone formation and resorption is
negative; (ii) Steady state window (100–1500 με). Here, the net volume of the bone remains steady;
(iii) Mild overload window (1500–3000 με). Here, the net effect of bone formation and resorption is
positive and bone volume increases; (iv) Fatigue failure window (>3000 με). Here, bone resorption
and destruction occur [6].
Figure 1. Diagram showing clinical effect on bone relative to strain level applied.
Theoretically, when we classify the reaction of bone to force application/distortion at the
implant–bone interface, we can use Frost’s definition of overload, the fatigue failure window. However,
Naert et al. noted that the definition of overload in implant dentistry is more complex, open to
interpretation and they suggested the range of distortion represented by Frost’s fatigue failure window
does not accurately represent the over load in the clinical situation [7].
Past reports focused on overload and CBL are presented in Table 1. Isidor et al. reported
on crestal bone reaction following excessive occlusal load or plaque accumulation in monkeys. In
this report, 6 months after insertion of implants, a fixed partial prosthesis was mounted and there
were two experimental groups: Excessive occlusal over load and plaque accumulation. A loss of
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osseointegration and/or CBL was observed 4.5 months to 15.5 months after overloading was initiated.
None of the implants with plaque accumulation experienced CBL [8]. Miyata et al. reported the
influence of controlled occlusal overload on peri-implant tissue, again in monkeys and in this model,
supra-occlusal contact was applied for four weeks to implants starting fourteen weeks after insertion.
Neither inflammation nor CBL was observed when supra-occlusal contact was of approximately 100
microns. In contrast, CBL was observed in the group with supra-occlusal contact was over 180 microns.
The authors concluded that peri-implant CBL occurred with 180 microns or more of supra-occlusion [9].
Esaki et al. reported the relationship between the magnitude of immediate loading and peri-implant
osteogenesis in a canine model [10]. In this report, immediate load (0 N, 10 N, 50 N) using a cyclic
loading device was applied to implants placed in healed sites. In the 10 N group, newly formed bone
was observed over a wide area from the implant neck toward the tip. In contrast, in the 50 N group,
newly formed bone was rarely observed around the neck and signs of infection were seen. The authors
suggested there is a certain load that is beneficial and promotes osteogenesis and an overload threshold
that is detrimental. Heitz-Mayfield et al. evaluated the effect of excessive occlusal load following
placement of implants in dog [11]. After six months of healing after implant insertion, supra-occlusal
crowns were placed. At eight months, all implants were osseointegrated with no statistically difference
between test and control implants observed with regard to osseous response.
Table 1. Animal experiments about biological complications related to implant loading.










N/s for 5 days Yes 6 months 4–15 months Astra
Miyata et al. [10] Monkeymandible
Supra-occlusal




et al. [12] Dog mandible
Supra-occlusal
contact No 6 months 8 months Straumann
Esaki et al. [11] Dog mandible Immediate load Yes None 3 weeks Branemark
Although each of the experiments described above employed different experimental models,
taken together, it is clear that certain dynamic force applications influence CBL and bone formation
around implants. Managing occlusal loading to achieve desirable effects and prevent undesirable
effects is an important consideration during treatment planning and treatment.
In recent years, attention has been paid to osseous activity at the molecular level when force is
applied to bone. As a result of technological advances of technology, the role of the osteocyte has
become better understood.
Osteocytes are most abundant bone cell in the adult skeleton and function as mechanosensors
directing osteoblast and osteoclast function in order to maintain the optimal integrity of load bearing
bone. Early histologists upon observing enlarged osteocyte lacunae in bone sections proposed that
mature osteocytes could remove their perilacunar matrix, a term called “osteocytic osteolysis”. New
insights into this process have occurred during the last decade using novel technology thereby
providing a means to identify molecular mechanisms responsible for osteocytic osteolysis [12].
Dendritic osteocytes connect to the vasculature, to each other and to periosteal bone surface
cells creating a broad communication network within bone tissue. Osteocytes lie in a fluid-filled
interstitium of lacunae and canaliculi and are capable of sensing when mechanical load that applied
to the skeleton [13]. In response to force application, osteocytes react to and transmit information
via secretion of molecules with a signaling function such as sclerostin and receptor activator of
nuclear factor kappa-B ligand (RANKL) which then regulate bone matrix turnover by osteoblasts and
osteoclasts [14,15]. Due to the recently discovered multi-functionality of osteocytes, ranging from
phosphate homeostasis to interaction with distant organs, the regulation of the osteoblast–osteoclast
axis is one mechanism by which the osteocyte network contributes to mechanosensory response to
loading and may lead to osteocyte apoptosis and targeted bone resorption by osteoclasts [16]. As a
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result of this mechanosensing communication stream, bone resorption and targeted bone remodeling,
in the absence of bacterial inflammation, may change peri-implant crestal bone contours.
2.2. Peri-Implant CBL and Periodontal Pathogens
The success of implant therapy ad modum Branemark in experiencing minimal CBL led to the
proposal of optimistic criteria for success of implant therapy by Albrektsson et al. in 1986 [1]. These
criteria were quickly accepted as clinicians and scholars worldwide were able to achieve the criteria
proposed based on ≤1–2 mm of CBL in the first year after placement and ≤0.2 mm mean CBL bone
loss in subsequent years. The fact that these criteria were based on clinical outcomes from implant
therapy in edentulous patients/subjects was appreciated and concern remained that implants placed
in partially edentulous patients with their dental reservoirs of periodontopathogens would not be
able to duplicate the excellent crestal bone response seen in edentulous patients. These concerns
were laid to rest by Van Steenberghe et al. who, from multi-center study findings published in 1993,
clearly demonstrated that implant therapy ad modum Branemark in partially edentulous patients also
exhibited the same excellent resistance to CBL as observed in edentulous patients [17].
Nevertheless, in the relatively uncommon cases of CBL seen, the concurrent peri-implant mucosal
inflammation and bacterial cultures yielding traditional periodontopathogens spawned an erroneous
belief system that peri-implant CBL was fashioned after the same etiology as periodontitis. This
despite that nowhere else in the human body is an artificial substitute considered to be the same
as the original biological tissue: A man-made substance is yet to be fabricated that is identical to
natural tissue (see next section). Today, one comes across people who simultaneously claim that bone
created from an allograft is different to native bone and yet who argue that periodontal bone loss is
the same as peri-implant CBL and should be prevented, diagnosed, and treated similarly. The use
of the term peri-implantitis has merely cemented the error of association in the minds of clinicians
and scholars despite the fact that, to date, there is no clear and compelling evidence that peri-implant
CBL is primarily a consequence of bacterial insult. Of course, many of the same bacteria are found in
diseased periodontal and peri-implant sites, more a consequence of anaerobic environments that lend
themselves to colonization and propagation of these bacteria [18]. The osseosufficiency model presents
the patient as an important element of the path towards successful implant therapy. Yet, it is critical to
recognize that is the host response of the patient that is important, not the presence or absence or site
concentration of specific bacterial species that prevails and the host response to an artificial implant
substitute is markedly different than the host response to a natural tooth. Once peri-implant CBL or
inflammation is observed, addressing the bacterial component may alleviate the symptoms and signs,
but it will not address the root cause of the problem which is more likely to be improper diagnosis,
treatment planning and treatment by the unaware clinician that then leads to peri-implant CBL.
Further erroneous implications are engendered when research models used to study periodontitis
are applied to the dental implant ecosystem, most notably, the use of ligature-induced peri-implantitis
canine model that creates an artificial scenario by which bacterial inflammation is induced around
implants in order to study the degree of CBL. Clinically irrelevant periods of oral hygiene cessation,
sometimes 4 months in duration, are combined with the introduction of plaque-attracting sulcular
ligatures in order to create a scenario that bears no resemblance to clinical practice and which, therefore,
have no clinical meaning [19,20].
2.3. Bone and the Immune System—Foreign Body Reaction
Any foreign-body implant that is placed in contact with vital tissues can activate the
immune/inflammatory systems whereby under normal conditions the defense cells, including
neutrophils, lymphocytes, reactive pro-inflammatory macrophages (i.e., M1 and OsteoMac), and
osteoclasts are activated and engulf and then digest the foreign body. The repair cells, such as
fibroblasts, osteoblasts as well as macrophages (M2 and OsteoMacs) are also activated and assist in
tissue repair and remodeling, and protection of the tissues from further destruction. However, when
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a foreign body is too large to be engulfed or digested by the immune cells, a fibrous (granuloma) or
osseous encapsulation of the foreign body is formed around the foreign body. This encapsulation
isolates the foreign body from the surrounding tissue and is characterized by a chronic presence of
macrophages and multinucleated foreign body giant cells (i.e., Langerhan’s cells) at the foreign-body
surface. These foreign-body giant cells are the result of fusion of monocytes and macrophages activated
upon adherence to the foreign-body surface during the earlier inflammation and tissue-repair stages.
While these giant cells may present throughout the foreign-body life-time, it is unclear whether they
remain active or become inactive with time. Another possible immune reaction to a foreign-body
occurs when the immune response is too vigorous or too prolonged, or its function is disrupted. In
such situations, the defense/repair balance may shift towards chronic inflammation and chronic tissue
destruction [21–24].
In the case of dental implants (see above), it is well established that when titanium implants are
placed in the jaw-bone, an evoked inflammatory reaction is followed by formation of new bone in
close approximation around the implant. Subsequently, a long-lasting (i.e., implant lifetime) steady
state bone remodeling activity is established which maintains the bone around the implant including
the marginal bone level height. This process has been named by Branemark ‘osseointegration’,
whereby titanium has been considered an immunologically inert material that supports the bone
healing process. It was Donath et al [25] who first suggested that in fact, this reaction of bone-tissue
engulfing a dental implant is consistent with a protective foreign body immune response whereby
the bone formed around the implant isolates it and thus protects the surrounding bone marrow
tissue (Figure 2). This hypothesis has been further investigated and subsequently supported by the
Wennerberg and Albrektsson group and others who have further suggested that once new bone is
formed around the implant, maintenance of a balance between bone resorption and bone formation
(i.e., ‘foreign-body equilibrium’) can maintain the osseointegration and the marginal bone height
around the implants [4,21,22,26–33]. Albrektsson and colleagues have proposed a revised definition
of osseointegration to state that “osseointegration is a foreign body reaction where interfacial bone is
formed as a defense reaction to shield off the implant from the tissues [34] and further elucidated the
importance of host response in long-term osseointegration outcomes [35]. However, the majority of
the studies on foreign-body response are in vitro studies or studies that have utilized titanium or other
biomaterial implants placed in limb bones or other body tissues. In vitro studies have shown that
titanium can activate macrophages [30], and that complement factors in blood plasma binds to titanium
implant surface which suggests that during the early stage of inflammation following titanium implant
placement, the implant surfaces can be recognized by the immune cells through complement factors in
the blood [36]. In the recent study in rabbits, it has been shown that the formation and subsequent
maintenance of new bone around titanium implants placed in a femur bone are associated with
time-dependent immune responses. These responses were manifested first (10 days) as up-regulation
of immune defense cells (i.e., macrophages), and subsequently (at 28 days) by up-regulation of
immune repair cells (macrophages, lymphocytes, neutrophils, and the complement system), plus
down-regulation of bone-resorbing cells (osteoclasts) around the implants [33]. In addition, similar to
foreign-body host response in other body parts, multinucleated giant cells are present at the dental
implant–bone interface [25,37], and while these giant cells can be present throughout the implant
life-time, it is unclear whether they become inactive with time, or remain active, or become active
under certain conditions leading to marginal bone resorption.
320
J. Clin. Med. 2019, 8, 166
Figure 2. A diagram illustrating brain–bone axis involving the sympathetic and parasympathetic
nervous systems that act through direct and direct neuronal innervation of bone tissue (black arrows).
Centrally modulated sympathetic activity inhibits osteoblasts and bone formation and enhances
osteoclast activity and bone resorption (red), while centrally modulated parasympathetic activity
enhances osteoblast activity and bone formation and inhibits osteoclasts and bone resorption (green).
Somatosensory and nociceptive inputs from the bone to the brain as well as pain, stress, and mood
responses can impact bone formation and resorption either directly through the autonomic nervous
system or indirectly through activation of the immune system that can also be activated directly by
bone injury.
Considering the intimate relations between the immune system and bone healing and remodeling,
when the immune response to titanium implants is coupled with certain factors or health conditions
that impact the immune system or the immune response, the balance between osteoblast and osteoclast
activity can shift during the healing phase from a net bone apposition to a net bone resorption resulting
in osseointegration failure or unwarranted CBL. Moreover, since osseointegration is a dynamic state
of bone remodeling, these factors or health conditions may also impact the osseointegration after it
had already been established. These factors or conditions include genetic factors, immunosuppressed
diseases, smoking, poorly controlled surgery, excess cement, and medications [26,38–42]. Therefore,
patient examination and medical history taking should be evaluated not only prior to implant
placement, but also on a regular basis as part of the postoperative follow-up appointments. Other
possible causes for impaired bone healing or marginal bone loss could be titanium ion leakage,
titanium particles detachment and implant surface contamination with metal or organic particles
that are residues of the implant manufacturing, implant cleaning and handling, surgical placement
or prosthetic installation processes, as well as prosthetic materials [43,44]. Such particles in the bone
surrounding the dental implants can induce chronic inflammatory reaction and immune response
which include activation of immune cell mediators such as cytokines (e.g., tumor necrosis factor-alpha
(TNF-α)) that can influence the activities of osteoblasts and osteoclasts and thereby impact on bone
healing and bone turnover around the implants [29,45–47]. On the other hand, if osseointegration
had already occurred, considering osseointegration is dynamic, the above-mentioned factors can also
impact bone homeostasis and shift bone turnover into a net bone resorption manifested as aseptic
osseoseparation and/or marginal bone resorption (see above). This condition is considered aseptic
since its initiation does not involve the oral microbiota however, this does not rule out the possibility
of a secondary bacterial infection or a bacterial-derived marginal bone resorption in individual
cases [4,22,26,27,29,34,35,47,48].
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2.4. The Role of the Brain in Modulating Osseointegration: Brain–Bone Axis
Novel evidence suggests that the brain and the nervous system in general play vital roles in
long-bone healing and remodeling processes [49–51]. Complex neural networks exist between the
central nervous system and the bones, and nerve fibers of sympathetic, parasympathetic, and somatic
origin innervate long bones [52,53]. Furthermore, nerve-derived neuropeptides [e.g., neuropeptide
Y, endocannabinoids (CB)], and neurotransmitters (e.g., norepinephrine, dopamine, serotonin, and
calcitonin gene-related peptide) were found in the vicinity of long-bone cells that express receptors
for these neuropeptides (e.g., β2-adrenergic, Y1 (the name of the receptor) and Y2 (the name of the
receptor), CB1 and CB2) and neurotransmitters (e.g., dopamine, and serotonin). These neuropeptides,
neurotransmitters and receptors can in turn contribute to the regulatory mechanisms underlying bone
remodeling [49,54]. In addition, the central nervous system can integrate internal (e.g., glycemia,
menstruation hormones) and external signals that can impact brain control of bone formation
and remodeling [51]. For example, experimental denervation of sensory and sympathetic nerve
fibers can impact bone development and remodeling [55,56]. While nerve fibers of sympathetic,
parasympathetic, and somatic origin also innervate jaw-bones including extraction sockets and
peri-implant tissues [53,57–61], no information is available on the role of the nervous system in
the healing and remodeling of jaw bones.
Recent studies have also shown important functional links between the central nervous system
and the immune system that as we have discussed above plays a key role in peri-implant bone
healing. Immune organs, such as lymphoid organs (e.g., lymph nodes, spleen) are innervated by
sympathetic and parasympathetic nerve fibers of the autonomic nervous system which can in turn
control bone remodeling [52,62]. The notion that the brain can modulate the immune response is also
supported by studies showing the effects of mental and physical stress on the general health and
immunity [63]. Moreover, usage of central nervous system medications (e.g., opioids, antidepressants,
anticonvulsants) as well as depression conditions are associated with low bone mass and increased risk
of osteoporosis and fractures [64]. It is interesting to note that recent studies have shown that impaired
osseointegration and failures of dental implants are higher in patients treated with antidepressant
drugs (selective serotonin reuptake inhibitors) [65–67]. However, it is unclear if the increased loss of
osseointegration is produced by the drug or by the mental health condition itself and the impaired
communication between the nervous system, immune system and bone healing and remodeling and
thus, more robust research is required to identify the exact cause of osseointegration loss.
Another evidence for the role of the brain in bone growth in general comes from the effects of
growth hormones in regulating bones growth during development, and bone remodeling throughout
life. Growth hormones are secreted from the cerebral pituitary gland under the control of the cerebral
hypothalamus. In fact, growth hormones can induce proliferation and activation of both osteoblasts
and osteoclasts with an overall net effect of either bone growth, bone resorption or homeostasis [68].
Furthermore, growth hormones play a crucial role in fracture healing, and novel therapeutic approaches
utilizing growth hormones (and other growth factors) to improve long bone healing are currently
under investigation and development [69].
Altogether, the clinical significance of these studies on brain–bone axis (Figure 2) lies in them
providing novel potential therapeutic targets for modulating bone remodeling. Thus, research is
needed to gain a better understanding of the possible role of brain–immune system interaction also on
jaw-bone remodeling and peri-implant bone healing and CBL.
3. Section B. Methods of Measuring Crestal Bone Loss
3.1. Current Methods
The need for measuring CBL has come with the spectrum of osseoseparation and peri-implantitis.
A “lifetime” treatment for a patient requires osseosufficiency, i.e., the harmonious relationship
between the host, the implant, and the clinician [3]. The rise of osseointegration science (and related
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expectations) led to the preservation of crestal bone height after implant placement in the context of
quantitative success criteria for implant osseointegration. Monitoring changes in the bony anchorage
routinely, at regular intervals, was advocated [1]. In this context, X-ray imaging techniques naturally
emerged as a convenient tool for characterizing the marginal bone loss.
Change in bone height (loss or gain) represents the difference in bone levels at the same site
at separate time-points. The initial reference bone level value is subtracted from each of the later
values, usually but not always, resulting in a negative measurement representing loss of crestal bone.
The initial reference is often recorded either right after implant placement (post-operative value) or
once the implant becomes functionally loaded (prosthetic loading). These calculations compare the
vertical distance between the crestal bone level at the implant contact and a reference point on the
implant (implant platform for example), and as a consequence, should be referred as “distance to bone”
values than to “bone level” values. Clinical routine measurements are often reported at the tenth of
millimeter, while experimental ones may exhibit more accuracy.
To be consistent, the use of a single technique for both measurements is recommended (same
imaging materials, same settings and same measure method). Then the known implant diameter,
platform diameter, implant length or distance between two threads of screw-type implants may be
used for calibration [70].
In the scientific literature, various imaging techniques have been used for measuring CBL, such
as standardized intraoral radiographs (SIR), panoramic radiographs, computerized tomography scans,
and cone beam computerized tomography (CBCT) scans [71]. The accuracy of the measurements have
usually been assessed on jaws from animals or human cadavers, and those studies have repeatedly
showed that panoramic radiographs lack reproducibility and resolution due to structure distortions
and superimpositions, while computed tomography scans are affected by metal artifacts combined
with an excessive exposure dose [71]. Today, SIR and CBCT appear to be the appropriate methods for
routine assessment of crestal bone levels on living patients.
3.1.1. Standardized Intraoral Radiographs (SIR)
Standardized intraoral (or periapical) radiographs have historically been, and remain to be, the most
commonly used method for longitudinal assessment of peri-implant bone loss. For limiting distortion,
the long cone paralleling technique is preferred to the intra-oral bisecting angle technique [72,73]. This
technique, routinely used in periodontology, consists in holding the radiographic film parallel to the long
axis of the implant and placing the X-ray beam perpendicularly to the receptor [74]. This paralleling
technique requires the use of a film holder for routine clinical care, but for research purpose, a
customized occlusal bite jig may be also fabricated to standardize the procurement of the implant
image at different time points. The bite jig improves comparative measurements by limiting the
parallax effect (apparent displacement of bony structures when radiographs are taken from different
angles). The bite jig, typically fabricated from silicone, wax, or resin, is a repositioning key that fits
to the film holder and can be stored by the dentist until next use. In some clinical studies, the bite
jig is clipped on the attachment (locator, ball) or screwed into the implant. However, bone level
interventions are not advocated as they may predispose to the bone loss. Some interesting devices have
been described for the assessment of functional implants, such as a bite jig designed to be perpendicular
to the initial implant placement driver [75].
Periapical radiographs used to be obtained on conventional films; however, the use of digital
radiography is expanding in dental practice. When routine measurements are performed on
conventional films, a magnifying lens can be used. Nowadays however, most research protocols
incorporate high-resolution digitalization of a conventionally-obtained radiograph film. When routine
measurements are performed directly with digital radiography, a sliding gauge tool can be used
with most of the currently-available radiograph-related software to assess the distance between the
crestal bone and the implant reference-point chosen. For research purposes, a method called the
digital subtraction technique has been developed to directly measure bone loss by superimposing
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two serial radiographic images before subtracting them to isolate/quantify bone changes using
specially-designed software [72].
Accuracy
Measurement accuracy is the closeness of agreement between measured and the true bone level.
The accuracy relies not only on the resolution and sharpness of the radiographic material, but also on
many clinical parameters, such as the degree of CBL, the jaw anatomy and configuration, the delay
between placement and function, and the quantity of serial radiographs on the same implant [76].
When using a magnifying lens, e.g. ×10, with conventional SIR, inter- and intra-observer
variability were shown to be approximately 0.14 mm and 0.08 mm respectively [76]. Conventional film
and digital radiography exhibit the same accuracy [77]. Digitized conventional films may exhibit more
noise artifacts and may lose density range but still provide comparable measurements [77,78].
Sensitivity and Specificity
In our context, the sensitivity of a radiographic technique consists in detecting the presence of
crestal bone, while its specificity is about correctly detecting the bone (or defect) absence. These
parameters have been tested in animals or in cadaver studies, when bone level estimations can be
compared to the physical measurements. In a recent meta-analysis pooling the results of 5 studies,
the SIR exhibited clinically acceptable sensitivity (60% when pooled; 56–100%) and specificity (59%
when pooled; 51–98%) [71]. SIR detected more precisely large defects (around 3 mm) than small
ones (1–2 mm) [71,79,80]. As a consequence, many authors reported the proximal bone loss to be
underestimated by SIR measurements [81–83].
Pros and Cons
The primary advantages of SIR are the low exposure dose and being the least invasive of all the
radiographic techniques. Combined with its low cost, the reliability of linear distance measurements,
easy access and easy handling for dentists, this technique remains the gold standard for routine
clinical measurements.
However, only the mesial and distal CBL can be assessed with this technique. Furthermore, in
the context of peri-implantitis, proximal bone levels were often shown to be more apical than the
radiographically measured ones [81–83]. The tangential measurements can be affected by geometric
distortions and anatomical superimpositions, especially since a strict parallel projection is difficult to
obtain in some clinical situations [84]. In addition, SIR do not allow identification of the 3D morphology
of a bone defect (intra-bony and supracrestal components) that influences diagnosis, prognosis and
treatment planning [83,85,86].
3.1.2. Cone Beam Computerized Tomography (CBCT)
The use of CBCT, also called digital volume tomography, to assess peri-implant bone level is
more recent as this technology emerged in dentistry only 20 years ago. Compared with traditional
CT, the lower irradiation dose and less severe metallic artifacts raised opportunities for new
dental applications.
In comparison with SIRs, CBCT image quality relies mainly on the technological performance
of the material. Some of the most influencing parameters are the voxel size and the field of view.
Indeed, image resolution is related to the size of volume elements, called voxels, which are often
cubes (with edge ranging from 0.08–0.3 mm in research studies on peri-implant defects). However,
small voxels come with additional noise [87]. Also, the field of view defines the volume of interest
undergoing examination (cube ranging from 4 × 4 to 8 × 8 cm) and influences accuracy. This
technological parameter is determined by the available detector, beam projection geometry and beam
collimation. Small voxels and small fields of view improve measurements; but seeking the most precise
peri-implant morphology when combining these two parameters will still deliver high radiation
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levels [80,88]. Image reconstruction parameters and filter software (used to lower metal artifacts) also
influence the performance quality of the peri-implant measurements [89,90].
Accuracy
As previously mentioned, CBCT accuracy is defined by the field of view size, but also by the device
scan mode and arc of rotation [91–93]. Indeed, the full-scan mode (360◦) provides a higher diagnostic
accuracy for peri-implant defects [90]. A recent systematic review concluded that large defects are
more accurately detected than small ones, and that circumferential and fenestration peri-implant
defects are more accurately detected than dehiscence defects [94].
Experimental measurements of peri-implant defects showed very low deviation when compared
with direct measurement (0.18 ± 0.12 mm) and the proximal values were comparable to those obtained
with periapical radiographs [95,96]. The spatial resolution can reach around 150–200 μm [72,97].
Sensitivity and Specificity
In a recent meta-analysis pooling the results of 9 studies, the CBCT exhibited clinically acceptable
sensitivity (59% when pooled; 28–97%) and specificity (67% when pooled; 25–97%) [71]. Sensitivity
globally increases with small voxels but remains challenged by small defects [90]. On the other hand,
some authors suggested that specificity may increase with bigger voxels [80]. Filters can improve the
detection of true positive or negative values [90].
Pros & Cons
When compared with SIR, CBCT delivers more radiation to patients, is more expensive for the
patient and for the medical team, and has relatively limited availability. Metal artifacts (streaking,
beam hardening, or scatter) increase with CBCT low energy settings and may add some false-positive
bone on the vestibular side and false-negative bone on the other sides [96].
Both SIR and CBCT are interesting and validated imaging techniques for measuring peri-implant
CBL. Their accuracy, sensitivity, and specificity are clinically acceptable [71,98]. On one hand, SIR
provides only proximal values, but the data obtained often are sufficient to confirm changes in
peri-implant CBL. On the other hand, CBCT exposes the patient to higher cost and radiation dose
but offers a 3D characterization of the peri-implant defect. For these reasons, SIR remains the gold
standard for routine assessment of bone level changes and for helping in peri-implantitis diagnosis,
while CBCT is still confined to providing clear 3D images of diagnosed peri-implantitis that require a
treatment plan [71,94,99]. In the future, CBL assessment may not be in X-ray imaging but rather in
non-invasive 3D procedures such as ultrasound [100].
3.2. Novel Method: Photoacoustic Ultrasound as an Innovative Method to Measure Peri-Implant Pocket Depths
and Bone Loss over Time
Ultrasound is the most widely used clinical imaging modality in medicine but has limited
deployment in dental and periodontal practices [101]. In recent years, however, the number of
preclinical dental applications of ultrasound has been increasing [102]. The advantages of ultrasound
include the ability to image soft tissues in real-time without ionizing radiation at a relatively low cost.
One of the drawbacks of ultrasound is its limited contrast (signal from target versus signal from
background). Contrast in conventional ultrasound is a function in differences in the acoustic impedance
of different tissue types. Photoacoustic imaging is a hybrid form of ultrasound that can overcome this
limitation and increase the contrast of ultrasound (Figure 3) [103]. It has a rapidly growing number of
applications and uses optical—rather than acoustic—excitation to harness the photoacoustic effect.
Photoacoustic imaging converts the incident light into sound following absorption and thermoelastic
expansion of a target material [104]. It combines the good spatial and temporal resolution of ultrasound
with the contrast and spectral imaging capabilities of optics. Typically, the optical excitation source
(5–50 ns pulses at ~ 5 Hz) is a pulsed near-infrared laser (Nd:YAG/OPO) but low-power LED sources
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can also be used [105]. These pulses are absorbed by tissue, and the energy is released acoustically and
detected by ultrasound transducers with center frequencies in the MHz range. The coupling of fiber
optics with ultrasound transducers allows simultaneous ultrasound and photoacoustic imaging [106].
A variety of algorithms can be used for image reconstruction to maximize contrast, resolution, and
signal-to-noise [107–110].
Figure 3. Acoustic Modalities. Ultrasound uses echoes to create contrast (“sound in/sound out”).
Photoacoustics is “light in/sound out” and is based on thermal expansion of the target tissue or
contrast agent.
The most common uses of photoacoustic imaging are image-guided therapies [111], diagnosis
of disease states [112,113], surgeries [114,115], and drug delivery [116,117]. These applications can
be achieved through either endogenous or exogenous contrast. Endogenous contrast is based on
the optical absorption of naturally occurring targets such as oxygenated/deoxygenated hemoglobin,
melanin, lipids, and water [118]. Exogenous contrast mechanisms leverage the absorption of materials
such as small-molecule dyes, fluorophores, and nanoparticles that originate from outside of the
body [119]. In both cases, because photoacoustic intensity is proportional to optical absorption, light
sources with specific wavelengths can be used for spectral differentiation between materials according
to their absorption spectra.
Imaging the Periodontal Pocket with Photoacoustic Ultrasound
Assessment of periodontal disease uses physical measurements (e.g., attachment level, probing
depth, bone loss, mobility, recession, and degree of inflammation) [120]. Periodontal probing offers
a numerical metric that reflects the extent of apical epithelial attachment relative to the gingival
margin [121] but suffers from poor reproducibility due to variation in probing force [122]. Indeed,
a recent meta-analysis showed a wide range of probing forces (51 to 995 N/cm2)—a variation of
~20-fold [123]. Other error sources include variation in the insertion point, probe angulation, the
patient’s overall gingival health (weakly inflamed tissue), and the presence of calculus [121,124].
Thus, the exam is subject to large errors with inter-operator variation as high as 40% with r values
between technicians <0.80 [125]. These errors can hamper clinical decision-making and epidemiological
studies ultimately resulting in poor patient outcomes [126]. Furthermore, many patients find probing
to be uncomfortable or painful—this can prevent patients from seeking care [127,128]. Moreover,
the periodontal probing is time consuming for the practitioners. It is perhaps not surprising that
periodontal examination was not performed in 50–90% of the audited dental records offices [129–131].
Finally, the benefit of traditional periodontal probing around implants is abrogated due to implant
threads that impede probe penetration along the implant surface [132,133]. This limits the clinical
assessment of these tissues, potentially leading to peri-implantitis [134,135].
The first study to use photoacoustic imaging for visualizing pocket depths was conducted by
Lin et al. in 2017 [136]. A commercially available tomographic system (Visualsonics Vevo LAZR) was
used for imaging porcine jaws extracted from frozen cadavers. A food-grade contrast agent containing
melanin nanoparticles derived from cuttlefish ink was used to increase the photoacoustic signal of the
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pockets. This material acted as a safe, highly absorbing material capable of filling the gingival sulcus
following oral irrigation. It had broad absorbance and photoacoustic signal.
This technique was recently expanded to a healthy young adult case [137]. The same imaging
system was adapted so that a subject could be scanned while seated (Figure 4A). Here, ultrasound gel
was used for coupling and a medical head immobilizer and cheek retractors were used to minimize
movements from the subject; 40 MHz ultrasound was used throughout. Again, the procedure began
with irrigation of the pocket followed by laser pulsing and imaging, removal of the contrast agent,
and image processing. The pocket depth could be visualized for a given sagittal plane (Figure 4B–D)
after administration of the agent. Because these experiments used ultrasound gel for coupling, it
was common during scanning for the agent to nonspecifically coat the surface of tooth. However,
this nonspecific signal could be removed in post-processing by using the ultrasound-only images
to locate the gingival margin. Any signal originating from tooth surface occlusal to the margin was
ignored allowing a final mapping of the pocket to be manually generated (Figure 4E). In the future,
this processing step will be automated.
Figure 4. Representative human data of photoacoustic-ultrasound imaging for pocket depth
measurements. (A) Overview of the imaging setup and methodology. The subject was seated in
front of the transducer (I) and ultrasound gel was used for coupling. The stepper motor (II) was used
for scanning the transducer and the sliding frame allowed positioning (III). First, the teeth of interest
were irrigated with the contrast agent followed by imaging, removal of the agent, and image analysis.
(B) A sagittal cross-section (dashed yellow line in Panel C) of a mandibular central incisor before (top)
and after (before) irrigation with the contrast agent, revealing the pocket depth, measured from the
gingival margin to the edge of photoacoustic signal. Nonspecific signal from the tooth, caused by the
movement of coupling gel during scanning, did not contribute to the measurement. (C) A frontal
view of the same tooth before (D) and after (E) irrigation. Nonspecific signal from contrast agent was
removed during image processing by measuring the pocket from each sagittal plane as in Panel B and
overlaying each measurement on the ultrasound-only image.
In the case of implants, physical probing is typically hindered by threads that impede probe
penetration along the implant surface [132,133]. This limits the ability for clinical assessment of these
tissues potentially leading to peri-implantitis [134,135]. We note that photoacoustic ultrasound has not
been explicitly tested yet for imaging the pockets around implants. However, because it relies on the
flow of contrast agent into the pocket rather than the physical penetration of a metal probe, the presence
of implant threads should not affect measurements. For this reason, we believe photoacoustic imaging
is promising for patients with implants that obstruct manual probing. Of course, additional work
remains to improve the clinical feasibility of the technique including development of a mouthpiece
transducer and the implementation of more affordable and stable excitation sources, such as LEDs or
laser diodes.
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4. Summary
New ways of appreciating CBL are blending traditional etiologies with novel mechanisms that
better reconcile what was originally thought to be taking place during osseointegration with actual
long-term clinical outcomes. Today, the ability to look back on osseointegration outcomes at the
implant level, the prosthesis level, the patient level and even the clinician level allow us to recognize
that osseointegration likely represents a form of foreign body reaction and focuses our attention on
elements that, therefore, influence the immune response or the consequence of a patient’s immune
response. In this way, traditional etiologies such as inflammation from infection and overloading
can be viewed as modulators of the immune response and the effect of immune response through
neuroimmunomodulation opens up new and exciting avenues for future research.
Clinically, measuring crystal bone loss remains at the mercy of the constraints of radiographic
imaging. Nevertheless, new methodologies and digital technologies portend the introduction of
non-invasive methods that may be more sensitive and specific with regard to measurement of crestal
bone position and changes in crestal bone position over time. Here too, innovations in imaging will
allow us to better assess the effect of new techniques, products, protocols and materials.
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Abstract: The permanent interaction between bone tissue and the immune system shows us the
complex biology of the tissue in which we insert oral implants. At the same time, new knowledge in
relation to the interaction of materials and the host, reveals to us the true nature of osseointegration.
So, to achieve clinical success or perhaps most importantly, to understand why we sometimes
fail, the study of oral implantology should consider the following advice equally important: a
correct clinical protocol, the study of the immunomodulatory capacity of the device and the
osteoimmunobiology of the host. Although osseointegration may seem adequate from the clinical
point of view, a deeper vision shows us that a Foreign Body Equilibrium could be susceptible
to environmental conditions. This is why maintaining this cellular balance should become our
therapeutic target and, more specifically, the understanding of the main cell involved, the macrophage.
The advent of new information, the development of new implant surfaces and the introduction of
new therapeutic proposals such as therapeutic mechanotransduction, will allow us to maintain a
healthy host-implant relationship long-term.
Keywords: oral implants; osseointegration; marginal bone loss; immunomodulation; mechanotransduction
1. Introduction
Titanium dental implants are inserted directly into the bone tissue, a complex and dynamic tissue.
This bone tissue not only participates in calcium homeostasis and functions as a hematopoietic organ,
but also plays an important role as a regulator of immunity [1].
Recent evidence on foreign body reactions (FBRs) in relation to implantable devices, such as
titanium dental implants, reveals that, to achieve a lasting relationship between the implant and the
host, titanium implants must have an optimal surface [2], and there must be an adequate healing
capacity of the host [3]. Recently, it has been shown that the presence of a titanium implant during
bone healing activates the immune system and displays type 2 inflammation, which seems to guide
the relationship between the host and the implant [4]. This appears to indicate that osseointegration is
a dynamic process, the result of a complex set of reactions in which several mechanisms and pathways
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of the host interact [1]. If the osseointegration is not altered, a continuous equilibrium occurs in the
form of Foreign Body Equilibrium (FBE), which has been documented for 20 years or more in oral
implantology [5]. Despite the high rates of survival achieved with titanium dental implants [6], it is
necessary to further improve the implant-host relationship to maintain the integrity of the FBE long
term; especially when the mechanisms involved in the breakdown of the osseointegration begin to
act [7]. Once this occurs the immune system could be activated changing the delicate balance between
the osteoblast and the osteoclast, which results in bone resorption [8].
The role of macrophages in osseointegration is greater than expected [1]. Macrophages respond
to all implanted materials, which play an essential role in the fate of an implant [9]. Currently,
immunomodulation strategies targeting macrophages are being developed around implants, both
dental and orthopedic ones; either through new surface treatments [10], the controlled release of
specific ions [11] or through specific cytokines [12]. The immunomodulatory effect of the Mesenchymal
stem cell (MSC) has also been explored [13], and in this line, the hypothesis of immunomodulation of
osseointegration through therapeutic mechanotransduction has recently been proposed, particularly
by extracorporeal shock waves therapy (ESWT) [14].
The field of mechanobiology has allowed us to analyze the effects of mechanical forces on cellular
processes [15], which has revealed the complex cellular regulation involved in the transduction of
mechanical signals [16]. Mechanical stimuli can stimulate the activity not only of bone cells but also
MSC [17]. Mechanical stimuli can also change the cellular form and affect the phenotype and function
of immune cells, such as macrophage and dendritic cells [18].
This review begins with (i) a discussion of key concepts related to bone tissue and the immune
system; (ii) next, we will discuss the FBR, focusing specifically on osseointegration; (iii) to then explore
the current strategies of immunomodulation in osseointegrated implants (iv) Finally, we will conclude
with a discussion on a topic that may become clinically relevant, the coupling between osseointegration
and mechanotransduction to maintain FBE long-term.
2. Bone Tissue and Immune System
The scientific field of osteoimmunology has revealed the vital role of immune cells in the regulation
of bone dynamics [19], this has led to the understanding of the existence of different molecular and
cellular mechanisms involved in a permanent interaction between bone tissue and the immune system.
For this reason, to understand bone healing in general and osseointegration in particular, it is necessary
to understand the biology and immunology of bones [20]. Bone is an organ composed of cortical,
trabecular, cartilaginous, hematopoietic and connective tissue [21], which is composed by more than
30 different cell populations which reside in the microenvironment of the bone marrow adjacent to an
implant. These cell populations, alone or in combination, have the ability to influence the formation
and the bone regeneration of the peri-implant environment [2]. In addition, the presence of multiple
anatomical and vascular contacts allow for a permanent interaction between the bone tissue and
the immune system [22]. In fact, the bone marrow shows structural and functional characteristics
that resemble a secondary lymphoid organ. That is why bone marrow is currently considered an
immunoregulatory organ, capable of significantly influencing systemic immunity [21].
The cells of the bone tissue and the cells of the immune system share common origins. Osteoclasts
(OC) come from stem cells of the monocyte-macrophage cell lineage [22]. However, certain subclasses
of circulating monocytes and dendritic cells (DCs) which reside in the bone marrow also have the
capacity to transform into OC if they are subjected to certain specific signals [23]. Perhaps this common
origin with cells of the immune system could be related to the ability of OCs to recruit CD8 + FoxP3 +
T cells and present antigens to them [24,25]. On the other hand, osteoblast (OBs) play a central role
in the differentiation of hematopoietic cells [22]. This common origin between osseous and immune
cells facilitates understanding of how molecular pathways are involved in bone remodeling (such as
in PTH, BMP and Wnt pathway) which also act in regulating the hematopoiesis [26].
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Immune cells regulate osteoclastogenesis by three main cytokines: macrophage colony stimulating
factor (M-CSF), receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) [19]. The main
element in osteoclastogenesis, the RANKL, can be expressed by activated T lymphocytes, dendritic cells
and neutrophils, indicating the participation of these immune cells during osteoclastogenesis [19,21].
The expression of RANKL by activated T cells has been implicated in osteoclastogenesis induced by
inflammation, linking adaptive immunity to skeletal biology [27]. This is related to the role of the
immune system in several bone diseases, such as osteoporosis, osteoarthritis and rheumatoid arthritis.
Several studies have clearly highlighted the role of developing T lymphocytes and the pathophysiology
of osteoporosis, which has given birth to a new field of biology called “immunoporosis” [28]. Moreover,
as the dendritic cells are responsible for the activation of virgin T cells and act as osteoclast precursors,
this could be directly involved in osteoclastogenesis induced by inflammation and bone loss [29].
It has been described that persistent inflammation is characterized by the continuous release of
proinflammatory cytokines (TNF-a, IL-1a/be IL-6), which is accompanied by a higher RANKL/OPG
ratio and an increased osteoclast activity [30]. On the other hand, it has been shown that B cells are an
important source of OPG derived from bone marrow, which implies that B cells are one of the main
inhibitors of osteoclastogenesis in normal physiology [19].
Macrophages are precursors of osteoclasts, and under the stimulation of M-CSF and RANKL,
they can differentiate into osteoclasts during bone remodeling [19]. Bone and bone marrow contain
multiple subpopulations of specialized resident macrophages (bone macrophages or osteomacs), which
contribute to bone biology and/or hematopoiesis [31]. Macrophages promote osteoblastogenesis in
in vitro matrix deposition and they could have an important role in the promotion of bone anabolism,
through the provision of trophic support to the osteoblast lineage [32]. In fact, the depletion of
macrophages leads to the complete loss of bone formation mediated by osteoblasts in vivo [33].
In addition, they would be important in the reversion phase of a basic multicellular unit (BMU),
which separates bone resorption and bone formation [34]. Macrophages are also abundant within
the bone callus during the inflammatory phase of bone healing in humans [35], so the presence and
diverse functionality of macrophages could allow an important contribution in bone homeostasis and
throughout the course of bone healing [32]. Furthermore, the healing of bone fractures is significantly
improved in knockout mice lacking T and B cells, which indicates that they may also have a detrimental
function during this process. This observation suggests the dual role of immune cells in osteogenesis,
through its expression and secretion of a wide range of regulatory molecules [19].
As we have seen, immune cells play an important role in bone homeostasis. Therefore, the insertion
of a foreign body into the bone tissue will inevitably be recognized by the immune system, affecting
the biological behavior of the bone cells. This event can determine the in vivo destination of an implant
or “biomaterial”.
3. Foreign Body Reaction and Osseointegration
The interaction between bone tissue and implants involves at least 3 components: immune cells
of the host, bone cells of the host and the material [19]. After implantation, the host will experience
a response to tissue injury, which will be conditioned by the material present and the degree of the
immune response [36].
In general, after a surgical implantation procedure, the damage of the endothelial cells exposes
the underlying vascular basement membrane and initiates the coagulation cascade that leads to
the formation of a clot of red blood cells-platelets-fibrin. This vascular damage also facilitates the
interaction of the implant with blood proteins and interstitial fluids, such as fibrinogen, vitronectin,
complement, fibronectin and albumin, which are adsorbed dynamically on the surface of the implant
(Vroman effect) in seconds, forming a superficial transient matrix [1,2,7,19,36,37]. This allows
physicochemical interactions between the host proteins and the implant’s surface, which leads to a
change in the molecular conformation of one or more of these host proteins, exposing previously hidden
amino acid sequences, which would act as antigenic epitopes [1,7]. Serum factors called “opsonins”
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will participate in the recognition of the foreign agent, the main ones being immunoglobulin G (IgG)
and the complement activated fragment, C3b, allowing for interactions with macrophages through
membrane receptors [38]. Hu et al. showed that adsorbed fibrinogen is the main protein responsible
for the accumulation of macrophages on the surfaces of implanted biomaterials [39]. It has also been
shown that adsorbed fibrinogen exposes two previously hidden amino acids, functioning as epitopes,
which allows for interaction with macrophages through the Mac-1 integrin (CD11b/CD18), leading to
a proinflammatory environment, modulating the response of the host to the biomaterial in this way [1].
In this same context, it has been suggested that another protein, fibronectin, could participate in the
chronic phase of FBR [40].
The complement system seems to play a key role at this early stage [7]. Arvidsson et al. showed
that the interaction between titanium and plasma coagulation factors, such as factor XII, could lead
to the activation of the complement through the alternative pathway, producing C3b [41]. As is
known, immune cells express inactivated C3b/C3b (iC3b) receptors, so that from the early phase of
inflammation, the surface of the implant is recognized by the immune system [7]. Recently it has been
demonstrated in titanium implants that there is a positive regulation of the C5a-1 receptor (C5aR1)
after the inflammatory period, which demonstrates a prolonged activation of innate immunity through
the continuous activation of the complement system [4].
After the initial interaction between the blood and the material, acute inflammation begins, which
is initiated by the cytokines and chemokines released by the damaged cells, leading to the influx of
neutrophils and mononuclear macrophages [19,36]. Neutrophils normally deplete rapidly, undergo
apoptosis and disappear from implantation sites within the first two days [19]. The prolonged presence
of neutrophils indicates that we are facing active chronic inflammation [36]. This has been observed
around titanium implants, probably due to the role of neutrophils in the promotion of vascularization
in tissue hypoxia and the ability of the macrophage to suppress the apoptosis of them [4]. It is important
to mention that neutrophils, in an effort to degrade the materials, release proteolytic enzymes and
reactive oxygen species (ROS), which can corrode the surface of the implanted material [19].
The influx of mononuclear macrophages occurs between 24 and 48 h, which have a phagocytic
function that includes the release of proteolytic enzymes that degrade cellular debris and the
extracellular matrix (ECM). Currently, these immune cells have aroused great interest among scientists
due to their multiple functions in the process of bone healing and high plasticity [19]. Macrophages
have been extensively characterized in phenotypes M1 and M2, reflecting the Th1/Th2 nomenclature
described for helper T cells [42]. Traditionally, it has been described that M1 proinflammatory
macrophages would dominate the early phase of the reparative response and, on the other hand, M2
macrophages (M2a, M2b and M2c), would play a more prominent role during the middle and later
stages of the response repair [19]. However, this classification represents only a simplification of the
in vivo scenario, since it is very likely that the macrophage phenotype occupies a continuum between
the M1 and M2 designations, with transient macrophages with characteristics of both phenotypes
present [43]. Therefore, it seems that both phenotypes of macrophages perform essential functions
during the process of bone healing, with the macrophage change pattern determining the osteogenesis
instead of a specific macrophage phenotype [44].
It has been described that a prolonged M1 polarization phase leads to an increase in
fibrosis-enhancing cytokine release pattern by the M2 macrophages, which results in the formation
of a fibrocapsule around the biomaterial [19]. This reaction could be related to the “primary failure”,
which occurs in 1–2% of all dental implants placed, probably due to a series of risk factors that are
predisposed to this total failure in osseointegration, like the following: low primary stability, premature
loading, traumatic surgery, infection, as well as patient conditions such as smoking or the consumption
of some pharmaceutical products [20].
On the contrary, an efficient and timely switch from M1 to M2 macrophage phenotype results
in an osteogenic cytokines release and with it the formation of new bone tissue [19]. This second
possible reaction is one that would generate the bone encapsulation that allows the commercial use
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of titanium implants [20]. In commercially pure (c.p.) titanium implants, the presence of the M2
phenotype of the macrophage (most likely M2a) is significantly high, which has been observed as early
as 10 days after surgery [4,45]. This indicates that there is an immunomodulated relationship between
the titanium implant and the host, which allows the deposit of bone in the implant, and the isolation
of this from the space of the bone marrow, through a type of FBR [4]. Albrektsson and colleagues
introduce the concept of FBE to describe this phenomenon, osseointegration being considered a mild
chronic inflammatory response that allows implant function with a bone-implant interface that remains
in a state of equilibrium, susceptible to changes in the environment [5].
Macrophages can swallow particles up to 5 μm, however, if the size of the material or the residue
is greater than 50–100 μm, the material is surrounded by macrophages that fuse to form foreign body
giant cells (FBGC) [19,46]. This induction of macrophage fusion probably occurs through the secretion
of IL-4 and IL-13 by mast cells, basophils, and helper T cells (Th) [40]. It has even been suggested that
FBGCs could express phenotypes of M1 and M2 macrophages, depending on the environment, similar
to their mononuclear precursors [47]. Although FBGCs are not normally found in healthy tissues, they
are abundant around implanted biomaterials, even years after implantation [48]. This is the reason why
the presence of FBGC in the interface of the host-implant is an indication of an FBR to the implanted
material or device [19,40,46]. Donath et al. described the presence of FGBC on the surface of titanium
implants, which were present in multiple cases of FBR through histological studies [49]. It has been
seen that the CD11b marker is extremely upregulated at 28 days, demonstrating how macrophages are
highly involved in the reaction to titanium implants since this marker has recently been implicated
in the fusion of macrophages [4]. For several years, multinucleated giant cells (MNGC) have been
described in relation to biomaterials, especially in the case of bone replacement materials, assuming
that MNGCs are osteoclasts. However, many studies indicate that these cells actually belong to the cell
line of FBGCs, which are of an "inflammatory origin" [47]. It is a fact that osteoclasts can be formed by
the fusion of multiple macrophages, and some authors even suggest that macrophages can perform
functions of bone resorption [50]. All of the above suggests that FBGS could play a central role in the
pathway of bone loss during the FBR [7].
Macrophages and dendritic cells can initiate an adaptive immune response through the presentation
of antigens, which can also be particles or ions. When a T cell recognizes an antigen, the T cell is activated
(activated TCD4 +) and may have inflammatory secretory profiles (Th1) or anti-inflammatory secretory
profiles (Th2) [51]. Recently a constant regulation of CD4 and the negative regulation of CD8, which
indicates a reaction of CD4 lymphocytes around the implant, was observed in titanium implants [45].
However, more research is needed to confirm the continued presence of the immune system over
time [4].
As we have seen, an implanted device activates the components of the immune system in bone:
complement, neutrophils, macrophages and lymphocytes. However, the role of the macrophage in the
host-biomaterial relationship is highlighted [4]. Although most implants will be successful, a rejection
mechanism may occur. This may be represented by marginal bone loss around the osseointegrated
implant, which could be a product of multiple factors such as the implant, the surgical procedure,
prosthetic conditions and factors in relation to the patient [20]. The loss of FBE could be the main cause
of this peri-implant bone loss. This leaves the door open for the development of different strategies to
face the pathology through a deeper understanding of the biology of osseointegration [1].
4. Current Immunomodulation Strategies in Osseointegrated Implants
Titanium is one of the few materials suitable for implantation requirements in the human
body, being widely used in oral surgery, maxillofacial surgery, craniofacial surgery and orthopedics.
The greater clinical use and popularity of oral implants have led to a growth in demands, with an
increasing need for treatments in places where the quality of bone is less than ideal, and in patients
with a compromise of scarring products of systemic affections [2]. Although less than 5% of oral
implants show failure under optimal clinical conditions. In some cases, through a triad consisting
339
J. Clin. Med. 2019, 8, 139
of poor clinical handling, combined with poor implant systems and the treatment of those who are
compromised, treating “poor” patients may lead to problems, probably increasing the number of
complications [20]. On the other hand, many orthopedic procedures require implants, however, not all
implanted devices last forever: up to 15% of the total joint implants require a surgical revision within
15 years of the initial surgery [52]. Therefore, there is a need to improve the biological function and
longevity of the implantable devices [20,52].
Recent studies on osseointegrated titanium oral implants demonstrate the presence of the M2
phenotype of the macrophage from the early stage of healing (days) [4,10,45,53]. However, the presence
of other chemical elements on the surface of the titanium implant seems to be relevant for the bone
balance of osseointegration [2]. Trindade et al. have demonstrated that the bone resorption markers
were significantly down-regulated around titanium in turned titanium grade IV implants. Interestingly,
the regulation balance of bone resorption RANKL/OPG is suppressed in its entirety, suggesting that
bone resorption has been kept to a minimum around Titanium [4]. However, Biguetti et al., using a
machined titanium implant of titanium-6 aluminum-4 vanadium alloy, demonstrated the opposite;
there was a remarkable remodeling process, evidenced by peaks corresponding to RANKL and OPG,
and also an increased area density of osteoclasts. Furthermore, the presence of ten chemical elements
in the surface composition of the implants used was determined through an analysis by Energy
Dispersive X-ray (EDX): Titanium [Ti], Aluminum [Al], Vanadium [V], Calcium [Ca], Nitrogen [N],
Niobium [Nb], Oxygen [O], Phosphorus [P], Sulfur [S] and Zinc [Zn] [53].
In this context, it is noteworthy that c.p. titanium is often alloyed with aluminum and vanadium
(Ti6Al4V). However, in some cases, further surface modification procedures such as sand-blasting
and acid etching are likely to remove passive layers from the surface of the metal, exposing less
stable elements underneath. This could generate an inflammatory response and possible reduction
in osteoblast differentiation [2]. Both of these effects can be detrimental to new bone formation and
implant integration. However, in relation to the aforementioned, this material has an acceptable clinical
success currently [10]. However, the degree of purity of the surfaces is an important issue to consider
since there are important studies of oral implants, which reveal the presence of organic and inorganic
contaminants onto some surfaces [54,55].
The above could be clinically relevant since, as we know, macrophages respond to all the
implanted materials, being fundamental for the fate of an implant [36]. Macrophages are capable
of releasing metal ions from solid surfaces in a matter of minutes by dissolucytosis [2]. The fused
macrophages in FBGC can remain in the interface biomaterial-tissue, generating a sealed compartment
between its surface and the underlying biomaterial, which allows the secretion of different mediators
such as ROS, degradative enzymes and acid. Due to this the "frustrated phagocytosis process” being
associated with the failure of some implanted devices [48]. Particles, ions, or degradation products
from implanted materials or devices may also be recognized as foreign by macrophages and dendritic
cells [9,56]. Dendritic cells may also be drawn to the implant site by the recognition of foreign
substances, inducing the expansion of CD4 cells [9,21], so that some dental implant could eventually
be able to cause a type IV hypersensitivity reaction [57]. Since the bone marrow contains structures
in the form of follicles, similar to that observed in lymph nodes or the spleen, although without an
organized T and B zone, but these lymphoid follicles can increase in the bone marrow during infections,
inflammations and autoimmunity [21].
It has been demonstrated that titanium leakage due to corrosion inevitably results in substantial
contact between the foreign material and the tissues. In fact, there was a gradient in titanium intensity
from the implant surface and out up to a distance away from it of about 1000 μm [20]. Titanium ions
could cause immune responses due to their ability to bind to proteins, such as albumin or transferrin,
creating a bioavailable metalloprotein that could serve as an antigen in immunological reactions. Many
studies have shown that proinflammatory cytokines such as IL-1β (interleukin 1beta), TNF-α tumor
necrosis alpha factor, and GM-CSF (granulocyte-macrophage colony stimulating factor) are jointly
regulated after stimulation of a hapten or particles [58]. However, it is likely that this first corrosion
340
J. Clin. Med. 2019, 8, 139
is coupled to the acidic environment that inevitably develops after the placement of an implant, a
situation that is present until approximately four weeks after surgery when the partial pressure of
oxygen has normalized [20]. In all probability at this stage, the released ionic titanium is stabilized by
biomolecules such as citrate, an important metal chelator in cellular fluids, forming relatively stable
complexes in solutions close to neutral pH [58]. Thereafter it seems likely that titanium corrosion
will be quite minimal, provided that there is no more mechanical interruption of the blood flow.
The presence of titanium ions in a stage subsequent to osseointegration could generate a synergistic
interaction with other negative factors, such as cement particles, leading to marginal bone loss [20].
This scenario where living tissues face the presence of materials in an immunologically active
environment allows for a better understanding of the dynamics of osseointegration, and also reveals
that the desired FBE in an oral implant can be threatened by clinical conditions [7]. This is why the
methods that control the polarization of the macrophage have emerged as an attractive means to
reduce inflammatory signaling [19]. It is known that the increase in bone formation correlates with
the resolution of the initial inflammatory response. That is, inflammation and osseointegration are
inversely proportional [2]. As osseointegration is an immunomodulated inflammatory process, where
the immune system is locally up-or down-regulated [57], the precise modulation of postoperative
inflammation and the innate immune reaction provide a promising approach for therapeutic
purposes [19].
Several immunomodulation strategies have been proposed, mainly through the implanted
device, and more recently, the immunomodulation by means of direct stimulation of Human bone
marrow-derived mesenchymal stem cell (HBMMSC). This aims to improve integration, avoid fibrosis,
prevent bone loss and so increase the useful life of the devices in the human body [14,19,59].
In relation to these immunomodulation strategies through implanted devices, the topographic
modification of the titanium dental implant surface has shown a significant positive effect in the
speed and degree of osseointegration. In fact, the use of microscale modified implant surfaces has
been one of the key factors in increasing the clinical success rate of implants, especially in areas of
compromised bone quality [2]. The surface topography of the implant can be optimized at a micro level
and nanoscale, influencing properties such as wettability and surface charge, modifying the kinetics of
adsorption, the folding of proteins adsorbed onto implant surface and the consequent presentation
of bioactive sites to macrophages [51,60]. The geometry of the material may also be relevant for the
phenotypic expression of macrophage. It has been demonstrated that micro- and nanopatterned
grooves of 400–500 nm wide can influence macrophage elongation, driving macrophages toward an
anti-inflammatory, pro-healing phenotype [61]. This interaction of the macrophage with its mechanical
environment, that is, the surface of the titanium, is possible through multiple mechanoreceptors on
the cell surface, perhaps through integrins [62]. At present, titanium can be alloyed with Zirconium
(TiZr). The combination of high-energy and altered surface chemistry (hydrophilic), seems to generate
an immunomodulatory effect towards the activation of M2 macrophages, decreasing the presence of
FGBC and increasing osseointegration [10].
A growing number of studies report success based on therapies with metal ions such as
magnesium, strontium, calcium, among others. These ions can be incorporated into devices, in
order to promote osteogenesis coupled with a pro-regenerative immune response. For example,
the production of proinflammatory cytokines such as TNF-α, IL-1b, IL-6 and PEG2 has been shown
to be reduced in the presence of high concentrations of magnesium, which highlights its role as an
immunomodulatory ion [63].
The incorporation of immunomodulatory molecules to the implant constitutes another strategy
to modulate the immune response [12,52]. Inflammation could be controlled by the local release
of M2 polarizing cytokines such as IL-4, IL-10, IL-13 [64], or the implant could directly inhibit
proinflammatory signals, using anti-TNF-α therapy, which are the most potent proinflammatory
cytokines that promote the polarization of M1 macrophages [65]. The transcription factor NF-κB has
also been pointed out as a possible target to generate implant-mediated immunomodulation. It has
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been shown that NF-κB decoy can suppress the production of essential chemokines for the recruitment
of monocytes, which could avoid the presence of immune cells at the bone-implant interface [66].
In spite of the above-mentioned issues, the biology is more complex. The determination of the
appropriate time frame of immunomodulation is critical for optimizing their application. Acute phase
inflammation is crucial for proper bone repair after trauma, so the macrophage polarization status
also plays a critical role in bone regeneration. As such, the interplay between M1- and M2-dominated
microenvironments and the temporal modulation of the transition M1 to M2 provide an interesting line
of investigation to pursue new immune-modulatory therapies and improve bone repair and implant
integration [52]. One possible method is to utilize a controlled release system to maintain a short
period of M1, followed by a transition to M2 polarization via cytokines in a biphasic manner. However,
future investigations are necessary [67].
A new therapeutic approach to achieve modulation of the transition from M1 to M2 in the appropriate
timeframe could be the MSC of the host, given their innate immunomodulatory capabilities [68]. More
than 400 studies have explored the immunomodulatory effect of MSCs for the treatment of various
autoimmune conditions, including graft-versus-host disease, diabetes, multiple sclerosis, Crohn’s disease,
and organ transplantation [69]. In relation to this, a new hypothesis has recently been proposed, that the
HBMMSC residing around the peri-implant bone tissue immunomodulate the osseointegration process
through the ESWT bio-activation effect. The mechanical stimuli generated by ESWT trigger the release of
exosomes by HBMMSCs, generating tolerogenic dendritic cells (Tol-Dcs) and increasing the presence of
the M2 phenotype of the macrophage [14].
5. Coupling between Osseointegration and Mechanotransduction to Maintain FBE Long-Term
At present we know that osteogenesis does not depend only on the bone cells of the skeletal system,
in fact, there is a multicellular collaboration. Over years, studies have focused on the interaction between
bone cells and the material surface, however, now studies in the field of advanced bone materials should
involve co-culture systems with the interaction between materials, bone cells, and immune cells. Only then
will we know the real osteoimmunomodulatory capacity of the material [19]. However, the complexity
becomes even greater when we consider a fourth factor that can become important to maintain the
balance of the material-host relationship, the mechanical stimuli. Physical forces also play important
roles in embryonic development, tissue homeostasis, and pathogenesis. However, the importance
of mechanical signals to control cellular processes has only been recognized more recently. That is
why, as interest grows in the field of mechanobiology, new study models are developed to analyze the
influence of mechanical forces on cells and tissues [70,71].
The cells are sensitive to shear, tension and compression forces. These mechanical signals have
important effects on tissues, such as the production of ECM components [72]. A mechanical alteration
can influence gene expression and cellular behavior through the mechanotransduction signal [73].
These mechanical signals would be transmitted by the filaments of the cytoskeleton, such as actin
and microtubules, and finally transduced into biochemical signals [74], being the integrins of the cell
surface essential for mechanotransduction [75].
The therapeutic mechanotransduction is part of modern Implantology, in fact, good clinical results
obtained through progressive loading protocol [76] and immediate loading protocol [77,78], reveal
to us that physiological mechanical stimuli can be beneficial to accompany the osseointegration of a
dental implant and allow for successful osseointegration [79]. In this sense Duyck et al. demonstrated
through a bone chamber model in an animal model that mechanical stimuli are capable of increasing
the bone-implant contact (BIC) [80]. However, we also know that mechanical stimuli are key in bone
remodeling, so greater trauma can lead to implant failure [20].
At present, ESWT are widely used in the context of therapeutic mechanotransduction. ESWT
are supersonic waves, generated by different types of devices, such as electrohydraulic, piezoelectric,
electromechanical or pneumatic, which generate transient pressure changes that propagate through
the tissues where they are applied [81,82]. ESWT is applied to treat various medical pathologies.
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In orthopedics, it is used mainly in the treatment of tendinopathies, the treatment of nonunion in
fractures of long bones, avascular necrosis of the femoral head, chronic diabetics, nondiabetic ulcers and
ischemic heart disease [83]. In dentistry, ESWT has been used in extracorporeal lithotripsy of salivary
stones [84] and painful mielogelosis of the masseter [85]. Recently, Falkensammer et al. used ESWT as a
supplement in Orthodontics [86], finding an absence of deleterious effects in the maxillofacial tissues or
for pulpal vitality [87].
It has been proposed that the mechanical stimuli generated by ESWT produce an increase in the
permeability of the cell membrane, which triggers the release of cytoplasmic ribonucleic acid (RNA)
through an active process dependent on exosomes. This event at the cellular level is the one that would
produce the effects observed in the accelerated repair of tissues. However, more studies are needed to
completely reveal the underlying mechanism [88].
It seems that the bone is programmed to seal immediately any area affecting its integrity, sealing
and protecting the marrow content through the restoration of a cortical bone barrier. Therefore, we
can assume that the "raw materials" (phosphate, calcium, etc.) could be more available from a source
of cortical bone [4]. In this sense, it has been described that oral implants installed in low-density
bone tissue (bone type IV) present a higher risk of failure [89]. On the other hand, in patients with
osteoporosis, even though there is no difference described to date in the survival rate of oral implants
placed in patients with and without osteoporosis, there is an increase in peri-implant bone loss [90].
In orthopedics, it is a proven fact that the fixation of screws and osteosynthesis plates can be hindered
in patients with low bone mass and especially with thin cortices. In fact, in osteoporotic fractures,
depending on the location, the type of fracture and the surgery performed, the failure rate can reach
up to 30% [91]. In this sense, the anabolic effect on the bone described in several studies with the use
of ESWT has become particularly attractive [82,92].
Recent research shows that this anabolic bone response through ESWT can also be generated
in relation to titanium devices in bone, which could have great therapeutic potential, especially in
patients with bone disease. Koolen et al. demonstrated at the histological level that in bone defects
reconstructed with a titanium scaffold as a bone substitute show the de novo bone formation after
ESWT in rats [93]. In this same line of investigation, Koolen et al. [91] hypothesized that peri-operative
shock wave treatment can improve screw fixation and the osteointegration of cortical and cancellous
orthopedic screws, especially in osteoporotic patients. They were able to demonstrate in a healthy
rodent bones model, that an ESWT immediately after the implantation of titanium screws (Ti6Al4V
grade 5) improved screw fixation of the cortical screw, visualized by improved mechanical strength and
osseointegration. Another finding was the formation of a neocortex in some animals after treatment.
However, the cancellous screw showed no differences in testing after ESWT [91]. In this context, it has
been reported that the ESWT not only achieves complete bone healing, but has also been observed
to help in the re-attachment of a loose orthopedic screw. This has been observed in a patient with a
typical case of non-union treated with ESWT [94].
It has been suggested that these anabolic effects in the bone are due to the fact that shock waves
can cause the conversion of progenitor cells into osteogenic precursor cells. Another possibility could
be that ESWT induces osteocytic cell death through a mechanism called cavitation. This death of
osteocytes could lead to the stimulation of local bone remodeling, activating the osteoblast to produce
more osteoid, which could eventually lead to a neocortex [91]. I Osteocytes are important regulators of
cellular homeostasis and can act as mechanosensors. In addition, direct contact between dendrites
of the osteocytes and the implant surface has been reported after an 8-week osseointegration period
in an in vivo model [1]. However, the presence of HBMMSC and immune cells in the peri-implant
environment leads us to think that the ESWT could also have a potent immunomodulatory effect in
favor of osseointegration [14].
HBMMSC are not only found in the peri-implant environment, but also adhere to the titanium
surface [95]. Current evidence indicates that BMMSCs can modulate the immune response by inhibiting
polarization induced to M1 macrophages and promote polarization to M2 macrophages through the
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release of paracrine factors [96]. In addition, HBMMSCs can modulate the immune response through the
generation of Tol-DC [97]. This is why the fact that ESWT can act as an effective bioactivator on HBMMSC,
increasing its rate of growth, proliferation, migration and reducing apoptosis of these cells, suggests that
ESWT could be an adequate tool to express all the potential therapeutic effects of HBMMSC [98]. This
evidence suggests that the findings described in relation to ESWT and titanium [91,93,94] are probably a
product of the local immunomodulatory effect of HBMMSC [14].
Mechanical signals play an important role in the regulation of immunological and cellular
processes in monocytes, macrophages, and dendritic cells [70]. In this sense, recent studies have
investigated the anti-inflammatory effect of ESWT in ischemic lesions in the animal model. Scientists
have observed that ESWT would regulate the inflammatory reactions reducing the infiltration of
inflammatory cells and promoting the differentiation of the M2 macrophage, that is, through the
immunomodulation effect [99]. Apparently, the ESWT also exerts direct modulation on the macrophage.
It has been demonstrated that the stimulation of macrophages derived from human monocytes
with ESWT causes the significant inhibition of some M1 marker genes (CD80, COX2, CCL5) in M1
macrophages and a significant synergistic effect for some M2 marker genes (ALOX15, MRC1, CCL18)
in the M2 macrophages. It has also been observed that ESWT affected the production of cytokines and
chemokines, inducing, in particular, a significant increase in IL-10 and a reduction in the production of
IL-1β [100].
No doubt, infiltrating immune cells play an important role in determining the variable outcome of
wound repair in mammals and amphibians. For example, it has been demonstrated that the systemic
depletion of macrophages results in a permanent failure in the regenerative capacity of the axolotl, with
extensive fibrosis. However, the regenerative capacity of the axolotl is recovered once the macrophage
population is restored [101].
While the use of immunomodulatory implants per se (clean implants) generates adequate
osseointegration [55], the FBE can be altered under certain clinical conditions, such as overload [1,5,7].
The possibility that we can guide the transition between the M1 inflammatory phase and the
M2 anti-inflammatory phase through mechanotransduction makes ESWT a promising therapeutic
alternative to improve clinical success in oral implants, maintaining FBE long-term [14]. This could
potentially improve the feedback path to the sensory cortex since, as described, the capacity for tactile
perception of osseointegrated implants, "osseoperception", increases over time [102]. Furthermore, it
has also been proposed that the topical addition of the nerve growth factor (NGF) in oral implants
could help to improve this tactile sensitivity in order to minimize occlusal overload [103], and it has
been demonstrated that ESWT is effective in increasing the expression of NGF [104].
6. Concluding Remarks
Mechanotransduction can improve the implant-host relationship. However, it is necessary to
perform studies at the cellular and molecular level that would allow us to determine both the medical
device and the most effective therapeutic range. All of this is in order to improve, maintain and
recover the harmony of this triad of elements, i.e., bone cells, immune cells and implants, which finally
determines the fate of FBE.
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